Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Homme And NotG. Giovannoni

List of bibliographic references

Number of relevant bibliographic references: 2368.
Ident.Authors (with country if any)Title
000009 Maya Ando [Japon] ; Manabu Funayama [Japon] ; YUANZHE LI [Japon] ; Kenichi Kashihara [Japon] ; Yoshitake Murakami [Japon] ; Nobutaka Ishizu [Japon] ; Chizuko Toyoda [Japon] ; Katsuhiko Noguchi [Japon] ; Takashi Hashimoto [Japon] ; Naoki Nakano [Japon] ; Ryogen Sasaki [Japon] ; Yasumasa Kokubo [Japon] ; Shigeki Kuzuhara [Japon] ; Kotaro Ogaki [Japon] ; Chikara Yamashita [Japon] ; Hiroyo Yoshino [Japon] ; Taku Hatano [Japon] ; Hiroyuki Tomiyama [Japon] ; Nobutaka Hattori [Japon]VPS35 Mutation in Japanese Patients with Typical Parkinson's Disease
000032 Katsunobu Sugihara [Japon] ; Hirofumi Maruyama [Japon] ; Hiroyuki Morino [Japon] ; Ryosuke Miyamoto [Japon] ; Hiroki Ueno [Japon] ; Masayasu Matsumoto [Japon] ; Ryuji Kaji [Japon] ; Hiroshi Kitaguchi [Japon] ; Motohiro Yukitake [Japon] ; Yasuto Higashi [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Yuishin Izumi [Japon] ; Hideshi Kawakami [Japon]The Clinical Characteristics of Spinocerebellar Ataxia 36: A Study of 2121 Japanese Ataxia Patients
000053 Raymond S. Schwartz [Australie] ; Glenda M. Halliday [Australie] ; Dennis J. Cordato [Australie] ; Jillian J. Kril [Australie]Small-Vessel Disease in Patients with Parkinson's Disease: A Clinicopathological Study
000055 Hiroshi Furushima [Japon] ; Takayoshi Shimohata [Japon] ; Hideaki Nakayama [Japon] ; Tetsutaro Ozawa [Japon] ; Masaomi Chinushi [Japon] ; Yoshifusa Aizawa [Japon] ; Masatoyo Nishizawa [Japon]Significance and Usefulness of Heart Rate Variability in Patients with Multiple System Atrophy
000056 Ozlem Celebi [Turquie] ; Ca Gbreve N Mesut Temucin [Turquie] ; Bulent Elibol [Turquie] ; Esen Saka [Turquie]Short Latency Afferent Inhibition in Parkinson's Disease Patients with Dementia
000060 Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Miriam Bömelburg [Allemagne] ; Frank Marzinzik [Allemagne] ; Georg Ebersbach [Allemagne] ; Thomas Müller [Allemagne]Severe Gastrointestinal Complications in Patients With Levodopa/Carbidopa Intestinal Gel Infusion
000066 Yoshihiko Furusawa [Japon] ; Yohei Mukai [Japon] ; Yoko Kobayashi [Japon] ; Takashi Sakamoto [Japon] ; Miho Murata [Japon]Role of the External Oblique Muscle in Upper Camptocormia for Patients with Parkinson's Disease
000106 Michael S. Okun [États-Unis]Parkinson's Disease Patients Cannot Get Their Dopamine Replacement: The 8-Sinemet Limit
000120 Julia Richter [Allemagne] ; Silke Appenzeller [Allemagne] ; Ole Ammerpohl [Allemagne] ; G. Deuschl [Allemagne] ; Steffen Paschen [Allemagne] ; Norbert Brüggemann [Allemagne] ; Christine Klein [Allemagne] ; Gregor Kuhlenb Umer [Allemagne]No Evidence for Differential Methylation of α-Synuclein in Leukocyte DNA of Parkinson's Disease Patients
000125 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Domenico Errico [Italie] ; Marianna Amboni [Italie] ; Anna Maria Barbarulo [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]Neuropsychological Correlates of Theory of Mind in Patients with Early Parkinson's Disease
000149 Vinko Palada [Allemagne] ; Sandra Stiern [Allemagne] ; Nicola Glockle [Allemagne] ; Pilar Gomez-Garre [Espagne] ; Fatima Carrillo [Espagne] ; Pablo Mir [Espagne] ; Krzysztof Szczaluba [Pologne] ; Michele Tinazzi [Italie] ; Domenico Ajena [Italie] ; Marta Romani [Italie] ; Enza Maria Valente [Italie] ; Ulrich Müller [Allemagne] ; Peter Bauer [Allemagne] ; Olaf Riess [Allemagne] ; Thomas Ott [Allemagne] ; Kathrin Grundmann [Allemagne]Lack of Sequence Variations in THAP1 Gene and THAP1-Binding Sites in TOR1A Promoter of DYT1 Patients
000152 Heike Stockner [Autriche] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Atbin Djamshidian [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Petra Katschnig [Royaume-Uni, Autriche] ; Klaus Seppi [Autriche] ; John Dickson [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; Kailash P. Bhatia [Royaume-Uni]Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
000158 Christian R. Baumann [Suisse] ; Lukas L. Imbach [Suisse] ; Heide Baumann-Vogel [Suisse] ; Mechtild Uhl [Suisse] ; Johannes Sarnthein [Suisse] ; Oguzkan Sürücü [Suisse]Interleaving Deep Brain Stimulation for a Patient With Both Parkinson's Disease and Essential Tremor
000160 Tanja Schmitz-Hübsch [Allemagne] ; Oleksandr Eckert [Allemagne] ; Uwe Schlegel [Allemagne] ; Thomas Klockgether [Allemagne] ; Sabine Skodda [Allemagne]Instability of Syllable Repetition in Patients with Spinocerebellar Ataxia and Parkinson's Disease
000163 Ivan Rektor [République tchèque] ; David Goldemund [République tchèque] ; Petr Bednarik [République tchèque] ; Katerina Sheardova [République tchèque] ; Zuzana Michalkova [République tchèque] ; Sabina Telecka [République tchèque] ; Michal Dufek [République tchèque] ; Irena Rektorova [République tchèque]Impairment of Brain Vessels May Contribute to Mortality in Patients With Parkinson's Disease
000171 Alisdair Mcneill [Royaume-Uni] ; Raquel Duran [Royaume-Uni] ; Christos Proukakis [Royaume-Uni] ; Jose Bras [Royaume-Uni] ; Derralyn Hughes [Royaume-Uni] ; Atuhl Mehta [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni]Hyposmia and Cognitive Impairment in Gaucher Disease Patients and Carriers
000173 Jorge Luis Guerrero Camacho [Mexique] ; Nancy Monroy Jaramillo [Mexique] ; Petra Yescas Gomez [Mexique] ; Mayela Rodriguez Violante [Mexique] ; Catherine Boll Woehrlen [Mexique] ; Ma. Elisa Alonso Vilatela [Mexique] ; Marisol Lopez Lopez [Mexique]High Frequency of Parkin Exon Rearrangements in Mexican-Mestizo Patients with Early-Onset Parkinson's Disease
000179 Megumi Shimizu [Japon] ; Yukihisa Suzuki [Japon] ; Motohiro Kiyosawa [Japon] ; Masato Wakakura [Japon] ; Kenji Ishii [Japon] ; Kiichi Ishiwata [Japon] ; Manabu Mochizuki [Japon]Glucose Hypermetabolism in the Thalamus of Patients with Hemifacial Spasm
000188 Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Luigi Luppariello [Italie] ; Ilaria Lista [Italie] ; Riccardo Tranfaglia [Italie] ; Alfonso Fasano [Italie] ; Marina Picillo [Italie] ; Carmine Vitale [Italie] ; Gabriella Santangelo [Italie] ; Valeria Agosti [Italie] ; Alessandro Lavarone [Italie] ; Giuseppe Sorrentino [Italie]Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment
000195 Giovanni Defazio [Italie] ; Giovanni Abbruzzese [Italie] ; Maria Stella Aniello [Italie] ; Roberta Di Fede [Italie] ; Marcello Esposito [Italie] ; Giovanni Fabbrini [Italie] ; Paolo Girlanda [Italie] ; Rocco Liguori [Italie] ; Lucio Marinelli [Italie] ; Davide Martino [Italie] ; Francesca Morgante [Italie] ; Lucio Santoro [Italie] ; Michele Tinazzi [Italie] ; Alfredo Berardelli [Italie]Eye Symptoms in Relatives of Patients with Primary Adult-Onset Dystonia
000204 Jennifer G. Goldman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Bryan Bernard [États-Unis] ; Travis R. Stoub [États-Unis] ; Christopher G. Goetz [États-Unis] ; Leyla Detoledo-Morrell [États-Unis]Entorhinal Cortex Atrophy Differentiates Parkinson's Disease Patients With and Without Dementia
000205 Wolf-Julian Neumann [Allemagne] ; Julius Huebl [Allemagne] ; Christof Brucke [Allemagne] ; Maria Herrojo Ruiz [Allemagne] ; Andreas Kupsch [Allemagne] ; Gerd-Helge Schneider [Allemagne] ; Andrea A. Kuhn [Allemagne]Enhanced Low-Frequency Oscillatory Activity of the Subthalamic Nucleus in a Patient with Dystonia
000218 Jinyoung Youn [Corée du Sud] ; JIN WHAN CHO [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; Gyeong-Moon Kim [Corée du Sud] ; SUNG TAE KIM [Corée du Sud] ; Hee-Tae Kim [Corée du Sud]Diffusion Tensor Imaging of Freezing of Gait in Patients with White Matter Changes
000221 Francesca Morgante [Italie] ; Mark J. Edwards [Royaume-Uni] ; Alberto J. Espay [États-Unis] ; Alfonso Fasano [Italie] ; Pablo Mir [Espagne] ; Davide Martino [Italie, Royaume-Uni]Diagnostic Agreement in Patients with Psychogenic Movement Disorders
000229 Atbin Djamshidian [Royaume-Uni] ; Sean S. O'Sullivan [Royaume-Uni] ; Yanosh Sanotsky [Ukraine] ; Stephen Sharman [Royaume-Uni] ; Yuriy Matviyenko [Ukraine] ; Thomas Foltynie [Royaume-Uni] ; Rosanna Michalczuk [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Ludmyla Fedoryshyn [Ukraine] ; Karen M. Doherty [Royaume-Uni] ; Yuriy Filts [Ukraine] ; Marianna Selikhova [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Eileen Joyce [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Bruno B. Averbeck [Royaume-Uni, États-Unis]Decision Making, Impulsivity, and Addictions: Do Parkinson's Disease Patients Jump to Conclusions?
000244 Elisabeth Ruppert [France] ; Benjamin Cretin [France] ; Christelle Meyer [France] ; Ulker Kilic-Huck [France] ; Patrice Bourgin [France]Characterization of Periodic Upper Limb Movement Disorder in a Patient With Restless Arms Syndrome
000255 Natalia Palacios [États-Unis] ; XIANG GAO [États-Unis] ; Marjorie L. Mccullough [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Roma Shah [États-Unis] ; Susan Gapstur [États-Unis] ; Alberto Ascherio [États-Unis]Caffeine and Risk of Parkinson's Disease in a Large Cohort of Men and Women
000263 Holly A. Shill [États-Unis] ; Charles H. Adler [États-Unis] ; Thomas G. Beach [États-Unis] ; Lih-Fen Lue [États-Unis] ; John N. Caviness [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Lucia I. Sue [États-Unis] ; Douglas G. Walker [États-Unis]Brain Biochemistry in Autopsied Patients with Essential Tremor
000268 Hans-Holger Capelle [Allemagne] ; Christian Blahak [Allemagne] ; Christoph Schrader [Allemagne] ; Hansjorg Baezner [Allemagne] ; Marwan I. Hariz [Suède, Royaume-Uni] ; Tommy Bergenheim [Suède] ; Joachim K. Krauss [Allemagne]Bilateral Deep Brain Stimulation for Cervical Dystonia in Patients with Previous Peripheral Surgery
000286 Elena V. Semenova [Russie] ; Maria I. Shadrina [Russie] ; Pyotr A. Slominsky [Russie] ; Irina A. Ivanova-Smolenskaya [Russie] ; Gulbakhar Bagyeva [Russie] ; Sergei N. Illarioshkin [Russie] ; Svetlana A. Limborska [Russie]Analysis of PARK2 Gene Exon Rearrangements in Russian Patients with Sporadic Parkinson's Disease
000289 Natalia Palacios [États-Unis] ; XIANG GAO [États-Unis] ; Eilis O'Reilly [États-Unis] ; Michael Schwarzschild [États-Unis] ; Marjorie L. Mccullough [États-Unis] ; Tinisha Mayo [États-Unis] ; Susan M. Gapstur [États-Unis] ; Alberto A. Ascherio [États-Unis]Alcohol and Risk of Parkinson's Disease in a Large, Prospective Cohort of Men and Women
000295 Esteban Pena [Espagne] ; Cristina Fernandez [Espagne]Abnormal DAT SCAN in a Patient with Parkinsonism after a Midbrain Ischemic Lesion
000300 Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse]A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients
000302 Wooyoung Jang [Corée du Sud] ; HYUK SUNG KWON [Corée du Sud] ; Joong-Seok Kim [Corée du Sud] ; JIN HWAN CHO [Corée du Sud] ; Hee-Tae Kim [Corée du Sud]A Parkinson's Disease Patient with Camptocormia Caused by an Esophageal Hiatal Hernia
000303 Rosa Guerrero-Lopez [Espagne] ; Pedro J. Garcia-Ruiz [Espagne] ; Beatriz G. Giraldez [Espagne] ; Carmen Duran-Herrera [Espagne] ; Maria Rosa Querol-Pascual [Espagne] ; Jose Maria Ramirez-Moreno [Espagne] ; Sebastian Mas [Espagne] ; Jose M. Serratosa [Espagne]A New SCARB2 Mutation in a Patient With Progressive Myoclonus Ataxia Without Renal Failure
000310 Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France]A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale
000326 Carmine Vitale [Italie] ; Vincenzo Marcelli [Italie] ; Teresa Furia [Italie] ; Gabriella Santangelo [Italie] ; Autilia Cozzolino [Italie] ; Katia Longo [Italie] ; Roberto Allocca [Italie] ; Marianna Amboni [Italie] ; Elio Marciano [Italie] ; Paolo Barone [Italie]Vestibular Impairment and Adaptive Postural Imbalance in Parkinsonian Patients with Lateral Trunk Flexion
000328 Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada]Ventricular Dilatation and Brain Atrophy in Patients with Parkinson's Disease with Incipient Dementia
000333 Ji E. Lee [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]Uric Acid as a Potential Disease Modifier in Patients with Multiple System Atrophy
000341 Francisco Grandas [Espagne] ; Carlos Fernandez-Carballal [Espagne] ; Juan Guzman-De-Villoria [Espagne] ; Israel Ampuero [Espagne]Treatment of a Dystonic Storm With Pallidal Stimulation in a Patient With PANK2 Mutation
000349 James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease
000350 Hana Srovnalova [République tchèque] ; Radek Marecek [République tchèque] ; Irena Rektorova [République tchèque]The Role of the Inferior Frontal Gyri in Cognitive Processing of Patients with Parkinson's Disease: A Pilot rTMS Study
000351 Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Steen Hvitfeldt Poulsen [Danemark]The Risk of Valvular Regurgitation in Patients with Parkinson's Disease Treated with Dopamine Receptor Agonists
000353 Magdalena Eriksson Domellöf [Suède] ; Eva Elgh [Suède] ; Lars Forsgren [Suède]The Relation Between Cognition and Motor Dysfunction in Drug-Naive Newly Diagnosed Patients with Parkinson's Disease
000355 Sook K. Song [Corée du Sud] ; Ji E. Lee [Corée du Sud] ; Hae-Jeong Park [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; JONG DOO LEE [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]The Pattern of Cortical Atrophy in Patients with Parkinson's Disease According to Cognitive Status
000356 Alexandra Gaenslen [Allemagne] ; Irene Swid [Allemagne] ; Inga Liepelt-Scarfone [Allemagne] ; Jana Godau [Allemagne] ; Daniela Berg [Allemagne]The Patients' Perception of Prodromal Symptoms Before the Initial Diagnosis of Parkinson's Disease
000367 Chiara Criscuolo [Pays-Bas, Italie] ; Anna De Rosa [Italie] ; Anna Guacci [Italie] ; Erik J. Simons [Pays-Bas] ; Guido J. Breedveld [Pays-Bas] ; Silvio Peluso [Italie] ; Giampiero Volpe [Italie] ; Alessandro Filla [Italie] ; Ben A. Oostra [Pays-Bas] ; Vincenzo Bonifati [Pays-Bas] ; Giuseppe De Michele [Italie]The LRRK2 R1441 C Mutation is More Frequent Than G2019S in Parkinson's Disease Patients from Southern Italy
000369 Pablo Martinez-Martin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Monica M. Kurtis [Espagne] ; K. Ray Chaudhuri [Royaume-Uni]The Impact of Non-Motor Symptoms on Health-Related Quality of Life of Patients with Parkinson's Disease
000370 Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; Pinar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
000377 Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis]Thalamic Neuronal and EMG Activity in Psychogenic Dystonia Compared with Organic Dystonia
000382 YI GUO [République populaire de Chine] ; Wei-Dong Le [États-Unis] ; Joseph Jankovic [États-Unis] ; Hua-Rong Yang [République populaire de Chine] ; Hong-Bo Xu [République populaire de Chine] ; Wen-Jie Xie [États-Unis] ; ZHI SONG [République populaire de Chine] ; HAO DENG [République populaire de Chine, États-Unis]Systematic Genetic Analysis of the PITX3 Gene in Patients with Parkinson Disease
000385 Han-Joon Kim [Corée du Sud] ; Beom S. Jeon [Corée du Sud] ; Jee-Young Lee [Corée du Sud] ; JI YOUNG YUN [Corée du Sud]Survival of Korean Patients with Multiple System Atrophy
000395 Alessandra Scontrini [Italie] ; Antonella Conte [Italie] ; Giovanni Fabbrini [Italie] ; Carlo Colosimo [Italie] ; Flavio Di Stasio [Italie] ; Gina Ferrazzano [Italie] ; Alfredo Berardelli [Italie]Somatosensory Temporal Discrimination Tested in Patients Receiving Botulinum Toxin Injection for Cervical Dystonia
000402 Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada]Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion
000404 Jonas Alex Morales Saute [Brésil] ; Andrew Chaves Feitosa Da Silva [Brésil] ; Alexandre Pastoris Muller [Brésil] ; Gisele Hansel [Brésil] ; Alexandre Silva De Mello [Brésil] ; Fábio Maeda [Brésil] ; Leonardo Vedolin [Brésil] ; Maria Luiza Saraiva-Pereira [Brésil] ; Diogo Onofre Souza [Brésil] ; Javier Arpa [Espagne] ; Ignacio Torres-Aleman [Espagne] ; Luis Valmor Cruz Portela [Brésil] ; Laura Bannach Jardim [Brésil]Serum Insulin-Like System Alterations in Patients with Spinocerebellar Ataxia Type 3
000405 Beth A. Belluscio [États-Unis] ; LILY JIN [États-Unis] ; Veronica Watters [États-Unis] ; Tiffany H. Lee [États-Unis] ; Mark Hallett [États-Unis]Sensory Sensitivity to External Stimuli in Tourette Syndrome Patients
000415 Alfonso Fasano [Italie] ; Alessandro Di Matteo [Italie] ; Carmine Vitale [Italie] ; Giovanna Squintani [Italie] ; Laura Ferigo [Italie] ; Federica Bombieri [Italie] ; Gabriella Santangelo [Italie] ; Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Michele Tinazzi [Italie]Reversible Pisa Syndrome in Patients with Parkinson's Disease on Rasagiline Therapy
000428 John W. Winkelman [États-Unis] ; Richard K. Bogan [États-Unis] ; Markus H. Schmidt [États-Unis] ; John D. Hudson [États-Unis] ; Sarah E. Derossett [États-Unis] ; Christina E. Hill-Zabala [États-Unis]Randomized Polysomnography Study of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome
000432 Marina Svetel [Serbie] ; Tatjana Pekmezovic [Serbie] ; Aleksandra Tomic [Serbie] ; Nikola Kresojevic [Serbie] ; Aleksandra Potrebic [Serbie] ; Rada Jesic [Serbie] ; Vladimir S. Kostic [Serbie]Quality of Life in Patients with Treated and Clinically Stable Wilson's Disease
000452 Gun-Marie Hariz [Suède] ; Patricia Limousin [Royaume-Uni] ; Stephen Tisch [Australie] ; Marjan Jahanshahi [Royaume-Uni] ; Anncristine Fjellman-Wiklund [Suède]Patients' Perceptions of Life Shift After Deep Brain Stimulation for Primary Dystonia-A Qualitative Study
000453 Phillip Fletcher [Royaume-Uni] ; Alison Leake [Royaume-Uni] ; Marie-Helene Marion [Royaume-Uni]Patients with Parkinson's Disease Dementia Stay in the Hospital Twice as Long as Those without Dementia
000454 Marcus M. Unger [Allemagne] ; Jens C. Möller [Allemagne] ; Katharina Mankel [Allemagne] ; Katrin Schmittinger [Allemagne] ; Karla M. Eggert [Allemagne] ; Maria Stamelou [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Katharina Bohne [Allemagne] ; Maren Bodden [Allemagne] ; Geert Mayer [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes J. Tebbe [Allemagne]Patients with Idiopathic Rapid-Eye-Movement Sleep Behavior Disorder Show Normal Gastric Motility Assessed by the 13C-Octanoate Breath Test
000456 Roberto Cilia [Canada, Italie] ; SANG SOO CHO [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; JI HYUN KO [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada]Pathological Gambling in Patients with Parkinson's Disease is Associated with Fronto-Striatal Disconnection: A Path Modeling Analysis
000469 Salima Assami [Algérie] ; Hamid Azzedine [France] ; Sonia Nouioua [Algérie] ; Emeline Mundwiller [France] ; Soulaiman Mahoui [Algérie] ; Samira Makri ; Meriam Djemai [Algérie] ; Djamel Grid [France] ; Alexis Brice [France] ; Tarik Hamadouche [Algérie] ; Giovanni Stevanin [France] ; Meriem Tazir [Algérie]Pantothenate Kinase-Associated Neurodegeneration: Clinical Description of 10 Patients and Identification of New Mutations
000474 Avigayil Ribner [Israël] ; Gheona Altarescu [Israël] ; Ari Zimran [Israël] ; Deborah Elstein [Israël]Osteopontin Polymorphic Susceptibility Factor for Parkinson's Disease Among Patients with Gaucher Disease
000477 Claudia Wenzel [Allemagne] ; Ulrich Wurster [Allemagne] ; Kirsten R. Müller-Vahl [Allemagne]Oligoclonal Bands in Cerebrospinal Fluid in Patients with Tourette's Syndrome
000480 Malene Flensborg Damholdt [Danemark] ; Per Borghammer [Danemark] ; Lars Larsen [Danemark] ; Karen Stergaard [Danemark]Odor Identification Deficits Identify Parkinson's Disease Patients with Poor Cognitive Performance
000499 Miryam Carecchio [Royaume-Uni, Italie] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; HEIDI CHAN [Royaume-Uni] ; Robin Lachmann [Royaume-Uni] ; Philip J. Lee [Royaume-Uni] ; Elaine Murphy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Movement Disorders in Adult Surviving Patients with Maple Syrup Urine Disease
000527 Giulia Longoni [Italie] ; Federica Agosta [Italie] ; Vladimir S. Kostic [Serbie] ; Tanja Stojkovic [Serbie] ; Elisabetta Pagani [Italie] ; Tatjana Stosic-Opincal [Serbie] ; Massimo Filippi [Italie]MRI Measurements of Brainstem Structures in Patients with Richardson's Syndrome, Progressive Supranuclear Palsy-Parkinsonism, and Parkinson's Disease
000530 Andrea Ciammola [Italie] ; Jenny Sassone [Italie] ; Monica Sciacco [Italie] ; Niccol E. Mencacci [Italie] ; Michela Ripolone [Italie] ; Caterina Bizzi [Italie] ; Clarissa Colciago [Italie] ; Maurizio Moggio [Italie] ; Gianfranco Parati [Italie] ; Vincenzo Silani [Italie] ; Gabriella Malfatto [Italie]Low Anaerobic Threshold and Increased Skeletal Muscle Lactate Production in Subjects with Huntington's Disease
000531 Inga Suttrup [Allemagne] ; Denise Oberdiek [Allemagne] ; Judith Suttrup [Allemagne] ; Nani Osada [Allemagne] ; Stefan Evers [Allemagne] ; Martin Marziniak [Allemagne]Loss of Sensory Function in Patients with Idiopathic Hand Dystonia
000532 Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Frances [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France]Long-Term Outcome of 32 Patients With Chorea and Systemic Lupus Erythematosus or Antiphospholipid Antibodies
000537 Mathias Toft [Norvège] ; Bard Lilleeng [Norvège] ; Jon Ramm-Pettersen [Norvège] ; Inger Marie Skogseid [Norvège] ; Vidar Gundersen [Norvège] ; Remo Gerdts [Norvège] ; Lena Pedersen [Norvège] ; Mona Skjelland [Norvège] ; Geir Ketil R Ste [Norvège] ; Espen Dietrichs [Norvège]Long-Term Efficacy and Mortality in Parkinson's Disease Patients Treated with Subthalamic Stimulation
000551 Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Frank Marzinzik [Allemagne]Jejunal Levodopa Infusion in Long-Term DBS Patients with Parkinson's Disease
000553 Giovanna Zorzi [Italie] ; Federica Zibordi [Italie] ; Luisa Chiapparini [Italie] ; Enrico Bertini [Italie] ; Lidia Russo [Italie] ; Antonio Piga [Italie] ; Filomena Longo [Italie] ; Barbara Garavaglia [Italie] ; Domenico Aquino [Italie] ; Mario Savoiardo [Italie] ; Alessandra Solari [Italie] ; Nardo Nardocci [Italie]Iron-Related MRI Images in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deferiprone: Results of a Phase II Pilot Trial
000563 Ho-Won Lee [Corée du Sud] ; Jihye Choi [Corée du Sud] ; Kyoungho Suk [Corée du Sud]Increases of Pentraxin 3 Plasma Levels in Patients with Parkinson's Disease
000565 Jarosław Marusiak [Pologne] ; Anna Jaskolska [Pologne] ; Sławomir Budrewicz [Pologne] ; Magdalena Koszewicz [Pologne] ; Artur Jaskolski [Pologne]Increased Muscle Belly and Tendon Stiffness in Patients with Parkinson's Disease, as Measured by Myotonometry
000568 Meng-Ting Wang [Taïwan] ; Pei-Wen Lian [Taïwan] ; Chin-Bin Yeh [Taïwan] ; Che-Hung Yen [Taïwan] ; Kao-Hsing Ma [Taïwan] ; Agnes L. F. Chan [Taïwan]Incidence, Prescription Patterns, and Determinants of Antipsychotic Use in Patients with Parkinson's Disease
000570 Angelo Antonini [Italie] ; Chiara Siri [Italie] ; Gabriella Santangelo [Italie] ; Roberto Cilia [Italie] ; Michele Poletti [Italie] ; Margherita Canesi [Italie] ; Alessandra Caporali [Italie] ; Francesca Mancini [Italie] ; Gianni Pezzoli [Italie] ; Roberto Ceravolo [Italie] ; Ubaldo Bonuccelli [Italie] ; Paolo Barone [Italie]Impulsivity and Compulsivity in Drug-Naïve Patients with Parkinson's Disease
000572 Mark J. Edwards [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Carla Cordivari [Royaume-Uni]Immediate Response to Botulinum Toxin Injections in Patients with Fixed Dystonia
000581 Maria Sierra [Espagne] ; Isabel Gonzalez-Aramburu [Espagne] ; Pascual Sanchez-Juan [Espagne] ; Coro Sanchez-Quintana [Espagne] ; Jose Miguel Polo [Espagne] ; Jose Berciano [Espagne] ; Onofre Combarros [Espagne] ; Jon Infante [Espagne]High Frequency and Reduced Penetrance of LRRK2 G2019S Mutation Among Parkinson's Disease Patients in Cantabria (Spain)
000584 Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni]Health-Related Quality-of-Life Scales in Parkinson's Disease: Critique and Recommendations
000592 Omar S. Mian [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Kailash P. Bhatia [Royaume-Uni] ; Brian L. Day [Royaume-Uni]Gait in SWEDDs Patients: Comparison with Parkinson's Disease Patients and Healthy Controls
000603 Adam Rosenblatt [États-Unis] ; Brahma V. Kumar [États-Unis] ; Russell L. Margolis [États-Unis] ; Claire S. Welsh [États-Unis] ; Christopher A. Ross [États-Unis]Factors Contributing to Institutionalization in Patients with Huntington's Disease
000605 Deborah A. Hall [États-Unis] ; Elizabeth Berry-Kravis [États-Unis] ; WENTING ZHANG [États-Unis] ; Flora Tassone [États-Unis] ; Elaine Spector [États-Unis] ; Gary Zerbe [États-Unis] ; Paul J. Hagerman [États-Unis] ; Bichun Ouyang [États-Unis] ; Maureen A. Leehey [États-Unis]FMR1 Gray-Zone Alleles: Association with Parkinson's Disease in Women?
000617 Giovanni Albani [Italie] ; Nadia El Assawy [Italie] ; Stefania Cattaldo [Italie] ; Marilena De Gennaro [Italie] ; Francesca Gregorini [Italie] ; Luca Pradotto [Italie] ; Alessandro Mauro [Italie]Electrogastrographyc Activity in Parkinson's Disease Patients With and Without Motor Fluctuations
000619 Richard A. Walsh [Canada] ; Anthony E. Lang [Canada]Early-Onset Tardive Dyskinesia in a Neuroleptic-Naive Patient Exposed to Low-Dose Quetiapine
000624 Tahir Nazir [Royaume-Uni] ; Alexander M. Thomson [Royaume-Uni]Domestic Violence and Mistreatment in Patients with Parkinsonism: Case Reports, Mechanisms, and Discussion
000629 Zang-Hee Cho [Corée du Sud] ; Se-Hong Oh [Corée du Sud] ; Jong-Min Kim [Corée du Sud] ; Sung-Yeon Park [Corée du Sud] ; Dae-Hyuk Kwon [Corée du Sud] ; Hye-Jin Jeong [Corée du Sud] ; Young-Bo Kim [Corée du Sud] ; Je-Geun Chi [Corée du Sud] ; Chan-Woong Park [Corée du Sud] ; John Iii Huston [États-Unis] ; Kendall H. Lee [États-Unis] ; Beom S. Jeon [Corée du Sud]Direct Visualization of Parkinson's Disease by In Vivo Human Brain Imaging Using 7.0T Magnetic Resonance Imaging
000641 Aida Ormazabal [Espagne] ; Mercedes Serrano [Espagne] ; Angels Garcia-Cazorla [Espagne] ; Jaume Campistol [Espagne] ; Rafael Artuch [Espagne] ; Pedro Castro De Castro [Espagne] ; Estíbaliz Barredo-Valderrama [Espagne] ; Judith Armstrong [Espagne] ; Claudio Toma [Espagne] ; Bru Cormand [Espagne]Deletion in the Tyrosine Hydroxylase Gene in a Patient with a Mild Phenotype
000643 Diane Ruge [Royaume-Uni] ; Stephen Tisch [Royaume-Uni, Australie] ; Marwan I. Hariz [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni]Deep Brain Stimulation Effects in Dystonia: Time Course of Electrophysiological Changes in Early Treatment
000645 Helen Ling [Royaume-Uni] ; Mark Braschinsky [Estonie] ; Pille Taba [Estonie] ; Siiri-Merike Luus [Estonie] ; Karen Doherty [Royaume-Uni] ; Anna Hotter [Autriche] ; Werner Poewe [Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]Decades of Delayed Diagnosis in 4 Levodopa-Responsive Young-Onset Monogenetic Parkinsonism Patients
000648 Thomas Müller [Allemagne] ; Siegfried Muhlack [Allemagne]Cysteinyl-Glycine Reduction as Marker for Levodopa-Induced Oxidative Stress in Parkinson's Disease Patients
000650 José L. Garcia-Gimenez [Espagne] ; Fabián Sanchis-Gomar [Espagne] ; Federico V. Pallardo [Espagne]Could Thiazolidinediones Increase the Risk of Heart Failure in Friedreich's Ataxia Patients?
000651 Hiroki Nishibayashi [Japon] ; Mitsuhiro Ogura [Japon] ; Koji Kakishita [Japon] ; Satoshi Tanaka [Japon] ; Yoshihisa Tachibana [Japon] ; Atsushi Nambu [Japon] ; Hitoshi Kita [États-Unis] ; Toru Itakura [Japon]Cortically Evoked Responses of Human Pallidal Neurons Recorded During Stereotactic Neurosurgery
000665 Thomas Opladen [Allemagne] ; Georg Hoffmann [Allemagne] ; Friederike Hörster [Allemagne] ; Anne-B Rbel Hinz [Allemagne] ; Katharina Neidhardt [Allemagne] ; Christine Klein [Allemagne] ; Nicole Wolf [Pays-Bas]Clinical and Biochemical Characterization of Patients with Early Infantile Onset of Autosomal Recessive GTP Cyclohydrolase I Deficiency without Hyperphenylalaninemia
000667 Oliver H. H. Gerlach [Pays-Bas] ; Ania Winogrodzka [Pays-Bas] ; Wim E. J. Weber [Pays-Bas]Clinical Problems in the Hospitalized Parkinson's Disease Patient: Systematic Review
000676 Daniel Weiss [Allemagne] ; Rathinaswamy B. Govindan [États-Unis] ; Albrecht Rilk [Allemagne] ; Tobias Wachter [Allemagne] ; Sorin Breit [Allemagne] ; Leopold Zizlsperger [Allemagne] ; Thomas Haarmeier [Allemagne] ; Christian Plewnia [Allemagne] ; Rejko Kruger [Allemagne] ; Alireza Gharabaghi [Allemagne]Central Oscillators in a Patient with Neuropathic Tremor: Evidence from Intraoperative Local Field Potential Recordings
000677 Ferdinando Squitieri [Italie] ; Mouna Esmaeilzadeh [Suède] ; Andrea Ciarmiello [Italie] ; Joseph Jankovic [États-Unis]Caudate Glucose Hypometabolism in a Subject Carrying an Unstable Allele of Intermediate CAG33 Repeat Length in the Huntington's Disease Gene
000680 Yasumasa Kokubo [Japon] ; Satoru Morimot [Japon] ; Akihiro Shindo [Japon] ; Yoshihumi Hirokawa [Japon] ; Taizo Shiraishi [Japon] ; Yuko Saito [Japon] ; Shigeo Murayama [Japon] ; Shigeki Kuzuhara [Japon]Cardiac 123I-Metalodobenzylguanidine Scintigraphy and Lewy Body Pathology in a Patient with Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex of Kii, Japan
000681 Nin P. S. Bajaj [Royaume-Uni] ; Maria Knöbel [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]Can Spiral Analysis Predict the FP-CIT SPECT Scan Result in Tremulous Patients?
000682 Morinobu Seki [Japon] ; Kazushi Takahashi [Japon] ; Atsuo Koto [Japon] ; Ban Mihara [Japon] ; Yoko Morita [Japon] ; Kazuo Isozumi [Japon] ; Kouichi Ohta [Japon] ; Kazuhiro Muramatsu [Japon] ; Jun Gotoh [Japon] ; Keiji Yamaguchi [Japon] ; Yutaka Tomita [Japon] ; Hideki Sato [Japon] ; Yoshihiro Nihei [Japon] ; Satoko Iwasawa [Japon] ; Norihiro Suzuki [Japon]Camptocormia in Japanese Patients with Parkinson's Disease: a Multicenter Study
000691 Maja Kojovic [Royaume-Uni, Slovénie] ; Antonio Caronni [Royaume-Uni, Italie] ; Matteo Bologna [Royaume-Uni, Italie] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni]Botulinum Toxin Injections Reduce Associative Plasticity in Patients with Primary Dystonia
000692 Arianna Guidubaldi [Italie] ; Alfonso Fasano [Italie] ; Tamara Lalongo [Italie] ; Carla Piano [Italie] ; Maurizio Pompili [Italie] ; Roberta Masciana [Italie] ; Luisa Siciliani [Italie] ; Mario Sabatelli [Italie] ; Anna Rita Bentivoglio [Italie]Botulinum Toxin A Versus B in Sialorrhea: A Prospective, Randomized, Double-Blind, Crossover Pilot Study in Patients with Amyotrophic Lateral Sclerosis or Parkinson's Disease
000719 Dimitri Anastasopoulos [Royaume-Uni, Grèce] ; Nafsica Ziavra [Royaume-Uni] ; Eugenia Sawidou [Grèce] ; Peter Bain [Royaume-Uni] ; Adolfo M. Bronstein [Royaume-Uni]Altered Eye-to-Foot Coordination in Standing Parkinsonian Patients During Large Gaze and Whole-Body Reorientations
000720 Maria Graciela Cersosimo [Argentine] ; Claudia Perandones [Argentine] ; Federico Eduardo Micheli [Argentine] ; Gabriela Beatriz Raina [Argentine] ; Ana Maria Beron [Argentine] ; Gustavo Nasswetter [Argentine] ; Martin Radrizzani [Argentine] ; Eduardo Elias Benarroch [États-Unis]Alpha-Synuclein Immunoreactivity in Minor Salivary Gland Biopsies of Parkinson's Disease Patients
000721 Carsten Eggers [Allemagne] ; Deniz Kahraman [Allemagne] ; Gereon R. Fink [Allemagne] ; Matthias Schmidt [Allemagne] ; Lars Timmermann [Allemagne]Akinetic-Rigid and Tremor-Dominant Parkinson's Disease Patients Show Different Patterns of FP-CIT Single Photon Emission Computed Tomography
000722 Marcelo Chouza [Espagne] ; Pablo Arias [Espagne] ; Susana Vinas [Espagne] ; Javier Cudeiro [Espagne]Acute Effects of Whole-Body Vibration at 3, 6, and 9 Hz on Balance and Gait in Patients with Parkinson's Disease
000730 Catherine L. Gallagher [États-Unis] ; Bradley T. Christian [États-Unis] ; James E. Holden [États-Unis] ; Onofre T. Dejesus [États-Unis] ; Robert J. Nickles [États-Unis] ; Laura Buyan-Dent [États-Unis] ; Barbara B. Bendlin [États-Unis] ; Sandra J. Harding [États-Unis] ; Charles K. Stone [États-Unis] ; Barb Mueller [États-Unis] ; Sterling C. Johnson [États-Unis]A Within-Subject Comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson's Disease
000733 Samar S. Ayache [France] ; Rechdi Ahdab [France] ; Pierre Brugieres [France] ; Jean-François Ejzenbaum [France] ; François-Jérôme Authier [France] ; Gilles Fenelon [France] ; Jean-Pascal Lefaucheur [France]A Reappraisal of Long-Latency Abdominal Muscle Reflexes in Patients with Propriospinal Myoclonus
000741 E. H. Reynolds [Royaume-Uni] ; D. G. Healy [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]A Film of Patients with Movement Disorders Made in Queen Square, London in the Mid-1920s by Samuel Alexander Kinnier Wilson
000754 David A. Gallagher [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Anette Schrag [Royaume-Uni]What Are the Most Important Nonmotor Symptoms in Patients with Parkinson's Disease and Are We Missing Them?
000764 Roser Pons [Grèce] ; Mercedes Serrano [Espagne] ; Aida Ormazabal [Espagne] ; Claudio Toma [Espagne] ; Angels Garcia-Cazorla [Espagne] ; Estela Area [États-Unis] ; Marta Ribases [Espagne] ; Emmanuel Kanavakis [Grèce] ; Kaliopi Drakaki [Grèce] ; Aristotelis Giannakopoulos [Grèce] ; Irene Orfanou [Grèce] ; Sotiris Youroukos [Grèce] ; Bru Cormand [Espagne] ; Rafael Artuch [Espagne]Tyrosine Hydroxylase Deficiency in Three Greek Patients with a Common Ancestral Mutation
000766 CHAE WON SHIN [Corée du Sud] ; HEE JIN KIM [Corée du Sud] ; SUNG SUP PARK [Corée du Sud] ; SUNG YEUN KIM [Corée du Sud] ; JI YEON KIM [Corée du Sud] ; BEOM SEOK JEON [Corée du Sud]Two Parkinson's Disease Patients With α-Synuclein Gene Duplication and Rapid Cognitive Decline
000771 Francisco De Assis Aquino Gondim [Brésil] ; Helida A. Costa [Brésil] ; Tauily C. D. Taunay [Brésil] ; Gisele R. De Oliveira [Brésil] ; Jamile Magalhaes Ferreira [Brésil] ; Francisco H. Rola [Brésil]Transient Amantadine-Induced Musical Hallucinations in a Patient with Parkinson's Disease
000774 CHUL HYOUNG LYOO [Corée du Sud] ; YOUNG HOON RYU [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud]Topographical Distribution of Cerebral Cortical Thinning in Patients with Mild Parkinson's Disease Without Dementia
000786 HYE YOUNG SUNG [Corée du Sud] ; Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; In-Uk Song [Corée du Sud] ; Sung-Woo Chung [Corée du Sud] ; Dong-Won Yang [Corée du Sud] ; YU KYUNG CHO [Corée du Sud] ; JAE MYUNG PARK [Corée du Sud] ; IN SEOK LEE [Corée du Sud] ; SANG WOO KIM [Corée du Sud] ; In-Sik Chung [Corée du Sud] ; Myung-Gyu Choi [Corée du Sud]The Prevalence and Patterns of Pharyngoesophageal Dysmotility in Patients with Early Stage Parkinson's Disease
000820 Philippa Carter [Australie] ; Jenny Downs [Australie] ; Ami Bebbington [Australie] ; Simon Williams [Australie] ; Peter Jacoby [Australie] ; Walter E. Kaufmann [États-Unis] ; Helen Leonard [Australie]Stereotypical Hand Movements in 144 Subjects with Rett Syndrome from the Population-Based Australian Database
000827 Hélio A. G. Teive [Brésil] ; Renato P. Munhoz [Brésil] ; Salmo Raskin [Brésil] ; Walter O. Arruda [Brésil] ; Luciano De Paola [Brésil] ; Lineu C. Werneck [Brésil] ; Tetsuo Ashizawa [États-Unis]Spinocerebellar Ataxia Type 10: Frequency of Epilepsy in a Large Sample of Brazilian Patients
000829 Constance Flamand-Rouviere [France] ; Emilie Guettard [France] ; Caroline Moreau [France] ; Nadia Bahi-Buisson [France] ; Vassili Valayannopoulos [France] ; David Grabli [France] ; Jacques Motte [France] ; Diana Rodriguez [France] ; Agathe Roubertie [France] ; Lisa Maintigneux [France] ; Isabelle Kemlin [France] ; Irène Ceballos-Picot [France] ; David Adams [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France]Speech Disturbances in Patients With Dystonia or Chorea Due to Neurometabolic Disorders
000832 I-Jin Yeh [Canada, Taïwan] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada]Somatosensory Evoked Potentials Recorded from the Human Pedunculopontine Nucleus Region
000838 V. Di Lazzaro [Italie] ; F. Pilato [Italie] ; P. Granone [Italie] ; A. Sestito [Italie] ; T. Pirronti [Italie]Shortness of Breath in a Parkinson's Disease Patient
000839 Stephany Fulda [Allemagne] ; Marie E. Beitinger [Allemagne] ; Simone Reppermund [Allemagne, Australie] ; Juliane Winkelmann [Allemagne] ; Thomas C. Wetter [Allemagne, Suisse]Short-Term Attention and Verbal Fluency is Decreased in Restless Legs Syndrome Patients
000852 Kathrine Rugbjerg [Danemark] ; S Ren Friis [Danemark] ; Thomas L. J Rgensen [Danemark] ; Beate Ritz [États-Unis] ; Lise Korbo [Danemark] ; J Rgen H. Olsen [Danemark]Risk for Parkinson's Disease Among Patients with Osteoarthritis: A Danish Cohort Study
000862 Daniele Lo Coco [Italie] ; Federico Piccoli [Italie] ; Vincenzo La Bella [Italie]Restless Legs Syndrome in Patients with Amyotrophic Lateral Sclerosis
000863 XIANG GAO [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Eilis J. O'Reilly [États-Unis] ; HAO WANG [États-Unis] ; Alberto Ascherio [États-Unis]Restless Legs Syndrome and Parkinson's Disease in Men
000864 Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis]Reply: Based on the Available Randomized Trial Patients Should Say No to Glutathione for Parkinson's Disease
000868 Marcus M. Unger [Allemagne] ; Katja Hattemer [Allemagne] ; Jens C. Möller [Allemagne] ; Katrin Schmittinger [Allemagne] ; Katharina Mankel [Allemagne] ; Karla Eggert [Allemagne] ; Konstantin Strauch [Allemagne] ; Johannes J. Tebbe [Allemagne] ; Boris Keil [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes T. Heverhagen [Allemagne] ; Susanne Knake [Allemagne]Real-time Visualization of Altered Gastric Motility by Magnetic Resonance Imaging in Patients with Parkinson's Disease
000875 YEW CHIEN VOON [Malaisie] ; Wan Nur Nafisah Wan Yahya Mmed [Malaisie] ; Shariful Hasan [Malaisie] ; Norlinah Mohamed Ibrahim [Malaisie]Pyridostigmine-Induced Dystonic Blepharospasm in a Patient With Ocular Myasthenia Gravis
000877 Alfonso Fasano [Italie] ; Mauro Pettorruso [Italie] ; Lucia Ricciardi [Italie] ; Gianluigi Conte [Italie] ; Anna Rita Bentivoglio [Italie]Punding in Parkinson's Disease: The Impact of Patient's Awareness on Diagnosis
000888 MYUNG SIK LEE [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; YOON HO CHOI [Corée du Sud]Primary Progressive Freezing Gait in a Patient with CO-Induced Parkinsonism
000889 Anne S. Söhn [Allemagne] ; Nicola Glöckle [Allemagne] ; Andrea Duarte Doetzer [Allemagne] ; Günther Deuschl [Allemagne] ; Ute Felbor [Allemagne] ; Helge R. Topka [Allemagne] ; Ludger Schöls [Allemagne] ; Olaf Riess [Allemagne] ; Peter Bauer [Allemagne] ; Ulrich Müller [Allemagne] ; Kathrin Grundmann [Allemagne]Prevalence of THAPI Sequence Variants in German Patients with Primary Dystonia
000901 Raquel Duran [Espagne] ; Francisco J. Barrero [Espagne] ; Blas Morales [Espagne] ; Juan D. Luna [Espagne] ; Manuel Ramirez [Espagne] ; Francisco Vives [Espagne]Plasma α-Synuclein in Patients with Parkinson's Disease With and Without Treatment
000904 Erich Talamoni Fonoff [Brésil] ; Ywzhe Sifuentes Almeida De Oliveira [Brésil] ; Santiago Driollet [Brésil] ; Griselda Jarra Garrido [Brésil] ; Daniel Ciampi De Andrade [Brésil] ; Flávio Sallem [Brésil] ; Egberto Reis Barbosa [Brésil] ; Manoel Jacobsen Teixeira [Brésil]Pet Findings in Reversible Improvement of Olfactory Dysfunction After STN Stimulation in a Parkinson's Disease Patient
000909 Chadwick W. Christine [États-Unis] ; Elisabeth R. Garwood [États-Unis] ; Lauren E. Schrock [États-Unis] ; Daniel E. Austin [États-Unis] ; Charles E. Mcculloch [États-Unis]Parkinsonism in Patients with a History of Amphetamine Exposure
000910 Rebecca M. Wolf Gilbert [États-Unis] ; Stanley Fahn [États-Unis] ; Hiroshi Mitsumoto [États-Unis] ; Lewis P. Rowland [États-Unis]Parkinsonism and Motor Neuron Diseases: Twenty-Seven Patients with Diverse Overlap Syndromes
000913 Marios Politis [Royaume-Uni] ; Kit Wu [Royaume-Uni] ; Sophie Molloy [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Paola Piccini [Royaume-Uni]Parkinson's Disease Symptoms: The Patient's Perspective
000917 Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Marco Onofrj [Italie]Paradoxical Kinesia in Parkinsonian Patients Surviving Earthquake
000918 Emilia Gatto [Argentine]Pantothenate Kinase-Associated Neurodegeneration: Novel Mutations in the PANK2 Gene in an Argentinean Young Woman
000921 Tiphaine Rouaud [France] ; Thibaut Dondaine [France] ; Sophie Drapier [France] ; Claire Haegelen [France] ; François Lallement [France] ; Julie Peron [France] ; Sylvie Raoul [France] ; Paul Sauleau [France] ; Marc Verin [France]Pallidal Stimulation in Advanced Parkinson's Patients with Contraindications for Subthalamic Stimulation
000932 Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Masaoki Iwanami [Japon] ; Koichi Hirata [Japon]Olfactory Dysfunction in Japanese Patients with Idiopathic REM Sleep Behavior Disorder: Comparison of Data Using the University of Pennsylvania Smell Identification Test and Odor Stick Identification Test for Japanese
000933 Randolph Stephenson [États-Unis] ; David Houghton [États-Unis] ; Sri Sundarararjan [États-Unis] ; Richard L. Doty [États-Unis] ; Matthew Stem [États-Unis] ; Sharon X. Xie [États-Unis] ; Andrew Siderowf [États-Unis]Odor Identification Deficits are Associated with Increased Risk of Neuropsychiatric Complications in Patients with Parkinson's Disease
000938 WON TAE YOON [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; Hee-Young Shin [Corée du Sud] ; Seung-Tae Lee [Corée du Sud] ; Chang-Seok Ki [Corée du Sud]Novel PANK2 Gene Mutations in Korean Patient with Pantothenate Kinase-Associated Neurodegeneration Presenting Unilateral Dystonic Tremor
000940 HUIJUAN LI [République populaire de Chine] ; MEIFEN ZHANG [République populaire de Chine] ; LING CHEN [République populaire de Chine] ; JUNE ZHANG [République populaire de Chine] ; ZHONG PEI [République populaire de Chine] ; AILING HU [République populaire de Chine] ; QING WANG [République populaire de Chine]Nonmotor Symptoms Are Independently Associated With Impaired Health-Related Quality of Life in Chinese Patients With Parkinson's Disease
000952 Simona Binelli [Italie] ; Pamela Agazzi [Italie] ; Laura Canafoglia [Italie] ; Vidmer Scaioli [Italie] ; Ferruccio Panzica [Italie] ; Elisa Visani [Italie] ; Giuseppe Di Fede [Italie] ; Giorgio Giaccone [Italie] ; Alberto Bizzi [Italie] ; Orso Bugiani [Italie] ; Guiliano Avanzini [Italie] ; Fabrizio Tagliavini [Italie] ; Silvana Franceschetti [Italie]Myoclonus in Creutzfeldt-Jakob Disease: Polygraphic and Video-Electroencephalography Assessment of 109 Patients
000961 Victor Peralta [Espagne] ; Maria S. Campos [Espagne] ; Elena Garcia De Jalon [Espagne] ; Manuel J. Cuesta [Espagne]Motor Behavior Abnormalities in Drug-Naïve Patients with Schizophrenia Spectrum Disorders
000976 Emanuele Cereda [Italie] ; Michela Barichella [Italie] ; Carlo Pedrolli [Italie] ; Gianni Pezzoli [Italie]Low-Protein and Protein-Redistribution Diets for Parkinson's Disease Patients with Motor Fluctuations: A Systematic Review
000980 Laura Cif [France] ; Xavier Vasques [France] ; Victoria Gonzalez [France] ; Patrice Ravel [France] ; Brigitte Biolsi [France] ; Gwenaelle Collod-Beroud [France] ; Sylvie Tuffery-Giraud [France] ; Hassan Elfertit [France] ; Mireille Claustres [France] ; Philippe Coubes [France]Long-Term Follow-Up of DYT1 Dystonia Patients Treated by Deep Brain Stimulation: An Open-Label Study
000995 Marcelo Merello [Argentine] ; Natalia Fantacone [Argentine] ; Jorge Balej [Argentine]Kinematic Study of Whole Body Center of Mass Position During Gait in Parkinson's Disease Patients with and Without Festination
000A00 Tobias B Umer [Allemagne] ; Götz Thomalla [Allemagne] ; Johan Kroeger [Allemagne] ; Melanie Jonas [Allemagne] ; Christian Gerloff [Allemagne] ; Friedhelm Christoph Hummel [Allemagne] ; Kirsten Müller-Vahl [Allemagne] ; Alfons Schnitzler [Allemagne] ; Hartwig Roman Siebner [Danemark] ; Michael Orth [Allemagne] ; Alexander Münchau [Allemagne]Interhemispheric Motor Networks are Abnormal in Patients with Gilles de la Tourette Syndrome
000A06 Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations
000A10 Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada]Incidence of Parkinson's Disease Among Hospital Patients with Methamphetamine-Use Disorders
000A17 Nebojša M. Lalic [Serbie] ; Nataša Dragasevic [Serbie] ; Elka Stefanova [Serbie] ; Aleksandra Jotic [Serbie] ; Katarina Lalic [Serbie] ; Tanja Milicic [Serbie] ; Igor Petrovic [Serbie] ; Marija Macesic [Serbie] ; Vladimir S. Kostic [Serbie]Impaired Insulin Sensitivity and Secretion in Normoglycemic Patients with Spinocerebellar Ataxia Type 1
000A18 MYUNG SIK LEE [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; MYUNG JUN LEE [Corée du Sud] ; Jaeeun Sim [Corée du Sud] ; Hanna Cho [Corée du Sud] ; YUN HO CHOI [Corée du Sud]Impaired Finger Dexterity in Patients with Parkinson's Disease Correlates with Discriminative Cutaneous Sensory Dysfunction
000A20 Melanie Jonas [Allemagne] ; Götz Thomalla [Allemagne] ; Katja Biermann-Ruben [Allemagne] ; Hartwig Roman Siebner [Danemark, Allemagne] ; Kirsten Müller-Vahl [Allemagne] ; Tobias B Umer [Allemagne] ; Christian Gerloff [Allemagne] ; Alfons Schnitzler [Allemagne] ; Michael Orth [Allemagne] ; Alexander Münchau [Allemagne]Imitation in Patients with Gilles de la Tourette Syndrome: A Behavioral Study
000A24 German Moris [Espagne] ; M Nica Arias [Espagne] ; Maria Valle Lopez [Espagne] ; Victoria Alvarez [Espagne]Hyperintensity in the Basis Pontis: Atypical Neuroradiological Findings in a Woman with FXTAS
000A25 BO ZHOU [République populaire de Chine] ; QIN CHEN [République populaire de Chine] ; QIN ZHANG [République populaire de Chine] ; LEI CHEN [République populaire de Chine] ; QIYONG GONG [République populaire de Chine] ; HUIFANG SHANG [République populaire de Chine] ; HEHAN TANG [République populaire de Chine] ; DONG ZHOU [République populaire de Chine]Hyperactive Putamen in Patients with Paroxysmal Kinesigenic Choreoathetosis: A Resting-State Functional Magnetic Resonance Imaging Study
000A32 Inbal Maidan [Israël] ; Meir Plotnik [Israël] ; Anat Mirelman [Israël, États-Unis] ; Aner Weiss [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis]Heart Rate Changes During Freezing of Gait in Patients with Parkinson's Disease
000A33 Kirsten Müller-Vahl [Allemagne] ; Ines Dodel [Allemagne] ; Norbert Müller [Allemagne] ; Alexander Münchau [Allemagne] ; Jens Peter Reese [Allemagne] ; Monika Balzer-Geldsetzer [Allemagne] ; Richard Dodel [Allemagne] ; Wolfgang H. Oertel [Allemagne]Health-Related Quality of Life in Patients with Gilles de la Tourette's Syndrome
000A42 Tomas Bjorklund [Suède] ; Jeffrey H. Kordower [États-Unis]Gene Therapy for Parkinson's Disease
000A47 XIN LIU [République populaire de Chine] ; Shu-Shan Zhang [République populaire de Chine] ; Deng-Fu Fang [République populaire de Chine] ; Ming-Yi Ma [République populaire de Chine] ; Xiao-Yan Guo [République populaire de Chine] ; YUAN YANG [République populaire de Chine] ; Hui-Fang Shang [République populaire de Chine]GCH1 Mutation and Clinical Study of Chinese Patients with Dopa-responsive Dystonia
000A55 LI CAO [République populaire de Chine] ; LAN ZHENG [République populaire de Chine] ; Wei-Guo Tang [République populaire de Chine] ; QIN XIAO [République populaire de Chine] ; TING ZHANG [République populaire de Chine] ; Hui-Dong Tang [République populaire de Chine] ; Song-Bin He [République populaire de Chine] ; Xi-Jin Wang [République populaire de Chine] ; Jian-Qing Ding [République populaire de Chine] ; Sheng-Di Chen [République populaire de Chine]Four Novel Mutations in the GCH1 Gene of Chinese Patients with Dopa-Responsive Dystonia
000A56 Rwei-Ling Yu [Taïwan] ; Ruey-Meei Wu [Taïwan] ; Chun-Hwei Tai [Taïwan] ; Chin-Hsien Lin [Taïwan] ; Mau-Sun Hua [Taïwan]Feeling-of-Knowing in Episodic Memory in Patients with Parkinson's Disease with Various Motor Symptoms
000A64 Kunio Kawamura [Japon] ; Takayoshi Shimohata [Japon] ; Hideaki Nakayama [Japon] ; Masahiko Tomita [Japon] ; Tetsutaro Ozawa [Japon] ; Masatoyo Nishizawa [Japon]Factors Influencing the Cognitive Function in Patients with Multiple System Atrophy
000A67 Simon Zhomitsky [Canada] ; Emmanuel Stip [Canada] ; Tania Pampoulova [Canada] ; Elie Rizkallah [Canada] ; Olivier Lipp [Canada] ; Lahcen Aït Bentaleb [Canada] ; Jean-Pierre Chiasson [Canada] ; Stéphane Potvin [Canada]Extrapyramidal Symptoms in Substance Abusers with and Without Schizophrenia and in Nonabusing Patients with Schizophrenia
000A72 Rogério Beato [Brésil] ; Débora P. Maia [Brésil] ; Antônio Lucio Jr Teixeira [Brésil] ; Francisco Cardoso [Brésil]Executive Functioning in Adult Patients with Sydenham's Chorea
000A76 Lior Greenbaum [Israël] ; Anna Alkelai [Israël] ; Amihai Rigbi [Israël] ; Yoav Kohn [Israël] ; Bernard Lerer [Israël]Evidence for Association of the GLI2 Gene with Tardive Dyskinesia in Patients with Chronic Schizophrenia
000A91 Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis]Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson's Disease Patients with Motor Fluctuations
000A95 Valerio Pisani [Italie] ; Vincenzo Moschella [Italie] ; Monica Bari [Italie] ; Filomena Fezza [Italie] ; Salvatore Galati [Italie] ; Giorgio Bernardi [Italie] ; Paolo Stanzione [Italie] ; Antonio Pisani [Italie] ; Mauro Maccarrone [Italie]Dynamic Changes of Anandamide in the Cerebrospinal Fluid of Parkinson's Disease Patients
000A97 Matthew Rizzo [États-Unis] ; Ergun Y. Uc [États-Unis] ; Jeffrey Dawson [États-Unis] ; Steven Anderson [États-Unis] ; Robert Rodnitzky [États-Unis]Driving Difficulties in Parkinson's Disease
000B06 Alberto Albanese [Italie] ; Stefania Lalli [Italie]Distinguishing Scan Without Evidence of Dopaminergic Depletion Patients with Asymmetric Resting Tremor from Parkinson's Disease: A Clinical Diagnosis of Dystonia is Required
000B07 Petra Schwingenschuh [Royaume-Uni, Autriche] ; Diane Ruge [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Carmen Terranova [Royaume-Uni] ; Petra Katschnig [Royaume-Uni, Autriche] ; Fatima Carrillo [Espagne] ; Laura Silveira-Moriyama [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Georg K Gi [Royaume-Uni] ; Francisco J. Palomar [Espagne] ; Penelope Talelli [Royaume-Uni] ; John Dickson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Pablo Mir [Espagne] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Distinguishing SWEDDs Patients with Asymmetric Resting Tremor from Parkinson's Disease: A Clinical and Electrophysiological Study
000B13 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Danilo De Gaspari [Italie] ; Leonilda Bilo [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie]Differential Neuropsychological Profiles in Parkinsonian Patients With or Without Vascular Lesions
000B19 Takeshi Inoue [Japon] ; Mayumi Kitagawa [Japon] ; Teruaki Tanaka [Japon] ; Shin Nakagawa [Japon] ; Tsukasa Koyama [Japon]Depression and Major Depressive Disorder in Patients with Parkinson's Disease
000B25 Sandra Paglionico [Italie] ; Gennarina Arabia [Italie] ; Domenico Pirritano [Italie] ; Aldo Quattrone [Italie] ; Angelo Lavano [Italie] ; Marisa De Rose [Italie]Deep Brain Stimulation in a Patient with Isolated Mixed Tremor
000B33 Giovanni Mostile [États-Unis, Italie] ; Joseph P. Giuffrida [États-Unis] ; Octavian R. Adam [États-Unis] ; Anthony Davidson [États-Unis] ; Joseph Jankovic [États-Unis]Correlation Between Kinesia System Assessments and Clinical Tremor Scores in Patients with Essential Tremor
000B37 Barbara Jasinska-Myga [États-Unis, Pologne] ; Jennifer Kachergus [États-Unis] ; Carles Vilarino-Güell [États-Unis] ; Christian Wider [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Mounir Kefi [Tunisie] ; Lefkos T. Middleton [Royaume-Uni] ; Lianna Ishihara-Paul [Royaume-Uni] ; Rachel A. Gibson [Royaume-Uni] ; Rim Amouri [Tunisie] ; SAMIA BEN YAHMED [Tunisie] ; SAMIA BEN SASSI [Tunisie] ; Mourad Zouari [Tunisie] ; Ghada El Euch [Tunisie] ; Owen A. Ross [États-Unis] ; Faycal Hentati [Tunisie] ; Matthew J. Farrer [États-Unis]Comprehensive Sequencing of the LRRK2 Gene in Patients with Familial Parkinson's Disease from North Africa
000B44 Flavio Nobili [Italie] ; Claudio Campus [Italie] ; Dario Amaldi [Italie] ; Fabrizio De Carli [Italie] ; Gaia Cabassi [Italie] ; Andrea Brugnolo [Italie] ; Barbara Dessi [Italie] ; Silvia Morbelli [Italie] ; Gianmario Sambuceti [Italie] ; Giovanni Abbruzzese [Italie] ; Guido Rodriguez [Italie]Cognitive-Nigrostriatal Relationships in De Novo, Drug-Naïve Parkinson's Disease Patients: A [I-123]FP-CIT SPECT Study
000B60 Hans-Holger Capelle [Allemagne] ; Christian Blahak [Allemagne] ; Christoph Schrader [Allemagne] ; Hansjörg Baezner [Allemagne] ; Thomas M. Kinfe [Allemagne] ; Jan Herzog [Allemagne] ; Reinhard Dengler [Allemagne] ; Joachim K. Krauss [Allemagne]Chronic Deep Brain Stimulation in Patients with Tardive Dystonia Without a History of Major Psychosis
000B63 Jia-Yi Li [Suède] ; Elisabet Englund [Suède] ; Hakan Widner [Suède] ; Stig Rehncrona [Suède] ; Anders Björklund [Suède] ; Olle Lindvall [Suède] ; Patrik Brundin [Suède]Characterization of Lewy Body Pathology in 12- and 16-Year-Old Intrastriatal Mesencephalic Grafts Surviving in a Patient With Parkinson's Disease
000B66 Thomas T. Barnikol [Allemagne] ; Norbert B. A. Pawelczyk [Allemagne] ; Utako B. Barnikol [Allemagne] ; Jens Kuhn [Allemagne] ; Doris Lenartz [Allemagne] ; Volker Sturm [Allemagne] ; Peter A. Tass [Allemagne] ; Hans-Joachim Freund [Allemagne]Changes in Apraxia After Deep Brain Stimulation of the Nucleus Basalis Meynert in a Patient With Parkinson Dementia Syndrome
000B68 Chen-San Su [Taïwan] ; Wen-Neng Chang [Taïwan] ; Shu-Hua Huang [Taïwan] ; Chun-Chung Lui [Taïwan] ; Tai-Long Pan [Taïwan] ; Chen-Hsien Lu [Taïwan] ; Yao-Chung Chuang [Taïwan] ; Chi-Ren Huang [Taïwan] ; Nei-Wen Tsai [Taïwan] ; Mei-Jen Hsieh [Taïwan] ; Chiung-Chih Chang [Taïwan]Cerebrotendinous Xanthomatosis Patients With and Without Parkinsonism: Clinical Characteristics and Neuroimaging Findings
000B96 Emily Rosenthal [États-Unis] ; Laura Brennan [États-Unis] ; SHARON XIE [États-Unis] ; HOWARD HURTIG [États-Unis] ; Joshua Milber [États-Unis] ; Daniel Weintraub [États-Unis] ; Jason Karlawish [États-Unis] ; Andrew Siderowf [États-Unis]Association Between Cognition and Function in Patients With Parkinson Disease With and Without Dementia
000C19 Joana Guimaraes [Portugal] ; Augusta Vieira-Coelho [Portugal] ; Maria Jose Rosas [Portugal] ; Eduardo Moura [Portugal] ; Rui Vaz [Portugal] ; Carolina Garrett [Portugal]Acute Renal Failure in Patients with Bilateral Deep Brain Stimulation
000C21 Ellison Fernando Cardoso [Brésil] ; Felipe Fregni [États-Unis] ; Fernanda Martins Maia [Brésil] ; Luciano M. Melo [Brésil] ; Joao R. Sato [Brésil] ; Antonio Cesario Jr Cruz [Brésil] ; Edno Tales Bianchi [Brésil] ; Danilo Botelho Fernandes [Brésil] ; Mário Luiz Ribeiro Monteiro [Brésil] ; Egberto Reis Barbosa [Brésil] ; Edson Jr Amaro [Brésil]Abnormal Visual Activation in Parkinson's Disease Patients
000C27 E. Ray Dorsey [États-Unis] ; Tiffini S. Voss [États-Unis] ; David R. Shprecher [États-Unis] ; Lisa M. Deuel [États-Unis] ; Christopher A. Beck [États-Unis] ; Irenita F. Gardiner [États-Unis] ; Margaret A. Coles [États-Unis] ; Richard S. Burns [États-Unis] ; Frederick J. Marshall [États-Unis] ; Kevin M. Biglan [États-Unis]A U.S. Survey of Patients with Parkinson's Disease: Satisfaction with Medical Care and Support Groups
000C28 Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Marina Picillo [Italie] ; Autilia Cozzolino [Italie] ; Katia Longo [Italie] ; Roberto Erro [Italie] ; Alessandro Iavarone [Italie]A Two-Year Follow-Up Study of Executive Dysfunctions in Parkinsonian Patients with Freezing of Gait at On-State
000C33 Tobias Warnecke [Allemagne] ; Thomas Duning [Allemagne] ; Anja Schirmacher [Allemagne] ; Siawoosh Mohammadi [Allemagne] ; Wolfram Schwindt [Allemagne] ; Hubertus Lohmann [Allemagne] ; Rainer Dziewas [Allemagne] ; Michael Deppe [Allemagne] ; E. Bernd Ringelstein [Allemagne] ; Peter Young [Allemagne]A Novel Splice Site Mutation in the SPG7 Gene Causing Widespread Fiber Damage in Homozygous and Heterozygous Subjects
000C35 Kerstin Ziegler [Allemagne] ; Frauke Schroeteler [Allemagne] ; Andres O. Ceballos-Baumann [Allemagne] ; Urban M. Fietzek [Allemagne]A New Rating Instrument to Assess Festination and Freezing Gait in Parkinsonian Patients
000C37 Prançois Vacherot [France] ; Shahram Attarian [France] ; Marianne Vaugoyeau [France] ; Jean-Philippe Azulay [France]A Motor Cortex Excitability and Gait Analysis on Parkinsonian Patients
000C43 Ji E. Lee [Corée du Sud] ; Bosuk Park [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; Hae-Jeong Park [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]A Comparison of Gray and White Matter Density in Patients with Parkinson's Disease Dementia and Dementia with Lewy Bodies Using Voxel-Based Morphometry
000C44 Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Bum [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni]A Comparison of Depression, Anxiety, and Health Status in Patients with Progressive Supranuclear Palsy and Multiple System Atrophy
000C45 Giovanni Merlino [Italie] ; Simone Lorenzut [Italie] ; Gian Luigi Gigli [Italie] ; Giulio Romano [Italie] ; Domenico Montanaro [Italie] ; Alessandro Moro [Italie] ; Mariarosaria Valente [Italie]A Case-Control Study on Restless Legs Syndrome in Nondialyzed Patients with Chronic Renal Failure
000C47 Joo-Hyun Seo [Corée du Sud] ; SEOK WOO YONG [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Ji E. Lee [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; PHIL HYU LEE [Corée du Sud]A Case-Control Study of Multiple System Atrophy in Korean Patients
000C62 Wey-Yil Lin [Taïwan] ; Chin-Chang Huang [Taïwan] ; Hong-Shiu Chang [Taïwan] ; Hung-Chou Kuo [Taïwan] ; Yih-Ru Wu [Taïwan]Various Movement Disorders in a Patient with Sjögren Syndrome
000C65 Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]Validation of the Freezing of Gait Questionnaire in Patients with Parkinson's Disease
000C71 Marco Y. C. Pang [Hong Kong] ; Margaret K. Y. Mak [Hong Kong]Trunk Muscle Strength, But Not Trunk Rigidity, Is Independently Associated with Bone Mineral Density of the Lumbar Spine in Patients with Parkinson's Disease
000C76 Takashi Satoh [Japon] ; Toshiyuki Takahashi [Japon] ; Koh Iwasaki [Japon] ; Hideaki Tago [Japon] ; Takashi Seki [Japon] ; Nobuo Yaegashi [Japon] ; Muneshige Tobita [Japon] ; Hiroyuki Arai [Japon]Traditional Chinese Medicine on Four Patients with Huntington's Disease
000C85 Matthew Menza [États-Unis] ; Roseanne Defronzo Dobkin [États-Unis] ; Humberto Marin [États-Unis] ; Margery H. Mark [États-Unis] ; Michael Gara [États-Unis] ; Steven Buyske [États-Unis] ; Karina Bienfait [États-Unis] ; Allison Dicke [États-Unis]The Impact of Treatment of Depression on Quality of Life, Disability and Relapse in Patients with Parkinson's Disease
000D09 Katja Ritz [Pays-Bas] ; Justus L. Groen [Pays-Bas] ; Jose J. M. Kruisdijk [Pays-Bas] ; Frank Baas [Pays-Bas] ; Johannes H. T. M. Koelman [Pays-Bas] ; Marina A. J. Tijssen [Pays-Bas]Screening for Dystonia Genes DYT1, 11 and 16 in Patients with Writer's Cramp
000D13 Nadège Limousin [France] ; Eric Konofal [France] ; Elias Karroum [France] ; Ebba Lohmann [France] ; Ioannis Theodorou [France] ; Alexandra Dürr [France] ; Isabelle Amulf [France]Restless Legs Syndrome, Rapid Eye Movement Sleep Behavior Disorder, and Hypersomnia in Patients with Two Parkin Mutations
000D18 Gottfried Kranz [Autriche] ; Dietrich Haubenberger [Autriche] ; Bemhard Voller [Autriche] ; Martin Posch [Autriche] ; Peter Schnider [Autriche] ; Eduard Auff [Autriche] ; Thomas Sycha [Autriche]Respective Potencies of Botox® and Dysport® in a Human Skin Model : A Randomized, Double-blind Study
000D23 Linda Truong [Australie] ; Daniel Brooks [Australie] ; Fabricio Amaral [Australie] ; Jasmine M. Henderson [Australie] ; Glenda M. Halliday [Australie]Relative Preservation of Thalamic Centromedian Nucleus in Parkinsonian Patients with Dystonia
000D24 Joseph Jankovic [États-Unis] ; Christopher Kenney [États-Unis] ; Susanne Grafe [Allemagne] ; Roman Goertelmeyer [Allemagne] ; George Comes [Allemagne]Relationship Between Various Clinical Outcome Assessments in Patients with Blepharospasm
000D25 Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Davide Uccellini [Italie] ; Gabriella Bertotti [Italie] ; Paola Abelli [Italie]Rehabilitation Treatment of Gait in Patients with Parkinson's Disease with Freezing: A Comparison Between Two Physical Therapy Protocols Using Visual and Auditory Cues with or Without Treadmill Training
000D26 Hiroshi Kataoka [Japon] ; Josep Dalmau [États-Unis] ; Toshiaki Taoka [Japon] ; Satoshi Ueno [Japon]Reduced N-Acetylaspartate in the Basal Ganglia of a Patient with Anti-NMDA Receptor Encephalitis
000D38 Andrew Mckeon [États-Unis] ; J. Eric Ahlskog [États-Unis] ; James H. Bower [États-Unis] ; Keith A. Josephs [États-Unis] ; Joseph Y. Matsumoto [États-Unis]Psychogenic Tremor : Long Term Prognosis in Patients with Electrophysiologically-Confirmed Disease
000D41 Marcondes C. Jr Franca [Brésil] ; Anelyssa D'Abreu [Brésil] ; Anamarli Nucci [Brésil] ; Fernando Cendes [Brésil] ; Iscia Lopes-Cendes [Brésil]Progression of Ataxia in Patients with Machado-Joseph Disease
000D43 Gregory M. Pontone [États-Unis] ; James R. Williams [États-Unis] ; Karen E. Anderson [États-Unis] ; Gary Chase [États-Unis] ; Susanne A. Goldstein [États-Unis] ; Stephen Grill [États-Unis] ; Elaina S. Hirsch [États-Unis] ; Susan Lehmann [États-Unis] ; John T. Little [États-Unis] ; Russell L. Margolis [États-Unis] ; Peter V. Rabins [États-Unis] ; Howard D. Weiss [États-Unis] ; Laura Marsh [États-Unis]Prevalence of Anxiety Disorders and Anxiety Subtypes in Patients with Parkinson's Disease
000D55 Jee-Young Lee [Corée du Sud] ; Woong-Woo Lee [Corée du Sud] ; JI SOO KIM [Corée du Sud] ; HEE JIN KIM [Corée du Sud] ; Jin-Kyung Kim [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Perverted Head-Shaking and Positional Downbeat Nystagmus in Patients With Multiple System Atrophy
000D57 Terri K. Pogoda [États-Unis] ; Irene E. Cramer [États-Unis] ; Mark Meterko [États-Unis] ; HAI LIN [États-Unis] ; Ann Hendricks [États-Unis] ; Robert G. Holloway [États-Unis] ; Martin P. Charns [États-Unis]Patient and Organizational Factors Related to Education and Support Use by Veterans with Parkinson's Disease
000D58 David Devos [France]Patient Profile, Indications, Efficacy and Safety of Duodenal Levodopa Infusion in Advanced Parkinson's Disease
000D59 Paul Wicks [États-Unis] ; Graeme J. A. Macphee [Royaume-Uni]Pathological Gambling Amongst Parkinson's Disease and ALS Patients in an Online Community (PatientsLikeMe.com)
000D68 Mariachiara Sensi [Italie] ; Michele A. Cavallo [Italie] ; Rocco Quatrale [Italie] ; Silvio Sarubbo [Italie] ; Sara Biguzzi [Italie] ; Cristian Lettieri [Italie] ; Jay G. Capone [Italie] ; Valeria Tugnoli [Italie] ; Maria Rosaria Tola [Italie] ; Roberto Eleopra [Italie]Pallidal Stimulation for Segmental Dystonia: Long Term Follow Up of 11 Consecutive Patients
000D69 Angelika Nebe [Allemagne] ; Georg Ebersbach [Allemagne]Pain Intensity On and Off Levodopa in Patients with Parkinson's Disease
000D70 Clecio Godeiro-Junior [Brésil] ; Patricia M. De Carvalho-Aguiar [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Sonia M. A. Silva [Brésil] ; Vanderci Borges [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Henrique Ballalai Ferraz [Brésil]PINK1 Mutations in a Brazilian Cohort of Early-Onset Parkinson's Disease Patients
000D74 Alberto J. Espay [États-Unis] ; Linda M. Goldenhar [États-Unis] ; Valerie Voon [États-Unis] ; Anette Schrag [Royaume-Uni] ; Noël Burton [États-Unis] ; Anthony E. Lang [Canada]Opinions and Clinical Practices Related to Diagnosing and Managing Patients with Psychogenic Movement Disorders: An International Survey of Movement Disorder Society Members
000D79 Johannes Levin [Allemagne] ; Siegbert Krafczyk [Allemagne] ; Peter Valkovic [Slovaquie] ; Thomas Eggert [Allemagne] ; Jens Claassen [Allemagne] ; Kai Bötzel [Allemagne]Objective Measurement of Muscle Rigidity in Parkinsonian Patients Treated with Subthalamic Stimulation
000D84 Erika Driver-Dunckley [États-Unis] ; Donald Connor [États-Unis] ; Joe Hentz [États-Unis] ; Marwan Sabbagh [États-Unis] ; Nina Silverberg [États-Unis] ; Jose Hernandez [États-Unis] ; Linda Vedders [États-Unis] ; Virgilio Gerald Evidente [États-Unis] ; Holly Shill [États-Unis] ; John Caviness [États-Unis] ; Charles Adler [États-Unis]No Evidence for Cognitive Dysfunction or Depression in Patients with Mild Restless Legs Syndrome
000D91 Katrin Bürk [Allemagne] ; Marie-Louise Farecki [Allemagne] ; Georg Lamprecht [Allemagne] ; Guenter Roth [Allemagne] ; Patrice Decker [Allemagne] ; Michael Weller [Suisse] ; Hans-Georg Rammensee [Allemagne] ; Wolfang Oertel [Allemagne]Neurological Symptoms in Patients with Biopsy Proven Celiac Disease
000D98 A. Sebastian Schroeder [Allemagne] ; Birgit Ertl-Wagner [Allemagne] ; Stefanie Britsch [Allemagne] ; J. Michael Schroder [Allemagne] ; Stefan Nikolin [Allemagne] ; Joachim Weis [Allemagne] ; Wolfgang Müller-Felber [Allemagne] ; Inga Koerte [Allemagne] ; Maximilian Stehr [Allemagne] ; Steffen Berweck [Allemagne] ; Ingo Borggraefe [Allemagne] ; Florian Heinen [Allemagne]Muscle Biopsy Substantiates Long-Term MRI Alterations One Year After A Single Dose of Botulinum Toxin Injected into the Lateral Gastrocnemius Muscle of Healthy Volunteers
000E01 Félix Javier Jimenez-Jimenez [Espagne] ; Lluisa Rubio [Espagne] ; Marisol Calleja [Espagne] ; Hortensia Alonso-Navarro [Espagne] ; Laura Turpin-Fenoll [Espagne] ; José Francisco Plaza-Nieto [Espagne] ; Belén Pilo-De-La-Fuente [Espagne] ; Pedro J. Garcia-Ruiz [Espagne] ; José A. G. Agundez [Espagne]Motor Performance in Patients with Restless Legs Syndrome
000E04 Sebastian Paus [Allemagne] ; Franziska Gadow [Allemagne] ; Michael Knapp [Allemagne] ; Christine Klein [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]Motor Complications in Patients Form the German Competence Network on Parkinson's Disease and the DRD3 Ser9Gly Polymorphism
000E09 Elan D. Louis [États-Unis] ; Eileen Rios [États-Unis] ; Claire Henchcliffe [États-Unis]Mirror Movements in Patients with Essential Tremor
000E12 Maria G. Cersosimo [Argentine] ; Gabriela B. Raina [Argentine] ; Eduardo E. Benarroch [États-Unis] ; Fabian Piedimonte [Argentine] ; Gabriela Gonzalez Aleman [Argentine] ; Federico E. Micheli [Argentine]Micro Lesion Effect of the Globus Pallidus Internus and Outcome with Deep Brain Stimulation in Patients with Parkinson Disease and Dystonia
000E23 Sophie Molloy [Royaume-Uni] ; Thais Minett [Brésil] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; David J. Burn [Royaume-Uni]Levodopa Use and Sleep in Patients with Dementia with Lewy Bodies
000E28 Cyrus P. Zabetian [États-Unis] ; Mitsutoshi Yamamoto [Japon] ; Alexis N. Lopez [États-Unis] ; Hiroshi Ujike [Japon] ; Ignacio F. Mata [États-Unis] ; Yuishin Izumi [Japon] ; Ryuji Kaji [Japon] ; Hirofumi Maruyama [Japon] ; Hiroyuki Morino [Japon] ; Masaya Oda [Japon] ; Carolyn M. Hutter [États-Unis] ; Karen L. Edwards [États-Unis] ; Gerard D. Schellenberg [États-Unis] ; Debby W. Tsuang [États-Unis] ; Dora Yearout [États-Unis] ; Eric B. Larson [États-Unis] ; Hideshi Kawakami [Japon]LRRK2 Mutations and Risk Variants in Japanese Patients with Parkinson's Disease
000E32 Roy Elbers [Pays-Bas] ; Erwin E. H. Van Wegen [Pays-Bas] ; Lynn Rochester [Royaume-Uni] ; Victoria Hetherington [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; Anne-Marie Willems [Belgique] ; Diana Jones [Royaume-Uni] ; Gert Kwakkel [Pays-Bas]Is Impact of Fatigue an Independent Factor Associated with Physical Activity in Patients with Idiopathic Parkinson's Disease?
000E37 Satoru Morimoto [Japon] ; Shigeki Kuzuhara [Japon] ; Yasumasa Kokubo [Japon]Increased Oxidative Stress in Patients with Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex in the Kii Peninsula, Japan
000E47 Stefano Zoccolella [Italie] ; Claudia Dell'Aquila [Italie] ; Giovanni Abruzzese [Italie] ; Angelo Antonini [Italie] ; Ubaldo Bonuccelli [Italie] ; Margherita Canesi [Italie] ; Silvano Cristina [Italie] ; Roberta Marchese [Italie] ; Claudio Pacchetti [Italie] ; Roberto Zagaglia [Italie] ; Giancarlo Logroscino [Italie] ; Giovanni Defazio [Italie] ; Paolo Lamberti [Italie] ; Paolo Livrea [Italie]Hyperhomocysteinemia in Levodopa-Treated Patients with Parkinson's Disease Dementia
000E52 Thomas Müller [Allemagne] ; Wilfried Kuhn [Allemagne]Homocysteine Levels After Acute Levodopa Intake in Patients with Parkinson's Disease
000E53 Richard M. Camicioli [Canada] ; Thomas P. Bouchard [Canada] ; Martin J. Somerville [Canada]Homocysteine Is Not Associated with Global Motor or Cognitive Measures in Nondemented Older Parkinson's Disease Patients
000E59 MYUNG SIK LEE [Corée du Sud] ; WON JOO KIM [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; SEON JEONG KIM [Corée du Sud]Giant Somatosensory Evoked Potential in a Patient with Shaking TIA
000E61 Maria G. Macedo [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; YUE FANG [Pays-Bas] ; Stephanie M. Van Rooden [Pays-Bas] ; Martine Visser [Pays-Bas] ; Burcu Anar [Pays-Bas] ; Antonella Uras [Pays-Bas] ; Justus L. Groen [Pays-Bas] ; Patrizia Rizzu [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Peter Heutink [Pays-Bas]Genotypic and Phenotypic Characteristics of Dutch Patients with Early Onset Parkinson's Disease
000E62 Ming-Jen Lee [Taïwan] ; Ignacio F. Mata [États-Unis] ; Chin-Hsien Lin [Taïwan] ; Kai-Yuan Tzen [Taïwan] ; Sarah J. Lincoln [États-Unis] ; Rebecca Bounds [États-Unis] ; Paul J. Lockhart [Australie] ; Mary M. Hulihan [États-Unis] ; Matthew J. Farrer [États-Unis] ; Ruey-Meei Wu [Taïwan]Genotype-Phenotype Correlates in Taiwanese Patients with Early-Onset Recessive Parkinsonism
000E75 Yasuyuki Okuma [Japon] ; Satoshi Kamei [Japon] ; Akihiko Morita [Japon] ; Fumihito Yoshii [Japon] ; Toshimasa Yamamoto [Japon] ; Shiori Hashimoto [Japon] ; Hiroya Utsumi [Japon] ; Taku Hatano [Japon] ; Nobutaka Hattori [Japon] ; Miyuki Matsumura [Japon] ; Kazushi Takahashi [Japon] ; Shigeru Nogawa [Japon] ; Yuka Watanabe [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon]Fatigue in Japanese Patients with Parkinson's Disease: A Study Using Parkinson Fatigue Scale
000E78 Ji E. Lee [Corée du Sud] ; Hae-Won Shin [Corée du Sud] ; Kyung S. Kim [Corée du Sud] ; Young H. Sohn [Corée du Sud]Factors Contributing to the Development of Restless Legs Syndrome in Patients with Parkinson Disease
000E81 Pierre-François Pradat [France] ; Gaelle Bruneteau [France] ; Elisabetta Munerati [France] ; François Salachas [France] ; Nadine Le Forestier [France] ; Lucette Lacomblez [France] ; Timothee Lenglet [France] ; Vincent Meininger [France]Extrapyramidal Stiffness in Patients with Amyotrophic Lateral Sclerosis
000E83 Lina Shehadeh [États-Unis] ; Georgia Mitsi [États-Unis] ; Nikhil Adi [États-Unis] ; Nanette Bishopric [États-Unis] ; Spyridon Papapetropoulos [États-Unis]Expression of Lewy Body Protein Septin 4 in Postmortem Brain of Parkinson's Disease and Control Subjects
000E92 Livia Brusa [Italie] ; Enrico Finazzi Agro [Italie] ; Filomena Petta [Italie] ; Francesco Sciobica [Italie] ; Sara Torriero [Italie] ; Emanuele Lo Gerfo [Italie] ; Cesare Iani [Italie] ; Paolo Stanzione [Italie] ; Giacomo Koch [Italie]Effects of Inhibitory rTMS on Bladder Function in Parkinson's Disease Patients
000E97 Elizabeth L. Stegemöller [États-Unis] ; Tanya Simuni [États-Unis] ; Colum Mackinnon [États-Unis]Effect of Movement Frequency on Repetitive Finger Movements in Patients with Parkinson's Disease
000F08 Vincenzo Rizzo [Italie] ; Irene Arico [Italie] ; Claudia Mastroeni [Italie] ; Francesca Morgante [Italie] ; Giovanna Liotta [Italie] ; Paolo Girlanda [Italie] ; Rosalia Silvestri [Italie] ; Angelo Quartarone [Italie]Dopamine Agonists Restore Cortical Plasticity in Patients with Idiopathic Restless Legs Syndrome
000F18 Adam Zaidel [Israël] ; Alexander Spivak [Israël] ; Lavi Shpigelman [Israël] ; Hagai Bergman [Israël] ; Zvi Israel [Israël]Delimiting Subterritories of the Human Subthalamic Nucleus by Means of Microelectrode Recordings and a Hidden Markov Model
000F25 Evangelia Delikanaki-Skaribas [États-Unis] ; Marilyn Trail [États-Unis] ; William Wai-Lun Wong [États-Unis] ; Eugene C. Lai [États-Unis]Daily Energy Expenditure, Physical Activity, and Weight Loss in Parkinson's Disease Patients
000F26 Thomas Müller [Allemagne] ; Wilfried Kuhn [Allemagne]Cysteine Elevation in Levodopa-Treated Patients with Parkinson's Disease
000F31 Kelvin L. Chou [États-Unis] ; Melissa M. Amick [États-Unis] ; Margaret Gagner [États-Unis]Contrast Sensitivity in Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation
000F40 Gabriel Robert [France] ; Dominique Drapier [France] ; Marc Verin [France] ; Bruno Millet [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France]Cognitive Impulsivity in Parkinson's Disease Patients: Assessment and Pathophysiology
000F42 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Francesca Verde [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson's Disease
000F47 Jason P. Covy [États-Unis] ; WUXING YUAN [États-Unis] ; Elisa A. Waxman [États-Unis] ; Howard I. Hurtig [États-Unis] ; Vivianna M. Van Deerlin [États-Unis] ; Benoit I. Giasson [États-Unis]Clinical and Pathological Characteristics of Patients with Leucine-Rich Repeat Kinase-2 Mutations
000F49 Maria Elisa Alonso [Mexique] ; Adriana Ochoa [Mexique] ; Marie-Catherine Boll [Mexique] ; Ana Luisa Sosa [Mexique] ; Petra Yescas [Mexique] ; Marisol Lopez [Mexique] ; Rosario Macias [Mexique] ; Itziar Familiar [États-Unis] ; Astrid Rasmussen [États-Unis]Clinical and Genetic Characteristics of Mexican Huntington's Disease Patients
000F53 Sibel Ertan [Turquie] ; Derya Uluduz [Turquie] ; Sibel Ozekmekci [Turquie] ; Günes Kiziltan [Turquie] ; Turan Ertan [Turquie] ; Cengiz Yalcinkaya [Turquie] ; Cigdem Ozkara [Turquie]Clinical Characteristics of 49 Patients with Psychogenic Movement Disorders in a Tertiary Clinic in Turkey
000F67 Martin Witt [Allemagne] ; Katja Bormann [Allemagne] ; Volker Gudziol [Allemagne] ; Kerstin Pehlke [Allemagne] ; Kathrin Barth [Allemagne] ; Amir Minovi [Allemagne] ; Antje H Hner [Allemagne] ; Heinz Reichmann [Allemagne] ; Thomas Hummel [Allemagne]Biopsies of Olfactory Epithelium in Patients with Parkinson's Disease
000F68 Elena Urrestarazu [Espagne] ; Jorge Iriarte [Espagne] ; Manuel Alegre [Espagne] ; Pedro Clavero [Espagne] ; Mari Cruz Rodnguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; José A. Obeso [Espagne] ; Julio Artieda [Espagne]Beta Activity in the Subthalamic Nucleus During Sleep in Patients with Parkinson's Disease
000F93 Edward J. Newman [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Accuracy of Parkinson's Disease Diagnosis in 610 General Practice Patients in the West of Scotland
000F94 Ana Djarmati [Allemagne] ; Johann Hagenah [Allemagne] ; Kathrin Reetz [Allemagne] ; Susen Winkler [Allemagne] ; Maria Isabel Behrens [Chili] ; Heike Pawlack [Allemagne] ; Katja Lohmann [Allemagne] ; Alfredo Ramirez [Allemagne] ; Vera Tadic [Allemagne] ; Norbert Brüggemann [Allemagne] ; Daniela Berg [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; Ferdinand Binkofski [Allemagne] ; Vladimir S. Kostic [Serbie] ; Jens Volkmann [Allemagne] ; Thomas Gasser [Allemagne] ; Christine Klein [Allemagne]ATP13A2 Variants in Early-Onset Parkinson's Disease Patients and Controls
001009 Seyedmehdi Shojaee [Iran] ; Farzad Sina [Iran] ; Niloofar Farboodi [Iran] ; Zeinab Fazlali [Iran] ; Farzaneh Ghazavi [Iran] ; SEYED ALI GHORASHI [Iran] ; Khosro Parsa [Iran] ; Homa Sadeghi [Iran] ; Gholam-Ali Shahidi [Iran] ; Mostafa Ronaghi [États-Unis] ; Elahe Elahi [Iran]A Clinic-Based Screening of Mutations in Exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's Disease Patients
001017 Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada]rCBF Changes Associated with PPN Stimulation in a Patient with Parkinson's disease : A PET Study
001022 Anne Marthe Meppelink [Pays-Bas] ; Janneke Koerts [Pays-Bas] ; Maarten Borg [Pays-Bas] ; Klaus Leonard Leenders [Pays-Bas] ; Teus Van Laar [Pays-Bas]Visual Object Recognition and Attention in Parkinson's Disease Patients with Visual Hallucinations
001026 Pablo Martinez-Martin [Espagne] ; Eduardo Tolosa [Espagne] ; Basilio Hernandez [Espagne] ; Xavier Badia [Espagne]Validation of the "QUICK" Questionnaire : A Tool for Diagnosis of "Wearing-Off" in Patients with Parkinson's Disease
001031 Seong-Beom Koh [Corée du Sud] ; Jee-Hoon Roh [Corée du Sud] ; JI HYUN KIM [Corée du Sud] ; Kyungmi Oh [Corée du Sud] ; Byung-Jo Kim [Corée du Sud] ; Gui-Sang Kim [Corée du Sud] ; Byung-Kyu Park [Corée du Sud] ; Se-Ju Kim [Corée du Sud] ; Joon-Shik Yoon [Corée du Sud]Ultrasonographic Findings of Shoulder Disorders in Patients with Parkinson's Disease
001035 Olalla Bello [Espagne] ; Jose Andres Sanchez [Espagne] ; Miguel Fernandez-Del-Olmo [Espagne]Treadmill Walking in Parkinson's Disease Patients : Adaptation and Generalization Effect
001062 Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada]The G2019S LRRK2 Mutation in Brazilian Patients with Parkinson's Disease : Phenotype in Monozygotic Twins
001086 Robert A. Hauser [États-Unis] ; Lisa M. Shulman [États-Unis] ; Joel M. Trugman [États-Unis] ; John W. Roberts [États-Unis] ; Akihisa Mori [Japon] ; Rocco Ballerini [États-Unis] ; Neil M. Sussman [États-Unis]Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor Fluctuations
001090 Cyril Gitiaux [France] ; Emmanuel Roze [France] ; Kiyoka Kinugawa [France] ; Constance Flamand-Rouviere [France] ; Nathalie Boddaert [France] ; Emmanuelle Apartis [France] ; Vassili Valayannopoulos [France] ; Guy Touati [France] ; Jacques Motte [France] ; David Devos [France] ; Karine Mention [France] ; Dries Dobbelaere [France] ; Diana Rodriguez [France] ; Agathe Roubertie [France] ; Brigitte Chabrol [France] ; Francois Feillet [France] ; Marie Vidailhet [France] ; Nadia Bahi-Buisson [France]Spectrum of Movement Disorders Associated with Glutaric Aciduria Type 1 : A Study of 16 Patients
001094 Julio Lopez-Bastida [Espagne] ; Lilisbeth Perestelo-Perez [Espagne] ; Fernando Monton-Alvarez [Espagne] ; Pedro Serrano-Aguilar [Espagne]Social Economic Costs and Health-Related Quality of Life in Patients with Degenerative Cerebellar Ataxia in Spain
001101 Paolo Barone [Italie] ; David J. Burn [Royaume-Uni] ; Teus Van Laar [Pays-Bas] ; Chuanchieh Hsu [États-Unis] ; Wemer Poewe [Autriche] ; Roger M. Lane [États-Unis]Rivastigmine Versus Placebo in Hyperhomocysteinemic Parkinson's Disease Dementia Patients
001102 Jean-Sébastien Vidal [France] ; Marie Vidailhet [France] ; Alexis Elbaz [France] ; Pascal Derkinderen [France] ; Christophe Tzourio [France] ; Annick Alperovitch [France]Risk Factors of Multiple System Atrophy : A Case-Control Study in French Patients
001104 Marcel J. H. Aries [Belgique] ; Hans Debruyne [Belgique] ; Sebastiaan Engelborghs [Belgique] ; Nathalie Le Bastard [Belgique] ; Nore Somers [Belgique] ; Dagmar Gorissen [Belgique] ; Barbara A. Pickut [Belgique] ; Peter Paul De Deyn [Belgique]Reversal of Head Drop After Discontinuation of Olanzapine in a DLB Patient
001109 Francisco Coria [Espagne] ; Maria Del Puig Cozar-Santiago [Espagne]Rasagiline Improves Freezing in a Patient with Primary Progressive Freezing Gait
001117 Wouter B. Reedijk [Pays-Bas] ; Monique A. Van Rijn [Pays-Bas] ; Karin Roelofs [Pays-Bas] ; Jolien P. Tuijl [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas]Psychological Features of Patients with Complex Regional Pain Syndrome Type I Related Dystonia
001128 Alison La Pean [États-Unis] ; Neal Jeffries [États-Unis] ; Chelsea Grow [États-Unis] ; Bernard Ravina [États-Unis] ; Nicholas A. Di Prospero [États-Unis]Predictors of Progression in Patients with Friedreich Ataxia
001143 Rebecca E. Ready [États-Unis] ; Melissa Mathews [États-Unis] ; Anne Leserman [États-Unis] ; Jane S. Paulsen [États-Unis]Patient and Caregiver Quality of Life in Huntington's Disease
001155 Pierre J. Blanchet [Canada] ; Romana Popovici [Canada] ; Francine Guitard [Canada] ; Pierre H. Rompre [Canada] ; Claude Lamarche [Canada] ; Gilles J. Lavigne [Canada]Pain and Denture Condition in Edentulous Orodyskinesia : Comparisons with Tardive Dyskinesia and Control Subjects
001159 Tim Anderson [Nouvelle-Zélande] ; Linda Luxon [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; C. David Marsden ; Adolfo Bronstein [Royaume-Uni]Oculomotor Function in Multiple System Atrophy : Clinical and Laboratory Features in 30 Patients
001171 Tomasz Litwin [Pologne] ; Grazyna Gromadzka [Pologne] ; Anna Członkowska [Pologne]Neurological Presentation of Wilson's Disease in a Patient After Liver Transplantation
001172 Sylvia Boesch [Autriche] ; Brigitte Sturm [Autriche] ; Sascha Hering [Autriche] ; Barbara Scheiber-Mojdehkar [Autriche] ; Hannes Steinkellner [Autriche] ; Hans Goldenberg [Autriche] ; Werner Poewe [Autriche]Neurological Effects of Recombinant Human Erythropoietin in Friedreich's Ataxia : A Clinical Pilot Trial
001177 Ji-Feng Guo [République populaire de Chine] ; BIN XIAO [République populaire de Chine] ; BING LIAO [République populaire de Chine] ; Xue-Wei Zhang [République populaire de Chine] ; Li-Luo Nie [République populaire de Chine] ; Yu-Hu Zhang [République populaire de Chine] ; LU SHEN [République populaire de Chine] ; HONG JIANG [République populaire de Chine] ; KUN XIA [République populaire de Chine] ; QIAN PAN [République populaire de Chine] ; Xin-Xiang Yan [République populaire de Chine] ; Bei-Sha Tang [République populaire de Chine]Mutation Analysis of Parkin, PINK1, DJ-1 and ATP13A2 Genes in Chinese Patients with Autosomal Recessive Early-Onset Parkinsonism
001182 Teresa Temudo [Portugal] ; Elisabete Ramos [Portugal] ; Karin Dias [Portugal] ; Clara Barbot [Portugal] ; Jose P. Vieira [Portugal] ; Ana Moreira [Portugal] ; Eulalia Calado [Portugal] ; Ines Carrilho [Portugal] ; Guiomar Oliveira [Portugal] ; Antonio Levy [Portugal] ; Maria Fonseca [Portugal] ; Alexandra Cabral [Portugal] ; Pedro Cabral [Portugal] ; Joao P. Monteiro [Portugal] ; Luis Borges [Portugal] ; Roseli Gomes [Portugal] ; Manuela Santos [Portugal] ; Jorge Sequeiros [Portugal] ; Patricia Maciel [Portugal]Movement Disorders in Rett Syndrome : An Analysis of 60 Patients with Detected MECP2 Mutation and Correlation with Mutation Type
001186 Susanne A. Schneider [Royaume-Uni] ; Penelope Talelli [Royaume-Uni] ; Binith J. Cheeran [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Motor Cortical Physiology in Patients and Asymptomatic Carriers of Parkin Gene Mutations
001189 Sylvie Piacentini [Italie] ; Luigi Romito [Italie] ; Angelo Franzini [Italie] ; Alberto Granato [Italie] ; Giovanni Broggi [Italie] ; Alberto Albanese [Italie]Mood Disorder Following DBS of the Left Amygdaloid Region in a Dystonia Patient with a Dislodged Electrode
001191 Donatella Ottaviani [Italie] ; Dorina Tiple [Italie] ; Antonio Suppa [Italie] ; Carlo Colosimo [Italie] ; Giovanni Fabbrini [Italie] ; Massimo Cincotta [Italie] ; Giovanni Defazio [Italie] ; Alfredo Berardelli [Italie]Mirror Movements in Patients with Parkinson's Disease
001198 Roy C. Martin [États-Unis] ; Ozioma C. Okonkwo [États-Unis] ; Joni Hill [États-Unis] ; H. Randall Griffith [États-Unis] ; Kristen Triebel [États-Unis] ; Alfred Bartolucci [États-Unis] ; Anthony P. Nicholas [États-Unis] ; Ray L. Watts [États-Unis] ; Natividad Stover [États-Unis] ; Lindy E. Harrell [États-Unis] ; David Clark [États-Unis] ; Daniel C. Marson [États-Unis]Medical Decision-Making Capacity in Cognitively Impaired Parkinson's Disease Patients Without Dementia
001201 Beata Tarnacka [Pologne] ; Wojciech Szeszkowski [Pologne] ; Marek Golebiowski [Pologne] ; Anna Czlonkowska [Pologne]MR Spectroscopy in Monitoring the Treatment of Wilson's Disease Patients
001210 Mercedes Serrano [Espagne] ; Belen Perez-Duenas [Espagne] ; Aida Ormazabal [Espagne] ; Rafael Artuch [Espagne] ; Jaume Campistol [Espagne] ; Rosa J. Torres [Espagne] ; Angels Garcia-Cazorla [Espagne]Levodopa Therapy in a Lesch-Nyhan Disease Patient : Pathological, Biochemical, Neuroimaging, and Therapeutic Remarks
001218 Rocco Agostino [Italie] ; Loredana Dinapoli [Italie] ; Nicola Modugno [Italie] ; Ennio Iezzi [Italie] ; Bruno Gregori [Italie] ; Vincenzo Esposito [Italie] ; Pantaleo Romanelli [Italie] ; Alfredo Berardelli [Italie]Ipsilateral Sequential Arm Movements After Unilateral Subthalamic Deep-Brain Stimulation in Patients with Parkinson's Disease
001225 Guilherme G. Riccioppo Rodrigues [Brésil] ; Ruth H. Walker [États-Unis] ; Alexis Brice [France] ; Cécile Cazeneuve [France] ; Odile Russaouen [France] ; Helio A. G. Teive [Brésil] ; Renato Puppi Munhoz [Brésil] ; Nilson Becker [Brésil] ; Salmo Raskin [Brésil] ; Lineu Cesar Wemeck [Brésil] ; Wilson Marques Junior [Brésil] ; Vitor Tumas [Brésil]Huntington's Disease-Like 2 in Brazil-Report of 4 Patients
001230 Alfonso Fasano [Italie] ; Caria Piano [Italie] ; Celestino De Simone [Italie] ; Beatrice Cioni [Italie] ; Daniela Di Giuda [Italie] ; Massimiliano Zinno [Italie] ; Antonio Daniele [Italie] ; Mario Meglio [Italie] ; Alessandro Giordano [Italie] ; Anna Rita Bentivoglio [Italie]High Frequency Extradural Motor Cortex Stimulation Transiently Improves Axial Symptoms in a Patient with Parkinson's Disease
001232 WON YONG LEE [Corée du Sud] ; WON TAE YOON [Corée du Sud] ; HEE YOUNG SHIN [Corée du Sud] ; SEONG HEE JEON [Corée du Sud] ; Poong-Lyul Rhee [Corée du Sud]Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease
001240 Patricia De Carvalho Aguiar [Brésil] ; Patricia Silva Lessa [Brésil] ; Clecio Godeiro Junior [Brésil] ; Orlando Barsottini [Brésil] ; Andre Carvalho Felicio [Brésil] ; Vanderci Borges [Brésil] ; Sonia Maria De Azevedo Silva [Brésil] ; Roberta Arb Saba [Brésil] ; Henrique Ballalai Ferraz [Brésil] ; Carlos A. Moreira-Filho [Brésil] ; Luiz Augusto F. Andrade [Brésil]Genetic and Environmental Findings in Early-onset Parkinson's Disease Brazilian Patients
001242 Evelien Huisman [Pays-Bas] ; Harry B. M. Uylings [Pays-Bas] ; Piet V. Hoogland [Pays-Bas, Afrique du Sud]Gender-Related Changes in Increase of Dopaminergic Neurons in the Olfactory Bulb of Parkinson's Disease Patients
001247 Marianna Amboni [Italie] ; Autilia Cozzolino [Italie] ; Katia Longo [Italie] ; Marina Picillo [Italie] ; Paolo Barone [Italie]Freezing of Gait and Executive Functions in Patients with Parkinson's Disease
001262 Barbara Leinweber [Allemagne] ; J. Carsten Möller [Allemagne] ; Andre Scherag [Allemagne] ; Ulrike Reuner [Allemagne] ; Peter Günther [Allemagne] ; Christoph J. G. Lang [Allemagne] ; Hartmut H. J. Schmidt [Allemagne] ; Christoph Schrader [Allemagne] ; Oliver Bandmann [Royaume-Uni] ; Anna Czlonkowska [Pologne] ; Wolfgang H. Oertel [Allemagne] ; Harald Hefter [Allemagne]Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German Patients with Treated Wilson's Disease
001264 Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Vanessa K. Hinson [États-Unis] ; Lucia M. Blasucci [États-Unis] ; Jennifer Zimmerman [États-Unis] ; WENQING FAN [États-Unis] ; Tiffany Nguyen [États-Unis] ; Ann Hsu [États-Unis]Evaluating Parkinson's Disease Patients at Home : Utility of Self-Videotaping for Objective Motor, Dyskinesia, and ON-OFF Assessments
001265 Samuel A. Frank [États-Unis] ; Renee Wilson [États-Unis] ; Robert G. Holloway [États-Unis] ; Carol Zimmerman [États-Unis] ; Derick R. Peterson [États-Unis] ; Karl Kieburtz [États-Unis] ; Scott Y. H. Kim [États-Unis]Ethics of Sham Surgery : Perspective of Patients
001266 Thomas Müller [Allemagne] ; Dirk Woitalla [Allemagne] ; Oliver Goetze [Allemagne, Suisse] ; Christoph Erdmann [Allemagne]Entacapone Improves Absorption of a Coadministered Salt in Patients with Parkinson's Disease
001268 Mia T. Minen [États-Unis] ; Elan D. Louis [États-Unis]Emergence of Parkinson's Disease in Essential Tremor : A Study of the Clinical Correlates in 53 Patients
001269 Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada]Elevated Serotonin Transporter Binding in Depressed Patients with Parkinson's Disease : A Preliminary PET Study with [11C]DASB
001283 Thomas A. Buckley [États-Unis] ; Chris Pitsikoulis [États-Unis] ; Chris J. Hass [États-Unis]Dynamic Postural Stability During Sit-to-Walk Transitions in Parkinson Disease Patients
001287 Julie H. Carter [États-Unis] ; Barbara J. Stewart [États-Unis] ; Karen S. Lyons [États-Unis] ; Patricia G. Archbold [États-Unis]Do Motor and Nonmotor Symptoms in PD Patients Predict Caregiver Strain and Depression?
001290 Nathalie Chastan [France] ; Bertrand Debono [France] ; David Maltete [France] ; Jacques Weber [France]Discordance Between Measured Postural Instability and Absence of Clinical Symptoms in Parkinson's Disease Patients in the Early Stages of the Disease
001298 Sierra Farris [États-Unis] ; Paul Ford [États-Unis] ; Joseph Demarco [États-Unis] ; Monique L. Giroux [États-Unis]Deep Brain Stimulation and the Ethics of Protection and Caring for the Patient with Parkinson's Dementia
001304 Alice Nieuwboer [Belgique]Cueing for Freezing of Gait in Patients with Parkinson's Disease : A Rehabilitation Perspective
001305 Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong]Cued Task-Specific Training is Better Than Exercise in Improving Sit-to-Stand in Patients with Parkinson's Disease : A Randomized Controlled Trial
001308 Laura Avanzino [Royaume-Uni, Italie] ; Davide Martino [Royaume-Uni, Italie] ; Bart P. C. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Susanne A. Schneider [Royaume-Uni] ; Giovanni Abbruzzese [Italie] ; Giovanni Defazio [Italie] ; Anette Schrag [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni]Cortical Excitability is Abnormal in Patients with the "Fixed Dystonia" Syndrome
001310 Stephen Tisch [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni]Cortical Evoked Potentials from Pallidal Stimulation in Patients with Primary Generalized Dystonia
001325 Minori Enomoto [Japon] ; Yuichi Inoue [Japon] ; Kazuyoshi Namba [Japon] ; Takashi Munezawa [Japon] ; Masato Matsuura [Japon]Clinical Characteristics of Restless Legs Syndrome in End-Stage Renal Failure and Idiopathic RLS Patients
001326 Daisy L. Whitehead [Royaume-Uni] ; Ann D. M. Davies [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni] ; Christopher J. Turnbull [Royaume-Uni]Circadian Rest-Activity Rhythm Is Altered in Parkinson's Disease Patients with Hallucinations
001338 Pablo Martinez-Martin [Espagne] ; Susana Arroyo [Espagne] ; Jose Manuel Rojo-Abuin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Belen Frades [Espagne] ; Jesus De Pedro Cuesta [Espagne]Burden, Perceived Health Status, and Mood Among Caregivers of Parkinson's Disease Patients
001340 Blanca Ramirez-Ruiz [Espagne] ; Maria-José Marti [Espagne] ; Eduardo Tolosa [Espagne] ; Carlos Falcon [Espagne] ; Nuria Bargallo [Espagne] ; Francesc Valldeoriola [Espagne] ; Carme Junque [Espagne]Brain Response to Complex Visual Stimuli in Parkinson's Patients with Hallucinations : A Functional Magnetic Resonance Imaging Study
001342 Anna L. Bartels [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Brain Imaging in Patients with Freezing of Gait
001343 Eric J. Pappert [États-Unis] ; Terry Germanson [Canada]Botulinum Toxin Type B vs. Type A in Toxin-Naïve Patients with Cervical Dystonia : Randomized, Double-Blind, Noninferiority Trial
001351 Claudia Schmidt [Allemagne] ; Birgit Herting [Allemagne] ; Silke Prieur [Allemagne] ; Susann Junghanns [Allemagne] ; Katherine Schweitzer [Allemagne] ; Heinz Reichmann [Allemagne] ; Daniela Berg [Allemagne] ; Tjalf Ziemssen [Allemagne]Autonomic Dysfunction in Patients with Progressive Supranuclear Palsy
001360 Ebba Lohmann [France] ; Marie-Laure Welter [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Suzanne Lesage [France] ; Sophie Laine [France] ; Marie-Laure Tanguy [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Pierre Pollak [France] ; Alexandra Durr [France] ; Yves Agid [France] ; Alexis Brice [France]Are Parkin Patients Particularly Suited for Deep-Brain Stimulation?
001370 CHUL HYOUNG LYOO [Corée du Sud] ; Holger Prokisch [Allemagne] ; Thomas Meitinger [Allemagne] ; SEUNG YEOB LEE [Corée du Sud] ; DO HYOUN KIM [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud]Anticholinergic-Responsive Gait Freezing in a Patient with Pantothenate Kinase-Associated Neurodegeneration
001374 Kenichi Kashihara [Japon] ; Takaki Imamura [Japon]Amantadine May Reverse Punding in Parkinson's Disease- : Observation in a Patient
001375 Alessandro M. De Nunzio [Italie] ; Antonio Nardone [Italie] ; Daniele Picco [Italie] ; Jan Nilsson [Italie] ; Marco Schieppati [Italie]Alternate Trains of Postural Muscle Vibration Promote Cyclic Body Displacement in Standing Parkinsonian Patients
001384 Marcin Lesniak [Pologne] ; Anna Czlonkowska [Pologne] ; Joanna Seniow [Pologne]Abnormal Antisaccades and Smooth Pursuit Eye Movements in Patients with Wilson's Disease
001391 Claudia Cagnoli [Italie] ; Alessandro Brussino [Italie] ; Luca Sbaiz [Italie] ; Eleonora Di Gregorio [Italie] ; Cristiana Atzori [Italie] ; Paola Caroppo [Italie] ; Laura Orsi [Italie] ; Nicola Migone [Italie] ; Carlo Buffa [Italie] ; Daniele Imperiale [Italie] ; Alfredo Brusco [Italie]A Previously Undiagnosed Case of Gerstmann-Sträussler-Scheinker Disease Revealed by Prnp Gene Analysis in Patients with Adult-Onset Ataxia
001393 Cecilia Marelli ; Laura Canafoglia ; Federica Zibordi ; Claudia Ciano ; Elisa Visani ; Giovanna Zorzi ; Barbara Garavaglia ; Chiara Barzaghi ; Alberto Albanese ; Paola Soliveri ; Massimo Leone ; Ferruccio Panzica ; Vidmer Scaioli ; Alessandro Pincherle ; Nardo Nardocci ; Silvana FranceschettiA Neurophysiological Study of Myoclonus in Patients with DYT11 Myoclonus-Dystonia Syndrome
001407 Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne]Valvular heart disease in parkinson's disease patients treated with dopamine agonists : A reader-blinded monocenter echocardiography study
001408 Dominic Jamora [Singapour, Philippines] ; Shih-Hui Lim [Singapour] ; Andrew Pan [Singapour] ; Louis Tan [Singapour] ; Eng-King Tan [Singapour]Valproate-induced parkinsonism in epilepsy patients
001410 Yael Manor [Israël] ; Nir Giladi [Israël] ; Alma Cohen [Israël] ; Dan M. Fliss [Israël] ; Jacob T. Cohen [Israël]Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with parkinson's disease
001411 Santiago Perez Lloret [Argentine] ; Gabriel Piran Arce [Argentine] ; Malco Rossi [Argentine] ; Maria Laura Caivano Nemet [Argentine] ; Paz Salsamendi [Argentine] ; Marcelo Merello [Argentine]Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease
001416 Anne-Marie Willems [Belgique] ; Alice Nieuwboer [Belgique] ; Fabienne Chavret [Belgique] ; Kaat Desloovere [Belgique] ; René Dom [Belgique] ; Lynn Rochester [Royaume-Uni] ; Gert Kwakkel [Pays-Bas] ; Erwin Van Wegen [Pays-Bas] ; Diana Jones [Royaume-Uni]Turning in parkinson's disease patients and controls : The effect of auditory cues
001424 Brenda L. Den Oudsten [Pays-Bas] ; Guus L. Van Heck [Pays-Bas] ; Jolanda De Vries [Pays-Bas]The suitability of patient-based measures in the field of Parkinson's disease : A systematic review
001438 Kelvin L. Chou [États-Unis] ; Maria L. Moro-De-Casillas [États-Unis] ; Melissa M. Amick [États-Unis] ; Leora L. Borek [États-Unis] ; Joseph H. Friedman [États-Unis]Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's
001439 Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]Ten-Year Follow-Up of Parkinson's Disease Patients Randomized to Initial Therapy with Ropinirole or Levodopa
001441 Ville Pursiainen [Finlande] ; Tarja H. Haapaniemi [Finlande] ; Juha T. Korpelainen [Finlande] ; Kyösti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande]Sweating in parkinsonian patients with wearing-off
001443 Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni]Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease
001446 Michael Schüpbach [France] ; Ebba Lohmann [France] ; Mathieu Anheim [France] ; Suzanne Lesage [France] ; Virginie Czernecki [France] ; Sadek Yaici [France] ; Yulia Worbe [France] ; Perrine Charles [France] ; Marie-Laure Welter [France] ; Pierre Pollak [France] ; Alexandra Dürr [France] ; Yves Agid [France] ; Alexis Brice [France]Subthalamic nucleus stimulation is efficacious in patients with parkinsonism and LRRK2 mutations
001449 Leonardo Bonilha [États-Unis] ; Paulien M. De Vries [Pays-Bas] ; Diana J. Vincent [États-Unis] ; Chris Rorden [États-Unis] ; Paul S. Morgan [Royaume-Uni] ; Mark W. Hurd [États-Unis] ; Nada Besenski [États-Unis] ; Kenneth J. Bergmann [États-Unis] ; Vanessa K. Hinson [États-Unis]Structural white matter abnormalities in patients with idiopathic dystonia
001452 Christopher D. Herzog [États-Unis] ; Biplob Dass [États-Unis] ; James E. Holden [États-Unis] ; James Iii Stansell [États-Unis] ; Mehdi Gasmi [États-Unis] ; Mark H. Tuszynski [États-Unis] ; Raymond T. Bartus [États-Unis] ; Jeffrey H. Kordower [États-Unis]Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys
001463 Joaquim Ferreira [Portugal] ; Joao Maia Silva [Portugal] ; Rita Freire [Portugal] ; Joao Pignatelli [Portugal] ; Leonor Correia Guedes [Portugal] ; Alexandra Feijo [Portugal] ; Mario Miguel Rosa [Portugal] ; Miguel Coelho [Portugal] ; Joao Costa [Portugal] ; Ana Noronha [Portugal] ; Russell Hewett [Portugal] ; A. Marques Gomes [Portugal] ; J. L. Cime De Castro [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal]Skin cancers and precancerous lesions in Parkinson's disease patients
001469 Francesca Gilio [Italie] ; Antonio Suppa [Italie] ; Matteo Bologna [Italie] ; Cinzia Lorenzano [Italie] ; Giovanni Fabbrini [Italie] ; Alfredo Berardelli [Italie]Short-term cortical plasticity in patients with dystonia : A study with repetitive transcranial magnetic stimulation
001481 Andrew Siderowf [États-Unis] ; Danna Jennings [États-Unis] ; James Connolly [États-Unis] ; Richard L. Doty [États-Unis] ; Kenneth Marek [États-Unis] ; Matthew B. Stern [États-Unis]Risk Factors for Parkinson's Disease and Impaired Olfaction in Relatives of Patients with Parkinson's Disease
001483 Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Sung-Chul Lim [Corée du Sud] ; Jae-Young Ahn [Corée du Sud] ; In-Uk Song [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; Bum-Soo Kim [Corée du Sud] ; Hee-Tae Kim [Corée du Sud]Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: A possible association with oral midodrine treatment
001484 Emmanuel Roze [France] ; Valérie Cochen [France] ; Sophie Sangla [France] ; Thierry Bienvenu [France] ; Anne Roubergue [France] ; Smaranda Leu-Semenescu [France] ; Marie Vidaihet [France]Rett syndrome : An overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, parkinsonism, and dystonia?
001488 Anja Weyer [Allemagne] ; Michael Abele [Allemagne] ; Tanja Schmitz-Hübsch [Allemagne] ; Beate Schoch [Allemagne] ; Markus Frings [Allemagne] ; Dagmar Timmann [Allemagne] ; Thomas Klockgether [Allemagne]Reliability and validity of the scale for the assessment and rating of ataxia : A study in 64 ataxia patients
001490 Thomas Eckert [États-Unis, Allemagne] ; Andrew Feigin [États-Unis] ; Daniel E. Lewis [États-Unis] ; Vijay Dhawan [États-Unis] ; Steven Frucht [États-Unis] ; David Eidelberg [États-Unis]Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging
001496 Anna-Gerlind Postma [Pays-Bas] ; Mart A. A. M. Heesters [Pays-Bas] ; Teus Van Laar [Pays-Bas]Radiotherapy to the Salivary Glands as Treatment of Sialorrhea in Patients with Parkinsonism
001509 Yevgeniy Kuznetsov [Canada] ; Abdesslem Khiat [Canada] ; Pierre J. Blanchet [Canada] ; Yvan Boulanger [Canada]Proton magnetic resonance spectroscopy study of dyskinesia patients
001518 Anna Modoni [Italie] ; Maria Fiorella Contarino [Italie] ; Anna Rita Bentivoglio [Italie] ; Elisabetta Tabolacci [Italie] ; Massimo Santoro [Italie] ; Maria Lucia Calcagni [Italie] ; Pietro A. Tonali [Italie] ; Giovanni Neri [Italie] ; Gabriella Silvestri [Italie]Prevalence of spinocerebellar ataxia type 2 mutation among italian parkinsonian patients
001519 Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Richard G. Brown [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Lisa Clayton [Royaume-Uni] ; Kazuo Abe [Japon] ; Yoshio Tsuboi [Japon] ; Dough Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Ubaldo Bonuccelli [Italie] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Annette Hand [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; William Ondo [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni]Prevalence of nonmotor symptoms in parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients
001521 Elan D. Louis [États-Unis] ; Steven J. Frucht [États-Unis]Prevalence of essential tremor in patients with Parkinson's disease vs. parkinson-plus syndromes
001526 Michael Macht [Allemagne] ; Yvonne Kaussner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Karla Maria Eggert [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Heiner Ellgring [Allemagne]Predictors of freezing in Parkinson's disease: A survey of 6,620 patients
001532 Marco Bove [Italie] ; Giampaolo Brichetto [Italie] ; Giovanni Abbruzzese [Italie] ; Roberta Marchese [Italie] ; Marco Schieppati [Italie]Postural responses to continuous unilateral neck muscle vibration in standing patients with cervical dystonia
001533 Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa [Japon] ; Sadako Kuno [Japon] ; Nobuo Yanagisawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Tomoyoshi Kondo [Japon]Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating Parkinsonian patients
001542 Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Pablo Mir [Royaume-Uni, Espagne] ; Carla Cordivari [Royaume-Uni] ; Juzar Hooker [Royaume-Uni] ; John Dickson [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Patients With Adult-Onset Dystonic Tremor Resembling Parkinsonian Tremor Have Scans Without Evidence of Dopaminergic Deficit (SWEDDs)
001544 Josef Parvizi [États-Unis] ; Jeffrey Joseph [États-Unis] ; Daniel Z. Press [États-Unis] ; Jeremy D. Schmahmann [États-Unis]Pathological laughter and crying in patients with multiple system atrophy-cerebellar type
001552 Jill L. Ostrem [États-Unis] ; William J. Jr Marks [États-Unis] ; Monica M. Volz [États-Unis] ; Susan L. Heath [États-Unis] ; Philip A. Starr [États-Unis]Pallidal deep brain stimulation in patients with cranial-cervical dystonia (meige syndrome)
001562 Francesca Del Sorbo [Italie] ; Antonio E. Elia [Italie] ; Gabriella De Joanna [Italie] ; Luigi M. Romito [Italie] ; Barbara Garavaglia [Italie] ; Alberto Albanese [Italie]Normal cardiovascular reflex testing in patients with parkin disease
001569 Katie Kompoliti [États-Unis] ; YAPING CHU [États-Unis] ; Kathleen M. Shannon [États-Unis] ; Jeffrey H. Kordower [États-Unis]Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient
001571 Anna L. Bartels [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Neuroinflammation in the pathophysiology of parkinson's disease : Evidence from animal models to human in vivo studies with [11C]-PK11195 PET
001578 Melissa J. Nirenberg [États-Unis] ; Jenny Libien [États-Unis] ; Jean-Paul Vonsattel [États-Unis] ; Stanley Fahn [États-Unis]Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation
001581 Michael W. M. Schupbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltete [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France]Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus
001583 Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada]Mood Stability during Acute Stimulator Challenge in Parkinson's Disease Patients Under Long-Term Treatment with Subthalamic Deep Brain Stimulation
001587 JI YOUN KIM [Corée du Sud] ; SEONG TAE KIM [Corée du Sud] ; SEONG HEE JEON ; WON YONG LEE [Corée du Sud]Midbrain transcranial sonography in Korean patients with parkinson's disease
001588 Heike Stockner [Autriche] ; Martin Sojer [Autriche] ; Klaus Seppi K [Autriche] ; Joerg Mueller [Autriche] ; Gregor K. Wenning [Autriche] ; Christoph Schmidauer [Autriche] ; Werner Poewe [Autriche]Midbrain sonography in patients with essential tremor
001592 Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne]Meta-analysis of heart valve abnormalities in parkinson's disease patients treated with dopamine agonists
001603 Chiara Balducci [Italie] ; Laura Pierguidi [Italie] ; Emanuele Persichetti [Italie] ; Lucilla Parnetti [Italie] ; Michele Sbaragli [Italie] ; Carmelo Tassi [Italie] ; Aldo Orlacchio [Italie] ; Paolo Calabresi [Italie] ; Tommaso Beccari [Italie] ; Aroldo Rossi [Italie]Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
001629 Stephany Fulda [Allemagne] ; Thomas C. Wetter [Allemagne]Is Daytime Sleepiness a Neglected Problem in Patients with Restless Legs Syndrome?
001632 Elan D. Louis [États-Unis] ; Lakeisha M. Applegate [États-Unis] ; Eileen Rios [États-Unis]Interest in participating in clinical research : A study of essential tremor patients
001636 Walter A. Rocca [États-Unis] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Alexis Elbaz [États-Unis, France] ; Brandon R. Grossardt [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Daniel J. Schaid [États-Unis] ; Demetrius M. Maraganore [États-Unis]Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease
001638 Yew-Long Lo [Singapour] ; Elan D. Louis [États-Unis] ; Stephanie Fook-Chong [Singapour] ; Eng-King Tan [Singapour]Impaired motor imagery in patients with essential tremor : A case control study
001654 Vanessa K. Lim [Nouvelle-Zélande]Health Related Quality of Life in patients with dystonia and their caregivers in New Zealand and Australia
001661 Anna Jelaso Langerveld [États-Unis] ; Daniel Mihalko [États-Unis] ; Cari Delong [États-Unis] ; Jeff Walburn [États-Unis] ; Charles F. Ide [États-Unis]Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients
001662 Ettore Accolla [Italie] ; Elena Caputo [Italie] ; Filippo Cogiamanian [Italie] ; Filippo Tamma [Italie] ; Simona Mrakic-Sposta [Italie] ; Sara Marceglia [Italie] ; Marcello Egidi [Italie] ; Paolo Rampini [Italie] ; Marco Locatelli [Italie] ; Alberto Priori [Italie]Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation
001674 Elliot L. Dimberg [États-Unis] ; Sheila E. Crowe [États-Unis] ; Joel M. Trugman [États-Unis] ; Russell H. Swerdlow [États-Unis] ; M. Beatriz Lopes [États-Unis] ; T. David Bourne [États-Unis] ; Ted M. Burns [États-Unis]Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm
001677 Siegfried Muhlack [Allemagne] ; Jacub Welnic [Allemagne] ; Dirk Woitalla [Allemagne] ; Thomas Müller [Allemagne]Exercise improves efficacy of levodopa in patients with Parkinson's disease
001684 Julie Zyss [France] ; Jing Xie-Brustolin [France] ; Philippe Ryvlin [France] ; Stephane Peysson [France] ; Albert Beschet [France] ; Dominique Sappey-Marinier [France] ; Marc Hermier [France] ; Stéphane Thobois [France]Epilepsia partialis continua with dystonic hand movement in a patient with a malformation of cortical development
001689 Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox [Allemagne] ; Torsten Roscher [Allemagne] ; Dieter Schremmer [Allemagne] ; Ariel Gordin [Allemagne]Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing-off
001690 PRAMOD KUMAR PAL [Inde] ; PONNATHPUR SATISH LAKSHMI [Inde] ; Muninarayanappa Nirmala [Inde]Efficacy and complication of botulinum toxin injection in palatal myoclonus : Experience from a patient
001705 Eman M. Khedr [Égypte] ; John C. Rothwell [Royaume-Uni] ; Ola A. Shawky [Égypte] ; Mohammed A. Ahmed [Égypte] ; Nageh Foly [Égypte] ; Ahmed Hamdy [Égypte]Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: Preliminary results
001710 Paolo Martinelli [Italie] ; Giovanni Rizzo [Italie] ; David Manners [Italie] ; Caterina Tonon [Italie] ; Fabio Pizza [Italie] ; Claudia Testa [Italie] ; Cesa Scaglione [Italie] ; Bruno Barbiroli [Italie] ; Raffaele Lodi [Italie]Diffusion-weighted imaging study of patients with essential tremor
001716 Francisco Javier Carod-Artal [Brésil] ; Antonio Pedro Vargas [Brésil] ; Pablo Martinez-Martin [Espagne]Determinants of quality of life in Brazilian patients with Parkinson's disease
001752 Keisuke Suzuki [Japon] ; Yasuyuki Okuma [Japon] ; Nobutaka Hattori [Japon] ; Satoshi Kamei [Japon] ; Fumihito Yoshii [Japon] ; Hiroya Utsumi [Japon] ; Yasuo Iwasaki [Japon] ; Mutsumi Iijima [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon]Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale
001756 Kenta Sato [Japon] ; Ryuji Kaji [Japon] ; Sadayuki Matsumoto [Japon] ; Satoshi Goto [Japon]Cell type-specific neuronal loss in the putamen of patients with multiple system atrophy
001758 Petra Schwingenschuh [Autriche] ; Karoline Wenzel [Autriche] ; Petra Katschnig [Autriche] ; Ronald Saurugg [Autriche] ; Erwin Ott [Autriche]Case of a palatal tic resembling palatal tremor in a patient with tourette syndrome
001763 Claudia Trenkwalder [Allemagne] ; Heike Benes [Allemagne] ; Ludger Grote [Suède] ; Svenja Happe [Allemagne] ; Birgit Högl [Autriche] ; Johannes Mathis [Suisse] ; Gerda M. Saletu-Zyhlarz [Autriche] ; Ralf Kohnen [Allemagne]Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome : Results from a multicenter, randomized, active controlled trial
001767 Richard M. Trosch [États-Unis] ; Charles H. Adler [États-Unis] ; Eric J. Pappert [États-Unis]Botulinum toxin type B (Myobloc®) in subjects with hemifacial spasm : Results from an open-label, dose-escalation safety study
001770 James G. Colebatch [Australie]Bereitschaftspotential and movement-related potentials : Origin, significance, and application in disorders of human movement
001787 Shalom Michaeli [États-Unis] ; Gulin Öz [États-Unis] ; Dennis J. Sorce [États-Unis] ; Michael Garwood [États-Unis] ; Kamil Ugurbil [États-Unis] ; Stacv Majestic [États-Unis] ; Paul Tuite [États-Unis]Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts
001799 JI YOUN KIM [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; Hun-Jong Dhong [Corée du Sud]Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease
001807 Marie-Laure Mille [États-Unis] ; Marjorie Johnson Hilliard [États-Unis] ; Katherine M. Martinez [États-Unis] ; Tanya Simuni [États-Unis] ; Mark W. Rogers [États-Unis]Acute effects of a lateral postural assist on voluntary step initiation in patients with Parkinson's disease
001811 Eduardo Tolosa [Espagne] ; Thierry Vander Borght [Belgique] ; Emilio Moreno [Espagne]Accuracy of DaTSCAN (123I-Ioflupane) SPECT in Diagnosis of Patients with Clinically Uncertain Parkinsonism : 2-Year Follow-Up of an Open-Label Study
001813 Chul H. Lyoo [Corée du Sud] ; SEUNG YEOB LEE [Corée du Sud] ; TAE JIN SONG [Corée du Sud] ; MYUNG SIK LEE [Corée du Sud]Abnormal temporal discrimination threshold in patients with multiple system atrophy
001815 Tobias B Umer [Allemagne] ; Cüneyt Demiralay [Allemagne] ; Ute Hidding [Allemagne] ; Rosalia Bikmullina [Allemagne] ; Rick C. Helmich [Allemagne] ; Silke Wunderlich [Allemagne] ; John Rothwell [Royaume-Uni] ; Joachim Liepert [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Alexander Munchau [Allemagne]Abnormal plasticity of the sensorimotor cortex to slow repetitive transcranial magnetic stimulation in patients with Writer's cramp
001816 Elisabeth M. J. Foncke [Pays-Bas] ; Johan N. Van Der Meer [Pays-Bas] ; Johannes H. T. M. Koelman [Pays-Bas] ; Marina A. J. Tijssen [Pays-Bas]Abnormal low frequency drive in myoclonus-dystonia patients correlates with presence of dystonia
001821 Spiridon Papapetropoulos [États-Unis] ; Jennifer Friedman [États-Unis] ; Craig Blackstone [États-Unis] ; Gary I. Kleiner [États-Unis] ; Brian C. Bowen [États-Unis] ; Carlos Singer [États-Unis]A progressive, fatal dystonia-parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
001823 Dietrich Haubenberger [Autriche] ; Silvia Bonelli [Autriche] ; Christoph Hotzy [Autriche] ; Petra Leitner [Allemagne] ; Peter Lichtner [Allemagne] ; Doris Samal [Autriche] ; Regina Katzenschlager [Autriche] ; Atbin Djamshidian [Autriche] ; Thomas Brücke [Autriche] ; Michaela Steffelbauer [Autriche] ; Christian Bancher [Autriche] ; Josef Grossmann [Allemagne] ; Gerhard Ransmayr [Autriche] ; Tim M. Strom [Allemagne] ; Thomas Meitinger [Allemagne] ; Thomas Gasser [Allemagne] ; Eduard Auff [Autriche] ; Alexander Zimprich [Autriche]A novel LRRK2 mutation in an austrian cohort of patients with parkinson's disease
001829 Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni]A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease
001833 Gabriella Santangelo [Italie] ; Luigi Trojano [Italie] ; Carmine Vitale [Italie] ; Marta Ianniciello [Italie] ; Marianna Amboni [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]A Neuropsychological Longitudinal Study in Parkinson's Patients With and Without Hallucinations
001848 William M. Mcdonald [États-Unis] ; Paul E. Holtzheimer [États-Unis] ; Michael Haber [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Kimberly Mcwhorter [États-Unis] ; Mahlon Delong [États-Unis]Validity of the 30-item geriatric depression scale in patients with Parkinson's disease
001850 Summer C. Wolfrath [États-Unis] ; Amy R. Borenstein [États-Unis] ; Skai Schwartz [États-Unis] ; Robert A. Hauser [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Theresa A. Zesiewicz [États-Unis]Use of nutritional supplements in Parkinson's disease patients
001851 Louis C. S. Tan [Singapour] ; Puay-Ngoh Lau [Singapour] ; Roland Dominic G. Jamora [Singapour] ; Edwin S. Y. Chan [Singapour]Use of complementary therapies in patients with Parkinson's disease in singapore
001853 Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola P. Piccini [Royaume-Uni]Upregulation of dopamine D2 receptors in dopaminergic drugnaive patients with Parkin gene mutations
001878 HONGLEI CHEN [États-Unis] ; Shumin M. Zhang [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Miguel A. Hernan [États-Unis] ; Alberto Ascherio [États-Unis]Survival of Parkinson's disease patients in a large prospective cohort of male health professionals
001879 Massimo Cincotta [Italie] ; Fabio Giovannelli [Italie] ; Alessandra Borgheresi [Italie] ; Fabrizio Balestrieri [Italie] ; Paola Vanni [Italie] ; Aldo Ragazzoni [Italie] ; Gaetano Zaccara [Italie] ; Ulf Ziemann [Allemagne]Surface electromyography shows increased mirroring in parkinson's disease patients without overt mirror movements
001881 Vicky L. Marshall [Royaume-Uni] ; Jim Patterson [Royaume-Uni] ; Donald M. Hadley [Royaume-Uni] ; Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Successful antiparkinsonian medication withdrawal in patients with parkinsonism and normal FP-CIT SPECT
001885 William G. Ondo [États-Unis] ; Yavuz Silay [États-Unis] ; Mike Almaguer [États-Unis] ; Joseph Jankovic [États-Unis]Subthalamic deep brain stimulation in patients with a previous pallidotomy
001892 Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas]Striatal dopa and glucose metabolism in PD patients with freezing of gait
001901 Michela Barichella [Italie] ; Agnieszka Marczewska [Italie] ; Roberta De Notaris [Italie] ; Antonella Vairo [Italie] ; Cinzia Baldo [Italie] ; Andrea Mauri [Italie] ; Chiara Savardi [Italie] ; Gianni Pezzoli [Italie]Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease
001902 Martina Rinnerthaler [Autriche] ; Joerg Mueller [Autriche] ; Viktor Weichbold [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Social stigmatization in patients with cranial and cervical dystonia
001903 Juan Carlos Gomez-Esteban [Espagne] ; Juan Jose Zarranz ; Elena Lezcano ; Fernando Velasco ; Roberto Ciordia ; Idoia Rouco ; Jose Losada ; Iker BilbaoSleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease
001913 Erika Driver-Dunckley [États-Unis] ; Virgilio Gerald H. Evidente [États-Unis] ; Charles H. Adler [États-Unis] ; Renee Hillman [États-Unis] ; Jose Hernandez [États-Unis] ; Geoffrey Fletcher [États-Unis] ; Mark K. Lyons [États-Unis]Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation
001916 Tanja Schmitz-Hübsch [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laszlo Baliko [Hongrie] ; Sylvia Boesch [Autriche] ; Sara Bonato [Belgique] ; Roberto Fancellu [Italie] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Jun-Suk Kang [Allemagne] ; Berry Kremer [Pays-Bas] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Sylvie Romano [Italie] ; Lodger Schols [Allemagne] ; Sandra Szymanski [Allemagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Elzbieta Zdzienicka [Pologne] ; Alexandra Dürr [France] ; Thomas Klockgether [Allemagne]Reliability and validity of the international cooperative ataxia rating scale : A study in 156 spinocerebellar ataxia patients
001917 Martine Visser [Pays-Bas] ; Albert F. G. Leentjens [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas]Reliability and validity of the beck depression inventory in patients with Parkinson's disease
001921 Nam-Jong Paik [Corée du Sud] ; Kyle Seo [Corée du Sud] ; HEE CHUL EUN [Corée du Sud]Reduced potency after refrigerated storage of botulitum toxin A : Human extensor digitorum brevis muscle study
001926 Kevin M. Biglan [États-Unis] ; Steven Schwid [États-Unis] ; Shirley Eberly [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Tamar Goren [Israël] ; Karl Kieburtz [États-Unis] ; David Oakes [États-Unis] ; Sandra Plumb [États-Unis] ; Andrew Siderowf [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis]Rasagiline improves quality of life in patients with early Parkinson's disease
001928 Angelo Antonini [Italie] ; Silvana Tesei [Italie] ; Anna Zecchinelli [Italie] ; Paolo Barone [Italie] ; Danilo De Gaspari [Italie] ; Margherita Canesi [Italie] ; Giorgio Sacilotto [Italie] ; Nicoletta Meucci [Italie] ; Claudio Mariani [Italie] ; Gianni Pezzoli [Italie]Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression : Effect on quality of life
001931 Delia Lorenz [Allemagne] ; Daniel Schwieger [Allemagne] ; Hans Moises [Allemagne] ; Günther Deuschl [Allemagne]Quality of life and personality in essential tremor patients
001938 Mariana Spitz [Brésil] ; Alexandre Aluizio Costa Machado [Brésil] ; Rodrigo Do Carmo Carvalho [Brésil] ; Fernanda Martins Maia [Brésil] ; Monica Santoro Haddad [Brésil] ; Dagoberto Calegaro [Brésil] ; Milberto Scaff [Brésil] ; Egberto Reis Barbosa [Brésil]Pseudoathetosis : Report of three patients
001940 Agnieszka Marczewska [Italie] ; Roberta De Notaris [Italie] ; Sabina Sieri [Italie] ; Michela Barichella [Italie] ; Elisabetta Fusconi [Italie] ; Gianni Pezzoli [Italie]Protein intake in parkinsonian patients using the EPIC food frequency questionnaire
001950 Maurizio Avanzi [Italie] ; Mario Baratti [Italie] ; Silvia Cabrini [Italie] ; Elena Uber [Italie] ; Gianni Brighetti [Italie] ; Flavio Bonfa [Italie]Prevalence of pathological gambling in patients with Parkinson's disease
001952 Takashi Nomura [Japon] ; Yuichi Inoue [Japon] ; Masahiro Miyake [Japon] ; Kenichi Yasui [Japon] ; Kenji Nakashima [Japon]Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease
001954 Alessandro Paluzzi [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; XUGUANG LIU [Royaume-Uni] ; John Yianni [Royaume-Uni] ; Kumar Kumarendran [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni]Pregnancy in dystonic women with in situ deep brain stimulators
001958 Marco Bove [Italie] ; Lucio Marinelli [Italie] ; Laura Avanzino [Italie] ; Roberta Marchese [Italie] ; Giovanni Abbruzzese [Italie]Posturographic analysis of balance control in patients with essential tremor
001962 Sergio Bagnato [Italie] ; Rocco Agostino [Italie] ; Nicola Modugno [Italie] ; Angelo Quartarone [Italie] ; Alfredo Berardelli [Italie]Plasticity of the motor cortex in Parkinson's disease patients On and Off therapy
001964 Mattia Gambarin [Italie] ; Angelo Antonini [Italie] ; Giuseppe Moretto [Italie] ; Paolo Bovi [Italie] ; Silvia Romito [Italie] ; Antonio Fiaschi [Italie] ; Michele Tinazzi [Italie]Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease : Case report
001967 Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lledo [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne]Pergolide versus levodopa monotherapy in early Parkinson's disease patients : The PELMOPET study
001968 Paula R. Arantes [Brésil] ; Ellison F. Cardoso [Brésil] ; Maria A. Barreiros [Brésil] ; Manoel J. Teixeira [Brésil] ; Marcia R. Goncalves [Brésil] ; Egberto R. Barbosa [Brésil] ; Sukhi Shergill Sukwinder [Royaume-Uni] ; Claudia C. Leite [Brésil] ; Edson Jr Amaro [Brésil, Royaume-Uni]Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation
001971 Jonathan W. Mink [États-Unis] ; John Walkup [États-Unis] ; Kirk A. Frey [États-Unis] ; Peter Como [États-Unis] ; Danielle Cath [Pays-Bas] ; Mahlon R. Delong [États-Unis] ; Gerald Erenberg [États-Unis] ; Joseph Jankovic [États-Unis] ; Jorge Juncos [États-Unis] ; James F. Leckman [États-Unis] ; Neal Swerdlow [États-Unis] ; Veerle Visser-Vandewalle [Pays-Bas] ; Jerrold L. Vitek [États-Unis]Patient selection and assessment recommendations for deep brain stimulation in tourette syndrome
001975 Sarah T. Camargos [Brésil] ; Antonio L. Jr Teixeira [Brésil] ; Francisco Cardoso [Brésil]Parkinsonism associated with basal ganglia cryptococcal abscesses in an immunocompetent patient
001982 Spiridon Papapetropoulos [États-Unis] ; Carlos Singer [États-Unis]Painless legs moving toes in a patient with wilson's disease
001984 Chiara Criscuolo [Italie] ; Giampiero Volpe [Italie] ; Anna De Rosa [Italie] ; Andrea Varrone [Italie] ; Roberta Marongiu [Italie] ; Pietro Mancini [Italie] ; Elena Salvatore [Italie] ; Bruno Dallapiccola [Italie] ; Alessandro Filla [Italie] ; Enza Maria Valente [Italie] ; Giuseppe De Michele [Italie]PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism
001987 Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada]Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies
001989 Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis]Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
001990 Peter Feys [Belgique] ; Werner F. Helsen [Belgique] ; Sabine Verschueren [Belgique] ; Stephan P. Swinnen [Belgique] ; Isabel Klok [Belgique] ; Ann Lavrysen [Belgique] ; Bart Nuttin [Belgique] ; Pierre Ketelaer [Belgique] ; XUGUANG LIU [Royaume-Uni]Online movement control in multiple sclerosis patients with tremor : Effects of tendon vibration
001A06 Blanca Ramirez-Ruiz [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Martf [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne]Neuropsychological deficits in parkinson's disease patients with visual hallucinations
001A07 Marcelo Merello [Argentine] ; Eduardo Tenca [Argentine] ; Daniel Cerquetti [Argentine]Neuronal activity of the zona incerta in Parkinson's disease patients
001A21 Stephan Klebe [Allemagne] ; Günther Deuschl [Allemagne] ; Henning Stolze [Allemagne]Methylphenidate fails to improve gait and muscle tone in patients with sporadic and hereditary spastic paraplegia
001A24 Ute Hidding [Allemagne] ; Tobias B Umer [Allemagne] ; Hartwig Roman Siebner [Allemagne] ; Cüneyt Demiralay [Allemagne] ; Carsten Buhmann [Allemagne] ; Thomas Weyh [Allemagne] ; Christian Moll [Allemagne] ; Wolfgang Hamel [Allemagne] ; Alexander Münchau [Allemagne]MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced parkinson's disease
001A34 Omit Chiba-Falek [États-Unis] ; Grisel J. Lopez [États-Unis] ; Robert L. Nussbaum [États-Unis]Levels of alpha-synuclein mRNA in sporadic parkinson disease patients
001A37 Hubertus J. A. Van Hedel [Suisse] ; Daniel Waldvogel [Suisse] ; Volker Dietz [Suisse]Learning a high-precision locomotor task in patients with Parkinson's disease
001A50 Julie Leegwater-Kim [États-Unis] ; Elan D. Louis [États-Unis] ; Seth L. Pullman [États-Unis] ; Alicia G. Floyd [États-Unis] ; Sarah Borden [États-Unis] ; Carol B. Moskowitz [États-Unis] ; Lawrence S. Honig [États-Unis]Intention tremor of the head in patients with essential tremor
001A56 Mandy Miller Koop [États-Unis] ; Amy Andrzejewski [États-Unis] ; Bruce C. Hill [États-Unis] ; Gary Heit [États-Unis] ; Helen M. Bronte-Stewart [États-Unis]Improvement in a quantitative measure of bradykinesia after microelectrode recording in patients with Parkinson's disease during deep brain stimulation surgery
001A61 Satoshi Goto [Japon] ; Kazumichi Yamada [Japon] ; Hideki Shimazu [Japon] ; Nagako Murase [Japon] ; Kazuhito Matsuzaki [Japon] ; Tetsuya Tamura [Japon] ; Shinji Nagahiro [Japon] ; Jun-Ichi Kuratsu [Japon] ; Ryuji Kaji [Japon]Impact of bilateral pallidal stimulation on DYT1-generalized dystonia in Japanese patients
001A65 Hideaki Matsui [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Narihiro Hara [Japon] ; Kenichi Komatsu [Japon] ; Tamotsu Kubori [Japon] ; Fukashi Udaka [Japon]Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations
001A66 Hideaki Matsui [Japon] ; Kazuto Nishinaka [Japon] ; Masaya Oda [Japon] ; Narihiro Hara [Japon] ; Kenichi Komatsu [Japon] ; Tamotsu Kubori [Japon] ; Fukashi Udaka [Japon]Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations
001A68 Aileen K. Ho [Royaume-Uni] ; Anna O. G. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]Huntington's disease patients have selective problems with insight
001A69 Cindy Zadikoff [Canada] ; Ekaterina Rogaeva [Canada] ; Ana Djarmati [Allemagne] ; Christine Sato [Canada] ; Shabnam Salehi-Rad [Canada] ; Peter St. George-Hyslop [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada]Homozygous and heterozygous PINK1 mutations : Considerations for diagnosis and care of parkinson's disease patients
001A80 Joseph J. Higgins [États-Unis] ; Roni Q. Lombardi [États-Unis] ; Joanna Pucilowska [États-Unis] ; Joseph Jankovic [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Leo Verhagen [États-Unis]HS1-BP3 gene variant is common in familial essential tremor
001A84 Katie Kompoliti [États-Unis] ; Christopher G. Goetz [États-Unis] ; Mary Morrissey [États-Unis] ; Sue Leurgans [États-Unis]Gilles de la tourette syndrome : Patient's knowledge and concern of adverse effects
001A87 Angelo Antonini [Italie] ; Stefano Goldwurm [Italie] ; Riccardo Benti [Italie] ; Holger Prokisch [Allemagne] ; Monika Ebhardt [Allemagne] ; Roberto Cilia [Italie] ; Michela Zini [Italie] ; Andrea Righini [Italie] ; Giovanni Cossu [Italie] ; Gianni Pezzoli [Italie]Genetic, clinical, and imaging characterization of one patient with late- onset, slowly progressive, pantothenate kinase-associated neurodegeneration
001A88 Paola Valentino [Italie] ; Grazia Annesi [Italie] ; Innocenza C. Ciro Candiano [Italie] ; Ferdinanda Annesi [Italie] ; Donatella Civitelli [Italie] ; Patrizia Tarantino [Italie] ; Francesco Naso [Italie] ; Patrizia Spadafora [Italie] ; Sara Carrideo [Italie] ; Elvira V. De Marco [Italie] ; Domenico Consoli [Italie] ; Mario Zappia [Italie] ; Antonio Gambardella [Italie] ; Aldo Quattrone [Italie]Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern
001A92 Roberta Marongiu [Italie] ; Daniele Ghezzi [Italie] ; Tamara Ialongo [Italie] ; Francesco Soleti [Italie] ; Antonio Elia [Italie] ; Stefania Cavone [Italie] ; Alberto Albanese [Italie] ; Maria Concetta Altavista [Italie] ; Paolo Barone [Italie] ; Livia Brusa [Italie] ; Pietro Cortelli [Italie] ; Lucia Petrozzi [Italie] ; Cesa Scaglione [Italie] ; Paolo Stanzione [Italie] ; Michele Tinazzi [Italie] ; Massimo Zeviani [Italie] ; Bruno Dallapiccola [Italie] ; Anna Rita Bentivoglio [Italie] ; Enza Maria Valente [Italie] ; Barbara Garavaglia [Italie]Frequency and phenotypes of LRRK2 G2019S mutation in italian patients with Parkinson's disease
001A93 Natasa T. Dragasevic [Serbie] ; Biljana Culjkovic [Serbie] ; Christine Klein [Allemagne] ; Aleksandar Ristic [Serbie] ; Milica Keckarevic [Serbie] ; Ivan Topisirovic [Serbie] ; Slobodanka Vukosavic [Serbie] ; Marina Svetel [Serbie] ; Norman Kock [Allemagne] ; Elka Stefanova [Serbie] ; Stanka Romac [Serbie] ; Vladimir S. Kostic [Serbie]Frequency analysis and clinical characterization of different types of spinocerebellar ataxia in serbian patients
001A98 Marko Korosec [Slovénie] ; Ignac Zidar [Slovénie] ; Dik Reits [Pays-Bas] ; Craig Evinger [États-Unis] ; Frans Vanderwerf [Pays-Bas]Eyelid movements during blinking in patients with Parkinson's disease
001B00 Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]Expectation and the placebo effect in parkinson's disease patients with subthalamic nucleus deep brain stimulation
001B01 Isaac Shpirer [Israël] ; Ala Miniovitz [Israël] ; Colin Klein [Israël] ; Richard Goldstein [Israël] ; Tatiana Prokhorov [Israël] ; Jack Theitler [Israël] ; Lea Pollak [Israël] ; Jose Martin Rabey [Israël]Excessive daytime sleepiness in patients with parkinson's disease : A polysomnography study
001B13 Jean-Pascal Lefaucheur [France] ; Isabelle Menard-Lefaucheur [France] ; Patrick Maison [France] ; Sophie Baudic [France] ; Pierre Cesaro [France] ; Marc Peschanski [France] ; Anne-Catherine Bachoud-Levi [France]Electrophysiological deterioration over time in patients with huntington's disease
001B16 J. Antonelle Demarcaida [États-Unis] ; Steven R. Schwid [États-Unis] ; William B. White [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Karl Kieburtz [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis]Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline
001B18 David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Ian Mckeith [Royaume-Uni] ; Peter Paul De Deyn [Belgique] ; Dag Aarsland [Norvège] ; Chuanchieh Hsu [États-Unis] ; Roger Lane [États-Unis]Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
001B22 Tanya Y. Gurevich [Israël] ; Herzel Shabtai [Israël] ; Amos D. Korczyn [Israël] ; Ely S. Simon [États-Unis] ; Nir Giladi [Israël]Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia
001B38 Lena Elisabeth Hjermind [Danemark] ; Lis Gitte Johannsen [Danemark] ; Nenad Blau [Suisse] ; Ron Allan Wevers [Pays-Bas] ; Christoph-Burkhard Lucking [Allemagne] ; Jens Michael Hertz [Danemark] ; Lars Friberg [Danemark] ; Lisbeth Regeur [Danemark] ; J Rgen Erik Nielsen [Danemark] ; Sven Asger S Rensen [Danemark]Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?
001B62 PHIL HYU LEE [Corée du Sud] ; SEUNG HYEON YEO [Corée du Sud] ; HYUN JOON KIM [Corée du Sud] ; HYO YOUNG YOUM [Corée du Sud]Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy
001B64 Afsane Riazi [Royaume-Uni] ; Stefan J. Cano [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Jane L. Bradley [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni]Coordinating outcomes measurement in ataxia research : Do some widely used generic rating scales tick the boxes?
001B65 Claudia Trenkwalder [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Andreas Kupsch [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Juergen Koester [Allemagne] ; Juergen Reess [Allemagne]Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome
001B66 Lauren H. Craig [États-Unis] ; Anna Svircev [États-Unis] ; Michael Haber [États-Unis] ; Jorge L. Juncos [États-Unis]Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease
001B68 William G. Ondo [États-Unis] ; Mike Almaguer [États-Unis] ; Helen Cohen [États-Unis]Computerized posturography balance assessment of patients with bilateral ventralis intermedius nuclei deep brain stimulation
001B74 Carmen Cristea Janvin [Norvège] ; Jan Petter Larsen [Norvège] ; David P. Salmon [États-Unis] ; Douglas Galasko [États-Unis] ; Kenneth Hugdahl [Norvège] ; Dag Aarsland [Norvège]Cognitive profiles of individual patients with Parkinson's disease and dementia : Comparison with dementia with lewy bodies and Alzheimer's disease
001B78 Hiroyuki Tomiyama [Japon] ; YUANZHE LI [Japon] ; Manabu Funayama [Japon] ; Kazuko Hasegawa [Japon] ; Hiroyo Yoshino [Japon] ; Shin-Ichiro Kubo [Japon] ; Kenichi Sato [Japon] ; Tatsuya Hattori [Japon] ; Chin-Song Lu [Taïwan] ; Rivka Inzelberg [Israël] ; Ruth Djaldetti [Israël] ; Eldad Melamed [Israël] ; Rim Amouri [Tunisie] ; Neziha Gouider-Khouja [Tunisie] ; Faycal Hentati [Tunisie] ; Yasuko Hatano [Japon] ; MEI WANG [Japon] ; Yoko Imamichi [Japon] ; Koichi Mizoguchi [Japon] ; Hiroaki Miyajima [Japon] ; Fumiya Obata [Japon] ; Tatsushi Toda [Japon] ; Matthew J. Farrer [États-Unis] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries
001B80 Liesl M. Allcock [Royaume-Uni] ; Rose Anne Kenny [Royaume-Uni] ; David J. Burn [Royaume-Uni]Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension : Autonomic symptom and demographic comparison
001B84 Servane Mouton [France] ; Jing Xie-Brustolin [France] ; Patrick Mertens [France] ; Gustavo Polo [France] ; Philippe Damier [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France]Chorea induced by globus pallidus externus stimulation in a dystonic patient
001B89 Milos Ljubisavljevic [Serbie, Émirats arabes unis] ; Aleksandra Kacar [Serbie] ; Sladjan Milanovic [Serbie] ; Marina Svetel [Serbie] ; Vladimir S. Kostic [Serbie]Changes in cortical inhibition during task-specific contractions in primary writing tremor patients
001B96 PHIL HYU LEE [Corée du Sud] ; JI WON KIM [Corée du Sud] ; OH YOUNG BANG [Corée du Sud] ; IN SOO JOO [Corée du Sud] ; Seok-Nam Yoon [Corée du Sud] ; Kyoon Huh [Corée du Sud]Cardiac 123I-MIBG scintigraphy in patients with essential tremor
001C10 Cornelius G. Bachmann [Allemagne] ; Claudia Trenkwalder [Allemagne]Body weight in patients with Parkinson's disease
001C15 Marcelo Merello [Argentine] ; Silvina Carpintiero [Argentine] ; Angel Cammarota [Argentine] ; Francisco Meli [Argentine] ; Ramon Leiguarda [Argentine]Bilateral mirror writing movements (mirror dystonia) in a patient with writer's cramp : Functional correlates
001C36 Marc J. Mentis [États-Unis] ; Dominique Delalot [États-Unis] ; Hassan Naqvi [États-Unis] ; Mark F. Gordon [États-Unis] ; Mark Gudesblatt [États-Unis] ; Christine Edwards [États-Unis] ; Luke Donatelli [États-Unis] ; Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis]Anticholinesterase effect on motor kinematic measures and brain activation in parkinson's disease
001C39 Anna Rita Bentivoglio [Italie] ; Antonio Daniele [Italie] ; Alberto Albanese [Italie] ; Pietro Attilio Tonali [Italie] ; Alfonso Fasano [Italie]Analysis of blink rate in patients with blepharospasm
001C43 Pablo Mir [Royaume-Uni, Espagne] ; Francesca Gilio [Italie] ; Mark Edwards [Royaume-Uni] ; Maurizio Inghilleri [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections
001C45 Christopher G. Goetz [États-Unis] ; Joanne Wuu [États-Unis] ; Linda Curgian [États-Unis] ; Sue Leurgans [États-Unis]Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients
001C46 Paolo Ragonese [Italie] ; Marco D'Amelio [Italie] ; Graziella Callari [Italie] ; Giuseppe Salemi [Italie] ; Letterio Morgante [Italie] ; Giovanni Savettieri [Italie]Age at menopause predicts age at onset of Parkinson's disease
001C61 Update on the management of motor complications in Parkinson's disease
001C73 Imad Ghorayeb [France] ; Federica Provini [Italie] ; Bernard Bioulac [France] ; Francois Tison [France]Unusual nocturnal motor restlessness in a patient with spinocerebellar ataxia 3
001C77 Bart P. C. Van De Warrenburg [Pays-Bas] ; Maaike Bakker [Pays-Bas, Suisse] ; Berry P. H. Kremer [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; John H. J. Allum [Suisse]Trunk sway in patients with spinocerebellar ataxia
001D17 Nico J. Diederich [Luxembourg (pays)] ; Michel Vaillant [Luxembourg (pays)] ; Mike Leischen [Luxembourg (pays)] ; Giovanna Mancuso [Luxembourg (pays)] ; Serge Golinval [Luxembourg (pays)] ; Romain Nati [Luxembourg (pays)] ; Marc Schlesser [Luxembourg (pays)]Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients
001D18 Kirn R. Kessler [Allemagne] ; Diane Ruge [Allemagne] ; Tihomir V. Ilic [Allemagne] ; Ulf Ziemann [Allemagne]Short latency afferent inhibition and facilitation in patients with writer's cramp
001D20 Antonio L. Jr Teixeira [Brésil] ; Melissa M. Guimaraes [Brésil] ; Marco Aurélio Romano-Silva [Brésil] ; Francisco Cardoso [Brésil]Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism
001D22 Leo Verhagen Metman [États-Unis] ; Shaun T. O'Leary [États-Unis]Role of surgery in the treatment of motor complications
001D23 Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis]Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations
001D25 Carlos Singer [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Manuel A. Gonzalez [États-Unis] ; Eugene L. Roberts [États-Unis] ; Abraham Lieberman [États-Unis]Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine : Report of a case series
001D39 Allison Fleming [États-Unis] ; Karon F. Cook [États-Unis] ; Naomi D. Nelson [États-Unis] ; Eugene C. Lai [États-Unis]Proxy reports in Parkinson's disease : Caregiver and patient self-reports of quality of life and physical activity
001D44 Henning Stolze [Allemagne] ; Stephan Klebe [Allemagne] ; Christoph Baecker [Allemagne] ; Christiane Zechlin [Allemagne] ; Lars Friege [Allemagne] ; Sabine Pohle ; Günther Deuschl [Allemagne]Prevalence of gait disorders in hospitalized neurological patients
001D51 Lorraine N. Clark [États-Unis] ; Angelique Nicolai [États-Unis] ; Shehla Afridi [États-Unis] ; Juliette Harris [États-Unis] ; Helen Mejia-Santana [États-Unis] ; Lisa Strug [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Howard Andrews [États-Unis] ; Cheryl Waters [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis] ; Stanley Fahn [États-Unis] ; Richard Mayeux [États-Unis] ; Ruth Ottman [États-Unis] ; K. Marder [États-Unis]Pilot association study of the β-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity
001D53 Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Patient-perceived involvement and satisfaction in Parkinson's disease : Effect on therapy decisions and quality of life
001D54 Katherine Widnell [États-Unis]Pathophysiology of motor fluctuations in Parkinson's disease
001D65 Chon-Haw Tsai [Taïwan] ; Fang-Chia Chang [Taïwan] ; Chin-Song Lu [Taïwan] ; Shih-Tseng Lee [Taïwan] ; Yu-Ting Huang [Taïwan] ; Ming-Kuei Lu [Taïwan] ; Rou-Shayn Chen [Taïwan] ; TONY WU [Taïwan] ; Jiann-Der Lee [Taïwan] ; Yi-Hsin Weng [Taïwan] ; Hsiu-Chen Chang [Taïwan]Pallidotomy effect on the cortical excitability in patients with severe Parkinson's disease
001D68 Cheryl Waters [États-Unis]Other pharmacological treatments for motor complications and dyskinesias
001D72 William G. Ondo [États-Unis] ; DEJIAN LAI [États-Unis]Olfaction testing in patients with tremor-dominant Parkinson's disease : Is this a distinct condition?
001D73 José L. Giroud-Benitez [Pays-Bas] ; Ali Akyol [Cuba] ; Egberto Barbosa [Turquie] ; Onno Schaap [Brésil] ; Herma C. Van Der Linde [Pays-Bas] ; Emilia Martignoni [Pays-Bas] ; Leonardo Lopiano [Italie] ; Paolo Lamberti [Italie] ; Emiliana Fincati [Italie] ; Angelo Antonini [Italie] ; Fabrizio Stocchi [Italie] ; Pasquale Montagna [Italie] ; Ferdinando Squitieri [Italie] ; Paolo Marini [Italie] ; Giovanni Abbruzzese [Italie] ; Giovanni Fabbrini [Italie] ; Roberto Marconi [Italie] ; Alessio Dalla Libera [Italie] ; Giorgio Trianni [Italie] ; Marco Guidi [Italie] ; Antonio De Gaetano [Italie] ; Gustavo Boff Maegawa [Italie] ; Antonino De Leo [Brésil] ; Virgilio Gallai [Italie] ; Giulia De Rosa [Italie] ; Nicola Vanacore [Italie] ; Giuseppe Meco [Italie] ; Cornelia M. Van Duijn [Italie] ; Ben A. Oostra [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Vincenzo BonifatiNovel parkin mutations detected in patients with early-onset Parkinson's disease
001D76 Yu-Hu Zhang [République populaire de Chine] ; Bei-Sha Tang [République populaire de Chine] ; Ai-Ling Zhao [République populaire de Chine] ; KUN XIA [République populaire de Chine] ; Zhi-Gao Long [République populaire de Chine] ; Ji-Feng Guo [République populaire de Chine] ; Shawn K. Westaway [États-Unis] ; Susan J. Hayflick [États-Unis]Novel compound heterozygous mutations in the PANK2 gene in a chinese patient with atypical pantothenate kinase- associated neurodegeneration
001D78 Charles H. Adler [États-Unis]Nonmotor complications in Parkinson's disease
001D81 Richard M. Dubinsky [États-Unis]No going home for hospitalized Huntington's disease patients
001D89 Anjum Misbahuddin [Royaume-Uni] ; Mark R. Placzek [Royaume-Uni] ; Jan-Willem Taanman [Royaume-Uni] ; Steve Gschmeissner [Royaume-Uni] ; Giampietro Schiavo [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]Mutant torsina, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells
001D92 Joseph Jankovic [États-Unis]Motor fluctuations and dyskinesias in Parkinson's disease : Clinical manifestations
001D93 ZHI LIU [Japon] ; Ryuji Sakakibara [Japon] ; Takeo Odaka [Japon] ; Tomoyuki Uchiyama [Japon] ; Tomoyuki Uchiyama [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; Masato Asahina [Japon] ; Kazuya Yamaguchi [Japon] ; Taketo Yamaguchi [Japon] ; Takamichi Hattori [Japon]Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients
001D95 Carsten Saft [Allemagne] ; Jochen Zange [Allemagne] ; Jiirgen Andrich [Allemagne] ; Klaus Müller [Allemagne] ; Katrin Lindenberg [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Matthias Vorgerd [Allemagne] ; Peter H. Kraus [Allemagne] ; Horst Przuntek [Allemagne] ; Ludger Schols [Allemagne]Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease
001E04 Inger Marie Skogseid [Norvège] ; Jo R Islien [Norvège] ; Bj Rgulf Claussen [Norvège] ; Emilia Kerty [Norvège]Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia
001E07 Pasquale Striano [Italie] ; Fiore Manganelli [Italie] ; Patrizia Boccella [Italie] ; Anna Perretti [Italie] ; Salvatore Striano [Italie]Levetiracetam in patients with cortical myoclonus : A clinical and electrophysiological study
001E18 Peter Feys [Belgique, Royaume-Uni] ; Werner F. Helsen [Belgique] ; XUGUANG LIU [Royaume-Uni] ; Bart Nuttin [Belgique] ; Ann Lavrysen [Belgique] ; Stephan P. Swinnen [Belgique] ; Pierre Ketelaer [Belgique]Interaction between eye and hand movements in multiple sclerosis patients with intention tremor
001E27 Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie]Identification of motor and nonmotor wearing-off in Parkinson's disease : Comparison of a patient questionnaire versus a clinician assessment
001E32 Atul Pathak [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France]Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure
001E37 Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ryuji Kaji [Japon] ; Katsuhito Yasuno [Japon] ; Hideshi Kawakami [Japon]Glutathione-S-transferase-1 and interleukin-1β gene polymorphisms in Japanese patients with Parkinson's disease
001E40 Manuela Contin [Italie] ; Paolo Martinelli [Italie] ; Mirella Mochi [Italie] ; Roberto Riva [Italie] ; Fiorenzo Albani [Italie] ; Agostino Baruzzi [Italie]Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease
001E42 Julie-Christine Levesque [Canada] ; André Parent [Canada]GABAergic interneurons in human subthalamic nucleus
001E47 Hans-Christian Jabusch [Allemagne] ; Dorothea Zschucke [Allemagne] ; Alexander Schmidt [Allemagne] ; Stephan Schuele [États-Unis] ; Eckart Altenmüller [Allemagne]Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients
001E51 Catherine L. Wielinski [États-Unis] ; Cordelia Erickson-Davis [États-Unis] ; Rose Wichmann [États-Unis] ; Maria Walde-Douglas [États-Unis] ; Sotirios A. Parashos [États-Unis]Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes
001E58 Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France]End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients : A pharmacokinetic/pharmacodynamic, randomized, double-blind study
001E64 Julie Carrier [Canada] ; Sonia Frenette [Canada] ; Jacques Montplaisir [Canada] ; Jean Paquet [Canada] ; Caroline Drapeau [Canada] ; Jocelyn Morettini [Canada]Effects of periodic leg movements during sleep in middle-aged subjects without sleep complaints
001E65 Paolo Lamberti [Italie] ; Stefano Zoccolella [Italie] ; Giovanni Iliceto [Italie] ; Elio Armenise [Italie] ; Angela Fraddosio [Italie] ; Michele De Mari [Italie] ; Paolo Livrea [Italie]Effects of levodopa and COMT inhibitors on plasma Homocysteine in Parkinson's disease patients
001E66 Anna Lena Törnqvist [Suède] ; Lucyna Schalen [Suède] ; Stig Rehncrona [Suède]Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation
001E67 Paulo S. Boggio [Brésil] ; Felipe Fregni [États-Unis] ; Felix Bermpohl [États-Unis] ; Carlos G. Mansur [Brésil] ; Moacyr Rosa [Brésil] ; Demetrio O. Rumi [Brésil] ; Egberto R. Barbosa [Brésil] ; Marina Odebrecht Rosa [Brésil] ; Alvaro Pascual-Leone [États-Unis] ; Sélgio Paulo Rigonatti [Brésil] ; Marco A. Marcolin [Brésil] ; Maria Teresa Araujo Silva [Brésil]Effect of repetitive TMS and fluoxetine on cognitive function in patients with parkinson's disease and concurrent depression
001E71 Svenja Happe [Allemagne] ; Martin Sommer [Allemagne] ; Johannes Meller [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Walter Paulus [Allemagne]Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder
001E74 Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie]Dopaminergic innervation of the human striatum in Parkinson's disease
001E81 Lisa M. Benrud-Larson [États-Unis] ; Paola Sandroni [États-Unis] ; Anette Schrag [Royaume-Uni] ; Phillip A. Low [États-Unis]Depressive symptoms and life satisfaction in patients with multiple system atrophy
001E84 J. Carsten Moller [Allemagne] ; Mira Rethfeldt [Allemagne] ; Yvonne Körner [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Werner Cassel [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Ida Rissling [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne]Daytime sleep latency in medication-matched parkinsonian patients with and without sudden onset of sleep
001E86 Angelo Quartarone [Italie] ; Sergio Bagnato [Italie] ; Vincenzo Rizzo [Italie] ; Francesca Morgante [Italie] ; Antonino Sant'Angelo [Italie] ; Domenica Crupi [Italie] ; Marcello Romano [Italie] ; Corrado Messina [Italie] ; Alfredo Berardelli [Italie] ; Paolo Girlanda [Italie]Corticospinal excitability during motor imagery of a simple tonic finger movement in patients with writer's cramp
001E91 Ivan Rektor [République tchèque] ; Martin Bares [République tchèque] ; Milan Brazdil [République tchèque] ; Petr Kanovsky [République tchèque] ; Irena Rektorova [République tchèque] ; Daniela Sochurkova [République tchèque] ; Dagmar Kubova [République tchèque] ; Robert Kuba [République tchèque] ; Pavel Daniel [République tchèque]Cognitive- and movement-related potentials recorded in the human basal ganglia
001E93 Sowmya Lakshminarayanan [États-Unis] ; Kanchana Devi Paramasivan [États-Unis] ; Arthur S. Walters [États-Unis] ; Mary L. Wagner [États-Unis] ; Shivani Patel [États-Unis] ; Vandna Passi [États-Unis]Clinically significant but unsuspected restless legs syndrome in patients with sleep apnea
001E98 Panida Piboolnurak [États-Unis] ; Qiping P. Yu [États-Unis] ; Seth L. Pullman [États-Unis]Clinical and neurophysiologic spectrum of orthostatic tremor : Case series of 26 subjects
001F03 Maria V. Recio [États-Unis] ; Robert A. Hauser [États-Unis] ; Elan D. Louis [États-Unis] ; Harsha Radhashakar [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Theresa A. Zesiewicz [États-Unis]Chorea in a patient with cerebral palsy : Treatment with levetiracetam
001F05 Marcello M. Mascia [Italie] ; Josep Valls-Sole [Espagne] ; Maria J. Marti [Espagne] ; Sergio Sanz [Espagne]Chewing pattern in patients with Meige's syndrome
001F14 Frank Skidmore [États-Unis] ; Irene Mikolenko [États-Unis] ; Howard Weiss [États-Unis] ; William Weiner [États-Unis]Camptocormia in a patient with multiple system atrophy
001F17 Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ryuji Kaji [Japon] ; Hideshi Kawakami [Japon]Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy
001F34 Kazumasa Shindo [Japon] ; Eri Kaneko [Japon] ; Harue Watanabe [Japon] ; Tetsuhiko Sugimoto [Japon] ; Emiko Ohta [Japon] ; Kenji Ohashi [Japon] ; Takamura Nagasaka [Japon] ; Zenji Shiozawa [Japon]Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I -metaiodobenzylguanidine uptake in patients with Parkinson's disease
001F40 Daniela Berg [Allemagne] ; Marc Niwar [Allemagne] ; Sylvia Maass [Allemagne] ; Alexander Zimprich [Autriche] ; J. Carsten Moller [Allemagne] ; Ullrich Wuellner [Allemagne] ; Tanja Schmitz-Hübsch [Allemagne] ; Christine Klein [Allemagne] ; Eng-King Tan [Singapour] ; Ludger Schöls [Allemagne] ; Laura Marsh [États-Unis] ; Ted M. Dawson [États-Unis] ; Bernd Janetzky [Allemagne] ; Thomas Müller [Allemagne] ; Dirk Woitalla [Allemagne] ; Vladimir Kostic [Serbie] ; Peter P. Pramstaller [Italie] ; Wolfgang H. Oertel [Allemagne] ; Peter Bauer [Allemagne] ; Rejko Krueger [Allemagne] ; Thomas Gasser [Allemagne] ; Olaf Riess [Allemagne]Alpha-synuclein and Parkinson's disease : Implications from the screening of more than 1,900 patients
001F50 Yoshihiro Sato [Japon] ; Yoshiaki Honda [Japon] ; Jun Iwamoto [Japon] ; Tomohiro Kanoko [Japon] ; Kei Satoh [Japon]Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients
001F57 Cheryl H. Waters [États-Unis] ; Kapil D. Sethi [États-Unis] ; Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; John M. Bertoni [États-Unis]Zydis selegiline reduces Off time in Parkinson's disease patients with motor fluctuations: A 3-month, randomized, placebo-controlled study
001F58 Paul H. Gordon [États-Unis] ; Stanley Fahn [États-Unis] ; Steven Chin [États-Unis] ; Lawrence I. Golbe [États-Unis] ; Timothy Lynch [Irlande (pays)] ; David Eidelberg [États-Unis]Woman with a 26-year history of Parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes
001F65 Judith Junker [Allemagne] ; Christoph Oberwittler [Allemagne] ; Didi Jackson [Allemagne] ; Klaus Berger [Allemagne]Utilization and perceived effectiveness of complementary and alternative medicine in patients with dystonia
001F67 Panda Piboolnurak [États-Unis] ; Seth L. Pullman [États-Unis] ; Elan D. Louis [États-Unis]Unusual forehead tremor in a patient with essential tremor
001F72 Constantine Constantoyannis [Canada] ; Ajit Kumar [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]Tremor induced by thalamic deep brain stimulation in patients with complex regional facial pain
001F80 Leo Verhagen Metman [États-Unis] ; Brian Myre [États-Unis] ; Niek Verwey [États-Unis] ; Sharon Hassin-Baer [Israël] ; Jean Arzbaecher [États-Unis] ; Diane Sierens [États-Unis] ; Roy Bakay [États-Unis]Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: An argument against multiple baseline assessments
001F88 Theresa A. Zesiewicz [États-Unis] ; Elan D. Louis [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Martin Menkin [États-Unis] ; Peter B. Dunne [États-Unis] ; Robert A. Hauser [États-Unis]Substantial improvement in a Meige's syndrome patient with levetiracetam treatment
001F98 Stephen Grill [États-Unis]Smothering dystonia in a patient with oromandibular dystonia
002005 Dolores Garcia Arocena [États-Unis] ; Elan D. Louis [États-Unis] ; Flora Tassone [États-Unis] ; T. Conrad Gilliam [États-Unis] ; Ruth Ottman [États-Unis] ; Sébastien Jacquemont [États-Unis] ; Paul J. Hagerman [États-Unis]Screen for expanded FMR1 alleles in patients with essential tremor
002006 Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France]Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study
002009 Alastair Wilkins [Royaume-Uni] ; Jerry M. Brown [Royaume-Uni] ; Roger A. Barker [Royaume-Uni]SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: A case report
002014 Peter Hobson [Royaume-Uni] ; Jolyon Meara [Royaume-Uni]Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom
002028 Galit Kleiner-Fisman [Canada] ; Anthony E. Lang [Canada] ; Catherine Bergeron [Canada] ; David J. Burn [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni]Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man
002033 Marcin Zach [Pologne] ; Andrzej Friedman [Pologne] ; Jarosław Sławek [Pologne] ; Mirosława Derejko [Pologne]Quality of life in Polish patients with long-lasting Parkinson's disease
002045 Rainer Linke [Allemagne] ; Ilonka Eisensehr [Allemagne] ; Thomas-Christian Wetter [Allemagne] ; Franz-Josef Gildehaus [Allemagne] ; Gabriele Pöpperl [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Soheyl Noachtar [Allemagne] ; Klaus Tatsch [Allemagne]Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease?
002047 Din-E. Shan [Taïwan] ; Ren-Shyan Liu [Taïwan] ; Chen-Ming Sun [Taïwan] ; Shwn-Jen Lee [Taïwan] ; Kwong-Kum Liao [Taïwan] ; Bing-Wen Soong [Taïwan]Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: Clinical implications
002060 Stefan J. Cano [Royaume-Uni] ; Jeremy C. Hobart [Royaume-Uni] ; Ray Fitzpatrick [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Alan J. Thompson [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]Patient-based outcomes of cervical dystonia: A review of rating scales
002061 Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen [Allemagne] ; Erwin Schollmayer [Allemagne] ; J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne]Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of Restless Legs Syndrome: A double-blind, placebo-controlled pilot study
002066 Frédéric Macia [France] ; Caroline Perlemoine [France] ; Irène Coman [France] ; Dominique Guehl [France] ; Pierre Burbaud [France] ; Emmanuel Cuny [France] ; Henri Gin [France] ; Vincent Rigalleau [France] ; Francois Tison [France]Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight
002067 Joseph Wiley [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Sarah Lincoln [États-Unis] ; Lisa Skipper [États-Unis] ; Mary Hulihan [États-Unis] ; David Gosal [Irlande (pays)] ; Gina Bisceglio [États-Unis] ; Jennifer Kachergus [États-Unis] ; John Hardy [États-Unis] ; Matthew J. Farrer [États-Unis]Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with Parkin mutations
002074 Jason D. Warren [Royaume-Uni] ; Michele T. M. Hu [Royaume-Uni] ; Malcolm Galloway [Royaume-Uni] ; Richard J. Greenwood [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni]Observations on the human rejection behaviour syndrome: Denny-Brown revisited
002077 Karin Stiasny-Kolster [Allemagne] ; J. Carsten Möller [Allemagne] ; Johannes Zschocke [Allemagne] ; Oliver Bandmann [Allemagne] ; Werner Cassel [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Georg F. Hoffmann [Allemagne]Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients
002083 Marcelo Merello [Argentine] ; Daniel Cerquetti [Argentine] ; Angel Cammarota [Argentine] ; Eduardo Tenca [Argentine] ; Carlos Artes [Argentine] ; Julio Antico [Argentine] ; Ramon Leiguarda [Argentine]Neuronal globus pallidus activity in patients with generalised dystonia
002084 Luiz C. M. Pereira [Canada] ; Vanessa N. Palter [Canada] ; Anthony E. Lang [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada]Neuronal activity in the globus pallidus of multiple system atrophy patients
002087 Willibald Gerschlager [Royaume-Uni, Autriche] ; Alexander Münchau [Allemagne] ; Regina Katzenschlager [Royaume-Uni] ; Peter Brown [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Natural history and syndromic associations of Orthostatic tremor: A review of 41 patients
002099 Meltem Müftüoglu [Turquie] ; Bülent Elibol [Turquie] ; Özlem Dalmizrak [Turquie] ; Ayse Ercan [Turquie] ; Gülnihal Kulaksiz [Turquie] ; Hamdi Ögüs [Turquie] ; Turgay Dalkara [Turquie] ; Nazmi Özer [Turquie]Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations
002100 David K. Simon [États-Unis] ; Seiji Nishino [États-Unis] ; Thomas E. Scammell [États-Unis]Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus ("Limp Man Syndrome")
002106 I. Hozumi [Japon] ; Y. S. Piao [Japon] ; T. Inuzuka [Japon] ; Z. Matsuyama [Japon] ; Y. Yamada [Japon] ; A. Hara [Japon] ; T. Hirose [Japon] ; K. Tsuchiya [Japon] ; H. Takahashi [Japon]Marked asymmetry of putaminal pathology in an MSA-P patient with Pisa syndrome
002109 Hubert H. Fernandez [États-Unis] ; Edward M. Donnelly [États-Unis] ; Joseph H. Friedman [États-Unis]Long-term outcome of clozapine use for psychosis in Parkinsonian patients
002110 Peter Haussermann [Allemagne] ; Stefanie Marczoch [Allemagne] ; Christiane Klinger [Allemagne] ; Michael Landgrebe [Allemagne] ; Bastian Conrad [Allemagne] ; Andres Ceballos-Baumann [Allemagne]Long-term follow-up of cervical dystonia patients treated with botulinum toxin A
002112 Svenja Happe [Allemagne] ; Tobias Tings [Allemagne] ; Kathrin Helmschmied [Allemagne] ; Karin Neubert [Allemagne] ; Wolfgang Wuttke [Allemagne] ; Walter Paulus [Allemagne] ; Claudia Trenkwalder [Allemagne]Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease
002117 Kathrin Grundmann [Allemagne] ; Ulrike Laubis-Herrmann [Allemagne] ; Dirk Dressier [Allemagne] ; Juliane Vollmer-Haase [Allemagne] ; Peter Bauer [Allemagne] ; Manfred Stuhrmann [Allemagne] ; Thorsten Schulte [Allemagne] ; Ludger Schöls [Allemagne] ; Helge Topka [Allemagne] ; Olaf Riess [Allemagne]Lack of mutations in the epsilon-sarcoglycan gene in patients with different subtypes of Primary dystonias
002127 David E. Hardesty [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Joseph Y. Matsumoto [États-Unis] ; Elan D. Louis [États-Unis]Increased risk of head tremor in women with essential tremor: Longitudinal data from the Rochester Epidemiology Project
002130 Niels Hjort [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark]Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus
002132 Antonio Curra [Italie] ; Rocco Agostino [Italie] ; Loredana Dinapoli [Italie] ; Sergio Bagnato [Italie] ; Mario Manfredi [Italie] ; Alfredo Berardelli [Italie]Impairment of individual finger movements in patients with hand dystonia
002135 Ana M. Catafau [Espagne] ; Eduardo Tolosa [Espagne]Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes
002138 Jürgen Andrich [Allemagne] ; Carsten Saft [Allemagne] ; Anneliese Arz [Allemagne] ; Birgit Schneider [Allemagne] ; Markus W. Agelink [Allemagne] ; Peter H. Kraus [Allemagne] ; Wilfried Kuhn [Allemagne] ; Thomas Müller [Allemagne]Hyperhomocysteinaemia in treated patients with Huntington's disease
002140 Motasem Al-Yacoub [États-Unis] ; Joseph H. Friedman [États-Unis] ; Hubert H. Fernandez [États-Unis]Hemiballismus from a parietal stroke in a Parkinson patient
002156 Patricia De Carvalho Aguiar [États-Unis, Brésil] ; Melissa Fazzari [États-Unis] ; Joseph Jankovic [États-Unis] ; Laurie J. Ozelius [États-Unis]Examination of the SGCE gene in Tourette's syndrome patients with obsessive-compulsive disorder
002170 Matthew B. Stern [États-Unis] ; Kenneth L. Marek [États-Unis] ; Joseph Friedman [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter A. Lewitt [États-Unis] ; Daniel Tarsy [États-Unis] ; C. Warren Olanow [États-Unis]Double-blind, randomized, controlled trial of Rasagiline as monotherapy in early Parkinson's Disease patients
002171 Ida Rissling [Allemagne] ; Frank Geller [Allemagne] ; Oliver Bandmann [Allemagne] ; Karim Stiasny-Kolster [Allemagne] ; Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; J. Carsten Möller [Allemagne]Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks"
002178 Roberto Eleopra [Italie] ; Valeria Tugnoli [Italie] ; Rocco Quatrale [Italie] ; Ornella Rossetto [Italie] ; Cesare Montecucco [Italie]Different types of botulinum toxin in humans
002183 Federico Micheli [Argentine] ; Maria Clara Scorticati [Argentine] ; Silvia Folgar [Argentine] ; Emilia Gatto [Argentine] ; MD [Argentine]Development of Parkinson's disease in patients with blepharospasm
002193 Pierre Payoux [France] ; Kader Boulanouar [France] ; Christine Sarramon [France] ; Nelly Fabre [France] ; Sylvie Descombes [France] ; Monique Galitsky [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Umberto Sabatini [Italie] ; Claude Manelfe [France] ; Francois Chollet [France] ; Laurent Schmitt [France] ; Olivier Rascol [France]Cortical motor activation in akinetic schizophrenic patients: A pilot functional MRI study
002197 Klaus Seppi [Autriche] ; Michael F. H. Schocke [Autriche] ; Eveline Donnemiller [Autriche] ; Regina Esterhammer [Autriche] ; Christian Kremser [Autriche] ; Christoph Scherfler [Autriche] ; Anja Diem [Autriche] ; Werner Jaschke [Autriche] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
002210 Marianna Capecci [Italie] ; Luca Passamonti [Italie] ; Ferdinanda Annesi [Italie] ; Grazia Annesi [Italie] ; Michele Bellesi [Italie] ; Innocenza Claudia Ciro Candiano [Italie] ; Riccardo Ricciuti [Italie] ; Maurizio Iacoangeli [Italie] ; Massimo Scerrati [Italie] ; Mario Zappia [Italie] ; Patrizia Tarantino [Italie] ; Elvira Valeria De Marco [Italie] ; Donatella Civitelli [Italie] ; Sara Carrideo [Italie] ; Leandro Provinciali [Italie] ; Maria Gabriella Ceravolo [Italie] ; Aldo Quattrone [Italie]Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the parkin gene
002216 Francesca Romana Pezzella [Italie] ; Maria Grazia Paglia [Italie] ; Carlo Colosimo [Italie]Cerebrospinal fluid analysis for Whipple's disease in patients with progressive supranuclear palsy
002220 Nicola Pavese [Royaume-Uni] ; Ornella Rimoldi [Royaume-Uni] ; Alexander Gerhard [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Panla Piccini [Royaume-Uni]Cardiovascular effects of methamphetamine in Parkinson's disease patients
002229 Kelvin L. Chou [États-Unis] ; Howard I. Hurtig [États-Unis] ; Jurg L. Jaggi [États-Unis] ; Gordon H. Baltuch [États-Unis]Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor
002235 Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong]Audiovisual cues can enhance sit-to-stand in patients with Parkinson's disease
002240 Ali Sazci [Turquie] ; Emel Ergul [Turquie] ; Kemal Bayulkem [Turquie]Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in patients with essential tremor in Turkey
002244 Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Ruth G. B. Schipper [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas]Assessing comorbidity in patients with Parkinson's disease
002263 Stefano Tamburin [Italie] ; Giampietro Zanette [Italie]Abnormalities of sensory processing and sensorimotor interactions in secondary dystonia : A neurophysiological study in two patients
002271 Parkinsonism and Dementia: Synucleinopathies, Tauopathies, and Beyond. Proceedings of the "Movement" Disorder Society-European Division-Sponsored Workshop, Istanbul, Turkey, 9-11 May 2002
002272 Dopamine transporter imaging
002273 Anette Schrag [Royaume-Uni] ; Anna Hovris [Royaume-Uni] ; David Morley [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]Young-versus older-onset Parkinson's disease: Impact of disease and psychosocial consequences
002274 Murat Emre [Turquie]What causes mental dysfunction in Parkinson's disease?
002275 Christian Brenneis [Autriche] ; Klaus Seppi [Autriche] ; Michael F. Schocke [Autriche] ; Jörg Müller [Autriche] ; Elisabeth Luginger [Autriche] ; Sylvia Bosch [Autriche] ; Wolfgang N. Loscher [Autriche] ; Christian Büchel [Allemagne] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy
002276 Takashi Nomura [Japon] ; Yuichi Inoue [Japon] ; Hidetaka Mitani [Japon] ; Ryuzo Kawahara [Japon] ; Masahiro Miyake [Japon] ; Kenji Nakashima [Japon]Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease
002277 Brian F. O'Donnell [États-Unis] ; Marcia A. Wilt [États-Unis] ; Ann Marie Hake [États-Unis] ; Julie C. Stout [États-Unis] ; Sandra C. Kirkwood [États-Unis] ; Tatiana Foroud [États-Unis]Visual function in Huntington's disease patients and presymptomatic gene carriers
002279 David J. Burn [Royaume-Uni] ; John T. O'Brien [Royaume-Uni]Use of functional imaging in parkinsonism and dementia
002280 Irene Litvan [États-Unis]Update on epidemiological aspects of progressive supranuclear palsy
002281 Mark Edwards [Royaume-Uni] ; Nicholas Wood [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni]Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature
002283 Gurutz Linazasoro [Espagne] ; Nadège Van Blercom [Espagne] ; Asier Lasa [Espagne]Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease
002284 Regina Katzenschlager [Royaume-Uni] ; Adriana Cardozo [Espagne] ; M. Rosario Avila Cobo [Espagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni]Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders
002285 Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne] ; Florian Kopper [Allemagne] ; Monika Potter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne]Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease
002286 Giovanni Pavesi [Italie] ; Luigi Cattaneo [Italie] ; Elisabetta Chierici [Italie] ; Domenico Mancia [Italie]Trigemino-facial inhibitory reflexes in idiopathic hemifacial spasm
002287 Francisco Cardoso [Brésil] ; Débora Maia [Brésil] ; Mauro César Q. S. Cunningham [Brésil] ; Guilherme Valenca [Brésil]Treatment of sydenham chorea with corticosteroids
002290 Philip C. Su [Taïwan] ; Ham-Min Tseng [Taïwan] ; Hon-Man Liu [Taïwan] ; Ruoh-Fang Yen [Taïwan] ; Horng-Huei Liou [Taïwan]Treatment of advanced Parkinson's Disease by subthalamotomy: One-year results
002291 Francisco Grandas [Espagne] ; Jaime Kulisevsky [Espagne]Treatment of Parkinson's disease in Spain
002293 JAE WOO KIM [Corée du Sud] ; Seoung-Ho Choi [Corée du Sud] ; Wook-Joo Kim [Corée du Sud] ; Sang-Myung Chun [Corée du Sud]Transient ischemic attacks presenting as hemiballism
002294 Ruth H. Walker [États-Unis] ; Paul F. Good [États-Unis] ; P. Shashidharan [États-Unis]TorsinA immunoreactivity in inclusion bodies in trinucleotide repeat diseases
002295 Katia Lin [Brésil] ; Jaime Lin [Brésil] ; Elcio Juliato Piovesan [Brésil] ; Francisco M. B. Germiniani [Brésil] ; Hélio A. G. Teive [Brésil] ; Lineu Cesar Werneck [Brésil]Tongue tremor in a patient with coma after electrical injury
002296 The unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
002297 John M. Walshe [Royaume-Uni]The story of penicillamine: A difficult birth
002299 Dominique Twelves [Royaume-Uni] ; Kate S. M. Perkins [Royaume-Uni] ; Carl Counsell [Royaume-Uni]Systematic review of incidence studies of Parkinson's disease
002302 Aida M. Bertoli-Avella [Pays-Bas, Cuba] ; Jose L. Giroud-Benitez [Cuba] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Eduardo Alvarez-Gonzalez [Cuba] ; Luis Heredero-Baute [Cuba] ; Cornelia M. Van Duijn [Pays-Bas] ; Peter Heutink [Pays-Bas]Suggestive linkage to chromosome 19 in a large Cuban family with late-onset Parkinson's disease
002304 Alessandra Pesenti [Italie] ; Alberto Priori [Italie] ; Marco Locatelli [Italie] ; Marcello Egidi [Italie] ; Paolo Rampini [Italie] ; Filippo Tamma [Italie] ; Elena Caputo [Italie] ; Valentina Chiesa [Italie] ; Sergio Barbieri [Italie]Subthalamic somatosensory evoked potentials in Parkinson's disease
002306 Pedro J. Garcia-Ruiz [Espagne] ; Vicente Villanueva [Espagne] ; Eva Gutierrez-Delicado [Espagne] ; Amaia Echeverria [Espagne] ; Antonio Perez-Higueras [Espagne] ; José M. Serratosa [Espagne]Subthalamic lesion and paroxysmal tonic spasms
002307 CHARULATA SANKHLA SAVANT [Inde] ; B. S. Singhal [Inde] ; Joseph Jankovic [États-Unis] ; Mak Khan [Inde] ; Amin Virani [Inde]Substantia nigra lesions in viral encephalitis
002309 Christopher G. Goetz [États-Unis] ; Peter A. Lewitt [États-Unis] ; Meredith Weidenman [États-Unis]Standardized training tools for the UPDRS Activities of Daily Living scale: Newly available teaching program
002313 YING PENG [États-Unis] ; Roger Crumley [États-Unis] ; John M. Ringman [États-Unis]Spasmodic dysphonia in a patient with the a to G transition at nucleotide 8344 in mitochondrial DNA
002314 Mikko Kuoppam Ki [Royaume-Uni] ; Paula Giunti [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Slowly progressive cerebellar ataxia and cervical dystonia: Clinical presentation of a new form of spinocerebellar ataxia?
002315 Matthew A. Brodsky [États-Unis] ; James Godbold [États-Unis] ; Tom Roth [États-Unis] ; C. Warren Olanow [États-Unis]Sleepiness in Parkinson's disease: A controlled study
002316 Sebastian Paus [Allemagne] ; Hans Michael Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Gert Seeger [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
002317 Klaus L. Leenders [Pays-Bas]Significance of non-presynaptic SPECT tracer methods in Parkinson's disease
002318 Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Takamichi Hattori [Japon] ; Tomonori Yamanishi [Japon]Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon
002320 Wolf-Rüdiger Sch Bitz [Allemagne] ; Katharina Glatz [Allemagne] ; Christian Schuhan [Allemagne] ; Clemens Sommer [Allemagne] ; Christian Berger [Allemagne] ; Markus Schwaninger [Allemagne] ; Marius Hartmann [Allemagne] ; Hans Hilmar Goebel [Allemagne] ; Hans-Michael Meinck [Allemagne]Severe forward flexion of the trunk in Parkinson's disease: Focal myopathy of the paraspinal muscles mimicking camptocormia
002321 Oren Cohen [États-Unis] ; Stanley Fahn [États-Unis] ; Steven J. Frucht [États-Unis]Severe cervical dystonia in pathologically proven Parkinson's disease and dementia
002322 Massimo Cincotta [Italie] ; Alessandra Borgheresi [Italie] ; Lara Balzini [Italie] ; Luca Vannucchi [Italie] ; Gabriele Zeloni [Italie] ; Aldo Ragazzoni [Italie] ; Francesco Benvenuti [Italie] ; Gaetano Zaccara [Italie] ; Graziano Arnetoli [Italie] ; Ulf Ziemann [Allemagne]Separate ipsilateral and contralateral corticospinal projections in congenital mirror movements: Neurophysiological evidence and significance for motor rehabilitation
002324 Giovanni Abbruzzese [Italie] ; Alfredo Berardelli [Italie]Sensorimotor integration in movement disorders
002325 Kirn R. Kessler [Allemagne] ; Gilbert Wunderlich [Allemagne] ; Harald Hefter [Allemagne] ; Rüdiger J. Seitz [Allemagne]Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density
002326 Mark S. Ledoux [États-Unis] ; Kimberly A. Brady [États-Unis]Secondary cervical dystonia associated with structural lesions of the central nervous system
002327 Irene Litvan [États-Unis] ; Kailash P. Bhatia ; David J. Burn ; Christopher G. Goetz ; Anthony E. Lang ; Ian Mckeith ; Niall Quinn ; Kapil D. Sethi ; Cliff Shults ; Gregor K. WenningSIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
002328 Haydeh Payami [États-Unis] ; John Nutt [États-Unis] ; Steven Gancher [États-Unis] ; Thomas Bird [États-Unis] ; Melissa Gonzales Mcneal [États-Unis] ; William K. Seltzer [États-Unis] ; Jennifer Hussey [États-Unis] ; Paul Lockhart [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Amanda A. Singleton [États-Unis] ; Andrew B. Singleton [États-Unis] ; John Hardy [États-Unis] ; Matthew Farrer [États-Unis]SCA2 may present as levodopa-responsive parkinsonism
002329 Alexis Elbaz [France] ; Clotilde Levecque [France] ; Jacqueline Clavel [France] ; Jean-Sébastien Vidal [France] ; Florence Richard [France] ; Jean-René Correze [France] ; Bernard Delemotte [France] ; Philippe Amouyel [France] ; Annick Alperovitch [France] ; Marie-Christine Chartier-Harlin [France] ; Christophe Tzourio [France]S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: Evidence for an age-dependent relationship
002330 Michele Tinazzi [Italie] ; Tiziana Rosso [Italie] ; Antonio Fiaschi [Italie]Role of the somatosensory system in primary dystonia
002331 Vicky Marshall [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders
002332 Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]Role of dopamine transporter imaging in routine clinical practice
002333 Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
002334 Wolfgang H. Oertel [Allemagne] ; Anja Gerstner [Allemagne] ; Helmut Höffken [Allemagne] ; Richard C. Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Jens C. Möller [Allemagne]Role of dopamine transporter SPECT for the practitioner and the general neurologist
002336 Gary W. Thickbroom [Australie] ; Michelle L. Byrnes [Australie] ; Rick Stell [Australie] ; Frank L. Mastaglia [Australie]Reversible reorganisation of the motor cortical representation of the hand in cervical dystonia
002337 Pudukode R. Krishnan [Inde] ; Manvir Bhatia [Inde] ; Madhuri Behari [Inde]Restless legs syndrome in Parkinson's disease: A case-controlled study
002338 Carson R. Reider [États-Unis] ; Cheryl A. Halter [États-Unis] ; Peter F. Castelluccio [États-Unis] ; David Oakes [États-Unis] ; William C. Nichols [États-Unis] ; Tatiana Foroud [États-Unis]Reliability of reported age at onset for Parkinson's disease
002340 Wolfgang H. Oertel [Allemagne] ; Tobias W Chter [Allemagne] ; Niall P. Quinn [Royaume-Uni] ; Gudrun Ulm [Allemagne] ; Dirk Brandst Dter [Allemagne]Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type
002341 Cynthia L. Comella [États-Unis] ; Sue Leurgans [États-Unis] ; Joanne Wuu [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Teresa Chmura [États-Unis]Rating scales for dystonia: A multicenter assessment
002343 Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor
002347 Joseph H. Friedman [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Lewis R. Sudarsky [États-Unis]REM Behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3)
002348 Katinka Tuisku [Finlande] ; Matti Mikael Holi [Finlande] ; Kristian Wahlbeck [Finlande] ; Aulikki Johanna Ahlgren [Finlande] ; Hannu Lauerma [Finlande]Quantitative rest activity in ambulatory monitoring as a physiological marker of restless legs syndrome: A controlled study
002350 José L. Molinuevo [Espagne] ; Maria J. Marti [Espagne] ; Rafael Blesa [Espagne] ; Eduardo Tolosa [Espagne]Pure akinesia: An unusual phenotype of Hallervorden-Spatz syndrome
002351 Noëlle G. A. Spliethoff-Kamminga [Pays-Bas] ; Aeilko H. Zwinderman [Pays-Bas] ; Machiel P. Springer [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas]Psychosocial problems in Parkinson's disease: Evaluation of a disease-specific questionnaire
002352 Werner Poewe [Autriche]Psychosis in Parkinson's disease
002354 USHA KANT MISRA [Inde] ; Jayantee Kalita [Inde] ; Anita Mahadevan [Inde] ; SUSARLA KRISHNA SHANKAR [Inde]Pseudoathetosis in a patient with leprosy
002356 Marc G. Weisskopf [États-Unis] ; HONGLEI CHEN [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Ichiro Kawachi [États-Unis] ; Alberto Ascherio [États-Unis]Prospective study of phobic anxiety and risk of Parkinson's disease
002357 Andrew Sharott [Royaume-Uni] ; Jon Marsden [Royaume-Uni] ; Peter Brown [Royaume-Uni]Primary orthostatic tremor is an exaggeration of a physiological response to instability
002359 Tatjana Pekmezovic [Serbie] ; Natasa Ivanovic [Serbie] ; Marina Svetel [Serbie] ; Dragana Nalic [Serbie] ; Tatjana Smiljkovic [Serbie] ; Ranko Raicevic [Serbie] ; Vladimir S. Kostic [Serbie]Prevalence of primary late-onset focal dystonia in the Belgrade population
002364 Carolyn Kwak [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Joseph Jankovic [États-Unis]Premonitory sensory phenomenon in Tourette's syndrome
002365 Daniel S. Sa [Canada] ; Angela Mailis-Gagnon [Canada] ; Keith Nicholson [Canada] ; Anthony E. Lang [Canada]Posttraumatic painful torticollis
002367 Andrew Kertesz [Canada]Pick's complex and FTDP-17
002368 Edith Werber [Israël] ; Colin Klein [Israël] ; Jonathan Grünfeld [Israël] ; José Martin Rabey [Israël]Phenotypic presentation of frontotemporal dementia with parkinsonism-chromosome 17 type p301s in a patient of jewish-algerian origin
002369 Ruth H. Walker [États-Unis] ; Joseph Jankovic [États-Unis] ; Elizabeth O'Hearn [États-Unis] ; Russell L. Margolis [États-Unis]Phenotypic features of Huntington's disease-like 2
002370 Joong-Seok Kim [Corée du Sud] ; Sang-Bong Lee [Corée du Sud] ; Soung-Kyeong Park [Corée du Sud] ; Si-Ryung Han [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud]Periodic limb movement during sleep developed after pontine lesion
002372 Vanessa K. Lim [Nouvelle-Zélande, Allemagne] ; John L. Bradshaw [Australie] ; Michael E. R. Nicholls [Australie] ; Eckart Altenmüller [Allemagne]Perceptual differences in sequential stimuli across patients with musician's and writer's cramp
002375 Peter Teismann [États-Unis] ; Kim Tieu [États-Unis] ; Oren Cohen [États-Unis] ; Dong-Kug Choi [États-Unis] ; DU CHU WU [États-Unis] ; Daniel Marks [États-Unis] ; Miquel Vila [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Serge Przedborski [États-Unis]Pathogenic role of glial cells in Parkinson's disease
002379 Andrew Lees (neurologue) [Royaume-Uni]Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings
002381 Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis]Parkinson's disease is associated with hippocampal atrophy
002382 Sarah J. Lincoln [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Rebecca Bounds [États-Unis] ; Mariza De Andrade [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Matthew J. Farrer [États-Unis]Parkin variants in North American Parkinson's disease: Cases and controls
002385 Rainer Dziewas [Allemagne] ; Gregor Kuhlenb Umer [Allemagne] ; Angelika Okegwo [Allemagne] ; Peter Lüdemann [Allemagne]Painless legs and moving toes in a mother and her daughter
002386 Peter Brown [Royaume-Uni]Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease
002387 Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel [Allemagne] ; Jörg Kazenwadel [Suisse] ; Thomas C. Wetter [Allemagne] ; Wolfgang Oertel [Allemagne] ; Roland Selzer [Allemagne] ; Ralf Kohnen [Allemagne]One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome?
002389 Christopher Hawkes [Royaume-Uni]Olfaction in neurodegenerative disorder
002390 Elan D. Louis [États-Unis] ; Eva C. Jurewicz [États-Unis]Olfaction in essential tremor patients with and without isolated rest tremor
002392 Martin Sommer [Allemagne] ; Stephan Wischer [Allemagne] ; Frithjof Tergau [Allemagne] ; Walter Paulus [Allemagne]Normal intracortical excitability in developmental stuttering
002393 Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada]Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
002394 Christopher D. Ward [Royaume-Uni]Neuropsychiatric interpretations of postencephalitic movement disorders
002395 Kurt A. Jellinger [Autriche]Neuropathological spectrum of Synucleinopathies
002398 Sergei N. Illarioshkin [Russie] ; Magali Periquet [France] ; Nina Rawal [France] ; Christoph B. Lücking [France] ; Tatyana B. Zagorovskaya [Russie] ; Pyotr A. Slominsky [Russie] ; Olga V. Miloserdova [Russie] ; Elena D. Markova [Russie] ; Svetlana A. Limborska [Russie] ; Irina A. Ivanova-Smolenskaya [Russie] ; Alexis Brice [France]Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism
002399 Gregor K. Wenning [Autriche] ; Felix Geser [Autriche] ; Michaela Stampfer-Kountchev [Autriche] ; Francois Tison [Autriche]Multiple system atrophy: An update
002400 Emmanuelle Waubant [France] ; Sophie Tezenas Du Montcel [France] ; Charles Jedynak [France] ; Michael Obadia [France] ; Hassan Hosseini [France] ; Philippe Damier [France] ; Catherine Lubetzki [France] ; Yves Agid [France] ; Jean-Denis DegosMultiple sclerosis tremor and the Stewart-Holmes manoeuvre
002401 Pedro Gonzalez-Alegre [États-Unis] ; Zakaria Ammache [États-Unis] ; Patricia H. Davis [États-Unis] ; Robert L. Rodnitzky [États-Unis]Moyamoya-induced paroxysmal dyskinesia
002403 Josep Valls-Sole [Espagne] ; Jordi MonteroMovement disorders in patients with peripheral facial palsy
002404 Thomas Gasser [Allemagne] ; Susan Bressman [États-Unis] ; Alexandra Dürr [France] ; Joseph Higgins [États-Unis] ; Thomas Klockgether [Allemagne] ; Richard H. Myers [États-Unis]Molecular diagnosis of inherited movement disorders. Movement disorders Society Task Force on Molecular Diagnosis
002405 Michael Orth [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni]Models of Parkinson's disease
002406 Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis]Mirtazapine in essential tremor: A double-blind, placebo-controlled pilot study
002407 John-Paul Bouffard [États-Unis] ; Hernando Mena [États-Unis] ; Mary Ripple [États-Unis] ; Juan Troncoso [États-Unis]Mesencephalic cryptococcal abscesses presenting with Parkinsonism as an initial manifestation of AIDS
002408 Walter Pirker [Autriche] ; Iris Holler [Autriche] ; Willibald Gerschlager [Autriche] ; Susanne Asenbaum [Autriche] ; Georg Zettinig [Autriche] ; Thomas Brücke [Autriche]Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT
002409 Louis C. Tan [États-Unis] ; Caroline M. Tanner [États-Unis] ; RONG CHEN [États-Unis] ; PIU CHAN [États-Unis] ; Matthew Farrer [États-Unis] ; John Hardy [États-Unis] ; J. William Langston [États-Unis]Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation
002410 Blanka Hejdukova [Suède, République tchèque] ; Nasser Hosseini [Suède] ; Bo Johnels [Suède] ; Pall E. Ingvarsson [Suède] ; Göran Steg [Suède] ; Torsten Olsson [Suède]Manual transport in Parkinson's disease
002411 Jan Herzog [Allemagne] ; Julia Reiff [Allemagne] ; Paul Krack [Allemagne] ; Karsten Witt [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Müller [Allemagne] ; Günther Deuschl [Allemagne]Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease
002413 Mona Ragothaman [Inde] ; Uday A. Murgod [Inde] ; Gopalkrishna Gururaj [Inde] ; Subbakrishna D. Kumaraswamy [Inde] ; Uday Muthane [Inde]Lower risk of Parkinson's disease in an admixed population of European and Indian origins
002415 Stig Rehncrona [Suède] ; Bo Johnels [Suède] ; Hakan Widner [Suède] ; Anna-Lena Törnqvist [Suède] ; Marwan Hariz [Suède] ; Olof Sydow [Suède]Long-term efficacy of Thalamic deep brain stimulation for tremor: Double-blind assessments
002416 Philip V. Theodosopoulos [États-Unis] ; William J. Jr Marks [États-Unis] ; Chadwick Christine [États-Unis] ; Philip A. Starr [États-Unis]Locations of movement-related cells in the human subthalamic nucleus in Parkinson's disease
002420 Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada]Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair
002422 David R. Lynch [États-Unis] ; P. David Mozley [États-Unis] ; Set Sokol [États-Unis] ; Nicole M. C. Maas [États-Unis] ; Laura J. Balcer [États-Unis] ; Andrew D. Siderowf [États-Unis]Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease
002423 Carlo Colosimo [Italie, Royaume-Uni] ; Yasushi Osaki [Royaume-Uni] ; Nicola Vanacore [Italie] ; Andrew Lees (neurologue) [Royaume-Uni]Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study
002424 Zelma H. T. Kiss [Canada] ; Marshall Wilkinson [Canada] ; Jerry Krcek [Canada] ; Oksana Suchowersky [Canada] ; BIN HU [Canada] ; William F. Murphy [Canada] ; Doug Hobson [Canada] ; Ron R. Tasker [Canada]Is the target for thalamic deep brain stimulation the same as for thalamotomy?
002425 Ilse M. F. Coulier [Belgique] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration?
002426 Onofre Combarros [Espagne] ; Jon Infante [Espagne] ; Javier Llorca [Espagne] ; José Berciano [Espagne]Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy
002427 Barry M. Seemungal [Royaume-Uni] ; Mary Faldon [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; David S. Zee [États-Unis] ; Adolfo M. Bronstein [Royaume-Uni]Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy
002428 Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ikuko Mizuta [Japon] ; Mitsuhiro Ohta [Japon] ; Hirofumi Maruyama [Japon] ; Ryuji Kaji [Japon] ; Hideshi Kawakami [Japon]Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease
002430 Rocco Agostino [Italie] ; Antonio Curra [Italie] ; Morena Giovannelli [Italie] ; Nicola Modugno [Italie] ; Mario Manfredi [Italie] ; Alfredo Berardelli [Italie]Impairment of individual finger movements in Parkinson's disease
002431 Laura Bertolasi [Italie] ; Silvia Romito [Italie] ; Michele Tinazzi [Italie] ; Niccolo Rizzuto [Italie] ; Alberto Priori [Italie]Impaired heteronymous somatosensory motor cortical inhibition in dystonia
002432 Takeshi Morimoto [Japon, États-Unis] ; Takuro Shimbo [Japon] ; John E. Orav [États-Unis] ; Kunihiko Matsui [Japon] ; Masashi Goto [Japon] ; Manabu Takemura [Japon] ; Kenji Hira [États-Unis] ; Tsuguya Fukui [Japon]Impact of social functioning and vitality on preference for life in patients with Parkinson's disease
002433 Christopher G. Goetz [États-Unis] ; Kimberly Janko [États-Unis] ; Lucy Blasucci [États-Unis] ; Jean A. Jaglin [États-Unis]Impact of placebo assignment in clinical trials of Parkinson's disease
002434 John Hardy [États-Unis, Royaume-Uni]Impact of Genetic analysis on Parkinson's disease research
002436 Paul K. Morrish [Royaume-Uni]How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?
002437 Albert F. G. Leentjens [Pays-Bas] ; Marjan Van Den Akker [Pays-Bas] ; Job F. M. Metsemakers [Pays-Bas] ; Richel Lousberg [Pays-Bas] ; Frans R. J. Verhey [Pays-Bas]Higher incidence of depression preceding the onset of Parkinson's disease: A register study
002438 Melih Vural [Turquie] ; Sibel Özekmekci [Turquie] ; Hülya Apaydin [Turquie] ; Attila Altinel [Turquie]High-dose piracetam is effective on cerebellar ataxia in a patient with cerebellar cortical atrophy
002439 Anette Schrag [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Jennifer Davis [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Health-related quality of life in patients with progressive supranuclear palsy
002440 Peter Hagell [Suède] ; Diane Whalley [Royaume-Uni] ; Stephen P. Mckenna [Royaume-Uni] ; Olle Lindvall [Suède]Health status measurement in Parkinson's disease: Validity of the PDQ-39 and Nottingham Health profile
002444 John Yianni [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Nir Giladi [Israël] ; Marieta Auca [Israël] ; Ralph Gregory [Royaume-Uni] ; Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; John Stein [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit
002445 Stefan Evers [Allemagne] ; Florian Stögbauer [Allemagne]Genetic association of Huntington's disease and restless legs syndrome? A family report
002446 Marwan I. Hariz [Suède, Royaume-Uni]From functional neurosurgery to "interventional" neurology: Survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001
002448 Neil Mahant [Australie] ; Dennis J. Cordato [Australie] ; Victor S. C. Fung [Australie]Focal myoclonus-dystonia of the leg secondary to a lesion of the posterolateral putamen: Clinical and neurophysiological features
002449 William G. Ondo [États-Unis] ; Christine Hunter [États-Unis]Flumazenil, a GABA antagonist, may improve features of Parkinson's Disease
002451 Allan L. Adkin [Canada] ; James S. Frank [Canada] ; Mandar S. Jog [Canada]Fear of falling and postural control in Parkinson's disease
002452 Niall Quinn [Royaume-Uni] ; Mikko Kuoppam Ki [Royaume-Uni, Finlande]Fast micrographia and pallidal pathology
002454 Giovanni Defazio [Italie] ; Francesco Brancati [Italie] ; Enza Maria Valente [Italie] ; Viviana Caputo [Italie] ; Antonio Pizzuti [Italie] ; Davide Martino [Italie] ; Giovanni Abbruzzese [Italie] ; Paolo Livrea [Italie] ; Alfredo Berardelli [Italie] ; Bruno Dallapiccola [Italie]Familial Blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene
002455 Elan D. Louis [États-Unis] ; Blair Ford [États-Unis] ; Steven Frucht [États-Unis]Factors associated with increased risk of head tremor in essential tremor: A community-based study in northern Manhattan
002458 Richard B. Scott [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Joanna Wilson [Royaume-Uni] ; Sarah Banks [Royaume-Uni] ; Anna Turner [Royaume-Uni] ; Simon Parkin [Royaume-Uni] ; Nir Giladi [Israël] ; Carol Joint [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Executive cognitive deficits in Primary dystonia
002459 Emma Mcintosh [Royaume-Uni] ; Alastair Gray [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Estimating the costs of surgical innovations: The case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease
002460 Simona Pigullo [Italie] ; Emilio Di Maria [Italie] ; Roberta Marchese [Italie] ; Emilia Bellone [Italie] ; Rossella Gulli [Italie] ; Cesa Scaglione [Italie] ; Stella Battaglia [Italie] ; Paolo Barone [Italie] ; Paolo Martinelli [Italie] ; Giovanni Abbruzzese [Italie] ; Franco Ajmar [Italie] ; Paola Mandich [Italie]Essential tremor is not associated with α-synuclein gene haplotypes
002461 Mark Edwards [Royaume-Uni] ; Geoffrey Schott [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni]Episodic focal lingual dystonic spasms
002463 Shinichi Matsumoto [Japon] ; Masataka Nishimura [Japon] ; Hiroshi Shibasaki [Japon] ; Ryuji Kaji [Japon]Epidemiology of primary dystonias in Japan: Comparison with western countries
002467 Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study
002468 Ryoichi Hayashi [Japon] ; Takao Hashimoto [Japon] ; Tsuyoshi Tada [Japon] ; Shu-Ichi Ikeda [Japon]Effects of unilateral pallidotomy on voluntary movement, and simple and choice reaction times in Parkinson's disease
002473 Kirsten E. Zeuner [États-Unis] ; Fiona M. Molloy [États-Unis] ; Richard O. Shoge [États-Unis] ; Susanne R. Goldstein [États-Unis] ; Robert Wesley [États-Unis] ; Mark Hallett [États-Unis]Effect of ethanol on the central oscillator in essential tremor
002474 Roberta Marchese [Italie] ; Marco Bove [Italie] ; Giovanni Abbruzzese [Italie]Effect of cognitive and motor tasks on postural stability in Parkinson's disease: A posturographic study
002477 Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni]Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest Tremor and UPDRS part III in Parkinson's disease
002478 Francesca Mancini [Italie] ; Roberta Zangaglia [Italie] ; Silvano Cristina [Italie] ; Maria Grazia Sommaruga [Italie] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Claudio Pacchetti [Italie]Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of Drooling in parkinsonism
002479 Carsten Buhmann [Allemagne] ; Alexandra Bussopulos [Allemagne] ; Matthias Oechsner [Allemagne]Dopaminergic response in Parkinsonian phenotype of Machado-Joseph Disease
002480 George R. Uhl [États-Unis]Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism
002481 Paola P. Piccini [Royaume-Uni]Dopamine transporter: Basic aspects and neuroimaging
002482 Richard C. Dodel [Allemagne] ; Helmut Höffken [Allemagne] ; J. Carsten Möller [Allemagne] ; Bernhard Bornschein [Allemagne] ; Thomas Klockgether [Allemagne] ; Thomas Behr [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Uwe Siebert [États-Unis, Allemagne]Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach
002483 Eng-King Tan [Singapour] ; YANNI TAN [Singapour] ; Anthea Chai [Singapour] ; Christopher Tan [Singapour] ; HUI SHEN [Singapour] ; Sau-Ying Lum [Singapour] ; Stephanie M. C. Fook-Cheong [Singapour] ; Mei-Ling Teoh [Singapour] ; YUAN YIH [Singapour] ; Meng-Cheong Wong [Singapour] ; YI ZHAO [Singapour]Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease
002485 Gun-Marie Hariz [Suède] ; Margareta Lindberg [Suède] ; Marwan I. Hariz [Suède] ; A. Tommy Bergenheim [Suède]Does the ADL Part of the Unified Parkinson's Disease Rating Scale Measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation
002486 Craig Henson [Irlande (pays)] ; Hugh Staunton [Irlande (pays)] ; Francesca M. Brett [Irlande (pays)]Does ageing have an effect on midbrain premotor nuclei for vertical eye movements?
002487 Leslie Findley [Royaume-Uni] ; Manjit Aujla [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] ; Mary Baker [Royaume-Uni] ; Catherine Beech [Royaume-Uni] ; Clive Bowman [Royaume-Uni] ; Jeremy Holmes [Royaume-Uni] ; Wendy K. Kingdom [Royaume-Uni] ; Douglas G. Macmahon [Royaume-Uni] ; Viv Peto [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni]Direct economic impact of Parkinson's disease: A research survey in the United Kingdom
002488 Amy J. Bastian [États-Unis] ; Valerie E. Kelly [États-Unis] ; Fredy J. Revilla [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Jonathan W. Mink [États-Unis]Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's Disease
002489 Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne] ; Carles Roig [Espagne] ; Berta Pascual-Sedano [Espagne] ; Antoni Rodriguez-Fornells [Allemagne] ; Pilar Otermin [Espagne]Diagnostic potential of acoustic startle reflex, acoustic blink reflex, and electro-oculography in progressive supranuclear palsy: A prospective study
002490 Keith A. Josephs [États-Unis] ; Dennis W. Dickson [États-Unis]Diagnostic accuracy of progressive supranuclear palsy in the society for Progressive Supranuclear Palsy Brain Bank
002491 Ruth H. Walker [États-Unis] ; P. Shashidharan [États-Unis]Developments in the molecular biology of DYT1 dystonia
002492 Mickie Welsh [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Robert G. Holloway [États-Unis] ; Sandy Plumb [États-Unis] ; Ronald Pfeiffer [États-Unis] ; Jean Hubble [États-Unis]Development and testing of the Parkinson's disease quality of life scale
002493 Durval C. Costa [Royaume-Uni, Portugal] ; Zuzana Walker [Royaume-Uni] ; Rodney W. H. Walker [Royaume-Uni] ; Flavia R. G. Fontes [Royaume-Uni]Dementia with Lewy bodies versus alzheimer's disease: Role of dopamine transporter imaging
002496 Patrice Peran [France] ; Olivier Rascol [France] ; Jean-Francois Demonet [France] ; Pierre Celsis [France] ; Jean-Luc Nespoulous [France] ; Bruno Dubois [France] ; Dominique Cardebat [France]Deficit of verb generation in nondemented patients with Parkinson's disease
002500 Eduardo Tolosa [Espagne] ; Miguel Coelho [Espagne] ; Marisol Gallardo [Espagne]DAT imaging in drug-induced and psychogenic parkinsonism
002501 David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni]Current treatment of Dementia with lewy bodies and Dementia associated with Parkinson's disease
002502 Anthony E. Lang [Canada]Corticobasal degeneration: Selected developments
002503 Naida L. Graham [Royaume-Uni] ; Thomas H. Bak ; John R. HodgesCorticobasal degeneration as a cognitive disorder
002504 Walter Pirker [Autriche]Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
002505 Nico J. Diederich [Luxembourg (pays), États-Unis] ; Vannina Pieri [Luxembourg (pays)] ; Christopher G. Goetz [États-Unis]Coping strategies for visual hallucinations in Parkinson's disease
002506 Demetrius M. Maraganore [États-Unis] ; Mariza De Andrade [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Matthew J. Farrer [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Complex interactions in Parkinson's disease: A two-phased approach
002507 Elan D. Louis [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Dryden Watner [États-Unis]Community-based data on associations of disease duration and age with severity of essential tremor: Implications for disease pathophysiology
002508 Pascal Grosse [Royaume-Uni, Allemagne] ; Andrea Kühn [Royaume-Uni, Allemagne] ; Carla Cordivari [Royaume-Uni] ; Peter Brown [Royaume-Uni]Coherence analysis in the myoclonus of corticobasal degeneration
002511 Maria J. Marti [Espagne] ; Eduardo Tolosa [Espagne] ; Jaume Campdelacreu [Espagne]Clinical overview of the synucleinopathies
002513 Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
002515 Walter Pirker [Autriche] ; Claude Back [Autriche] ; Willibald Gerschlager [Autriche] ; Franco Laccone [Allemagne] ; Francois Alesch [Autriche]Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2
002516 Saeed Bohlega [Arabie saoudite] ; Adel Al-Jishi [Bahreïn] ; Carol Dobson-Stone [Royaume-Uni] ; Luca Rampoldi [Royaume-Uni, Italie] ; Parthasarathi Saha [Arabie saoudite] ; Hatem Murad [Arabie saoudite] ; Abid Kareem [Arabie saoudite] ; George Roberts [Arabie saoudite] ; Anthony P. Monaco [Royaume-Uni]Chorea-acanthocytosis: Clinical and genetic findings in three families from the arabian peninsula
002517 David Mckee [Royaume-Uni] ; Paul Talbot [Royaume-Uni]Chorea as a presenting feature of variant Creutzfeldt-Jakob disease
002519 Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications
002520 Björn Holmberg [Suède] ; Bo Johnels [Suède] ; Kaj Blennow [Suède] ; Lars Rosengren [Suède]Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
002522 Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Mariza De Andrade [États-Unis] ; James H. Bower [États-Unis] ; Dena Hernandez [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Case-control study of the α-synuclein interacting protein gene and Parkinson's disease
002525 Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada]Burden of parkinsonism: A population-based study
002527 A. K. M. Moinul Hossain [Japon] ; Yuji Murata [Japon] ; LIN ZHANG [Japon] ; Shin-Ichi Taura [Japon] ; Yukinobu Saitoh [Japon] ; Hidehiro Mizusawa [Japon] ; Kenji Oda [Japon] ; Eisuke Matsushima [Japon] ; Yoshiro Okubo [Japon] ; Hitoshi Shibuya [Japon]Brain perfusion SPECT in patients with corticobasal degeneration: Analysis using statistical parametric mapping
002529 Michela Barichella [Italie] ; Agnieszka M. Marczewska [Italie] ; Claudio Mariani [Italie] ; Andrea Landi [Italie] ; Antonella Vairo [Italie] ; Gianni Pezzoli [Italie]Body weight gain rate in patients with Parkinson's disease and deep brain stimulation
002533 Giuseppe Galardi [Italie] ; Silvestro Micera [Italie] ; Jacopo Carpaneto [Italie] ; Silvana Scolari [Italie] ; Massimo Gambini [Italie] ; Paolo Dario [Italie]Automated assessment of cervical dystonia
002536 Luis M. Barreiro De Madariaga [Argentine] ; José E. Sian [Argentine] ; Ignacio Casas Parera [Argentine] ; Federico Micheli [Argentine]Arm chorea secondary to an unruptured giant aneurysm
002537 Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni]Anatamopathological spectrum of tauopathies
002538 Enza-Maria Valente [Italie] ; Anjum Misbahuddin [Royaume-Uni] ; Francesco Brancati [Italie] ; Mark R. Placzek [Royaume-Uni] ; Barbara Garavaglia [Italie] ; Sergio Salvi [Italie] ; Andrea Nemeth [Royaume-Uni] ; Charles Shaw-Smith [Royaume-Uni] ; Nardo Nardocci [Italie] ; Anna-Rita Bentivoglio [Italie] ; Alfredo Berardelli [Italie] ; Roberto Eleopra [Italie] ; Bruno Dallapiccola [Italie] ; Thomas T. Warner [Royaume-Uni]Analysis of the ∈-sarcoglycan gene in familial and sporadic myoclonus-dystonia: Evidence for genetic heterogeneity
002539 Georg Ebersbach [Allemagne]An artist's view of drug-induced hallucinosis
002540 Ronald D. Chervin [États-Unis] ; Flavia B. Consens [États-Unis] ; Ekrem Kutluay [États-Unis]Alternating leg muscle activation during sleep and arousals: A new sleep-related motor phenomenon?
002542 Graham T. A. Warner [Royaume-Uni] ; John H. Mcauley [Royaume-Uni]Alcohol-induced paroxysmal nonkinesogenic dyskinesia after pallidal hypoxic insult
002543 Christian Prueter [Allemagne] ; Benedikt Habermeyer [Allemagne] ; Christine Norra [Allemagne] ; Christoph M. Kosinski [Allemagne]Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease
002545 Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Nadège Van Blercom [France] ; JING XIE [France] ; Elena Moro [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease
002546 Renato P. Munhoz [Canada] ; Ritsuko Hanajima [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada]Acute effect of transcutaneous electrical nerve stimulation on Tremor
002547 Stefano Tamburin [Italie] ; Antonio Fiaschi [Italie] ; Domenico Idone [Italie] ; Piergiorgio Lochner [Italie] ; Paolo Manganotti [Italie] ; Giampietro Zanette [Italie]Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: A TMS study
002548 John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Donald J. Connor [États-Unis] ; Jose L. Hernandez [États-Unis] ; Terrence D. Lagerlund [États-Unis]Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease
002549 Stephen Butterworth [Royaume-Uni] ; Sue Francis [Royaume-Uni] ; Edward Kelly [États-Unis] ; Francis Mcglone [Royaume-Uni] ; Richard Bowtell [Royaume-Uni] ; Guy V. Sawle [Royaume-Uni]Abnormal cortical sensory activation in dystonia: An fMRI study
002550 Philippe Le Cavorzin [France] ; Guy Carrault [France] ; Francis Chagneau [France] ; Pierre Rochcongar [France] ; Hervé Allain [France]A computer model of rigidity and related motor dysfunction in Parkinson's disease
002551 Shingo Okabe [Japon] ; Yoshikazu Ugawa [Japon] ; Ichiro Kanazawa [Japon]0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's Disease
002552 Second European meeting on brain stem reflexes, functions, and related movement disorders, Amsterdam, The Netherlands, April 2001
002553 Management of Parkinson's disease: an evidence-based review
002554 Deep Brain Stimulation for Movement Disorders
002555 Abstracts of the Seventh International Congress of Parkinson's Disease and "Movement" Disorders, November 10-14, 2002, Miami, Florida, USA
002560 Egon Stenager [Danemark] ; Michael Binzer [Danemark]Woman with facial spasm induced exclusively by sound
002561 Thomas Brandt [Allemagne] ; Stefan Glasauer [Allemagne] ; Marianne Dieterich [Allemagne]Vestibular brainstem disorders: Clinical syndromes in roll plane and their model simulation
002563 Francisco Escamilla-Sevilla [Espagne] ; Adolfo Minguez-Castellanos [Espagne] ; Ventura Arjona-Moron [Espagne] ; Jose Maria Martin-Linares [Espagne] ; Juan Carlos Sanchez-Alvarez [Espagne] ; Angel Ortega-Morenoa [Espagne] ; Teresa Garcia-Gomez [Espagne]Unilateral pallidal stimulation for segmental cervical and truncal dystonia: Which side?
002564 Simon G. Parkin [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Peter Silbum [Australie] ; Bruce Hall [Australie] ; Richard Boyle [Australie] ; Carole Joint [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni]Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients
002566 Esmaeil Nikfekr [Royaume-Uni] ; Kathleen Kerr [Royaume-Uni] ; Steve Attfield [Royaume-Uni] ; Diane E. Playford [Royaume-Uni]Trunk movement in Parkinson's disease during rising from seated position
002567 Hanns C. Hopf [Allemagne]Trigeminal reflexes
002568 Jens Ellrich [Allemagne]Trigeminal nociceptive reflexes
002569 Georgio Cruccu [Italie] ; Francesca Galeotti [Italie] ; Gian D. Iannetti [Italie] ; Antonietta Romaniello [Italie, Danemark] ; Andrea Truini [Italie] ; Mario Manfredi [Italie]Trigeminal neuralgia: Update on reflex and evoked potential studies
002571 Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France]Treatment results: Parkinson's disease
002573 Manavdeep Grewal [Canada] ; Raed Hawa [Canada] ; Colin Shapiro [Canada]Treatment of periodic limb movements in sleep with selegiline HCl
002574 Treatment of depression in idiopathic Parkinson's disease
002575 Kin-Lun Tsang [Hong Kong] ; Iris Chi [Hong Kong] ; Shu-Leong Ho [Hong Kong] ; Vivian Weiqun Lou [Hong Kong] ; Tatia M. C. Lee [Hong Kong] ; Leung-Wing Chu [Hong Kong]Translation and validation of the standard Chinese version of PQD-39: A quality-of-life measure for patients with Parkinson's disease
002576 Luigi Michele Romito [Italie] ; Michele Raja [Italie] ; Antonio Daniele [Italie] ; Maria Fiorella Contarino [Italie] ; Anna Rita Bentivoglio [Italie] ; Annalisa Barbier [Italie] ; Massimo Scerrati [Italie] ; Alberto Albanese [Italie]Transient mania with hypersexuality after surgery for high-frequency stimulation of the subthalamic nucleus in Parkinson's disease
002577 Annie Lannuzel [France] ; Patrick P. Michel [France] ; Dominique Caparros-Lefebvre [France] ; Jacqueline Abaul [France] ; Reynald Hocquemiller [France] ; Merle Ruberg [France]Toxicity of annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe
002580 Peter Brown [Royaume-Uni]The startle syndrome
002581 Tamar C. Rubinstein [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis]The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease
002586 Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Lucas Kempf [États-Unis] ; Steven B. Wilkinson [États-Unis] ; William C. Koller [États-Unis]Thalamic stimulation for midbrain tremor after partial hemangioma resection
002588 Andrew Feigin [États-Unis] ; Angelo Antonini [Italie] ; Masafumi Fukuda [États-Unis] ; Roberta De Notaris [Italie] ; Riccardo Benti [Italie] ; Gianni Pezzoli [Italie] ; Marc J. Mentis [États-Unis] ; James R. Moeller [États-Unis] ; David Eidelberg [États-Unis]Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of Parkinsonism
002591 Katherine H. O. Deane [Royaume-Uni] ; Caroline Ellis-Hill [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni]Systematic review of paramedical therapies for Parkinson's disease
002592 Claudia Ramaker [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Anne Margarethe Stiggelbout [Pays-Bas] ; Bob Johannes Van Hilten [Pays-Bas]Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
002593 Margaret K. Y. Mak [Hong Kong] ; Christina W. Y. Hui-Chan [Hong Kong]Switching of movement direction is central to parkinsonian bradykinesia in sit-to-stand
002594 Dryden Watner [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Elan D. Louis [États-Unis]Survey of essential tremor patients on their knowledge about the genetics of the disease
002595 Surgical treatment for Parkinson's disease: Neural transplantation
002596 Surgical treatment for Parkinson's disease: Deep brain surgery
002597 Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis]Surgery of the motor thalamus: Problems with the present nomenclatures
002599 Kenneth B. Baker [États-Unis] ; Erwin B. Jr Montgomery [États-Unis] ; Ali R. Rezai [États-Unis] ; Richard Burgess [États-Unis] ; Hans O. Lüders [États-Unis]Subthalamic nucleus deep brain stimulus evoked potentials: Physiological and therapeutic implications
002600 H. Christopher Hyson [Canada] ; Andrew M. Johnson [Canada] ; Mandar S. Jog [Canada]Sublingual atropine for sialorrhea secondary to parkinsonism: A pilot study
002602 Hans-Michael Meinck [Allemagne] ; Philip D. Thompson [Australie]Stiff man syndrome and related conditions
002603 Johannes D. Speelman [Pays-Bas] ; Richard Schuurman [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; D. Andries Bosch [Pays-Bas]Stereotactic neurosurgery for tremor
002604 Hidehiro Hirabayashi [Japon] ; Magnus Tengvar [Suède] ; Marwan I. Hariz [Suède]Stereotactic imaging of the pallidal target
002606 Blas Morales [Espagne] ; Armando Martinez [Espagne] ; Isabel Gonzalo [Espagne] ; Lidice Vidal [Espagne] ; Raquel Ros [Espagne] ; Estrella Gomez-Tortosa [Espagne] ; Alberto Rabano [Espagne] ; Israel Ampuero [Espagne] ; Marina Sanchez [Espagne] ; Janet Hoenicka [Espagne] ; Justo Garcia De Yebenes [Espagne]Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein
002608 Speech therapy in Parkinson's disease
002609 John N. Caviness [États-Unis] ; Charles H. Adler [États-Unis] ; Thomas G. Beach [États-Unis] ; Kristi L. Wetjen [États-Unis] ; Richard J. Caselli [États-Unis]Small-amplitude cortical myoclonus in Parkinson's disease: Physiology and clinical observations
002611 Antoon De Laat [Belgique] ; Giudo M. Macaluso [Italie]Sleep bruxism as a motor disorder
002614 Eric K. Richfield [États-Unis] ; Jean-Paul Vonsattel [États-Unis] ; Marcy E. Macdonald [États-Unis] ; ZHIQIANG SUN [États-Unis] ; Yun-Ping P. Deng [États-Unis] ; Anton Reiner [États-Unis]Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease
002615 Virginia Macdonald [Australie] ; Glenda M. Halliday [Australie]Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease
002616 Jaishri Blakeley [États-Unis] ; Joseph Jankovic [États-Unis]Secondary paroxysmal dyskinesias
002617 Brad A. Racette [États-Unis] ; Mikula Stambuk [États-Unis] ; Joel S. Perlmutter [États-Unis]Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024)
002619 J. C. Rothwell [Royaume-Uni] ; C. D. Mackinnon [Royaume-Uni] ; J. Valls-Sole [Royaume-Uni]Role of brainstem-spinal projections in voluntary movement
002623 Laurent Vercueil [France] ; Paul Krack [France] ; Pierre Pollak [France]Results of deep brain stimulation for dystonia: A critical reappraisal
002624 Peter Hagell [Suède] ; Sara Nordling [Suède] ; Jan Reimer [Suède] ; Martin Grabowski [Suède] ; Ulf Persson [Suède]Resource use and costs in a Swedish cohort of patients with Parkinson's disease
002627 Roger A. Barker [Royaume-Uni]Repairing the brain in Parkinson's disease: Where next?
002628 Didier Flament [États-Unis] ; Mark B. Shapiro [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Charity G. Moore [États-Unis] ; Richard D. Penn [États-Unis] ; Daniel M. Corcos [États-Unis]Reaction time is not impaired by stimulation of the ventral-intermediate nucleus of the thalamus (Vim) in patients with tremor
002629 Padraig O'Suilleabhain [États-Unis] ; Richard B. Jr Dewey [États-Unis]Randomized trial comparing primidone initiation schedules for treating essential tremor
002631 Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's Disease
002632 Joseph O'Neill [États-Unis] ; Norbert Schuff [États-Unis] ; William J. Jr Marks [États-Unis] ; Robert Feiwell [États-Unis] ; Michael J. Aminoff [États-Unis] ; Michael W. Weiner [États-Unis]Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease
002634 Willibald Gerschlager [Royaume-Uni, Autriche] ; Anette Schrag [Royaume-Uni] ; Peter Brown [Royaume-Uni]Quality of life in stiff-person syndrome
002635 Psychosocial counseling in Parkinson's disease
002636 Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery R. Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada]Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases
002637 Mikko Kuoppam Ki [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Progressive delayed-onset dystonia after cerebral anoxic insult in adults
002639 Marie Sarazin [France] ; Bernard Deweer [France] ; Angela Merkl [France] ; Natalia Von Poser [France] ; Bernard Pillon [France] ; Bruno Dubois [France]Procedural learning and striatofrontal dysfunction in Parkinson's disease
002640 Frank L. Mastaglia [Australie] ; Russell D. Johnsen [Australie] ; Byron A. Kakulas [Australie]Prevalence of stroke in Parkinson's disease: A postmortem study
002641 Luis Erik Claveria [Espagne] ; Jacinto Duarte [Espagne] ; Maria Dolores Sevillano [Espagne] ; Angel Perez-Sempere [Espagne] ; Carmen Cabezas [Espagne] ; Fernanda Rodriguez [Espagne] ; Jesus De Pedro-Cuesta [Espagne, Suède]Prevalence of Parkinson's disease in Cantalejo, Spain: A door-to-door survey
002643 Joseph H. Friedman [États-Unis]Presumed rapid eye movement behavior disorder in Machado-Joseph disease (Spinocerebellar ataxia type 3)
002644 Ann L. Smiley-Oyen [États-Unis] ; Charles J. Worringham [Australie] ; Carol L. Cross [États-Unis]Practice effects in three-dimensional sequential rapid aiming in Parkinson's disease
002646 Jan Zijlmans [Royaume-Uni, Pays-Bas] ; Jan Booij [Pays-Bas] ; Jaap Valk [Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Martin Horstink [Pays-Bas]Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway
002647 Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France]Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
002648 Patricia Dowsey-Limousin [Royaume-Uni]Postoperative management of Vim DBS for tremor
002652 Pauline L. Lee [États-Unis] ; Terri Gelbart [États-Unis] ; Carol West [États-Unis] ; Carol Halloran [États-Unis] ; Jack C. Sipe [États-Unis] ; Ernest Beutler [États-Unis]Polymorphisms in iron-responsive binding protein 2 and lack of association with sporadic Parkinson's disease
002653 Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Rema Raman [États-Unis]Placebo-associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease
002655 Cumhur Ertekin [Turquie]Physiological and pathological aspects of oropharyngeal swallowing
002656 Physical and occupational therapy in Parkinson's disease
002657 Anna Rita Bentivoglio [Italie] ; Mario Loi [Italie] ; Enza M. Valente [Italie] ; Tamara Ialongo [Italie] ; Pietro Tonali [Italie] ; Alberto Albanese [Italie]Phenotypic variability of DYTI-PTD: Does the clinical spectrum include psychogenic dystonia?
002658 Virgilio Gerald H. Evidente [États-Unis, Philippines] ; Joel Advincula [Philippines] ; Raymund Esteban [Philippines] ; Paul Pasco [Philippines] ; Jhoe Anthony Alfon [Philippines] ; Filipinas F. Natividad [Philippines] ; Joven Cuanang [Philippines] ; Amado San Luis [Philippines] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] ; Dena Hernandez [États-Unis] ; Andrew Singleton [États-Unis]Phenomenology of "Lubag" or X-linked dystonia-parkinsonism
002659 Günther Deuschl [Allemagne] ; Hagai Bergman [Israël]Pathophysiology of nonparkinsonian tremors
002660 Jerrold L. Vitek [États-Unis]Pathophysiology of dystonia: A neuronal model
002661 Hagai Bergman [Israël] ; Günther Deuschl [Allemagne]Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
002662 Alfredo Berardelli [Italie] ; Antonio Curra [Italie]Pathophysiology and treatment of cranial dystonia
002665 Irene Hegeman Richard [États-Unis] ; Michelle Papka [États-Unis] ; Ana Rubio [États-Unis] ; Roger Kurlan [États-Unis]Parkinson's disease and dementia with Lewy bodies: One disease or two?
002669 Stéphanie Thobois [France] ; Pierric Giraud [France] ; Pierre Debat [France] ; Michel Gouttard [France] ; Anne Maurizi [France] ; Armand Perret-Liaudet [France] ; Nicolas Kopp [France] ; Emmanuel Broussolle [France]Orofacial dyskinesias in a patient with primary biliary cirrhosis: A clinicopathological case report and review
002670 Lo Bour [Pays-Bas] ; Bram Ongerboer De Visser [Pays-Bas] ; Majid Aramideh [Pays-Bas] ; Johannes Speelman [Pays-Bas]Origin of eye and eyelid movements during blinking
002671 Ruth Djaldetti [Israël] ; Rivkah Inzelberg [Israël] ; Nir Giladi [Israël] ; Amos D. Korczyn [Israël] ; Yehudit Peretz-Aharon [Israël] ; Martin J. Rahey [Israël] ; Yuval Herishano [Israël] ; Silvia Honigman [Israël] ; Sami Badarny [Israël] ; Eldad Melamed [Israël]Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease
002672 William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]Olanzapine treatment for dopaminergic-induced hallucinations
002674 Adriano Jimenez-Escrig [Espagne] ; Juan M. San-Millan [Espagne] ; Manuel Baron [Espagne]Oculo-auricular phenomenon secondary to vestibular dysfunction
002678 J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas]Neurosurgical treatment modalities in Parkinson's disease
002679 Bernard Pillon [France]Neuropsychological assessment for management of patients with deep brain stimulation
002681 Nicola Modugno [Italie] ; Yusaku Nakamura [Italie] ; Sven Bestmann [Royaume-Uni] ; Antonio Curra [Italie] ; Alfredo Berardelli [Italie] ; John Rothwell [Italie, Royaume-Uni]Neurophysiological investigations in patients with primary writing tremor
002682 José M. Delgado-Garcia [Espagne] ; Agnès Gruart [Espagne] ; Alejandro Munera [Espagne]Neural organization of eyelid responses
002683 Aman Badhwar [Canada] ; Auli Siren [Canada] ; Eva Andermann [Canada] ; Frederick Andermann [Canada]Myoclonic status epilepticus: Video presentation
002686 Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease
002688 Hans Brunner [Allemagne] ; Thomas C. Wetter [Allemagne] ; Birgit Hoegl [Allemagne] ; Alexander Yassouridis [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Elisabeth Friess [Allemagne] ; MD [Allemagne]Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of dopaminergic treatment
002690 Andres M. Lozano [Canada] ; William D. Hutchison [Canada]Microelectrode recordings in the pallidum
002691 Jong-Hoon Kim [Corée du Sud] ; HEE YEON JUNG [Corée du Sud] ; UNG GU KANG [Corée du Sud] ; SEONG HOON JEONG [Corée du Sud] ; YONG MIN AHN [Corée du Sud] ; Hee-Jung Byun [Corée du Sud] ; Kyoo-Seob Ha [Corée du Sud] ; YONG SIK KIM [Corée du Sud]Metric characteristics of the Drug-Induced extrapyramidal Symptoms Scale (DIEPSS): A practical combined rating Scale for drug-induced movement disorders
002692 Rajeev Kumar [États-Unis]Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson's disease and dystonia
002693 Gilberto Levy [États-Unis] ; Diane M. Jacobs [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis]Memory and executive function impairment predict dementia in Parkinson's disease
002694 Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada]Mechanisms of deep brain stimulation
002695 Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France]Mechanisms of deep brain stimulation
002696 Jerrold L. Vitek [États-Unis]Mechanisms of deep brain stimulation: Excitation or inhibition
002697 Peter Svensson [Danemark]Masseter reflexes modulated by pain
002699 Charles Majoie [Pays-Bas]Magnetic resonance imaging of the brainstem and cranial nerves III-VII
002700 MAO-B inhibitors for the treatment of Parkinson's disease
002702 G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A.-L. Lafontaine [Canada] ; O. Suchowersky [Canada]Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
002703 Juliane Winkelmann [Allemagne] ; Anette Stautner [Allemagne] ; Walter Samtleben [Allemagne] ; Claudia Trenkwalder [Allemagne]Long-term course of Restless legs syndrome in dialysis patients after kidney transplantation
002705 Levodopa
002709 Jong-Min Kim [Corée du Sud] ; KI HYEONG LEE [Corée du Sud] ; Yoon-La Choi [Corée du Sud] ; GI YEONG CHOE [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy
002713 David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada]Large French-Canadian family with Lewy body parkinsonism: Exclusion of known loci
002715 André Parent [Canada]Jules Bernard Luys and the subthalamic nucleus
002716 Paul Morrish [Royaume-Uni]Is it time to abandon functional imaging in the study of neuroprotection?
002717 Kevin C. Brennan [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Blair Ford [États-Unis] ; Seth L. Pullman [États-Unis] ; Elan D. Louis [États-Unis]Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study
002718 XUGUANG LIU [Royaume-Uni] ; Ivan C. Griffin [Royaume-Uni] ; Simon G. Parkin [Royaume-Uni] ; R. Christopher Miall [Royaume-Uni] ; Jeremy G. Rowe [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard B. Scott [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; John F. Stein [Royaume-Uni]Involvement of the medial pallidum in focal myoclonic dystonia: A clinical and neurophysiological case study
002719 Jens Volkmann [Allemagne] ; Jan Herzog [Allemagne] ; Florian Kopper [Allemagne] ; Güntner Deuschl [Allemagne]Introduction to the programming of deep brain stimulators
002721 Abdelhamid Benazzouz [France] ; Sorin Breit [France] ; Adnan Koudsie [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Alim-Louis Benabid [France]Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease
002722 Ira M. Garonzik [États-Unis] ; Sherwin E. Hua [États-Unis] ; Shinji Ohara [États-Unis] ; Frederick A. Lenz [États-Unis]Intraoperative microelectrode and semi-microelectrode recording during the physiological localization of the thalamic nucleus ventral intermediate
002723 Pierre Pollak [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Elena Moro [France] ; Stephan Chabardes [France] ; Alim-Louis Benabid [France]Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease
002724 Puneet Opal [États-Unis] ; Ron Tintner [États-Unis] ; Joseph Jankovic [États-Unis] ; Joanne Leung [États-Unis] ; Xandra O. Breakefield [États-Unis] ; Jennifer Friedman [États-Unis] ; Laurie Ozelius [États-Unis]Intrafamilial phenotypic variability of the DYT1 dystonia: From asymptomatic TOR1A gene carrier status to dystonic storm
002726 Martin Sommer [Allemagne] ; Diane Ruge [Allemagne] ; Frithjof Tergau [Allemagne] ; Wolfgang Beuche [Allemagne] ; Eckart Altenmüller [Allemagne] ; Walter Paulus [Allemagne]Intracortical excitability in the hand motor representation in hand dystonia and blepharospasm
002731 Laura Camfield [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]Impact of cervical dystonia on quality of life
002732 Alim-Louis Benabid [France] ; Adnan Koudsie [France] ; Abdelhamid Benazzouz [France] ; Jean-Francois Le Bas [France] ; Pierre Pollak [France]Imaging of subthalamic nucleus and ventralis intermedius of the thalamus
002734 Hélio A. G. Teive [Brésil] ; Alessandra Zanatta [Brésil] ; Francisco M. B. Germiniani [Brésil] ; Sérgio M. Almeida [Brésil] ; Lineu C. Werneck [Brésil]Holmes' tremor and neuroparacoccidioidomycosis: A case report
002735 David A. Grimes [Canada] ; Fabin Han [Canada] ; Dennise Bulman [Canada] ; Mary Lou Nicolson [Canada] ; Oksana Suchowersky [Canada]Hereditary chin trembling: A new family with exclusion of the chromosome 9q13-q21 locus
002737 Yoon-Ho Hong [Corée du Sud] ; Tae-Beom Ahn [Corée du Sud] ; Chang Wan Oh [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Hemichorea as an initial manifestation of moyamoya disease: Reversible striatal hypoperfusion demonstrated on single photon emission computed tomography
002738 Chiung-Chu Chen [Taïwan] ; Shih-Tseng Lee [Taïwan] ; Tony Wu [Taïwan] ; Chi-Jen Chen [Taïwan] ; Chin-Chang Huang [Taïwan] ; Chin-Song Lu [Taïwan]Hemiballism after subthalamotomy in patients with Parkinson's disease: Report of 2 cases
002740 Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; Simon Parkin [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Tipu Aziz [Royaume-Uni]Hardware-related problems of deep brain stimulation
002742 Katrina Gwinn-Hardy [États-Unis]Genetics of parkinsonism
002743 Sian D. Spacey [Royaume-Uni, Canada] ; Enza-Maria Valente [Royaume-Uni, Italie] ; Gurusidheshwar M. Wali [Inde] ; Thomas T. Warner [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; Peter H. Dixon [Royaume-Uni] ; Mary B. Davis [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni]Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: Evidence for a third EKD gene
002745 Pau Pastor [Espagne] ; Mario Ezquerra [Espagne] ; Eduardo Tolosa [Espagne] ; Esteban Munoz [Espagne] ; Maria José Marti [Espagne] ; Francesc Valldeoriola [Espagne] ; José Luis Molinuevo [Espagne] ; Matilde Calopa [Espagne] ; Rafael Oliva [Espagne]Further extension of the H1 haplotype associated with progressive supranuclear palsy
002746 Andrea Carmine [Suède] ; Silvia Buervenich [Suède] ; Olof Sydow [Suède] ; Maria Anvret [Suède] ; Lars Olson [Suède]Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease
002747 Michael H. Barnett [Royaume-Uni] ; Paul R. Jarman [Royaume-Uni] ; Simon J. R. Heales [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]Further case of paroxysmal exercise-induced dystonia and some insights into pathogenesis
002748 J. Yelnik [France]Functional anatomy of the basal ganglia
002750 Giovanna Zorzi [Italie] ; Barbara Garavaglia [Italie] ; Federica Invernizzi [Italie] ; Floriano Girotti [Italie] ; Paola Soliveri [Italie] ; Massimo Zeviani [Italie] ; Lucia Angelini [Italie] ; Nardo Nardocci [Italie]Frequency of DYT1 mutation in early-onset primary dystonia in Italian patients
002751 Alain Lagueny [France] ; Pierre Burbaud [France] ; Jean Louis Dubos [France] ; Gwendel Le Masson [France] ; Dominique Guelh [France] ; Frederic Macia [France] ; Corinne Debras [France] ; Francois Tison [France]Freezing of shoulder flexion impeding boule throwing: A form of task-specific focal dystonia in petanque players
002752 Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Nadia Stefanova [Autriche] ; Werner Poewe [Autriche] ; Irene Litvan [États-Unis] ; Gregor K. Wenning [Autriche]Freezing of gait in postmortem-confirmed atypical parkinsonism
002755 Mark A. Hellmann [Israël] ; Eldad Melamed [Israël]Focal dystonia as the presenting sign in Creutzfeldt-Jakob disease
002756 Maria Dolores Sevillano [Espagne] ; Jesus De Pedro-Cuesta [Espagne, Suède] ; Jacinto Duarte [Espagne] ; Luis Erik Claveria [Espagne]Field validation of a method for population screening of parkinsonism
002757 Anne-Catherine Bachoud-Levi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France]Fetal neural grafts for Huntington's disease: A prospective view
002758 Giuseppe Nicoletti [Italie] ; Grazia Annesi [Italie] ; Sara Carrideo [Italie] ; Carmine Tomaino [Italie] ; Alfonso Di Costanzo [Italie] ; Mario Zappia [Italie] ; Aldo Quattrone [Italie]Familial essential tremor is not associated with SCA-12 mutation in Southern Italy
002759 Thomas D. Bird [États-Unis]Familial dyskinesia and facial myokymia
002761 Josep Valls-Sole [Espagne]Facial palsy, postparalytic facial syndrome, and hemifacial spasm
002762 Tricia M. Zawacki [États-Unis] ; Janet Grace [États-Unis] ; Joseph H. Friedman [États-Unis] ; Lewis Sudarsky [États-Unis]Executive and emotional dysfunction in Machado-Joseph disease
002763 Giovanni Fabbrini [Italie] ; Piero Barbanti [Italie] ; Cinzia Aurilia [Italie] ; Nicola Vanacore [Italie] ; Caterina Pauletti [Italie] ; Giuseppe Meco [Italie]Excessive daytime sleepiness in de novo and treated Parkinson's disease
002765 J. Carsten Moller [Allemagne] ; Karin Stiasny [Allemagne] ; Volker Hargutt [Allemagne] ; Werner Cassel [Allemagne] ; Heiko Tietze [Allemagne] ; J. Hermann Peter [Allemagne] ; H.-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne]Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: A pilot study
002766 S. H. Subramony [États-Unis] ; Dena Hernandez [États-Unis] ; Amanda Adam [États-Unis] ; Stephanie Smith-Jefferson [États-Unis] ; Jennifer Hussey [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Timothy Lynch [États-Unis, Irlande (pays)] ; Olga Mcdaniel [États-Unis] ; John Hardy [États-Unis, Royaume-Uni] ; Matt Farrer [États-Unis] ; Andrew Singleton [États-Unis]Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians
002767 Joseph Jankovic [États-Unis]Essential tremor: A heterogenous disorder
002768 Rodger J. Elble [États-Unis]Essential tremor is a monosymptomatic disorder
002769 Giovanni Defazio [Italie] ; Paolo Livrea [Italie]Epidemiology of primary blepharospasm
002770 Alexander Fisher [Australie] ; James Croft-Baker [Australie] ; Michael Davis [Australie] ; Patrick Purcell [Australie] ; Allan J. Mclean [Australie]Entacapone-induced hepatotoxicity and hepatic dysfunction
002771 Ashfaq A. Sharif [États-Unis]Entacapone in restless legs syndrome
002773 Gert Holstege [Pays-Bas]Emotional innervation of facial musculature
002774 Cumhur Ertekin [Turquie] ; Sultan Tarlaci [Turquie] ; Ibrahim Aydogdu [Turquie] ; Nefati Kiylioglu [Turquie] ; Nur Yuceyar [Turquie] ; A. Bulent Turman [Australie] ; Yaprak Secil [Turquie] ; Figen Esmeli [Turquie]Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease
002780 Julie A. Robichaud [États-Unis] ; Kerstin D. Pfann [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis]Effect of medication on EMG patterns in individuals with Parkinson's disease
002781 Katherine A. Johnson [Australie] ; Ross Cunnington [Australie, Royaume-Uni] ; John L. Bradshaw [Australie] ; Edmond Chiu [Australie] ; Robert Iansek [Australie]Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease
002783 Carla Cordivari [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Peter Brown [Royaume-Uni]EMG-EMG coherence in writer's cramp
002787 Drugs to treat urinary frequency, urgency, and/or urge incontinence
002788 Drugs to treat gastrointestinal motility problems
002789 Drugs to treat dementia and psychosis
002790 Drugs to treat autonomic dysfunction in Parkinson's disease
002792 Oleh Hornykiewicz [Autriche]Dopamine miracle: From brain homogenate to dopamine replacement
002793 Monica J. Ling [Australie] ; Arun Aggarwal [Australie] ; John G. L. Morris [Australie]Dopa-responsive parkinsonism secondary to right temporal lobe haemorrhage
002794 Chin-Song Lu [Taïwan] ; Yah-Huei Wu Chou [Taïwan] ; Tzu-Chen Yen [Taïwan] ; Chon-Haw Tsai [Taïwan] ; Rou-Shayn Chen [Taïwan] ; Hsiu-Chen Chang [Taïwan]Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2
002795 Bettina Schrader [Allemagne] ; Wolfgang Hamel [Allemagne] ; Dieter Weinert [Allemagne] ; H. Maximilian Mehdorn [Allemagne]Documentation of electrode localization
002796 Gilberto Levy [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis]Do risk factors for Alzheimer's Disease predict dementia in Parkinson's disease? An exploratory study
002799 EUN AH LEE [Corée du Sud] ; B. Joon Kim [Corée du Sud] ; WON YONG LEE [Corée du Sud]Diagnosing multiple system atrophy with greater accuracy: Combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography
002801 Marina A. J. Tijssen [Royaume-Uni, Pays-Bas] ; Alex Münchau [Royaume-Uni] ; John F. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Peter Brown [Royaume-Uni]Descending control of muscles in patients with cervical dystonia
002802 Paresh K. Doshi [Inde] ; Niraj Chhaya [Inde] ; Mohit H. Bhatt [Inde]Depression leading to attempted suicide after bilateral Subthalamic nucleus stimulation for Parkinson's disease
002803 Michele Tinazzi [Italie] ; Antonio Fiaschi [Italie] ; Emma Frasson [Italie] ; Mirta Fiorio [Italie] ; Feliciana Cortese [Italie] ; Salvatore M. Aglioti [Italie]Deficits of temporal discrimination in dystonia are independent from the spatial distance between the loci of tactile stimulation
002804 Günther Deuschl [Allemagne] ; Peter Bain [Royaume-Uni]Deep brain stimulation for trauma: Patient selection and evaluation
002805 Jens Volkmann [Allemagne] ; Reiner Benecke [Allemagne]Deep brain stimulation for dystonia: Patient selection and evaluation
002806 Anthony E. Lang [Canada] ; Hakan Widner [Suède]Deep brain stimulation for Parkinson's disease: Patient selection and evaluation
002807 Diego Garcia-Borreguero [Espagne] ; Ana B. Caminero [Espagne] ; Yolanda De La Llave [Espagne] ; Oscar Larrosa [Espagne] ; Soledad Barrio [Espagne] ; Juan J. Granizo [Espagne] ; Juan A. Pareja [Espagne]Decreased phasic EMG activity during Rapid eye movement sleep in treatment-naïve Parkinson's disease: Effects of treatment with levodopa and progression of illness
002808 DA agonists: ergot derivatives: Bromocriptine
002809 DA agonists: Non-Ergot derivatives: Ropinirole
002810 DA agonists: Non-Ergot derivatives: Pramipexole
002811 DA agonists: Non-Ergot derivatives: Piribedil
002812 DA agonists: Non-Ergot derivatives: Apomorphine
002813 DA agonists: Ergot derivatives: Pergolide
002814 DA agonists: Ergot derivatives: Lisuride
002815 DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC)
002816 DA agonists: Ergot derivatives: Cabergoline
002818 Mark Hallett [États-Unis]Cortical control of brainstem motor systems
002819 Christoph Pohl [Allemagne] ; Jörg Happe [Allemagne] ; Thomas Klockgether [Allemagne]Cooling improves the writing performance of patients with writer's cramp
002821 Marwan I. Hariz [Suède]Complications of deep brain stimulation surgery
002822 Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada]Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP
002823 Joanna Seniow [Pologne] ; Thomas Bak [Royaume-Uni] ; Jolanta Gajda [Pologne] ; Renata Poniatowska [Pologne] ; Anna Czlonkowska [Pologne]Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease
002824 Anne Thiriaux [France] ; Anne De St Martin [France] ; Laurent Vercueil [France] ; Fabrice Battaglia [France] ; Jean-Paul Armspach [France] ; Edouard Hirsch [France] ; Christian Marescaux [France] ; Izzie J. Namer [France]Co-occurrence of infantile epileptic seizures and childhood paroxysmal choreoathetosis in one family: Clinical, EEG, and SPECT characterization of episodic events
002825 Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis]Clozapine withdrawal symptoms in a Parkinson's disease patient
002826 Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche]Clinical-pathological study of levodopa complications
002827 Valeria Isella [Italie] ; Paola Melzi [Italie] ; Marco Grimaldi [Italie] ; Simona Iurlaro [Italie] ; Roberto Piolti [Italie] ; Carlo Ferrarese [Italie] ; Lodovico Frattola [Italie] ; Ildebrando Appollonio [Italie]Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease
002828 Ruey-Meei Wu [Taïwan] ; Din-E Shan [Taïwan] ; Chen-Ming Sun [Taïwan] ; Ren-Shyan Liu [Taïwan] ; Wuh-Liang Hwu [Taïwan] ; Chun-Hwei Tai [Taïwan] ; Jennifer Hussey [États-Unis] ; Andrew West [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] ; Judy Chen [États-Unis] ; Matt Farrer [États-Unis] ; Sarah Lincoln [États-Unis]Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations
002829 Günther Deuschl [Allemagne] ; Henrik Wilms [Allemagne]Clinical spectrum and physiology of palatal tremor
002830 Jean-Pascal Lefaucheur [France] ; Anne-Catherine Bachoud-Levi [France] ; Catherine Bourdet [France] ; Thierry Grandmougin [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Jean-Denis Degos [France] ; Marc Peschanski [France] ; Fabrice Lisovoski [France]Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease
002831 James H. Bower [États-Unis] ; Dennis W. Dickson [États-Unis] ; Laura Taylor [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis]Clinical correlates of the pathology underlying parkinsonism: A population perspective
002836 John L. Goudreau [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis] ; Timothy G. Lesnick [États-Unis] ; Andrew B. Singleton [États-Unis] ; James H. Bower [États-Unis] ; John A. Hardy [États-Unis] ; Walter A. Rocca [États-Unis]Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease
002838 Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark]Cabergoline plasma concentration is increased during concomitant treatment with itraconazole
002839 COMT inhibitors
002840 Dipankar Nandi [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] ; XUGUANG LIU [Royaume-Uni] ; John F. Stein [Royaume-Uni]Brainstem motor loops in the control of movement
002846 John D. O'Sullivan [Royaume-Uni] ; John Rothwell [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Peter Brown [Royaume-Uni]Bilaterally coherent tremor resembling enhanced physiological tremor: Report of three cases
002848 Pablo Martinez-Martin [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Manuela Pilleri [Espagne] ; José Luis Molinuevo [Espagne] ; Jordi Rumia [Espagne] ; Enric Ferrer [Espagne]Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease
002850 David J. Burn [Royaume-Uni]Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease
002852 Peter C. G. Nijssen [Pays-Bas] ; Esther Brusse [Pays-Bas] ; Antonius C. M. Leyten [Pays-Bas] ; J. J. Martin [Belgique] ; Johannes L. J. M. Teepen [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas]Autosomal dominant adult neuronal ceroid lipofuscinosis: Parkinsonism due to both striatal and nigral dysfunction
002853 John G. L. Morris [Australie] ; Padraic Grattan-Smith [Australie] ; Stacey K. Jankelowitz [Australie] ; Victor S. C. Fung [Australie] ; Paul D. Clouston [Australie] ; Michael W. Hayes [Australie]Athetosis. II: The syndrome of mild athetoid cerebral palsy
002854 John G. L. Morris [Australie] ; Stacey K. Jankelowitz [Australie] ; Victor S. C. Fung [Australie] ; Paul D. Clouston [Australie] ; Michael W. Hayes [Australie] ; Padraic Grattan-Smith [Australie]Athetosis. I: Historical considerations
002855 Pierre-Francois Pradat [France] ; Francois Salachas [France] ; Stéphanie Cartalat-Carel [France] ; Lucette Lacomblez [France] ; Nathalie Patte [France] ; Nadine Leforestier [France] ; Véronique Gaura [France] ; Vincent Meininger [France]Association of chorea and motor neuron disease
002857 Francois Tison [France] ; Farid Yekhlef [France] ; Eric Balestre [France] ; Virginie Chrysostome [France] ; Niall Quinn [Royaume-Uni] ; Gregor K. Wenning [Autriche] ; Werner Poewe [Autriche]Application of the International Cooperative ataxia scale rating in multiple system atrophy
002858 Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients
002859 Anticholinergic therapies in the treatment of Parkinson's disease
002860 ZHIGAO HUANG [États-Unis] ; Michael Jacewicz [États-Unis] ; Ronald F. Pfeiffer [États-Unis]Anticardiolipin antibody in vascular parkinsonism
002862 Michele T. M. Hu [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] ; Jozef Jarosz [Royaume-Uni] ; Lidia Yaguez [Royaume-Uni] ; David J. Brooks [Royaume-Uni]An imaging study of parkinsonism among African-Caribbean and Indian London communities
002863 Amantadine and other antiglutamate agents
002868 Lavanya Vijayaraghavan [Royaume-Uni] ; Ennapadam S. Krishnamoorthy [Singapour] ; Richard G. Brown [Royaume-Uni] ; Michael R. Trimble [Royaume-Uni]Abulia: A Delphi survey of British neurologists and psychiatrists
002869 JIAN WANG [République populaire de Chine] ; Chun-Ying Zhao [République populaire de Chine] ; Yan-Mei Si [République populaire de Chine] ; Zhuo-Lin Liu [République populaire de Chine] ; BIAO CHEN [République populaire de Chine] ; LONG YU [République populaire de Chine]ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset
002870
002871 Abstracts of the First International Symposium on Mental and Behavioral Dysfunction in Movement Disorders, Montreal, Canada, October 10-13, 2001
002872 Andrea Varrone [États-Unis] ; Kenneth L. Marek [États-Unis] ; Danna Jennings [États-Unis] ; Robert B. Innis [États-Unis] ; John P. Seibyl [États-Unis][123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's Disease and multiple system atrophy
002873 Tarja H. Haapaniemi [Finlande] ; Aapo Ahonen [Finlande] ; Pentti Tomiainen [Finlande] ; Kyosti A. Sotaniemi [Finlande] ; Vilho V. Myllyl [Finlande][123I]β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients
002874 Matthias F. Nitschke [Allemagne] ; Gunnar Krüger [Allemagne] ; Harald Bruhn [Allemagne] ; Christine Klein [Allemagne] ; Eckart Gehrking [Allemagne] ; Karl Wessel [Allemagne] ; Jens Frahm [Allemagne] ; Peter Vieregge [Allemagne]Voluntary palatal tremor is associated with hyperactivation of the inferior olive: A functional magnetic resonance imaging study
002876 John D. O'Sullivan [Royaume-Uni] ; Peter Browns ; Andrew Lees (neurologue) [Royaume-Uni]Unusual tremor associated with a posterolateral thalamic lesion in a drummer
002877 Jorge Iriarte [Espagne] ; Manuel Alegre [Espagne] ; Javier Arbizu [Espagne] ; Purificacion De Castro [Espagne]Unilateral Periodic limb movements during sleep in corticobasal degeneration
002878 B. Okuda [Japon] ; H. Tanaka [Japon] ; K. Kawabata [Japon] ; H. Tachibana [Japon] ; M. Sugita [Japon]Truncal and limb apraxia in corticobasal degeneration
002880 Frithjof Tergau [Allemagne] ; Stephan Wischer [Allemagne] ; Christian Wolf [Allemagne] ; Walter Paulus [Allemagne]Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine
002881 Han-Cheng Wang [Taïwan] ; YOLOUNG HSIEH [Taïwan]Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
002883 Alessandra Pesenti [Italie] ; Alberto Priori [Italie] ; Guglielmo Scarlato [Italie] ; Sergio Barbieri [Italie]Transient improvement induced by motor fatigue in focal occupational dystonia: The Handgrip test
002884 J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis]Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study
002885 Hilde Risvoll [Norvège] ; Emilia Kerty [Norvège]To test or not? The value of diagnostic tests in cervical dystonia
002886 Lawrence I. Golbe [États-Unis] ; Alice M. Lazzarini [États-Unis] ; John R. Spychala [États-Unis] ; William G. Johnson [États-Unis] ; Edward S. Stenroos [États-Unis] ; Margery H. Mark [États-Unis] ; Jacob I. Sage [États-Unis]The tau A0 allele in Parkinson's disease
002887 M. C. Carboneini [Italie] ; D. Manzoni [Italie] ; S. Strambi [Italie] ; U. Bonuccelli [Italie] ; N. Pavese [Italie] ; P. Andre [Italie] ; B. Rossi [Italie]The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in Parkinsonian bradykinesia
002888 Steven J. Frucht [États-Unis] ; Stanley Fahn [États-Unis] ; Paul E. Greene [États-Unis] ; Christopher O'Brien [États-Unis] ; Michael Gelb [États-Unis] ; Daniel D. Truong [États-Unis] ; John Welsh [États-Unis] ; Stewart Factor [États-Unis] ; Blair Ford [États-Unis]The natural history of embouchure dystonia
002889 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]The history of Parkinson's disease : Part 2 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june, 2000
002891 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]The basal ganglia : Part 1 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002892 Markus Kofler [Autriche] ; Jörg Müller [Espagne] ; Gregor K. Wenning [Espagne] ; Laura Reggiani [Espagne] ; Pia Hollosi [Espagne] ; Sylvia Bösch [Espagne] ; Gerhard Ransmayr [Espagne] ; Josep Valls-Sole [Autriche] ; Werner Poewe [Espagne]The auditory startle reaction in Parkinsonian disorders
002893 D. A. Mcfarling [États-Unis]The "ragin' cajuns" of Louisiana
002894 William Ondo [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard K. Simpson [États-Unis]Thalamic deep brain stimulation: Effects on the nontarget limbs
002895 C. Marchini [Italie] ; L. Verriello [Italie] ; M. Mucchiut [Italie] ; G. Tion [Italie] ; P. Bergonzi [Italie]Task-specific dystonia in a horn player
002897 F. Tracik [Allemagne] ; G. Ebersbach [Allemagne]Sudden daytime Sleep onset in Parkinson's disease: Polysomnographic recordings
002898 Arthur Korten [Pays-Bas] ; Jan Lodder [Pays-Bas] ; Fred Vreeling [Pays-Bas] ; Anita Boreas [Pays-Bas] ; Lisette Van Raak [Pays-Bas] ; Fons Kessels [Pays-Bas]Stroke and idiopathic Parkinson's disease : Does a shortage of dopamine offer protection against stroke?
002899 Mahmut Edip Gürol [Turquie] ; Mustafa Ertas [Turquie] ; Hasmet Ayhan Hanagasi [Turquie] ; Hüseyin Alparslan Sahin [Turquie] ; Gencay Gürsoy [Turquie] ; Murat Emre [Turquie]Stiff leg syndrome: Case report
002900 A. Münchau [Royaume-Uni] ; S. R. Filipovic [Royaume-Uni] ; A. Oester-Barkey [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni]Spontaneously changing muscular activation pattern in patients with cervical dystonia
002901 D. B. Vodusek [Slovénie]Sphincter EMG and differential diagnosis of Multiple system atrophy
002902 Elan D. Louis [États-Unis] ; Linda Winfield [États-Unis] ; Stanley Fahn [États-Unis] ; Blair Ford [États-Unis]Speech dysfluency exacerbated by levodopa in Parkinson's disease
002903 Emma Frasson [Italie] ; Alberto Priori [Italie] ; Laura Bertolasi [Italie] ; Francois Mauguiere [France] ; Antonio Fiaschi [Italie] ; Michele Tinazzi [Italie]Somatosensory disinhibition in dystonia
002904 S. Thobois [France] ; E. Broussolle [France] ; L. Toureille [France] ; C. Vial [France]Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy
002906 D. Olga Mcdaniel [États-Unis] ; Bronya Keats [États-Unis] ; V. V. Vedanarayanan [États-Unis] ; S. H. Subramony [États-Unis]Sequence variation in GAA repeat expansions may cause differential penotype display in Friedreich's ataxia
002907 Douglas J. Lanska [États-Unis] ; Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis]Seminal figures in the history of movement disorders: Hammond, Osler, and Huntington. Part 11 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002908 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Seminal figures in the history of movement disorders: Gilles de la Tourette, Oppenheim, the Vogts, von Economo, Wilson, and Marsden. Part 12 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002909 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Seminal figures in the history of movement disorders : Sydenham, Parkinson, and Charcot: Part 6 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002910 Paul J. Reading [Royaume-Uni] ; Anna K. Luce [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni]Rivastigmine in the treatment of Parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial
002912 Ania Winogrodzka [Pays-Bas] ; Robert C. Wagenaar [Pays-Bas] ; Paul Bergmans [Pays-Bas] ; Astrid Vellinga [Pays-Bas] ; Jan Booij [Pays-Bas] ; Eric A. Van Royen [Pays-Bas] ; Richard E. A. Van Emmerik [États-Unis] ; Johannes C. Stoof [Pays-Bas] ; Erik Ch. Wolters [Pays-Bas]Rigidity decreases resting Tremor intensity in Parkinson's disease: A [123I]β-CIT SPECT study in early, nonmedicated patients
002913 Adam Wichniak [Allemagne] ; Ferenc Tracik [Allemagne] ; Peter Geisler [Allemagne] ; Georg Ebersbach [Allemagne] ; Sean P. Morrissey [Allemagne] ; Jürgen Zulley [Allemagne]Rhythmic feet movements while falling asleep
002914 E. K. Tan [Singapour] ; A. Seah [Singapour] ; S. J. See [Singapour] ; E. Lim [Singapour] ; K. K. Koh [Singapour] ; M. C. Wong [Singapour]Restless legs syndrome in an Asian population: A study in Singapore
002915 Georg Berding [Allemagne] ; Per Odin [Allemagne] ; David J. Brooks [Royaume-Uni] ; Guido Nikkhah [Allemagne] ; Cordula Matthies [Allemagne] ; Thomas Peschel [Allemagne] ; Mona Shing [Allemagne] ; Hans Kolbe [Allemagne] ; Jörg Van Den Hoff [Allemagne] ; Harald Fricke [Allemagne] ; Reinhard Dengler [Allemagne] ; Madjid Samii [Allemagne] ; Wolfram H. Knapp [Allemagne]Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the Off and On conditions with [18F]FDG-PET
002917 Joohi Shahed [États-Unis] ; Joseph Jankovic [États-Unis]Re-emergence of Childhood stuttering in Parkinson's disease : A hypothesis
002918 Elina Nurmi [Finlande] ; Hanna M. Ruottinen [Finlande] ; Jörgen Bergman [Finlande] ; Merja Haaparanta [Finlande] ; Olof Solin [Finlande] ; Pirkko Sonninen [Finlande] ; Juha O. Rinne [Finlande]Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study
002920 J. P. P. Van Vugt [Pays-Bas] ; S. Siesling [Pays-Bas] ; K. K. E. Piet [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; H. A. M. Middelkoop [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas]Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease
002921 Pierre C. Jedynak [France] ; Christine Tranchant [France] ; Diederik Zegers De Beyl [Belgique]Prospective clinical study of Writer's cramp
002923 Hiroshi Ujike [Japon] ; Mitsutoshi Yamamoto [Japon] ; Akihiro Kanzaki [Japon] ; Kazuya Okumura [Japon] ; Manabu Takaki [Japon] ; Shigetoshi Kuroda [Japon]Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease
002924 Jan Ulfberg [Suède] ; Birgitta Nyström [Suède] ; Ned Carter [Suède] ; Christer Edling [Suède]Prevalence of Restless Legs Syndrome among men aged 18 to 64 years: An association with somatic disease and neuropsychiatric symptoms
002925 Hubert H. Fernandez [États-Unis] ; Rowena E. J. Tabamo [États-Unis] ; Raymund R. David [États-Unis] ; Joseph H. Friedman [États-Unis]Predictors of depressive symptoms among spouse caregivers in Parkinson's Disease
002926 K. Biirk [Allemagne] ; M. Skalej [Allemagne] ; J. Dichgans [Allemagne]Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA)
002927 Anette Schrag [Royaume-Uni] ; Michael Trimble [Royaume-Uni]Poetic talent unmasked by treatment of Parkinson's disease
002928 Emilia Mabel Gatto [Argentine] ; Manuel Maria Fernandez Pardal [Argentine] ; Ricardo Claudio Reisin [Argentine] ; Ana Maria Pardal [Argentine]Playing harp, another unusual task-specific dystonia
002929 Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France]Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
002930 Virgilio Gerald H. Evidente [Philippines]Piribedil for restless legs syndrome: A pilot study
002932 Anna R. Bentivoglio [Italie] ; Pietro Cortelli [Italie] ; Enza M. Valente [Italie] ; Tamara Ialongo [Italie] ; Alessandro Ferraris [Italie] ; Antonio Elia [Italie] ; Pasquale Montagna [Italie] ; Alberto Albanese [Italie]Phenotypic characterisation of autosomal recessive PARK6-linked Parkinsonism in three unrelated Italian families
002934 Joseph H. Friedman [États-Unis] ; Neetha Shettv [États-Unis]Permanent cerebellar toxicity of cytosine arabinoside (ara C) in a young woman
002935 Ilias Papathanasiou [Royaume-Uni] ; Lea Macdonald [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]Perceived stigma in spasmodic torticollis
002936 Marina Svetel [Serbie] ; Nadezda Sternic [Serbie] ; Sanja Pejovic [Serbie] ; Vladimir S. Kostic [Serbie]Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease
002937 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Parkinsonism-plus syndromes: Part 7 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002938 Egberto R. Barbosa [Brésil] ; Maria D. Leiros Da Costa [Brésil] ; Luiz A. Bacheschi [Brésil] ; Milberto Scaff [Brésil] ; Claudia C. Leite [Brésil]Parkinsonism after glycine-derivate exposure
002941 D. Joel [Israël]Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease
002946 J. Hoenicka [Espagne] ; L. Vidal [Espagne] ; M. Godoy [Espagne] ; J. J. Ochoa [Espagne] ; J. Garcia De Yebenes [Espagne]New nonsense mutation in the GTP-cyclohydrolase I gene in L-DOPA responsive dystonia-parkinsonism
002947 Thomas Trottenberg [Allemagne] ; Wassilios Meissner [Allemagne] ; Guy Arnold [Allemagne] ; Karl-Max Einhaupl [Allemagne] ; Andreas Kupsch [Allemagne] ; Christian Kabus [Allemagne] ; Thomas Funk [Allemagne]Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome
002948 Jaime Kulisevsky [Espagne] ; Irene Litvan [États-Unis] ; Marcelo L. Berthier [Espagne] ; Berta Pascual-Sedano [Espagne] ; Jane S. Paulsen [États-Unis] ; Jeffrey L. Cummings [États-Unis]Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders
002950 Georg Becker [Allemagne] ; Daniela Berg [Allemagne]Neuroimaging in basal ganglia disorders : Perspectives for Transcranial ultrasound
002953 James W. Lance [Australie] ; Raymond D. Adams [États-Unis]Negative myoclonus in posthypoxic patients : Historical note
002955 R. Richard Sloop [États-Unis] ; Dorothee Cole [États-Unis] ; Milan C. Patel [États-Unis]Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals
002957 Massimo Pandolfo [Canada]Molecular basis of friedreich ataxia
002959 Mandar S. Jog [Canada] ; Linda Grantier [Canada]Methods for digital Video recording, storage, and communication of movement disorders
002960 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]Medical art and photography in the history of movement disorders: Part 13 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002961 Tobias E. Eichhorn [Allemagne] ; Wolfgang H. Oertel [Allemagne]Macrogol 3350/Electrolyte improves constipation in Parkinson's disease and multiple system atrophy
002962 G. Tissingh [Pays-Bas] ; H. W. Berendse [Pays-Bas] ; P. Bergmans [Pays-Bas] ; R. Dewaard [Pays-Bas] ; B. Drukarch [Pays-Bas] ; J. C. Stoof [Pays-Bas] ; E. Ch. Wolters [Pays-Bas]Loss of olfaction in de novo and treated Parkinson's disease : Possible implications for early diagnosis
002963 William C. Koller [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Troster [États-Unis] ; Rajesh Pahwa [États-Unis]Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor
002964 Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
002965 Arthur S. Walters [États-Unis] ; Juliane Winkelmann [Allemagne] ; Claudia Trenkwalder [Allemagne] ; June M. Fry [États-Unis] ; Vandana Kataria [États-Unis] ; Mary Wagner [États-Unis] ; Rakesh Sharma [États-Unis] ; Wayne Hening [États-Unis] ; LIREN LI [États-Unis]Long-term follow-up on restless legs syndrome patients treated with opioids
002967 Brad A. Racette [États-Unis] ; Arie Perry [États-Unis] ; Giovanni D'Avossa [États-Unis] ; Joel S. Perlmutter [États-Unis]Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum
002968 Caroline M. Tanner [États-Unis] ; Jerry Chamberland [Indonésie]Latah in Jakarta, Indonesia
002970 Marie-Hélène Saint-Hilaire [États-Unis] ; Jean-Marc Saint-Hilaire [Canada]Jumping frenchmen of Maine
002971 Birgit Högl [Autriche] ; Md. Klaus Seppi [Autriche] ; Elisabeth Brandauer [Autriche] ; Gregor Wenning [Autriche] ; Werner Poewe [Autriche]Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy: Placebo-controlled, polysomnographic case report
002973 Paolo Del Dotto [Italie] ; Nicola Pavese [Italie] ; Gianna Gambaccini [Italie] ; Silvia Bernardini [Italie] ; Leonard Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Ubaldo Bonuccelli [Italie]Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study
002975 Ivan Rektor [République tchèque] ; Martin Bares [République tchèque] ; Petr Kanovsky [République tchèque] ; Miloslav Kukleta [République tchèque]Intracerebral recording of readiness potential induced by a complex motor task
002976 D. A. Grimes [Canada] ; D. Bulman [Canada] ; P. St. George-Hyslop [Canada] ; A. E. Lang [Canada]Inherited myoclonus-dystonia : Evidence supporting genetic heterogeneity
002980 Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
002982 Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Teresa A. Chmura [États-Unis]Home alone: Methods to maximize Tic expression for objective Videotape assessments in Gilles de la tourette syndrome
002983 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of tic disorders and Gilles de la Tourette syndrome : Part 5 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002984 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of myoclonus: Part 8 of the MDS-sponsored history of movement disorders exhibit, Barcelona, june 2000
002985 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002986 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of dystonia : Part 4 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June, 2000
002987 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of chorea : Part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002988 P. Shanahan [Irlande (pays)] ; M. Hutchinson [Irlande (pays)] ; A. Bohan [Irlande (pays)] ; D. O'Donoghue [Irlande (pays)] ; K. Sheahan [Irlande (pays)] ; A. Owens [Irlande (pays)]Hemichorea, moya-moya, and ulcerative colitis
002989 S. Ohara [Japon] ; S. Nakagawa [Japon] ; K. Tabata [Japon] ; T. Hashimoto [Japon]Hemiballism with hyperglycemia and striatal T1-MRI hyperintensity: An autopsy report
002991 Marwan I. Hariz [Suède] ; Folke Johansson [Suède]Hardware failure in Parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency
002992 Nihal Tas [Turquie] ; Gülcin Kaymak Karatas [Turquie] ; Vesile Sepici [Turquie]Hand orthosis as a writing aid in Writer's cramp
002993 Federico M. Farin [États-Unis] ; Yolanda Hitosis [États-Unis] ; Sarah E. Hallagan [États-Unis] ; John Kushleika [États-Unis] ; James S. Woods [États-Unis] ; Patricia S. Janssen [États-Unis] ; Terri Smith-Weller [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Harvey Checkoway [États-Unis]Genetic polymorphisms of superoxide dismutase in Parkinson's disease
002994 Ruth Hardoff [Israël] ; Michael Sula [Israël] ; Ada Tamir [Israël] ; Adrian Soil [Israël] ; Avi Front [Israël] ; Samich Badarna [Israël] ; Silvia Honigman [Israël] ; Nir Giladi [Israël]Gastric emptying time and gastric motility in patients with Parkinson's disease
002995 Robert Jech [République tchèque] ; Dusan Urgosik [République tchèque] ; Jaroslav Tintera [République tchèque] ; Antonin Nebuzelsky [République tchèque] ; Jan Krasensky [République tchèque] ; Roman Liscak [République tchèque] ; Jan Roth [République tchèque] ; Evzen Ruzicka [République tchèque]Functional magnetic resonance imaging during deep brain stimulation: A pilot study in four patients with Parkinson's disease
002996 Zbigniew K. Wszolek [États-Unis] ; Randy H. Kardon [États-Unis] ; Erik Ch. Wolters [Pays-Bas] ; Ronald F. Pfeiffer [États-Unis]Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration
002997 J. Eric Ahlskog [États-Unis] ; Manfred D. Muenter [États-Unis]Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
002998 Neil S. Lava [États-Unis] ; Stewart A. Factor [États-Unis]Focal myopathy as a cause of anterocollis in Parkinsonism
002999 J. H. Friedman [États-Unis] ; H. Friedman [États-Unis]Fatigue in Parkinson's disease: A nine-year follow-up
002A00 E. Apartis [France] ; F. Tison [France] ; P. Arne [France] ; C. P. Jedynak [France] ; M. Vidailhet [France]Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor
002A02 T. Perniola [Italie] ; L. Margari [Italie] ; M. G. De Iaco [Italie] ; A. Presicci [Italie] ; P. Ventura [Italie] ; E. Ferrannini [Italie] ; G. Illiceto [Italie]Familial paroxysmal exercise-induced dyskinesia, epilepsy, and mental retardation in a family with autosomal dominant inheritance
002A04 Elan D. Louis [États-Unis]Etiology of essential tremor: Should we be searching for environmental causes?
002A08 Peter Brown [Royaume-Uni] ; Philip D. Thompson [Australie]Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor
002A10 Joseph H. Friedman [États-Unis]Effects of reviewing DATATOP videotapes on IQ and MMPI in PSG coordinators and investigators, or, whatever happened to tony lang?
002A11 N. Allert [Allemagne] ; J. Volkmann [Allemagne] ; S. Dotse [Allemagne] ; H. Hefter [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne]Effects of Bilateral pallidal or subthalamic stimulation on gait in advanced Parkinson's Disease
002A12 Birgit Högl [Allemagne] ; Cecilia Peralta [Argentine] ; Thomas C. Wetter [Allemagne] ; Oscar Gershanik [Argentine] ; Claudia Trenkwalder [Allemagne]Effect of sleep deprivation on motor performance in patients with Parkinson's Disease
002A14 Marina Svetel [Serbie] ; Dusko Kozic [Serbie] ; Elka Stefanova [Serbie] ; Robert Semnic [Serbie] ; Natasa Dragasevic [Serbie] ; Vladimir S. Kostic [Serbie]Dystonia in Wilson's disease
002A16 L. Alvarez [Cuba] ; R. Macias [Cuba] ; J. Guridi [Espagne] ; G. Lopez [Cuba] ; E. Alvarez [Cuba] ; C. Maragoto [Cuba] ; J. Teijeiro [Cuba] ; A. Torres [Cuba] ; N. Pavon [Cuba] ; M. C. Rodriguez-Oroz [Espagne] ; L. Ochoa [Cuba] ; H. Hetherington [États-Unis] ; J. Juncos [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne]Dorsal subthalamotomy for Parkinson's disease
002A19 Richard Camicioli [États-Unis] ; Sandra J. Grossmann [États-Unis] ; Peter S. Spencer [États-Unis] ; Ken Hudnell [États-Unis] ; W. Kent Anger [États-Unis]Discriminating mild Parkinsonism : Methods for epidemiological research
002A20 Douglas J. Lanska [États-Unis] ; Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis]Development of instruments for abnormal movements: Postural sway and gait analyses. Part 10 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002A23 Marcelo Merello [Argentine] ; Angel Cammarota [Argentine] ; Ramon Leiguarda [Argentine] ; Ralph Pikielny [Argentine]Delayed intracerebral electrode infection after bilateral STN implantation for Parkinson's disease: Case report
002A24 G. Wihl [Allemagne] ; J. Volkmann [Allemagne] ; N. Allert [Allemagne] ; R. Lehrke [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne]Deep brain stimulation of the internal pallidum did not improve chorea in a patient with neuro-acanthocytosis
002A25 N. J. Cordato [Australie] ; G. M. Halliday [Australie] ; L. Davies [Australie] ; P. Williamson [Australie] ; M. Fulham [Australie] ; J. G. L. Morris [Australie]Corticobasal syndrome with tau pathology
002A27 Kerstin D. Pfann [États-Unis] ; Aron S. Buchman [États-Unis] ; Cynthia L. Comella [États-Unis] ; Daniel M. Corcos [États-Unis]Control of movement distance in Parkinson's disease
002A28 Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
002A30 Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Tröster [États-Unis] ; John Overman [États-Unis] ; Jennifer Kieltyka [États-Unis] ; William C. Koller [États-Unis]Comparison of thalamotomy to deep brain Stimulation of the thalamus in Essential tremor
002A31 Elan D. Louis [États-Unis] ; Seth L. Pullman [États-Unis]Comparison of clinical vs. electrophysiological methods of diagnosing of Essential tremor
002A32 Lisa M. Shulman [États-Unis] ; Robin Leifert Taback [États-Unis] ; Judy Bean [États-Unis] ; William J. Weiner [États-Unis]Comorbidity of the nonmotor symptoms of Parkinson's disease
002A33 Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis]Clozapine for the treatment of drug-induced psychosis in Parkinson's disease : Results of the 12 week open label extension in the PSYCLOPS trial
002A34 S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; A. Papadimitriou [Grèce] ; V. Veletza [Grèce] ; G. Hatzigeorgiou [Grèce] ; A. Lees [Royaume-Uni]Clinical features of parkinsonian patients with the α-synuclein (G209A) mutation
002A35 C.-S. Lu [Taïwan] ; J.-C. Wu [Taïwan] ; C.-H. Tsai [Taïwan] ; R.-S. Chen [Taïwan] ; Y.-H. Wu Chou [Taïwan] ; N. Hattori [Japon] ; H. Yoshino [Japon] ; Y. Mizuno [Japon]Clinical and genetic studies on familial parkinsonism : The first report on a Parkin gene mutation in a Taiwanese family
002A37 Lorraine O. Ramig [États-Unis] ; Shimon Sapir [États-Unis] ; Cynthia Fox [États-Unis] ; Stefanie Countryman [États-Unis]Changes in vocal loudness following intensive voice Treatment (LSVT®) in individuals with Parkinson's disease : A comparison with untreated patients and normal age-matched controls
002A38 Silke Wunderlich [Allemagne] ; Karlheinz Reiners [Allemagne] ; Thomas Gasser [Allemagne] ; Markus Naumann [Allemagne]Cervical dystonia in monozygotic twins: Case report and review of the literature
002A39 Christopher O'Brien [États-Unis] ; Allison Brashear [États-Unis] ; Paul Cullis [États-Unis] ; Daniel Truong ; Eric Molho [États-Unis] ; Stephen Jenkins [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Thomas O'Neil [États-Unis] ; Stewart Factor [États-Unis] ; Lauren Seeberger [États-Unis]Cervical Dystonia Severity scale reliability study
002A43 Pierre-Francois Pradat [France] ; Corinne Dupel-Pottier [France] ; Lucette Lacomblez [France] ; Francois Salachas [France] ; Vincent Meininger [France] ; Laurent Spelle [France] ; Isabelle Bonnaud [France] ; Marie Joao Ribeiro [France] ; Philippe Remy [France] ; Yves Samson [France]Case record of pallido-pyramidal disease with supplementary motor area involvement
002A44 JINWHAN CHO [Corée du Sud] ; KON CHU [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Case of essential palatal tremor: Atypical features and remarkable benefit from botulinum toxin injection
002A45 Björn Holmberg [Suède] ; Mika Kallio [Finlande] ; Bo Johnels [Suède] ; Mikael Elam [Suède]Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes
002A46 William J. Weiner [États-Unis]Can peripheral trauma induce dystonia? No!
002A47 Joseph Jankovic [États-Unis]Can peripheral trauma induce dystonia and other movement disorders? Yes!
002A50 Christopher J. Earley [États-Unis] ; Keith Hyland [États-Unis] ; Richard P. Allen [États-Unis]CSF dopamine, serotonin, and biopterin metabolites in patients with Restless Legs Syndrome
002A51 Mareina Kudo [Japon] ; Satoshi Goto [Japon] ; Shigeyuki Nishikawa [Japon] ; Tadashi Hamasaki [Japon] ; Naohiro Soyama [Japon] ; Yukitaka Ushio [Japon] ; Shuji Mita [Japon] ; Yoshifumi Hirata [Japon]Bilateral thalamic stimulation for Holmes' tremor caused by unilateral brainstem lesion
002A52 Bala V. Manyam [États-Unis] ; Arthur S. Walters [États-Unis] ; Koteswara R. Narla [États-Unis]Bilateral striopallidodentate calcinosis : Clinical characteristics of patients seen in a registry
002A53 Daisuke Muta [Japon] ; Satoshi Goto [Japon] ; Shigeyuki Nishikawa [Japon] ; Tadashi Hamasaki [Japon] ; Yukitaka Ushio [Japon] ; Nobuhiro Inoue [Japon] ; Shuji Mita [Japon]Bilateral pallidal stimulation for idiopathic segmental axial dystonia advanced from Meige syndrome refractory to bilateral thalamotomy
002A54 Simon Parkin [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni]Bilateral internal globus pallidus stimulation for the treatment of spasmodic torticollis
002A56 D. Laplane [France] ; B. Dubois [France]Auto-activation deficit: A basal ganglia related syndrome
002A57 G. M. Wali [Inde]Asymmetrical blepharospasm associated with a left frontal cortical infarct
002A58 Bradley F. Boeve [États-Unis] ; Michael H. Silber [États-Unis] ; Tanis J. Ferman [États-Unis] ; John A. Lucas [États-Unis] ; Joseph E. Parisi [États-Unis]Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy
002A59 Armin J. Grau [Allemagne] ; Vera Willig [Allemagne] ; Wolfgang Fogel [Allemagne] ; Egon Werle [Allemagne]Assessment of plasma lactoferrin in Parkinson's disease
002A61 Pau Pastor [Espagne] ; Esteban Munoz [Espagne] ; Mario Ezquerra [Espagne] ; Victor Obach [Espagne] ; Maria José Marti [Espagne] ; Francese Valldeoriola [Espagne] ; Eduard Tolosa [Espagne] ; Rafael Oliva [Espagne]Analysis of the coding and the 5' flanking regions of the α-synuclein gene in patients with Parkinson's disease
002A62 L. Quinn [États-Unis] ; R. Reilmann [États-Unis] ; K. Marder [États-Unis] ; A. M. Gordon [États-Unis]Altered movement trajectories and force control during object transport in Huntington's Disease
002A63 José A. Dominguez-Moran [Espagne] ; Juan M. Callejo [Espagne] ; Luis C. Fernandez-Ruiz [Espagne] ; Juan C. Martinez-Castrillo [Espagne]Acute paroxysmal dystonia induced by fluoxetine
002A64 Anette V. Nieves [Canada] ; Janis M. Miyasaki [Canada] ; Anthony E. Lang [Canada]Acute onset dystonic camptocormia caused by lenticular lesions
002A65 F. Carella [Italie] ; S. Genitrini [Italie] ; M. Bressanelli [Italie] ; P. Soliveri [Italie] ; D. Servello [Italie] ; G. Broggi [Italie] ; S. Piacentini [Italie] ; G. Geminiani [Italie] ; F. Girotti [Italie]Acute effects of bilateral subthalamic nucleus stimulation on clinical and kinematic parameters in Parkinson's disease
002A66 J. A. Burguera [Espagne] ; L. Bataller [Espagne] ; C. Valero [Espagne]Action hand dystonia after cortical parietal infarction
002A67 J. I. Hoff [Pays-Bas] ; A. A. V. D. Plas [Pays-Bas] ; E. A. H. Wagemans [Pays-Bas] ; J. J. Van Hilten [Pays-Bas]Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease
002A68 Satoshi Goto [Japon] ; Naoko Kunitoku [Japon] ; Tadashi Hamasaki [Japon] ; Shigeyuki Nishikawa [Japon] ; Yukitaka Ushio [Japon]Abolition of postapoplectic hemichorea by Vo-complex thalamotomy: Long-term follow-up study
002A69 Alice Nieuwboer [Belgique] ; René Dom [Belgique] ; Willy De Weerdt [Belgique] ; Kaat Desloovere [Belgique] ; Steffen Fieuws [Belgique] ; Eva Broens-Kaucsik [Belgique]Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease
002A70 Terence D. Sanger [États-Unis] ; Daniel Tarsy [États-Unis] ; Alvaro Pascual-Leone [États-Unis]Abnormalities of spatial and temporal sensory discrimination in Writer's cramp
002A71 Elan D. Louis [États-Unis] ; Livia Barnes [États-Unis] ; Kristin J. Wendt [États-Unis] ; Blair Ford [États-Unis] ; Maria Sangiorgio [États-Unis] ; Samer Tabbal [États-Unis] ; Linda Lewis [États-Unis] ; Petra Kaufmann [États-Unis] ; Carol Moskowitz [États-Unis] ; Cynthia L. Comella [États-Unis] ; Christopher C. Goetz [États-Unis] ; Anthony E. Lang [Canada]A Teaching videotape for the assessment of Essential Tremor
002A72 Connie Marras [Canada] ; Anthony E. Lang [Canada] ; LEE CYN ANG [Canada] ; Jcm Zijlmans [Royaume-Uni] ; G. K. Wenning [Autriche]69-year-old man with gait disturbance and parkinsonism
002A73
002A74 Posthypoxic Myoclonus
002A75 Abstracts of the sixth international congress of Parkinson's disease and movement disorders, Barcelona, Spain, June 11-15, 2000
002A76 Abstracts from International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando, FL, USA, November 16-18, 1999
002A78 C. W. Olanow [États-Unis] ; A. H. V. Schapira [Royaume-Uni] ; T. Roth [États-Unis]Waking up to sleep episodes in Parkinson's disease
002A79 Gaetan Garraux [Belgique] ; Eric Salmon [Belgique] ; Philippe Peigneux [Belgique] ; Alexandre Kreisler [France] ; Christian Degueldre [Belgique] ; Christian Lemaire [Belgique] ; Alain Destée [France] ; Georges Franck [Belgique]Voxel-based distribution of metabolic impairment in corticobasal degeneration
002A83 D. S. Latchman [Royaume-Uni] ; R. S. Coffin [Royaume-Uni]Viral vectors in the treatment of Parkinson's disease
002A85 E. D. Louis [États-Unis] ; L. F. Barnes [États-Unis] ; K. J. Wendt [États-Unis] ; S. M. Albert [États-Unis] ; S. L. Pullman [États-Unis] ; QIPING YU [États-Unis] ; F. R. Schneier [États-Unis]Validity and test-retest reliability of a Disability Questionnaire for Essential Tremor
002A86 E. D. Louis [États-Unis] ; E. Yousefzadeh [États-Unis] ; L. F. Barnes [États-Unis] ; QIPING YU [États-Unis] ; S. L. Pullman [États-Unis] ; K. J. Wendt [États-Unis]Validation of a portable instrument for assessing tremor severity in epidemiologic field studies
002A92 R. A. Hauser [États-Unis] ; W. C. Koller [États-Unis] ; J. P. Hubble [États-Unis] ; T. Malapira [États-Unis] ; K. Busenbark [États-Unis] ; C. W. Olanow [États-Unis]Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's Disease
002A97 Roberta Marchese [Italie] ; Manuela Diverio [Italie] ; Francesca Zucchi [Italie] ; Carmelo Lentino [Italie] ; Giovanni Abbruzzese [Italie]The role of sensory cues in the rehabilitation of parkinsonian patients : A comparison of two physical therapy protocols
002A99 Evelyn Jaros [Royaume-Uni] ; David J. Burn [Royaume-Uni]The pathogenesis of multiple system atrophy : Past, present, and future
002B01 T. Klockgether [Allemagne] ; U. Wüllner [Allemagne] ; A. Spauschus [Royaume-Uni] ; B. Evert [Allemagne]The molecular biology of the autosomal-dominant cerebellar ataxias
002B03 C. Ramaker [Pays-Bas] ; W. J. T. Van De Beek [Pays-Bas] ; M. J. J. Finken [Pays-Bas] ; B. J. J. Van Hilten [Pays-Bas]The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications : A systematic review
002B05 I. Reuter [Royaume-Uni] ; S. Harder [Allemagne] ; M. Engelhardt [Allemagne] ; H. Baas [Allemagne]The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
002B07 S. Frucht [États-Unis] ; S. Fahn [États-Unis]The clinical spectrum of posthypoxic myoclonus
002B09 Christoph Kamm [Allemagne] ; Markus Naumann [Allemagne] ; Joerg Mueller [Autriche] ; Norbert Mai [Allemagne] ; Leonhard Riedel [Allemagne] ; Joerg Wissel [Autriche] ; Thomas Gasser [Allemagne]The DYT1 GAG deletion is infrequent in sporadic and familial writer's cramp
002B12 F. Birklein [Allemagne] ; F. Erbguth [Allemagne]Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A : A preliminary observation
002B14 M. H. Silber [États-Unis] ; S. Levine [États-Unis]Stridor and death in multiple system atrophy
002B20 C. Mcrae [États-Unis] ; G. Diem [États-Unis] ; A. Vo [États-Unis] ; C. O'Brien [États-Unis] ; L. Seeberger [États-Unis]Schwab & England : Standardization of administration
002B23 Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
002B24 W. Ondo [États-Unis] ; ENG KING TAN [États-Unis] ; J. Mansoor [États-Unis]Rheumatologic serologies in secondary restless legs syndrome
002B27 E. H. Aylward [États-Unis] ; A.-M. Codori [États-Unis] ; A. Rosenblatt [États-Unis] ; M. Sherr [États-Unis] ; J. Brandt [États-Unis] ; O. C. Stine [États-Unis] ; P. E. Barta [États-Unis] ; G. D. Pearlson [États-Unis] ; C. A. Ross [États-Unis]Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease
002B29 H. M. Bronte-Stewart [États-Unis] ; LONG DING [États-Unis] ; C. Alexander [États-Unis] ; YI ZHOU [États-Unis] ; G. P. Moore [États-Unis]Quantitative digitography (QDG) : A sensitive measure of digital motor control in idiopathic Parkinson's disease
002B36 R. A. Hauser [États-Unis] ; L. Gauger [États-Unis] ; W. M. Anderson [États-Unis] ; T. A. Zesiewicz [États-Unis]Pramipexole-induced somnolence and episodes of daytime sleep
002B38 S. Vanhatalo [Finlande] ; R. Paetau [Finlande] ; K. Mustonen [Finlande] ; J. Hernesniemi [Finlande] ; R. Riikonen [Finlande]Posttraumatic tremor and arnold chiari malformation : No sign of compression, but cure after surgical decompression
002B41 J. J. Higgins [États-Unis] ; K. Kluetzman [États-Unis] ; J. Berciano [Espagne] ; O. Combarros [Espagne] ; J. M. Loveless [États-Unis]Posterior column ataxia and retinitis pigmentosa : A distinct clinical and genetic disorder
002B42 M. Hallett [États-Unis]Physiology of human posthypoxic myoclonus
002B47 A. Brashear [États-Unis] ; K. Bergan [États-Unis] ; J. Wojcieszek [États-Unis] ; E. R. Siemers [États-Unis] ; W. Ambrosius [États-Unis]Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A
002B48 José Antonio Molina [Espagne] ; Maria José Sainz-Artiga [Espagne] ; Talicia Fraile [Espagne] ; Félix Javier Jimenez-Jimenez [Espagne] ; Clara Villanueva [Espagne] ; Miguel Orti-Pareja [Espagne] ; Félix Bermeio-P [Espagne]Pathologic gambling in Parkinson's disease : A behavioral manifestation of pharmacologic treatment?
002B49 P. R. Jarman [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. Davie [Royaume-Uni] ; S. J. R. Heales [Royaume-Uni] ; N. Turjanski [Royaume-Uni] ; S. D. Taylor-Robinson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Paroxysmal dystonic choreoathetosis : Clinical features and investigation of pathophysiology in a large family
002B50 P. E. Greene [États-Unis] ; S. B. Bressman [États-Unis] ; B. Ford [États-Unis] ; K. Hyland [États-Unis]Parkinsonism, dystonia, and hemiatrophy
002B54 V. S. C. Fung [Australie] ; J. A. Burne [Australie] ; J. G. L. Morris [Australie]Objective quantification of resting and activated parkinsonian rigidity : A comparison of angular impulse and work scores
002B55 Federica Provini [Italie] ; Pasquale Montagna [Italie] ; Giuseppe Plazzi [Italie] ; Elio Lugaresi [Italie]Nocturnal frontal lobe epilepsy: A wide spectrum of seizures
002B56 JIAN WANG [République populaire de Chine] ; ZHUOLIN LIU [République populaire de Chine]No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a chinese population
002B59 Jean A. Saint-Cyr [Canada] ; Lisa L. Trepanier [Canada]Neuropsychologic assessment of patients for movement disorder surgery
002B62 J. Raethjen [Allemagne] ; M. Lindemann [Allemagne] ; H. Schmaljohann [Allemagne] ; R. Wenzelburger [Allemagne] ; G. Pfister [Allemagne] ; G. Deuschl [Allemagne]Multiple oscillators are causing parkinsonian and essential tremor
002B64 R. Kurlan [États-Unis] ; I. H. Richard [États-Unis] ; M. Papka [États-Unis] ; F. Marshall [États-Unis]Movement disorders in Alzheimer's disease : More rigidity of definitions is needed
002B65 F. Alarcon [Royaume-Uni] ; G. Duenas [Royaume-Uni] ; N. Cevallos [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Movement disorders in 30 patients with tuberculous meningitis
002B66 A. Curra [Italie] ; A. Berardelli [Italie] ; R. Agostino [Italie] ; M. Giovannelli [Italie] ; G. Koch [Italie] ; M. Manfredi [Italie]Movement cueing and motor execution in patients with dystonia : A kinematic study
002B68 E. B. Jr Montgomery [États-Unis] ; K. B. Baker [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Motor initiation and execution in essential tremor and Parkinson's disease
002B70 Ikuko Mizuta [Japon] ; Eiji Mizuta [Japon] ; Shunzou Yamasaki [Japon] ; Sadako Kuno [Japon] ; Minoru Yasuda [Japon] ; Chikako Tanaka [Japon]Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson's disease in Japan
002B74 Matt Farrer [États-Unis, France] ; Alain Destée [France] ; Estelle Becquet ; Fabienne Wavrant-De Vrieze [États-Unis] ; Vincent Mouroux ; Florence Richard ; Luc Defebvre [France] ; Sarah Lincoln [États-Unis] ; John Hardy [États-Unis] ; Philippe Amouyel ; Marie-Christine Chartier-HarlinLinkage exclusion in French families with probable Parkinson's disease
002B77 J. A. Bueri [Argentine] ; G. Saposnik [Argentine] ; J. Maurino [Argentine] ; R. Saizar [Argentine] ; N. S. Garretto [Argentine]Lazarus' sign in brain death
002B78 Ida Tonolli [France] ; Roselyne Aurenty [France] ; Robert George Lee [France, Canada] ; Francois Viallet [France] ; Jean Massion [France]Lateral leg raising in patients with Parkinson's disease : Influence of equilibrium constraint
002B87 Ruth H. Walker [États-Unis] ; Fabio O. Danisi [États-Unis] ; David M. Swope [États-Unis] ; Robert R. Goodman [États-Unis] ; Isabelle M. Germano [États-Unis] ; Mitchell F. Brin [États-Unis]Intrathecal baclofen for dystonia: Benefits and complications during six years of experience
002B89 J. M. Hurtado [États-Unis] ; J.-P. Lachaux [États-Unis] ; D. J. Beckley [États-Unis] ; C. M. Gray [États-Unis] ; K. A. Sigvardt [États-Unis]Inter- and intralimb oscillator coupling in parkinsonian tremor
002B90 James H. Bower [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; Walter A. Rocca [États-Unis]Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease
002B93 M. D. Welsh [États-Unis] ; T. Dorflinger [États-Unis] ; D. Chernik [États-Unis] ; C. Waters [États-Unis]Illness Impact and Adjustment to Parkinson's disease : Before and after treatment with tolcapone
002B96 Anette Schrag [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]How does Parkinson's Disease affect quality of life? A comparison with quality of life in the general population
002B99 H. H. Fernandez [États-Unis] ; K. L. Lapane [États-Unis] ; B. R. Ott [États-Unis] ; J. H. Friedman [États-Unis]Gender differences in the frequency and treatment of behavior problems in Parkinson's disease
002C00 W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; K. Dat Vuong [États-Unis] ; K. Schwartz [États-Unis] ; Joseph Jankovic [États-Unis]Gabapentin for Essential tremor : A multiple-dose, double-blind, placebo-controlled trial
002C03 R. A. Wright [États-Unis] ; J. E. Ahlskog [États-Unis]Focal shoulder-elevation dystonia
002C13 E. B. Jr Montgomery [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Early detection of probable idiopathic Parkinson's disease : II. A prospective application of a diagnostic test battery
002C14 E. B. Jr Montgomery [États-Unis] ; W. C. Koller [États-Unis] ; T. J. K. Lamantia [États-Unis] ; M. C. Ii Newman [États-Unis] ; A. W. Kaszniak [États-Unis] ; K. Lyons [États-Unis]Early detection of probable idiopathic Parkinson's disease : I. Development of a diagnostic test battery
002C15 Canan Ozsancak [France] ; Pascal Auzou [France] ; Didier Hannequin [France]Dysarthria and orofacial apraxia in corticobasal degeneration
002C18 Deborah J. Serrien [Suisse] ; Jean-Marc Burgunder [Suisse] ; Mario Wiesendanger [Suisse]Disturbed sensorimotor processing during control of precision grip in patients with writer's cramp
002C19 R. Leiguarda [Argentine] ; M. Merello [Argentine] ; J. Balej [Argentine] ; S. Starkstein [Argentine] ; M. Nogues [Argentine] ; C. D. Marsden [Royaume-Uni]Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy
002C21 C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis]Differential progression of motor impairment in levodopa-treated Parkinson's Disease
002C22 John G. Nutt [États-Unis] ; Eric S. Lea ; Laura Van Houten ; Robert A. Schuff ; Gary J. SextonDeterminants of tapping speed in normal control subjects and subjects with Parkinson's disease : Differing effects of brief and continued practice
002C23 N. L. W. Keijsers [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; J. I. Hoff [Pays-Bas] ; C. C. A. M. Gielen [Pays-Bas]Detection and assessment of the severity of levodopa-induced dyskinesia in patients with Parkinson's disease by neural networks
002C24 O. Bandmann [Royaume-Uni] ; J. R. Vaughan [Royaume-Uni] ; P. Holmans [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT2) and familial Parkinson's disease
002C27 Hiroshi Morita [Japon] ; Masaomi Shindo [Japon] ; Shu-Ichi Ikeda [Japon] ; Nobuo Yanagisawa [Japon]Decrease in presynaptic inhibition on heteronymous monosynaptic Ia terminals in patients with Parkinson's disease
002C28 Harvey S. Singer [États-Unis]Current issues in tourette syndrome
002C29 A. D. Siderowf [États-Unis] ; R. G. Holloway [États-Unis] ; M. B. Stern [États-Unis]Cost-effectiveness analysis in Parkinson's disease : Determining the value of interventions
002C30 H. T. S. Benamer [Royaume-Uni] ; J. Patterson [Royaume-Uni] ; D. J. Wyper [Royaume-Uni] ; D. M. Hadley [Royaume-Uni] ; G. J. A. Macphee [Royaume-Uni] ; D. G. Grosset [Royaume-Uni]Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake
002C31 Andrew Gillies [Royaume-Uni] ; Gordon Arbuthnott [Royaume-Uni]Computational models of the basal ganglia
002C32 H. H. Fernandez [États-Unis] ; M. C. Lannon [États-Unis] ; J. H. Friedman [États-Unis] ; B. P. Abbott [États-Unis]Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
002C36 Sergei N. Illarioshkin [Russie] ; Irina A. Ivanova-Smolenskaya [Russie] ; Rahmatullo A. Rahmonov [Russie] ; Elena D. Markova [Russie] ; Giovanni Stevanin [France] ; Alexis Brice [France]Clinical and genetic study of familial essential tremor in an isolate of Northern Tajikistan
002C37 J. Kulisevsky [Espagne] ; C. Garcia-Sanchez [Espagne] ; M. L. Berthier [Espagne] ; M. Barbanoj [Espagne] ; B. Pascual-Sedano [Espagne] ; A. Gironell [Espagne] ; A. Estevez-Gonzalez [Espagne]Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease : A two-year follow-up study of previously untreated patients
002C41 D. M. Maraganore [États-Unis] ; M. J. Farrer [États-Unis] ; J. A. Hardy [États-Unis] ; S. K. Mcdonnell [États-Unis] ; D. J. Schaid [États-Unis] ; W. A. Rocca [États-Unis]Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease
002C47 D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni]Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay
002C51 A. Schrag [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Benign hereditary chorea : Entity or syndrome?
002C52 E. Luginger [Autriche] ; G. K. Wenning [Autriche] ; S. Bosch [Autriche] ; Werner Poewe [Autriche]Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's Disease
002C53 K. Ray Chaudhuri [Royaume-Uni] ; M. T. M. Hu [Royaume-Uni] ; D. J. Brooks [Royaume-Uni]Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK
002C54 J. H. Friedman [États-Unis] ; S. A. FactorAtypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
002C55 M. Michaud [Canada] ; A. Chabli [Canada] ; G. Lavigne [Canada] ; J. Montplaisir [Canada]Arm restlessness in patients with restless legs syndrome
002C56 E. Cubo [États-Unis] ; G. T. Stebbins [États-Unis] ; L. I. Golbe [États-Unis] ; A. V. Nieves [États-Unis] ; S. Leurgans [États-Unis] ; C. G. Goetz [États-Unis] ; K. Kompoliti [États-Unis]Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy : Factor analysis of the motor scale
002C57 Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Apomorphine : An underutilized therapy for Parkinson's disease
002C58 M. Shiba [États-Unis] ; J. H. Bower [États-Unis] ; D. M. Maraganore [États-Unis] ; S. K. Mcdonnell [États-Unis] ; B. J. Peterson [États-Unis] ; J. E. Ahlskog [États-Unis] ; D. J. Schaid [États-Unis] ; W. A. Rocca [États-Unis]Anxiety disorders and depressive disorders preceding Parkinson's disease : A case-control study
002C67 V. G. H. Evidente [États-Unis, Philippines] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; J. G. Hentz [États-Unis] ; K. Gwinn-Hardy [États-Unis]Amantadine is beneficial in restless legs syndrome
002C69 L. Grevle [Norvège] ; C. Güzey [Norvège] ; H. Hadidi [Norvège] ; R. Brennersted [Norvège] ; J. R. Idle [Norvège] ; J. Aasly [Norvège]Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease
002C70 Silvia Buervenich [Suède] ; Olof Sydow [Suède] ; Andrea Carmine [Suède] ; ZHIPING ZHANG [Suède] ; Maria Anvret [Suède] ; Lars Olson [Suède]Alcohol dehydrogenase alleles in Parkinson's disease
002C74 H. T. S. Benamer [Royaume-Uni, Allemagne] ; J. Patterson [Royaume-Uni] ; D. G. Grosset [Royaume-Uni] ; J. Booij ; K. De Bruin ; E. Van Royen ; J. D. Speelman [Pays-Bas] ; M. H. I. M. Horstink [Pays-Bas] ; T. J. W. A. Sips [Pays-Bas] ; R. A. Dierckx [Belgique] ; J. Versijpt [Belgique] ; D. Decoo [Belgique] ; C. Van Der Linden [Belgique] ; D. M. Hadley [Royaume-Uni] ; M. Doder [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. C. Costa [Royaume-Uni] ; S. Gacinovic [Royaume-Uni] ; W. H. Oertel [Allemagne] ; O. Pogarell [Allemagne] ; H. Hoeffken [Allemagne] ; K. Joseph [Allemagne] ; K. Tatsch [Belgique] ; J. Schwarz [Allemagne] ; V. Ries [Allemagne]Accurate differentiation of parkinsonism and essential tremor using Visual assessment of [123I]-FP-CIT SPECT imaging : The [123I]-FP-CIT study group
002C75 A. Filla [Italie] ; G. De Michele [Italie] ; G. Coppola [Italie] ; A. Federico [Italie] ; G. Vita [Italie] ; A. Toscano [Italie] ; A. Uncini [Italie] ; P. Pisanelli [Italie] ; P. Barone [Italie] ; V. Scarano [Italie] ; A. Perretti [Italie] ; L. Santoro [Italie] ; A. Monticelli [Italie] ; F. Cavalcanti [Italie] ; G. Caruso [Italie] ; S. Cocozza [Italie]Accuracy of clinical diagnostic criteria for Friedreich's Ataxia
002C77 B. M. Ross [Canada] ; K. Eder [Allemagne] ; A. Moszczynska [Canada] ; N. Mamalias [Canada] ; J. Lamarche [Canada] ; LEE ANG [Canada] ; M. Pandolfo [Canada] ; G. Rouleau [Canada] ; M. Kirchgessner [Allemagne] ; S. J. Kish [Canada]Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1
002C80 Susan H. Fox [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease
002C81 D. J. Lanska [États-Unis]19th-century American contributions to the recording of tremors
002C82 K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis] ; S. Leurgans [États-Unis] ; M. Morrissey [États-Unis] ; I. M. Siegel [États-Unis]"On" freezing in Parkinson's disease : Resistance to visual cue walking devices
002C83
002C84 Dyskinesias
002C86 G. Ebersbach [Autriche] ; M. Stöck [Autriche] ; J. Müller [Autriche] ; G. Wenning [Autriche] ; J. Wissel [Autriche] ; Werner Poewe [Autriche]Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration
002C87 E. S. Molho [États-Unis] ; S. A. Factor [États-Unis]Worsening of motor features of Parkinsonism with olanzapine
002C88 F. Durif [France] ; M. Vidailhet [France] ; B. Debilly [France] ; Yves Agid [France]Worsening of levodopa-induced dyskinesias by motor and mental tasks
002C89 M. Schwartz [Israël] ; S. Badarny [Israël] ; S. Gofman [Israël] ; S. Hocherman [Israël]Visuomotor performance in patients with essential tremor
002C90 M. H. Thaut [États-Unis] ; R. Miltner [Allemagne] ; H. W. Lange [Allemagne] ; C. P. Hurt [États-Unis] ; V. Hoemberg [Allemagne]Velocity modulation and rhythmic synchronization of gait in Huntington's disease
002C91 G. D. Mellick [Australie] ; D. D. Buchanan [Australie] ; S. J. Mccann [Australie] ; K. M. James [Australie] ; A. G. Johnson [Australie] ; D. R. Davis [Australie] ; N. Liyou [Australie] ; D. Chan [Australie] ; D. G. Le Couteur [Australie]Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease
002C92 E. D. Louis [États-Unis] ; B. Ford [États-Unis] ; K. J. Wendt [États-Unis] ; R. Ottman [États-Unis]Validity of family history data on essential tremor
002C94 R. M. A. De Bie [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; P. S. De Haan [Pays-Bas] ; D. A. Bosch [Pays-Bas] ; J. D. Speelman [Pays-Bas]Unilateral pallidotomy in advanced Parkinson's disease : A retrospective study of 26 patients
002C95 J. Wissel [Autriche] ; J. Müller [Autriche] ; G. Ebersbach [Autriche] ; Werner Poewe [Autriche]Trick maneuvers in cervical dystonia : Investigation of movement- and touch-related changes in polymyographic activity
002C96 P. Kanovsky [République tchèque] ; H. Streitova [République tchèque] ; M. Bares [République tchèque] ; H. Hortova [République tchèque]Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A : Evidence of a long-lasting effect
002C97 J. L. Montastruc [France] ; Olivier Rascol [France] ; J.-M. Senard [France]Treatment of Parkinson's disease should begin with a dopamine agonist
002C98 S. A. Factor [États-Unis] ; E. S. Molho [États-Unis]Transient benefit of amantadine in Parkinson's disease : The facts about the myth
002C99 F. Cardoso [Brésil] ; R. Faleiro [Brésil]Tourette syndrome : Another cause of movement disorder of the ear
002D00 J. Y. Matsumoto [États-Unis] ; D. W. Dodick [États-Unis] ; L. N. Stevens [États-Unis] ; R. C. Newman [États-Unis] ; P. E. Caskey [États-Unis] ; W. Fjerstad [États-Unis]Three-dimensional measurement of essential tremor
002D02 A. E. Kingsbury [Royaume-Uni] ; D. Marsden [Royaume-Uni] ; O. J. F. Foster [Royaume-Uni]The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis : An in situ hybridization study
002D03 M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
002D04 W. J. Weiner [États-Unis]The initial treatment of Parkinson's disease should begin with levodopa
002D06 C. D. Hardman [Australie] ; G. M. Halliday [Australie]The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy
002D07 J. E. Ahlskog [États-Unis] ; R. J. Uitti [États-Unis] ; M. K. O'Connor [États-Unis] ; D. M. Maraganore [États-Unis] ; J. Y. Matsumoto [États-Unis] ; K. F. Stark [États-Unis] ; M. F. Turk [États-Unis] ; O. L. Burnett [États-Unis]The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
002D08 A. Schrag [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The dancing larynx : A variant of palatal tremor?
002D10 M. D. Hill [Canada] ; R. Kumar [Canada] ; A. Lozano [Canada] ; C. H. Tator [Canada] ; P. Ashby [Canada] ; A. E. Lang [Canada]Syringomyelic dystonia and athetosis
002D12 A. Lazzarini [États-Unis] ; A. S. Walters [États-Unis] ; K. Hickey [États-Unis] ; G. Coccagna [Italie] ; E. Lugaresi [Italie] ; B. L. Ehrenberg [États-Unis] ; D. L. Picchietti [États-Unis] ; M. F. Brin [États-Unis] ; E. S. Stenroos [États-Unis] ; T. Verrico [États-Unis] ; W. G. Johnson [États-Unis]Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees
002D13 C. Dentresangle [France] ; L. Veyre [France] ; D. Le Bars [France] ; C. Pierre [France] ; F. Lavenne [France] ; Pierre Pollak [France] ; J. Guerin [France] ; J.-C. Froment [France] ; E. Brousolle [France]Striatal D2 dopamine receptor status in Parkinson's disease : An [18F]dopa and [11C]raclopride PET study
002D15 A. Dalvi [États-Unis] ; L. Winfield [États-Unis] ; QIPING YU [États-Unis] ; L. Cote [États-Unis] ; R. R. Goodman [États-Unis] ; S. L. Pullman [États-Unis]Stereotactic posteroventral pallidotomy : Clinical methods and results at 1-year follow up
002D17 A. Thomas [Italie] ; M. Onofrj [Italie]Sporadic acetazolamide-responsive episodic ataxia
002D18 MYUNG SIK LEE [Corée du Sud] ; YOUNG DUK KIM [Corée du Sud] ; WON CHAN KIM [Corée du Sud] ; CHUL HYOUNGL YOO [Corée du Sud]Slow rhythmic dyskinesia of the shoulder : One idiopathic and two symptomatic cases
002D19 G. M. Wali [Inde]Shoulder girdle dyskinesia following local surgery
002D20 G. M. Wali [Inde]Shoulder girdle dyskinesia associated with a thalamic infarct
002D22 A. Churchyard [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Selegiline-induced postural hypotension in Parkinson's disease : A longitudinal study on the effects of drug withdrawal
002D24 R. Kumar [Canada] ; R. Chen [Canada] ; P. Ashby [Canada]Safety of transcranial magnetic stimulation in patients with implanted deep brain stimulators
002D25 D. Mathen [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni]SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia
002D28 V. G. H. Evidente [États-Unis, Philippines] ; K. Gwinn-Hardy [États-Unis] ; J. N. Caviness [États-Unis] ; C. H. Adler [États-Unis]Risperidone is effective in severe hemichorea/hemiballismus
002D29 H. D. Rosas [États-Unis] ; W. J. Koroshetz [États-Unis] ; B. G. Jenkins [États-Unis] ; Y. I. Chen [États-Unis] ; D. L. Hayden [États-Unis] ; M. F. Beal [États-Unis] ; M. E. Cudkowicz [États-Unis]Riluzole therapy in Huntington's Disease (HD)
002D30 W. Meissner [Allemagne] ; T. Schmidt [Allemagne] ; A. Kupsch [Allemagne] ; T. Trottenberg [Allemagne] ; T. Lempert [Allemagne]Reversible leucopenia related to olanzapine
002D32 A. Schrag [Royaume-Uni] ; L. Schelosky [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche]Reduction of parkinsonian signs in patients with parkinson's disease by dopaminergic versus anticholinergic single-dose challenges
002D33 C. G. Goetz [États-Unis]Rating scales for dyskinesias in Parkinson's disease
002D36 P. R. Burkhard [États-Unis] ; H. Shale [États-Unis] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis]Quantification of dyskinesia in Parkinson's disease : Validation of a novel instrumental method
002D37 H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis]Punding on L-dopa
002D39 G. K. Wenning [Autriche] ; G. Ebersbach [Autriche] ; M. Verny [France] ; K. Ray Chaudhuri [Royaume-Uni] ; K. Jellinger [Autriche] ; A. Mckee [États-Unis] ; Werner Poewe [États-Unis] ; I. Litvan [États-Unis]Progression of falls in postmortem-confirmed Parkinsonian disorders
002D40 A. Minguez-Castellanos [Espagne] ; C. Carnero-Pardo [Espagne] ; A. Gomez-Camello [Espagne] ; A. Ortega-Moreno [Espagne] ; T. Garcia-Gomez [Espagne] ; V. Arjona [Espagne] ; J. M. Martin-Linares [Espagne]Primary writing tremor treated by chronic thalamic stimulation
002D42 J. M. Errea [Espagne] ; J. R. Ara [Espagne] ; C. Aibar [Espagne] ; J. De Pedro-Cuesta [Espagne, Suède]Prevalence of Parkinson's disease in Lower Aragon, Spain
002D43 A. G. E. M. De Boer [Pays-Bas] ; M. A. G. Sprangers [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; H. C. J. M. De Haes [Pays-Bas]Predictors of health care use in patients with Parkinson's disease : A longitudinal study
002D44 G. K. Wenning [Autriche] ; E. Luginger [Autriche] ; U. Sailer [Autriche] ; Werner Poewe [Autriche] ; E. Donnemiller [Autriche] ; G. Riccabona [Autriche]Postoperative parkinsonian tremor in a patient with a frontal meningioma
002D45 E. S. Molho [États-Unis] ; S. A. Factor [États-Unis]Possible tardive dystonia resulting from clozapine therapy
002D50 F. Cardoso [Brésil] ; A. P. Vargas [Brésil] ; L. D. Oliveira [Brésil] ; A. A. Guerra [Brésil] ; S. V. Amaral [Brésil]Persistent Sydenham's chorea
002D51 G. J. Brewer [États-Unis]Penicillamine should not be used as initial therapy in Wilson's disease
002D52 J. M. Walshe [Royaume-Uni]Penicillamine : The treatment of first choice for patients with Wilson's disease
002D53 A. Berardelli [Italie] ; J. Noth [Allemagne] ; P. D. Thompson [Australie] ; E. L. E. M. Bollen [Pays-Bas] ; A. Curra [Italie] ; G. Deuschl [Allemagne] ; J. G. Van Dijk [Pays-Bas] ; R. Töpper [Allemagne] ; T. Schwarz [Allemagne] ; R. A. C. Roos [Pays-Bas]Pathophysiology of chorea and bradykinesia in Huntington's disease
002D54 P. J. Bedard [Canada] ; P. J. Blanchet [Canada] ; D. Levesque [Canada] ; J.-J. Soghomonian [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; F. Calon [Canada] ; P. Falardeau [Canada] ; B. Gomez-Mancilla [Canada] ; J.-P. Doucet [Canada] ; G. S. Robertson [Canada] ; T. Dipaolo [Canada]Pathophysiology of L-Dopa-induced dyskinesias
002D58 M. G. Cerosimo [Argentine] ; F. Micheli [Argentine]Paroxysmal dyskinesia and gonadal sex hormones
002D61 R. H. Walker [États-Unis] ; H. Spiera [États-Unis] ; M. F. Brin [États-Unis] ; C. W. Olanow [États-Unis]Parkinsonism associated with Sjögren's syndrome : Three cases and a review of the literature
002D64 P. K. Kulkarni [Inde] ; U. B. Muthane [Inde] ; A. B. Taly [Inde] ; P. N. Jayakumar [Inde] ; R. Shetty [Inde] ; H. Sathyanarayana Swamy [Inde]Palatal tremor, progressive multiple cranial nerve palsies, and cerebellar ataxia : A case report and review of literature of palatal tremors in neurodegenerative disease
002D65 B. Jabbari [États-Unis] ; A. Salardini [Australie]Painful tonic/dystonic spasms in Sjogren's syndrome
002D66 J. Pitagoras De Mattos [Brésil] ; M. Oliveira Py [Brésil] ; C. Andre [Brésil]Painful legs and moving toes associated with neuropathy in HIV-infected patients
002D67 D. Tarsy [États-Unis] ; E. R. First [États-Unis]Painful cervical dystonia : Clinical features and response to treatment with botulinum toxin
002D70 P.-A. Fall [Suède] ; M. Fredrikson [Suède] ; O. Axelson [Suède] ; A.-K. Granerus [Suède]Nutritional and occupational factors influencing the risk of parkinson's disease : A case-control study in southeastern Sweden
002D72 Pierre Pollak [France]Neurosurgical treatment of dyskinesias : Pathophysiological consideration
002D73 H. R. Morris [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Neurofibrillary tangle Parkinsonian disorders : Tau pathology and Tau genetics
002D74 J. Kimber [Royaume-Uni] ; L. Watson ; C. J. MathiasNeuroendocrine responses to levodopa in multiple system atrophy (MSA)
002D75 T. Yanagisawa [Japon] ; H. Sugihara [Japon] ; K. Shibahara [Japon] ; T. Kamo [Japon] ; K. Fujisawa [Japon] ; M. Murayama [Japon]Natural course of combined limb and palatal tremor caused by cerebellar-brain stem infarction
002D76 K. R. Müller-Vahl [Allemagne] ; U. Schneider [Allemagne] ; H. M. Emrich [Allemagne]Nabilone increases choreatic movements in Huntington's disease
002D77 S. Nagamitsu [Japon] ; T. Matsuishi [Japon] ; K. Hashimoto [Japon] ; Y. Yamashita [Japon] ; M. Aihara [Japon] ; K. Shimizu [Japon] ; M. Mizuguchi [Japon] ; H. Iwamoto [Japon] ; S. Saitoh [Japon] ; Y. Hirano [Japon] ; H. Kato [Japon] ; Y. Fukuyama [Japon] ; M. Shimada [Japon]Multicenter study of paroxysmal dyskinesias in Japan : Clinical and pedigree analysis
002D80 K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis] ; D. C. Gajdusek [France] ; E. Cubo [États-Unis]Movement disorders in Kuru
002D82 L. J. P. Defebvre [France] ; P. Derambure [France] ; J.-L. Bourriez [France] ; F. Cassim [France] ; J. D. Guieu [France] ; A. Destee [France]Motor programming is more affected in progressive supranuclear palsy than in Parkinson's disease : A spatiotemporal study of event-related desynchronization
002D83 D. A. Grimes [Canada] ; C. B. Bergeron [Canada] ; A. E. Lang [Canada]Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration
002D84 P. Praamstra [Pays-Bas] ; E. M. Plat [Pays-Bas] ; A. S. Meyer [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas]Motor cortex activation in Parkinson's disease : Dissociation of electrocortical and peripheral measures of response generation
002D86 N. Giladi [Israël] ; H. Shabtai [Israël]Melatonin-induced withdrawal emergent dyskinesia and akathisia
002D89 B. Jabbari [États-Unis] ; K. Khajevi [États-Unis] ; K. Rao [États-Unis]Medullary dystonia
002D90 J. Winkelmann [Allemagne] ; D. P. Auer [Allemagne] ; C. Lechner [Allemagne] ; G. Elbel [Allemagne] ; C. Trenkwalder [Allemagne]Magnetic resonance imaging findings in corticobasal degeneration
002D91 L. Baum [Hong Kong] ; Z.-Y. Dong [République populaire de Chine] ; H.-K. Ng [Hong Kong] ; L. K. Law [Hong Kong] ; J. Woo [Hong Kong] ; CHI PUI PANG [Hong Kong]Low-density lipoprotein receptor-related protein (LRP) gene 766T polymorphism and Parkinson's disease
002D92 K. L. Tsang [Hong Kong] ; K. Y. Fong [Hong Kong] ; S. L. Ho [Hong Kong]Localized neuromyotonia of neck muscles after radiotherapy for nasopharyngeal carcinoma
002D94 P. Kanovsky [République tchèque] ; H. Streitova [République tchèque] ; J. Dufek [République tchèque] ; V. Znojil [République tchèque] ; P. Daniel [République tchèque] ; I. Rektor [République tchèque]Lateralization of the P22/N30 precentral cortical component of the median nerve somatosensory evoked potentials is different in patients with a tonic or tremulous form of cervical dystonia
002D95 D. C. C. Wan [Hong Kong] ; L. K. Law [Hong Kong] ; D. T. M. Ip [Hong Kong] ; W. T. Cheung [Hong Kong] ; W. K. K. Ho [Hong Kong] ; K. W. K. Tsim [Hong Kong] ; R. Kay [Hong Kong] ; J. Woo [Hong Kong] ; C. P. Pang [Hong Kong]Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a chinese population
002D96 Olivier Rascol [France]L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease : A clinical pharmacologic approach
002D98 E. Cassetta [Italie] ; N. Del Grosso [Italie] ; A. R. Bentivoglio [Italie] ; E. M. Valente [Italie, Royaume-Uni] ; M. Frontali [Italie] ; A. Albanese [Italie, Suisse]Italian family with cranial cervical dystonia : Clinical and genetic study
002D99 V. G. H. Evidente [Philippines] ; J. N. Caviness [Philippines] ; B. Jamieson [États-Unis] ; A. Weaver [États-Unis] ; N. Joshi [États-Unis]Intersubject variability and intrasubject reproducibility of the bereitschaftspotential
002E00 G. Ebersbach [Allemagne] ; M. Heijmenberg [Allemagne] ; L. Kindermann [Allemagne] ; T. Trottenberg [Allemagne] ; J. Wissel [Autriche] ; Werner Poewe [Autriche]Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson's disease : Evidence for impaired locomotor pattern generation in early Parkinson's disease
002E01 P. Barbanti [Italie] ; G. Fabbrini [Italie] ; A. Ricci [Italie] ; R. Cerbo [Italie] ; E. Bronzetti [Italie] ; B. Caronti [Italie] ; C. Calderaro [Italie] ; L. Felici [Italie] ; F. Stocchi [Italie] ; G. Meco [Italie] ; F. Amenta [Italie] ; G. L. Lenzi [Italie]Increased expression of dopamine receptors on lymphocytes in Parkinson's disease
002E02 F. Stocchi [Italie] ; C. Farina [Italie] ; G. Nordera [Italie] ; S. Ruggieri [Italie]Implantable venous access system for apomorphine infusion in complicated Parkinson's disease
002E03 T. Kato [France, Canada] ; J. Y. Montplaisir [France, Canada] ; P. J. Blanchet [Canada] ; J. P. Lund [Canada] ; G. J. Lavigne [France, Canada]Idiopathic myoclonus in the oromandibular region during sleep : A possible source of confusion in sleep bruxism diagnosis
002E05 S. Diaz [Argentine] ; M. C. Scorticati [Argentine] ; F. Micheli [Argentine]Hereditary chin tremor/myoclonus : A report from Latin America
002E06 E. Marchioni [Italie] ; D. Soragna [Italie] ; M. Versino [Italie] ; L. Sibilla [Italie] ; E. Alfonsi [Italie] ; A. Romani [Italie] ; R. Manni [Italie] ; F. Savoldi [Italie] ; C. Messa [Italie] ; A. D'Amico [Italie] ; F. Fazio [Italie]Hemiparkinsonism-hemiatrophy with brain hemihypoplasia
002E07 H. Miwa [Japon] ; A. Yoritaka [Japon] ; Y. Mizuno [Japon]Hemifacial spasm in Parkinson's disease
002E08 L. D. Oliveira [Brésil] ; F. Cardoso [Brésil] ; A. P. Vargas [Brésil]Hemifacial spasm and arterial hypertension
002E12 C. Kamm [Allemagne] ; E. Castelon-Konkiewitz [Allemagne] ; M. Naumann [Allemagne] ; F. Heinen [Allemagne] ; M. Brack [États-Unis] ; A. Nebe [Allemagne] ; A. Ceballos-Baumann [Allemagne] ; T. Gasser [Allemagne]GAG deletion in the DYT1 gene in early limb-onset idiopathic torsion dystonia in Germany
002E15 T. Brannan [États-Unis] ; M. D. Yahr [États-Unis]Focal tremor following striatal infarct: A case report
002E17 G. T. Stebbins [Canada] ; C. G. Goetz [Canada] ; A. E. Lang [Canada] ; E. Cubo [Canada]Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state
002E18 E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège]Excessive daytime sleepiness and sleep benefit in Parkinson's disease : A community-based study
002E19 K. A. Reardon [Australie] ; M. Shiff [Australie] ; P. A. Kempster [Australie]Evolution of motor fluctuations in Parkinson's disease : A longitudinal study over 6 years
002E22 A.-M. Kuopio [Finlande] ; R. J. Marttila [Finlande] ; H. Helenius [Finlande] ; U. K. Rinne [Finlande]Environmental risk factors in Parkinson's disease
002E23 W. C. Koller [États-Unis] ; K. E. Lyons [États-Unis] ; S. B. Wilkinson [États-Unis] ; R. Pahwa [États-Unis]Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor
002E26 R. Chen [États-Unis, Canada] ; B. I. Karp [États-Unis] ; S. R. Goldstein [États-Unis] ; W. Bara-Jimenez [États-Unis] ; Z. Yaseen [États-Unis] ; M. Hallett [États-Unis]Effect of muscle activity immediately after botulinum toxin injection for writer's cramp
002E27 J. S. P. Van Den Berg [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] ; F. H. J. Van Den Hoogen [Pays-Bas] ; W. J. G. Oyen [Pays-Bas]Dystonia; a central nervous system presentation of Sjögren's syndrome
002E30 P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France]Dyskinesias assessment in phase II studies
002E31 P. Brown [Royaume-Uni] ; A. Manson [Royaume-Uni]Dyskinesias assessment and ambulatory devices
002E32 H. Widner [Suède] ; G.-L. Defer [France]Dyskinesias assessment : From CAPIT to CAPSIT
002E33 Y. Furukawa [Canada] ; S. J. Kish [Canada]Dopa-responsive dystonia : Recent advances and remaining issues to be addressed
002E34 M. M. Pinter [Autriche] ; M. Murg [Autriche] ; F. Alesch [Autriche] ; B. Freundl [Autriche] ; R. J. Helscher [Autriche] ; H. Binder [Autriche]Does deep brain stimulation of the nucleus ventralis intermedius affect postural control and locomotion in Parkinson's disease?
002E35 A. H. Nemeth [Royaume-Uni] ; K. R. Mills [Royaume-Uni] ; J. S. Elston [Royaume-Uni] ; A. Williams [Royaume-Uni] ; E. Dunne [Royaume-Uni] ; N. M. Hyman [Royaume-Uni]Do the same genes predispose to Gilles de la Tourette syndrome and dystonia? Report of a new family and review of the literature
002E38 N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; E. Chiu [Australie] ; A. Tudor [Australie] ; L. O'Gorman [Australie] ; J. G. Phillips [Australie]Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease
002E41 I. Vermes [Pays-Bas] ; E. N. H. J. Steur [Pays-Bas] ; C. Reutelingsperger [Pays-Bas] ; C. Haanen [Pays-Bas]Decreased concentration of annexin v in parkinsonian cerebrospinal fluid : Speculation on the underlying cause
002E43 G.-L. Defer [France] ; H. Widner [Suède] ; R.-M. Marie [France] ; P. Remy [France] ; M. Levivier [Belgique]Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
002E45 T. Rosolacci [France] ; V. Neuville [France] ; R. Huric [France] ; P. Dobbelaere [France]Complex hyperkinesias ipsilateral to right frontoparietal cortical infarction
002E46 T. Mezaki [Japon] ; R. Kaji [Japon] ; M. F. Brin [États-Unis] ; M. Hirota-Katayama [Japon] ; T. Kubori [Japon] ; T. Shimizu [Japon] ; J. Kimura [Japon]Combined use of type A and F botulinum toxins for blepharospasm : A double-blind controlled trial
002E47 C. Junque [Suède] ; M. Alegret [Suède] ; F. A. Nobbe [Espagne] ; F. Valldeoriola [Espagne] ; R. Pueyo [Suède] ; P. Vendrell [Suède] ; E. Tolosa [Espagne] ; J. Rumia [Espagne] ; J. M. Mercader [Espagne]Cognitive and behavioral changes after unilateral posteroventral pallidotomy : Relationship with lesional data from MRI
002E50 P. Chariot [France] ; P. Brugieres [France] ; M.-C. Eliezer-Vanerot [France] ; C. Geny [France] ; M. Binaghi [France] ; P. Cesaro [France]Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy
002E51 H. R. Siebner [Allemagne] ; A. Ceballos-Baumann [Allemagne] ; H. Standhardt [Autriche] ; C. Auer [Allemagne] ; B. Conrad [Allemagne] ; F. Alesch [Autriche]Changes in handwriting resulting from bilateral high-frequency stimulation of the subthalamic nucleus in Parkinson's disease
002E52 O. Lindvall [Suède]Cerebral implantation in movement disorders : State of the art
002E55 G. Northoff [Allemagne] ; A. Koch [Allemagne] ; J. Wenke [Allemagne] ; J. Eckert [Allemagne] ; H. Böker [Allemagne] ; B. Pflug [Allemagne] ; B. Bogerts [Allemagne]Catatonia as a psychomotor syndrome : A rating scale and extrapyramidal motor symptoms
002E57 N. Sabbagh [France] ; A. Brice [France] ; D. Marez [France] ; A. Dürr [France] ; M. Legrand [France] ; J.-M. Lo Guidice [France] ; A. Destee [France] ; Yves Agid [France] ; F. Broly [France]CYP2D6 polymorphism and Parkinson's disease susceptibility
002E58 G. Cicarelli [Italie] ; M. T. Pellecchia [Italie] ; F. Maiuri [Italie] ; P. Barone [Italie]Brain stem cystic astrocytoma presenting with "pure" parkinsonism
002E60 R. Kaji [Japon] ; M. Katayama-Hirota [Japon] ; N. Kohara [Japon] ; Y. Kojima [Japon] ; QING YANG [Japon] ; J. Kimura [Japon]Blepharospasm induced by an LED flashlight
002E61 E. K. Tan [États-Unis] ; Joseph Jankovic [États-Unis]Bilateral hemifacial spasm : A report of five cases and a literature review
002E62 H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis] ; J. V. Centofanti [États-Unis]Benedikt's syndrome with delayed-onset rubral tremor and hemidystonia : A complication of tic douloureux surgery
002E64 E. D. Louis [États-Unis] ; K. Marder [États-Unis] ; C. Moskowitz [États-Unis] ; P. Greene [États-Unis]Arm elevation in Huntington's disease : Dystonia or levitation?
002E67 E. Moro [Italie] ; A. Albanese [Italie, Suisse]Apomorphine and levodopa challenge in patients with a focal midbrain lesion
002E69 A. Spissu [Italie] ; A. Cannas [Italie] ; P. Ferrigno [Italie] ; A. E. Pelaghi [Italie] ; M. Spissu [Italie]Anatomic correlates of painful tonic spasms in multiple sclerosis
002E72 C. G. Goetz [États-Unis] ; E. J. Pappert [États-Unis] ; E. D. Louis [États-Unis] ; R. Raman [États-Unis] ; S. Leurgans [États-Unis]Advantages of a modified scoring method for the rush video-based tic rating scale
002E73 R. Ceravolo [Italie] ; S. Salvetti [Italie] ; P. Piccini [Royaume-Uni] ; C. Lucetti [Italie] ; G. Gambaccini [Italie] ; U. Bonuccelli [Italie]Acute and chronic effects of clozapine in essential tremor
002E74 M. Onofrj [Italie] ; A. Thomas [Italie]Acetazolamide-responsive periodic ataxia induced by amiodarone
002E75 O. Joost [États-Unis] ; C. A. Taylor [États-Unis] ; C. A. Thomas [États-Unis] ; L. A. Cupples [États-Unis] ; M. H. Saint-Hilaire [États-Unis] ; R. G. Feldman [États-Unis] ; C. T. Baldwin [États-Unis] ; R. H. Myers [États-Unis]Absence of effect of seven functional mutations in the CYP2D6 gene in Parkinson's disease
002E76 M. W. Hayes [Australie] ; S. Graham [Australie] ; P. Heldorf [Australie] ; G. De Moore [Australie] ; J. G. L. Morris [Australie]A video review of the diagnosis of psychogenic gait : Appendix and commentary
002E77 J. I. Hoff [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas]A review of the assessment of dyskinesias
002E78 J.-L. Montastruc [France] ; M. Ziegler [France] ; Olivier Rascol [France] ; M. Malbezin [France]A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease
002E80 W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; M. Almaguer [États-Unis] ; Joseph Jankovic [États-Unis]A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease
002E81 R. J. Caselli [États-Unis] ; G. E. Stelmach [États-Unis] ; J. N. Caviness [États-Unis] ; D. Timmann [Allemagne] ; T. Royer [États-Unis] ; B. F. Boeve [États-Unis] ; J. E. Parisi [États-Unis]A kinematic study of progressive apraxia with and without dementia
002E82 S. Frucht [États-Unis] ; S. Fahn [États-Unis] ; B. Ford [États-Unis] ; M. Gelb [États-Unis]A geste antagoniste device to treat jaw-closing dystonia
002E83 M. Fukuda [Japon] ; O. Hashimoto [Japon] ; S. Nagakubo [Japon] ; A. Hata [Japon]A family with an atonic variant of paroxysmal kinesigenic choreoathetosis and hypercalcitoninemia
002E84 J. M. Graham [Royaume-Uni] ; BSC [Royaume-Uni] ; H. J. Sagar [Royaume-Uni] ; DM [Royaume-Uni]A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease : Identification of three distinct subtypes
002E85 E. D. Louis [États-Unis] ; B. Ford [États-Unis] ; K. J. Wendt [États-Unis] ; H. Lee [États-Unis] ; H. Andrews [États-Unis]A comparison of different bedside tests for essential tremor
002E87 K. Bötzel [Allemagne] ; K. J. Werhahn [Allemagne]A case of myoclonic cortical tremor after extirpation of a parietal meningioma
002E88 S. Frucht [États-Unis] ; S. Fahn [États-Unis] ; K. M. Shannon [États-Unis] ; C. H. Waters [États-Unis]A 32-year-old man with progressive spasticity and parkinsonism
002E89 Tremor: basic mechanisms and clinical aspects
002E91 A. Schrag [Royaume-Uni] ; Y. Ben-Shlomo [Royaume-Uni] ; R. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. Quinn [Royaume-Uni]Young-onset Parkinson's disease revisited : Clinical features, natural history, and mortality
002E93 I. Shoulson [États-Unis]Where do we stand on neuroprotection? Where do we go from here?
002E94 C. Klein [Allemagne] ; E. Gehrking [Allemagne] ; P. Vieregge [Allemagne]Voluntary palatal tremor in two siblings
002E95 M. R. Trimble [Royaume-Uni] ; R. Whurr [Royaume-Uni] ; G. Brookes [Royaume-Uni] ; M. M. Robertson [Royaume-Uni]Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections
002E97 C. Sankhla [États-Unis] ; Joseph Jankovic [États-Unis] ; D. Duane [États-Unis]Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections
002E98 O. Lindvall [Suède]Update on fetal transplantation : The Swedish experience
002E99 G. Ebersbach [Autriche] ; L. Schelosky [Allemagne] ; A. Schenkel [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche]Unilateral painful legs and moving toes syndrome with moving fingers : Evidence for distinct oscillators
002F00 S. Siesling [Pays-Bas] ; J. P. P. Van Vugt [Pays-Bas] ; K. A. H. Zwinderman [Pays-Bas] ; K. Kieburtz [États-Unis] ; R. A. C. Roos [Pays-Bas]Unified Huntington's disease rating scale : A follow up
002F02 P. Krack [France] ; A. Benazzouz [France] ; Pierre Pollak [France] ; P. Limousin [France] ; B. Piallat [France] ; D. Hoffmann [France] ; JING XIE [France] ; Alim-Louis Benabid [France]Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation
002F03 J. Winkelmann [Allemagne] ; T. C. Wetter [Allemagne] ; K. Stiasny [Allemagne] ; W. H. Oertel [Allemagne] ; C. Trenkwalder [Allemagne]Treatment of restless leg syndrome with pergolide : An open clinical trial
002F04 M. Bakar [Turquie] ; M. Zarifoglu [Turquie] ; I. Bora [Turquie] ; F. Turan [Turquie] ; C. Sen [Turquie] ; E. Ogul [Turquie]Treatment of hereditary trembling chin with botulinum toxin
002F06 Y.-C. Liu [Taïwan] ; Z.-A. Wu ; S.-J. Wang ; D.-E. Shan ; K.-P. LinTransient syndrome of continuous muscle fiber activity associated with staphylococcal infection
002F08 M. C. Rodriguez [Espagne] ; O. J. Guridi [Espagne] ; L. Alvarez [Cuba] ; K. Mewes [États-Unis] ; R. Macias [Cuba] ; J. Vitek [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne]The subthalamic nucleus and tremor in Parkinson's disease
002F09 S. Hua [États-Unis] ; S. G. Reich ; A. T. Zirh ; V. Perry ; P. M. Dougherty ; F. A. LenzThe role of the thalamus and basal ganglia in parkinsonian tremor
002F10 T. Van Laar [Pays-Bas] ; B. Van Hilten [Pays-Bas] ; C. Neef [Pays-Bas] ; A. W. F. Rutgers [Pays-Bas] ; S. Pavel [Pays-Bas] ; J. A. Bruijn [Pays-Bas]The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease : A histologic study
002F12 E. A. Chrischilles [États-Unis] ; L. M. Rubenstein [États-Unis] ; M. D. Voelker [États-Unis] ; R. B. Wallace [États-Unis] ; R. L. Rodnitzky [États-Unis]The health burdens of Parkinson's disease
002F13 A. S. Buchman [États-Unis] ; C. L. Comella [États-Unis] ; S. Leurgans [États-Unis] ; G. T. Stebbins [États-Unis] ; C. G. Goetz [États-Unis]The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD)
002F14 J. D. Speelman [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; D. A. Bosch [Pays-Bas]Thalamic surgery and tremor
002F16 D. J. Burn [Royaume-Uni] ; A. Coulthard [Royaume-Uni] ; S. Connolly [Royaume-Uni] ; N. E. F. Cartlidge [Royaume-Uni]Tardive diaphragmatic flutter
002F17 P. Sachdev [Australie]Tardive blepharospasm
002F18 G. De Boo [Pays-Bas] ; A. Tibben [Pays-Bas] ; J. Hermans [Pays-Bas] ; A. Maat [Pays-Bas] ; R. A. C. Roos [Pays-Bas]Subtle involuntary movements are not reliable indicators of incipient Huntington's disease
002F20 J. C. Detoledo [États-Unis] ; R. Dow [États-Unis]Sternomastoid function during hemispheric suppression by amytal : Insights into the inputs to the spinal accessory nerve nucleus
002F22 S. L. Pullman [États-Unis]Spiral analysis : A new technique for measuring tremor with a digitizing tablet
002F23 M. S. Ledoux [États-Unis] ; L. J. Mcgill ; W. A. Pulsinelli ; R. F. Pfeiffer ; G. Deuschl [Allemagne] ; A. Siderowf [États-Unis] ; R. Kurlan [États-Unis] ; K. Sethi [États-Unis]Severe bilateral tremor in a liver transplant recipient taking cyclosporine
002F24 A. Kupsch [Allemagne] ; W. H. Oertel [Allemagne]Selegiline, pregnancy, and Parkinson's disease
002F25 A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie]Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study
002F26 Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie]Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study
002F27 R. C. Duvoisin [États-Unis]Role of genetics in the cause of Parkinson's disease
002F28 I. Ziv [Israël] ; E. MelamedRole of apoptosis in the pathogenesis of Parkinson's disease : A novel therapeutic opportunity?
002F29 J. Sunden-Cullberg [Suède] ; J. Tedroff [Suède] ; S.-M. Aquilonius [Suède]Reversible chorea in primary antiphospholipid syndrome
002F30 J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas]Resurgence of functional neurosurgery for Parkinson's disease : A historical perspective
002F33 C. P. Pang [Hong Kong] ; JUN ZHANG [Hong Kong] ; T. Woo [Hong Kong] ; D. Chan [Hong Kong] ; L. K. Law [Hong Kong] ; S. F. Tong [Hong Kong] ; T. Kwok [Hong Kong] ; T. Kay [Hong Kong]Rarity of debrisoquine hydroxylase gene polymorphism in chinese patients with Parkinson's disease
002F34 F. Blandini [Italie] ; G. Nappi [Italie] ; J. T. Greenamyre [États-Unis]Quantitative study of mitochondrial complex I in platelets of parkinsonian patients
002F36 MEE OHK KIM [Corée du Sud] ; J.-H. Im [Corée du Sud] ; CHOONG GON CHOI [Corée du Sud] ; MYOUNG CHONG LEE [Corée du Sud]Proton MR spectroscopic findings in paroxysmal kinesigenic dyskinesia
002F37 S. E. Johnson [Norvège] ; A. Dahl [Norvège] ; O. Sjaastad [Norvège]Progressive pseudobulbar paresis, early choreiform movements, and later rigidity : Appearance in two sets of dizygotic twins in the same family
002F38 R. E. Burke [États-Unis]Programmed cell death and Parkinson's disease
002F39 A. Chio [Italie] ; C. Magnani [Italie] ; D. Schiffer [Italie]Prevalence of Parkinson's disease in Northwestern Italy : Comparison of tracer methodology and clinical ascertainment of cases
002F40 D. J. Cordato [Australie] ; M. J. Fulham [Australie] ; C. Yiannikas [Australie]Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease
002F41 P. Hagell [Suède] ; P. Odin [Allemagne] ; E. Vinge [Suède]Pregnancy in Parkinson's disease : A review of the literature and a case report
002F43 P. C. Jacob [Oman] ; R. Pratap Chand [Oman]Posttraumatic rubral tremor responsive to clonazepam
002F44 R. Kurlan [États-Unis]Postprandial (reactive) hypoglycemia and restless leg syndrome : Related neurologic disorders?
002F46 A. D. Siderowf [États-Unis] ; S. L. Galetta [États-Unis] ; H. I. Hurtig [États-Unis] ; G. T. Liu [États-Unis]Posey and Spiller and progressive supranuclear palsy : An incorrect attribution
002F47 T. C. Wetter [Allemagne] ; K. Stiasny [Allemagne] ; R. Kohnen [Allemagne] ; W. H. Oertel [Allemagne] ; C. Trenkwalder [Allemagne]Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome
002F48 C. Colosimo [Italie]Pisa syndrome in a patient with multiple system atrophy
002F49 H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël]Physiology of MPTP tremor
002F50 J. C. Rothwell [Royaume-Uni]Physiology and anatomy of possible oscillators in the central nervous system
002F51 P. G. Wasielewski [États-Unis] ; J. M. Burns [États-Unis] ; W. C. Koller [États-Unis]Pharmacologic treatment of tremor
002F52 M. Vidailhet [France] ; C.-P. Jedynak [France] ; Pierre Pollak [France] ; Yves Agid [France]Pathology of symptomatic tremors
002F55 H. R. Morris [Royaume-Uni] ; Neville F. Moriabadi [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. J. Dick [États-Unis] ; Nora F. Moriabadi [Royaume-Uni] ; D. Turjanski [Royaume-Uni]Parkinsonism following electrical injury to the hand
002F56 F. Simonetti [Italie] ; P. Pergami [Italie] ; K. M. Aktipi [Italie] ; G. Giardini [Italie] ; M. Ceroni [Italie] ; P. Lattuada [Italie] ; G. Valenti [Italie]Paraneoplastic "rubral" tremor : A case report
002F57 E. J. Skalabrin [États-Unis] ; E. R. Jr Laws [États-Unis] ; J. P. Jr Bennett [États-Unis]Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease
002F60 R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; A. E. Lang [Canada]Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease
002F61 A. G. Riedl [Royaume-Uni] ; P. M. Watts [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]P450 enzymes and Parkinson's disease : The story so far
002F62 P. Jenner [Royaume-Uni]Oxidative mechanisms in nigral cell death in Parkinson's disease
002F63 M. Hallett [États-Unis]Overview of human tremor physiology
002F64 J. Volkmann [Allemagne]Oscillations of the human sensorimotor system as revealed by magnetoencephalography
002F66 C. H. Adler [États-Unis] ; K. A. Gwinn [États-Unis] ; S. Newman [États-Unis]Olfactory function in restless legs syndrome
002F68 D. Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Nicotine nasal spray is not reliable treatment for blepharospasm : Results of a pilot study
002F70 R. Töpper [Allemagne] ; M. Schwarz [Allemagne] ; H. W. Lange [Allemagne] ; H. Hefter [Allemagne] ; J. Noth [Allemagne]Neurophysiological abnormalities in the Westphal variant of Huntington's disease
002F71 J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; C. W. Olanow [États-Unis]Neuropathology of fetal nigral grafts in patients with Parkinson's disease
002F72 M. S. Schwartz [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; J. Filshie [Royaume-Uni]Neuromyotonia in a muscle flap producing a convulsing breast : Successful treatment with botulinum toxin
002F73 O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne]Neural transplantation in Parkinson's disease and its effects on rest tremor : A review of the literature
002F74 V. P. Calabrese [Canada] ; K. A. Lloyd [Canada] ; P. Brancazio [Canada] ; E. Cefali [États-Unis] ; P. Martin [États-Unis] ; J. Jr Wall [États-Unis] ; D. Sica [États-Unis]N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonism
002F75 C. Carnero-Pardo [Espagne] ; J. C. Sanchez-Alvarez [Espagne] ; A. Gomez-Camello [Espagne] ; A. Minguez-Castellanos [Espagne] ; F. J. Hernandez-Ramos [Espagne] ; T. Garcia-Gomez [Espagne]Myoclonus associated with thoracodorsal neuropathy
002F78 S. Ohara [Japon] ; R. Hayashi [Japon] ; H. Momoi [Japon] ; J. Miki [Japon] ; N. Yanagisawa [Japon]Mexiletine in the treatment of spasmodic torticollis
002F79 S. Przedborski [États-Unis] ; V. Jackson-Lewis [États-Unis]Mechanisms of MPTP toxicity
002F80 S. Spieker [Allemagne] ; A. Boose [Allemagne] ; S. Breit [Allemagne] ; J. Dichgans [Allemagne]Long-term measurement of tremor
002F81 Alim-Louis Benabid [France] ; A. Benazzouz [France] ; D. Hoffmann [France] ; P. Limousin [France] ; P. Krack [France] ; Pierre Pollak [France]Long-term electrical inhibition of deep brain targets in movement disorders
002F82 J. H. Carter [États-Unis] ; B. J. Stewart [États-Unis] ; P. G. Archbold [États-Unis] ; I. Inoue [États-Unis] ; J. Jaglin [États-Unis] ; M. Lannon [États-Unis] ; E. Rost-Ruffner [États-Unis] ; M. Tennis [États-Unis] ; M. P. Mcdermott [États-Unis] ; D. Amyot [Canada] ; R. Barter [États-Unis] ; L. Cornelius [États-Unis] ; C. Demong [Canada] ; J. Dobson [États-Unis] ; J. Duff [Canada] ; J. Erickson [États-Unis] ; N. Gardiner [États-Unis] ; L. Gauger [États-Unis] ; P. Gray [Canada] ; B. Kanigan [Canada] ; B. Kiryluk [États-Unis] ; P. Lewis [États-Unis] ; K. Mistura [États-Unis] ; T. Malapira [États-Unis] ; M. Pay [États-Unis] ; C. Sheldon [États-Unis] ; L. Winfield [États-Unis] ; K. Wolfington-Shallow [États-Unis] ; K. Zoog [États-Unis]Living with a person who has Parkinson's disease : The spouse's perspective by stage of disease
002F83 G. Denes [Italie] ; M. C. Mantovan [Italie] ; A. Gallana [Italie] ; J. Y. Cappelletti [Italie]Limb-kinetic apraxia
002F84 P. Duffey [Royaume-Uni] ; A. Coulthard ; D. J. BurnLate observation of the Goutières Aicardi syndrome
002F87 E. C. Hirsch [France] ; B. A. Faucheux [France]Iron metabolism and Parkinson's disease
002F92 B. Holmberg [Suède] ; L. Rosengren [Suède] ; J.-E. Karlsson [Suède] ; B. Johnels [Suède]Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease
002F95 J.-P. Nguyen [France] ; B. Pollin [France] ; A. Feve [France] ; C. Geny [France] ; P. Cesaro [France]Improvement of action tremor by chronic cortical stimulation
002F98 R. M. Oliveira [Royaume-Uni, Brésil] ; J. M. Gurd [Royaume-Uni] ; P. Nixon ; J. C. Marshall [Royaume-Uni] ; R. E. Passingham [Royaume-Uni]Hypometria in Parkinson's disease : Automatic versus controlled processing
003000 K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis]Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome
003001 E. Silber [Afrique du Sud] ; J. Kromberg [Afrique du Sud] ; J. A. Temlett [Afrique du Sud] ; A. Krause [Afrique du Sud] ; D. Saffer [Afrique du Sud]Huntington's disease confirmed by genetic testing in five African families
003002 E. D. Louis [États-Unis] ; R. Ottman [États-Unis] ; W. A. Hauser [États-Unis]How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world
003003 S. Fahn [États-Unis] ; R. Elliott [États-Unis]Highlights of the Parkinson's Disease Foundation
003005 P. Krack [Allemagne] ; S. Schneider [Allemagne] ; G. Deuschl [Allemagne]Geste device in tardive dystonia with retrocollis and opisthotonic posturing
003006 O. Bandmann [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni]Genetic aspects of Parkinson's disease
003008 J. M. Hausdorff [États-Unis] ; M. E. Cudkowicz [États-Unis] ; R. Firtion [États-Unis] ; J. Y. Wei [États-Unis] ; A. L. Goldberger [États-Unis]Gait variability and basal ganglia disorders : Stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease
003009 S. Palliyath [États-Unis] ; M. Hallett ; S. L. Thomas ; M. K. Lebiedowska [États-Unis]Gait in patients with cerebellar ataxia
003010 M. Van Zagten [Pays-Bas] ; J. Lodder [Pays-Bas] ; F. Kessels [Pays-Bas]Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions
003011 J. D. O'Sullivan [Australie] ; C. M. Said [Australie] ; L. C. Dillon [Australie] ; M. Hoffman [Australie] ; A. J. Hughes [Australie]Gait analysis in patients with Parkinson's disease and motor fluctuations : Influence of levodopa and comparison with other measures of motor function
003012 S.-L. Ho [Hong Kong] ; M. H. W. Kung [Hong Kong]G209A mutation in the α-synuclein gene is rare and not associated with sporadic Parkinson's disease
003014 H. Boecker [Royaume-Uni, Allemagne] ; D. J. Brooks [Royaume-Uni]Functional imaging of tremor
003015 E. M. Gatto [Argentine] ; M. C. Zurru [Argentine] ; C. Rugilo [Argentine] ; S. Mitre [Argentine] ; A. M. Pardal [Argentine] ; M. Martinez [Argentine] ; M. M. Fernandez Pardal [Argentine]Focal myoclonus associated with posterior thalamic hematoma
003016 J. H. Kordower [États-Unis] ; T. B. Freeman [États-Unis] ; E.-Y. Chen [États-Unis] ; E. J. Mufson [États-Unis] ; P. R. Sanberg [États-Unis] ; R. A. Hauser [États-Unis] ; B. Snow [Canada] ; C. W. Olanow [États-Unis]Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
003017 C. Klein [Allemagne] ; P. Vieregge [Allemagne]Fahr's disease : Far from a disease
003019 R. Djaldetti [Israël] ; I. Ziv ; E. MelamedExtreme anticipation in young-onset Parkinson's disease
003020 P. E. Greene [États-Unis] ; S. Bressman [États-Unis]Exteroceptive and interoceptive stimuli in dystonia
003021 C. L. Comella [États-Unis] ; K. M. Shannon [États-Unis] ; J. Jaglin [États-Unis]Extensor truncal dystonia : Successful treatment with botulinum toxin injections
003022 J. J. Higgins [États-Unis] ; J. M. Loveless [États-Unis] ; Joseph Jankovic [États-Unis] ; P. I. Patel [États-Unis]Evidence that a gene for essential tremor maps to chromosome 2p in four families
003024 V. G. H. Evidente [États-Unis] ; C. H. Adler [États-Unis] ; C. Giannini [États-Unis] ; C. R. Conley [États-Unis] ; J. E. Parisi [États-Unis] ; G. P. Fletcher [États-Unis]Erdheim-chester disease with extensive intraaxial brain stem lesions presenting as a progressive cerebellar syndrome
003025 M. F. Brin [États-Unis] ; W. Koller [États-Unis]Epidemiology and genetics of essential tremor
003026 C. S. Lu [Taïwan] ; A. Ikeda [Japon] ; K. Terada [Japon] ; T. Mima [Japon] ; T. Nagamine [Japon] ; H. Fukuyama [Japon] ; N. Kohara [Japon] ; Y. Kojima [Japon] ; Y. Yonekura [Japon] ; R. S. Chen [Taïwan] ; C. H. Tsai [Taïwan] ; N. S. Chu [Taïwan] ; J. Kimura [Japon] ; H. Shibasaki [Japon]Electrophysiological studies of early stage corticobasal degeneration
003028 V. G. H. Evidente [États-Unis] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; K. A. Gwinn [États-Unis]Effective treatment of orthostatic tremor with gabapentin
003029 C. M. Gudex [Danemark] ; M. R. Hawthorne [Royaume-Uni] ; A. G. Butler [Royaume-Uni] ; P. Duffey [Royaume-Uni]Effect of dystonia and botulinum toxin treatment on health-related quality of life
003032 V. G. H. Evidente [États-Unis] ; K. A. Gwinn [États-Unis] ; J. N. Caviness [États-Unis] ; M. Muenter [États-Unis] ; D. W. Mulder [États-Unis]Early cinematographic cases of postencephalitic parkinsonism and other movement disorders
003035 R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; J. P. Hubble [États-Unis] ; K. Busenbark [États-Unis] ; J. D. Rienerth [États-Unis] ; A. Pahwa [États-Unis] ; W. C. Koller [États-Unis]Double-blind controlled trial of gabapentin in essential tremor
003036 H. L. Ryoo [États-Unis] ; D. Pierrotti [États-Unis] ; J. N. Joyce [États-Unis]Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
003037 I. Delalande [France] ; J. C. Hache [France] ; G. Forzy [France] ; M. Bughin [France] ; J. Benhadjali [France] ; A. Destee [France]Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy?
003040 G. Logroscino [États-Unis, Italie] ; K. Marder [États-Unis] ; J. Graziano [États-Unis] ; G. Freyer [États-Unis] ; V. Slavkovich [États-Unis] ; N. Lojacono [États-Unis] ; L. Cote [États-Unis] ; R. Mayeux [États-Unis]Dietary iron, animal fats, and risk of Parkinson's disease
003042 S. E. Starkstein [Argentine] ; G. Petracca [Argentine] ; E. Chemerinski [Argentine] ; A. Teson [Argentine] ; L. Sabe [Argentine] ; T. Merello [Argentine] ; T. Leiguarda [Argentine]Depression in classic versus akinetic-rigid Parkinson's disease
003043 B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France]Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum
003045 A. E. Kingsbury [Royaume-Uni] ; C. D. Mardsen [Royaume-Uni] ; O. J. F. Foster [Royaume-Uni]DNA fragmentation in human substantia nigra : Apoptosis or perimortem effect?
003046 C. W. Olanow [États-Unis] ; C. Mytilineou [États-Unis] ; W. Tatton [États-Unis]Current status of selegiline as a neuroprotective agent in Parkinson's disease
003047 R. C. Dodel [Allemagne] ; K. M. Eggert [Allemagne] ; M. S. Singer [Allemagne] ; T. E. Eichhorn [Allemagne] ; O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne]Costs of drug treatment in Parkinson's disease
003048 J. N. Caviness [États-Unis] ; C. H. Adler [États-Unis] ; S. Newman [États-Unis] ; R. J. Caselli [États-Unis] ; M. D. Muenter [États-Unis]Cortical myoclonus in levodopa-responsive Parkinsonism
003049 M. Kofler [Autriche] ; G. K. Wenning [Autriche] ; Werner Poewe [Autriche]Cortical and brain stem hyperexcitability in striatonigral degeneration
003051 G. Deuschl [Allemagne] ; P. Bain [Royaume-Uni] ; M. Brin [États-Unis]Consensus statement of the movement disorder society on tremor
003053 M. Merello [Argentine] ; A. Cammarota [Argentine] ; M. I. Nouzeilles [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine]Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test
003054 I. M. Bronner [Pays-Bas] ; J. A. L. Vanneste [Pays-Bas]Complex movement disorder associated with fluvoxamine
003055 A. Brashear [États-Unis] ; W. T. Ambrosius [États-Unis] ; G. J. Eckert [États-Unis] ; E. R. Siemers [États-Unis]Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A
003056 D. Tarsy [États-Unis]Comparison of acute- and delayed-onset posttraumatic cervical dystonia
003057 R. M. Trosch [États-Unis] ; J. H. Friedman [États-Unis] ; M. C. Lannon [États-Unis] ; R. Pahwa [États-Unis] ; D. Smith [États-Unis] ; L. C. Seeberger [États-Unis] ; C. F. O'Brien [États-Unis] ; P. A. Lewitt [États-Unis] ; W. C. Koller [États-Unis]Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience
003060 P. G. Bain [Royaume-Uni]Clinical measurement of tremor
003061 R. Agostino [Italie] ; A. Berardelli ; A. Curra ; N. Accornero ; M. ManfrediClinical impairment of sequential finger movements in Parkinson's disease
003062 E. S. Molho [États-Unis] ; P. J. Feustel [États-Unis] ; S. A. Factor [États-Unis]Clinical comparison of tardive and idiopathic cervical dystonia
003063 E. D. Louis [États-Unis] ; B. Ford [États-Unis] ; K. J. Wendt [États-Unis] ; G. Cameron [États-Unis]Clinical characteristics of essential tremor : Data from a community-based study
003064 C. Potagas [France] ; G. Dellatolas [France] ; M. Ziegler [France] ; J. Leveteau [France] ; N. Bathien [France] ; P. Macleod [France] ; P. Rondot [France]Clinical assessment of olfactory dysfunction in Parkinson's disease
003065 J. F. Marti-Masso [Espagne] ; J. J. Poza [Espagne]Cinnarizine-induced Parkinsonism : Ten years later
003066 A. Kluge [Allemagne] ; B. Kettner [Allemagne] ; R. Zschenderlein [Allemagne] ; D. Sandrock [Allemagne] ; D. L. Munz [Allemagne] ; S. Hesse [Allemagne] ; H. Meierkord [Allemagne]Changes in perfusion pattern using ECD-SPECT indicate frontal lobe and cerebellar involvement in exercise-induced paroxysmal dystonia
003067 P. Katlovsky [République tchèque] ; H. Streitova [République tchèque] ; J. Dufek [République tchèque] ; V. Znojil [République tchèque] ; P. Daniel [République tchèque] ; I. Rektor [République tchèque]Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A
003068 M. Tanaka [Japon] ; S. Hirai [Japon] ; S. Kondo [Japon] ; X. Sun [Japon] ; T. Nakagawa [Japon] ; S. Tanaka [Japon] ; K. Hayashi [Japon] ; K. Okamoto [Japon]Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis : A combined PET and MRI study
003069 T. Odergren [Suède] ; S. Stone-Elander [Suède] ; M. Ingvar [Suède]Cerebral and cerebellar activation in correlation to the action-induced dystonia in Writer's cramp
003070 D. W. Anderson [États-Unis] ; W. A. Rocca [États-Unis] ; M. C. De Rijk [Pays-Bas] ; F. Grigoletto [Italie] ; M. O. Melcon [Argentine] ; M. B. Breteler [Pays-Bas] ; D. M. Maraganore [États-Unis]Case ascertainment uncertainties in prevalence surveys of Parkinson's disease
003071 K. Eder [Allemagne] ; S. J. Kish [Canada] ; M. Kirchgessner [Allemagne] ; B. M. Ross [Canada]Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1
003073 M. Miranda [Chili] ; A. Millar [Chili]Blepharospasm associated with bilateral infarcts confined to the thalamus : Case report
003074 P. Thajeb [Taïwan]Bibrachial sensory athetosis and dystonia in delayed postirradiation myelopathy
003076 C. Singer [États-Unis] ; N. J. Schatz [États-Unis] ; B. Bowen [États-Unis] ; D. Eidelberg [États-Unis] ; K. Kazumata [États-Unis] ; L. Sternau [États-Unis] ; L. M. Shulman [États-Unis] ; W. J. Weiner [États-Unis]Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst
003077 G.-M. Hariz [Suède] ; A. T. Bergenheim [Suède] ; M. I. Hariz [Suède] ; M. Lindberg [Suède]Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor
003079 J. D. O'Sullivan [Australie] ; A. J. Hughes [Australie]Apomorphine-induced penile erections in Parkinson's disease
003080 M. Gassen [Allemagne] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003081 M. Gassen [Israël] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003082 T. Van Laar [Pays-Bas] ; G.-J. Lammers [Pays-Bas] ; R. A. C. Roos [Pays-Bas] ; J. J. Gerritsen [Pays-Bas] ; A. E. Meinders [Pays-Bas]Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion
003084 J. W. Lance [Australie] ; I. Hickie [Brésil] ; D. Wakefield [Australie] ; J. G. Colebatch [Australie] ; F. Cardoso [Brésil] ; M. Vidailhet [France]An akinetic-rigid syndrome, depression, and stereotypies in a young man
003086 S. Rona [Italie] ; A. Berardelli ; L. Vacca ; M. Inghilleri ; M. ManfrediAlterations of motor cortical inhibition in patients with dystonia
003087 M. F. Mendez [États-Unis] ; A. MireaAdult head-banging and stereotypic movement disorders
003088 J. M. Brotchie [Royaume-Uni]Adjuncts to dopamine replacement : A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease
003090 H.-C. Wang [Taïwan] ; P. Brown [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Acute movement disorders with bilateral basal ganglia lesions in uremia
003091 P. Brown [Royaume-Uni] ; D. M. Corcos [Royaume-Uni, États-Unis] ; J. C. Rothwell [Royaume-Uni]Action tremor and weakness in Parkinson's disease : A study of the elbow extensors
003092 MYUNG SIK LEE [Corée du Sud] ; YOUNG DUK KIM [Corée du Sud] ; JEONG TAEK KIM [Corée du Sud] ; CHUL HYUNG LYOO [Corée du Sud]Abrupt onset of transient pseudochoreoathetosis associated with proprioceptive sensory loss as a result of a thalamic infarction
003093 M. Morris [Australie] ; R. Iansek [Australie] ; T. Matyas [Australie] ; J. Summers [Australie]Abnormalities in the stride length-cadence relation in parkinsonian gait
003094 L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; P. Van Den Munckhof [États-Unis] ; P. Del Dotto [États-Unis] ; R. Natte [États-Unis] ; T. N. Chase [États-Unis]A trial of dextromethorphan in Parkinsonian patients with motor response complications
003097 R. B. Jr Dewey [États-Unis] ; D. M. Maraganore [États-Unis] ; J. E. Ahlskog [États-Unis] ; J. Y. Matsumoto [États-Unis]A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease
003098 E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège]A community-based study of sleep disorders in patients with Parkinson's disease
003099 F. Delecluse [Belgique] ; J. A. Elosegi [Belgique] ; J.-M. Gerard [Belgique]A case of tardive tremor successfully treated with clozapine
003100 M. Naumann [Allemagne] ; M. Warmuth-Metz [Allemagne] ; C. Hillerer [Allemagne] ; L. Solymosi [Allemagne] ; K. Reiners [Allemagne]1H magnetic resonance spectroscopy of the lentiform nucleus in primary focal hand dystonia
003101 G. K. Wenning [Autriche] ; E. Donnemiller [Autriche] ; R. Granata [Autriche] ; G. Riccabona [Autriche] ; Werner Poewe [Autriche]123I-β-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease
003102 J. Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Gasser [Allemagne] ; G. Arnold [Allemagne] ; O. Pogarell [Allemagne] ; G. Künig [Allemagne] ; W. H. Oertel [Allemagne]123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism
003103
003104
003105
003106 J. Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Gasser ; G. Arnold ; W. H. Oertel[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy
003107 M. Naumann [Allemagne] ; W. Pirker [Autriche] ; K. Reiners [Allemagne] ; K. Lange [Allemagne] ; G. Becker [Allemagne] ; T. Brücke [Autriche][123I]β-CIT single-photon emission tomography in DOPA-responsive dystonia
003108 H. Rickards [Royaume-Uni] ; M. M. Robertson [Royaume-Uni]Vomiting and retching in Gilles de la Tourette syndrome: A report of ten cases and a review of the literature
003109 L. M. Shulman [États-Unis]Viewpoint : Reductionism and the study of neurodegenerative disorders
003110 S. Spieker [Allemagne] ; V. Ströle [Allemagne] ; A. Sailer [Allemagne] ; A. Boose [Allemagne] ; J. Dichgans [Allemagne]Validity of long-term electromyography in the quantification of tremor
003111 A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects
003112 F. Micheli [Argentine] ; N. Granana [Argentine] ; M. C. Scorticati [Argentine] ; R. J. Giannaula [Argentine] ; G. Reboredo [Argentine]Unilateral postural and action tremor resulting from thalamic toxoplasmosis in a patient with acquired immunodeficiency syndrome
003113 G. Fenelon [France] ; J.-L. Houeto [France]Unilateral parkinsonism following a large infarct in the territory of the lenticulostriate arteries
003114 C. E. Clarke [Royaume-Uni] ; M. Lowry [Royaume-Uni] ; A. Horsman [Royaume-Uni]Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy
003115 P. J. Koehler [Pays-Bas] ; A. KeyserTremor in Latin texts of Dutch physicians : 16th-18th centuries
003116 S. Ohara [Japon] ; J. Miki [Japon] ; H. Momoi [Japon] ; H. Unno [Japon] ; M. Shindo [Japon] ; N. Yanagisawa [Japon]Treatment of spasmodic torticollis with mexiletine : A case report
003117 A. R. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; C. Wolsley [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Torticollis due to disinhibition of the vestibulo-collic reflex in a patient with Steele-Richardson-Olszewski syndrome
003118 E. Dupont [Danemark] ; J.-M. Burgunder [Suisse] ; L. J. Findley [Royaume-Uni] ; J.-E. Olsson [Suède] ; E. Dorflinger [États-Unis]Tolcapone added to levodopa in stable parkinsonian patients : A double-blind placebo-controlled study
003119 J. K. Krauss [États-Unis] ; Joseph Jankovic [États-Unis]Tics secondary to craniocerebral trauma
003120 R. Eleopra [Italie] ; V. Tugnoli [Italie] ; D. De Grandis [Italie]The variability in the clinical effect induced by botulinum toxin type A : The role of muscle activity in humans
003121 E. J. Pappert [États-Unis] ; J. W. Lipton [États-Unis] ; C. G. Goetz [États-Unis] ; Z. D. Ling [États-Unis] ; G. T. Stebbins [États-Unis] ; P. M. Carvey [États-Unis]The stability of carbidopa in solution
003122 E. D. Louis [États-Unis]The shaking palsy, the first forty-five years : A journey through the British literature
003123 E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]The role of the immune system in neurodegenerative disorders
003125 P. Lewitt [États-Unis] ; D. Oakes [États-Unis] ; L. Cui [États-Unis]The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol
003126 S. A. Factor [États-Unis] ; J. H. Friedman [États-Unis]The emerging role of clozapine in the treatment of movement disorders
003127 J. P. Larsen [Norvège] ; J. Boas [Danemark]The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability : An interim analysis of a Norwegian-Danish 5-year study
003129 F. Lobbezoo [Canada] ; G. J. Lavigne [Canada] ; R. Tanguay [Canada] ; J. Y. Montplaisir [Canada]The effect of the catecholamine precursor L-dopa on sleep bruxism : A controlled clinical trial
003131 K. J. Werhahn [Royaume-Uni] ; P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The clinical features and prognosis of chronic posthypoxic myoclonus
003133 F. Valldeoriola [Espagne] ; J. Valls-Sole [Espagne] ; E. Tolosa [Espagne] ; F. A. Nobbe [Espagne] ; J. E. Munoz [Espagne] ; J. Marti [Espagne]The acoustic startle response is normal in patients with multiple system atrophy
003134 K. R. Kessler [Allemagne] ; R. Benecke [Allemagne]The EDB test : A clinical test for the detection of antibodies to botulinum toxin type A
003135 S. Kösel [Allemagne] ; R. Egensperger [Allemagne] ; N. M. Schnopp [Allemagne] ; M. B. Graeber [Allemagne]The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction
003136 C. Klein [Royaume-Uni] ; R. Brown [Royaume-Uni] ; G. Wenning [Royaume-Uni] ; N. Quinn [Royaume-Uni]The "cold hands sign" in multiple system atrophy
003137 C. L. Comella [États-Unis] ; G. T. Stebbins [États-Unis] ; C. G. Goetz [États-Unis] ; T. A. Chmura [États-Unis] ; S. B. Bressman [États-Unis] ; A. E. Lang [Canada]Teaching tape for the motor section of the Toronto Western spasmodic torticollis scale
003138 E. Storey [Australie] ; J. Lloyd [Australie]Tardive tremor
003139 G. Ebersbach [Autriche] ; F. Tracik [Autriche] ; J. Wissel [Autriche] ; Werner Poewe [Autriche]Tardive jaw tremor
003140 A. Meyer-Lindenberg [Allemagne] ; B. Krausnick [Allemagne]Tardive dyskinesia in a neuroleptic-naive patient with bipolar-I disorder : Persistent exacerbation after lithium intoxication
003141 E. G. Gonera [Pays-Bas] ; M. Van'T Hof [Pays-Bas] ; H. J. C. Berger [Pays-Bas] ; C. Van Weel [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas]Symptoms and duration of the prodromal phase in Parkinson's disease
003142 T. E. Kimber [Australie] ; P. D. Thompson [Australie]Symptomatic hyperekplexia occurring as a result of pontine infarction
003143 N. J. Diederich [Luxembourg (pays), États-Unis] ; C. L. Comella [États-Unis] ; G. Matge [Luxembourg (pays)] ; G. Becker [Luxembourg (pays)] ; F. Schiltz [Luxembourg (pays)] ; H. Metz [Luxembourg (pays)]Sustained effect of high-dose intrathecal baclofen in primary generalized dystonia : A 2-year follow-up study
003144 M. Poyurovsky [Israël] ; M. Schneidman [Israël] ; A. Weizman [Israël]Successful treatment of fluoxetine-induced dystonia with low-dose mianserin
003145 A. A. Yorio [Argentine] ; J. C. Mesri [Argentine] ; M. A. Pagano [Argentine] ; G. Lera [Argentine]Stereotypies in Wilson's disease
003146 A. Burleigh-Jacobs [États-Unis] ; F. B. Horak [États-Unis] ; J. G. Nutt [États-Unis] ; J. A. Obeso [Espagne]Step initiation in Parkinson's disease : Influence of levodopa and external sensory triggers
003147 P. Brown [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; D. Barnes [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Spinal rigidity following acute myelitis
003148 B. Ford [États-Unis] ; S. L. Pullman [États-Unis] ; A. Khandji [États-Unis] ; R. Goodman [États-Unis]Spinal myoclonus induced by an intrathecal catheter
003149 M. Svetel [Serbie] ; N. Sternic [Serbie] ; S. Filipovic [Serbie] ; V. Kostic [Serbie]Spasmodic torticollis associated with multiple sclerosis : Report of two cases
003150 M. Merello [Argentine] ; A. Hughes [Australie] ; C. Colosimo [Argentine] ; M. Hoffman [Australie] ; S. Starkstein [Argentine] ; R. Leiguarda [Argentine]Sleep benefit in Parkinson's disease
003151 J. Lyytinen [Finlande] ; S. Kaakkola [Finlande] ; S. Ahtila [Finlande] ; P. Tuomainen [Finlande] ; H. Ter V Inen [Finlande]Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with Parkinson's disease
003152 M. Zappia [Italie] ; R. Montesanti [Italie] ; R. Colao [Italie] ; D. Branca [Italie] ; G. Nicoletti [Italie] ; U. Aguglia [Italie] ; A. Quattrone [Italie]Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease
003153 V. Müller [Allemagne] ; B. Mohr [Allemagne] ; R. Rosin [Allemagne] ; F. Pulvermüller [Allemagne] ; F. Müller [Allemagne] ; N. Birbaumer [Allemagne, Italie]Short-term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease : A controlled clinical study
003154 M. Welsh [États-Unis] ; L. Hung [États-Unis] ; C. H. Waters [États-Unis]Sexuality in women with Parkinson's disease
003155 D. Dressler [Allemagne] ; R.-O. Oeljesch Ger [Allemagne] ; E. Rüther [Allemagne]Severe tardive dystonia: Treatment with continuous intrathecal baclofen administration
003156 A. Albanese ; G. Maria [Italie] ; A. Bentivoglio ; T. Brisinda [Italie] ; E. Cassetta [Italie] ; P. TonaliSevere constipation in Parkinson's disease relieved by botulinum toxin
003157 R. A. Hauser [États-Unis] ; T. A. Zesiewicz [États-Unis]Sertraline for the treatment of depression in Parkinson's disease
003158 G. Abbruzzese [Italie] ; R. Marchese [Italie] ; C. Trompetto [Italie]Sensory and motor evoked potentials in multiple system atrophy : A comparative study with Parkinson's disease
003159 A. Straube [Allemagne] ; J.-B. Mennicken [Allemagne] ; M. Riedel [Allemagne] ; T. Eggert [Allemagne] ; N. Müller [Allemagne]Saccades in Gilles de la Tourette's syndrome
003160 K. A. Gwinn [États-Unis] ; J. N. Caviness [États-Unis]Risperidone-induced tardive dyskinesia and parkinsonism
003161 G. Meco [Italie] ; A. Alessandri [Italie] ; P. Giustini [Italie] ; V. Bonifati [Italie]Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study
003162 L. Derex [France] ; P. Trouillas [France]Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy
003163 J. Federlein [Allemagne] ; T. Postert [Allemagne] ; A. Allgeier [Allemagne] ; V. Hoffmann [Allemagne] ; D. Pöhlau [Allemagne] ; H. Przuntek [Allemagne]Remitting parkinsonism as a symptom of multiple sclerosis and the associated magnetic resonance imaging findings
003164 A. Strafella [Canada] ; P. Ashby [Canada] ; A. E. Lang [Canada]Reflex myoclonus in cortical-basal ganglionic degeneration involves a transcortical pathway
003165 S. Avissar [Israël] ; L. Barki-Harrington [Israël] ; Y. Herishanu [Israël] ; G. Schreiber [Israël]Reduced Gs protein function and Gαs levels in leukocytes of patients with Parkinson's disease
003166 J. Wissel [Allemagne, Autriche] ; F. Masuhr [Allemagne] ; L. Schelosky [Allemagne] ; G. Ebersbach [Allemagne, Autriche] ; Werner Poewe [Autriche]Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
003167 C. A. Davie [Royaume-Uni] ; G. J. Barker [Royaume-Uni] ; C. Machado [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome
003168 F. Federico [Italie] ; I. L. Simone [Italie] ; V. Lucivero [Italie] ; G. Iliceto [Italie] ; M. De Mari [Italie] ; P. Giannini [Italie] ; D. M. Mezzapesa [Italie] ; A. Tarantino [Italie] ; P. Lamberti [Italie]Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders
003169 P. Montagna [Italie] ; F. Provini [Italie] ; G. Plazzi [Italie] ; R. Liguori [Italie] ; E. Lugaresi [Italie]Propriospinal myoclonus upon relaxation and drowsiness : A cause of severe insomnia
003171 A. Creange [France] ; F. Sedel [France] ; P. Brugieres [France] ; M.-C. Voisin [France] ; J.-D. Degos [France]Primary Sjögren's syndrome presenting as progressive Parkinsonian syndrome
003172 M. O. Melcon [Argentine] ; D. W. Anderson [États-Unis] ; R. H. Vergara [Argentine] ; W. A. Rocca [États-Unis]Prevalence of Parkinson's disease in Junín, Buenos Aires Province, Argentina
003173 J. K. Krauss [Allemagne, Suisse] ; R. Tr Nkle [Allemagne] ; K.-H. Kopp [Allemagne]Posttraumatic movement disorders after moderate or mild head injury
003174 K. Ray Chaudhuri [Royaume-Uni] ; C. Ellis ; S. Love-Jones ; T. Thomaides ; S. Clift ; C. J. Mathias ; J. D. ParkesPostprandial hypotension and parkinsonian state in Parkinson's disease
003175 C. I. Blake [États-Unis] ; E. Spitz [États-Unis] ; M. Leehey [États-Unis] ; B. J. Hoffer [États-Unis] ; S. J. Boyson [États-Unis]Platelet mitochondrial respiratory chain function in Parkinson's disease
003177 MYUNG SIK LEE [Corée du Sud] ; CHUL HYOUNG LYOO [Corée du Sud] ; WON CHAN KIM [Corée du Sud] ; HO JEONG KANG [Corée du Sud]Periodic bursts of rhythmic dyskinesia associated with spinal anesthesia
003178 A. Curra [Italie] ; A. Berardelli ; R. Agostino ; N. Modugno ; C. Conti Puorger ; N. Accornero ; M. ManfrediPerformance of sequential arm movements with and without advance knowledge of motor pathways in Parkinson's disease
003179 D. Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; M. A. Gresty [Royaume-Uni]Perception of spatial orientation in spasmodic torticollis. Part 2 : The visual vertical
003180 D. Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; M. A. Gresty [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Perception of spatial orientation in spasmodic torticollis part I: The postural vertical
003181 K. P. Bhatia [Royaume-Uni] ; V. L. Soland [Royaume-Uni] ; M. H. Bhatt [Inde] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Paroxysmal exercise-induced dystonia : Eight new sporadic cases and a review of the literature
003183 N. Turjanski [Royaume-Uni] ; B. Pentland [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; D. J. Brooks [Royaume-Uni]Parkinsonism associated with acute intracranial hematomas : An [18F]dopa positron-emission tomography study
003184 P. K. Morrish [Royaume-Uni]Parkinson's disease is not a long-latency illness
003185 M. W. Kellett [Royaume-Uni] ; G. R. Young [Royaume-Uni] ; N. A. Fletcher [Royaume-Uni]Painful tonic spasms and pure motor hemiparesis due to lacunar pontine infarct
003186 A. H. Rajput [Canada] ; J. D. Mchattie [Canada]Ophthalmoplegia and leg myorhythmia in Whipple's disease : Report of a case
003187 J. Valls-Sole [Espagne] ; E. S. Tolosa [Espagne] ; F. Nobbe [Espagne] ; E. Dieguez [Espagne] ; E. Munoz [Espagne] ; P. Sanz [Espagne] ; F. Valldeoriola [Espagne]Neurophysiological investigations in patients with head tremor
003188 T. Stojkovic [France] ; L. Defebvre [France] ; X. Quilliet [France] ; E. Eveno [France] ; A. Sarasin [France] ; M. Mezzina [France] ; A. Destee [France]Neurological manifestations in two related xeroderma pigmentosum group D patients: Complications of the late-onset type of the juvenile form
003189 F. Carella [Italie] ; C. Ciano [Italie] ; F. Panzica [Italie] ; V. Scaioli [Italie]Myoclonus in corticobasal degeneration
003190 G. K. Wenning [Royaume-Uni, Autriche] ; F. Tison [Royaume-Uni] ; Y. Ben Shlomo [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni]Multiple system atrophy : A review of 203 pathologically proven cases
003192 C. E. Clarke [Royaume-Uni] ; C. Sampaio [Portugal]Movement disorders cochrane collaborative review group
003193 R. Kurlan [États-Unis] ; M. F. Brin [États-Unis] ; S. Fahn [États-Unis]Movement disorder in reflex sympathetic dystrophy : A case proven to be psychogenic by surveillance video monitoring
003194 J. G. Nutt [États-Unis] ; J. H. Carter [États-Unis] ; E. S. Lea [États-Unis] ; W. R. Woodward [États-Unis]Motor fluctuations during continuous Levodopa infusions in patients with Parkinson's disease
003195 S. A. Factor [États-Unis] ; K. D. Barron [États-Unis]Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism
003196 M. Gu [Royaume-Uni] ; M. T. Gash [Royaume-Uni] ; J. M. Cooper [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. H. V. Schapira [Royaume-Uni]Mitochondrial respiratory chain function in multiple system atrophy
003197 G. M. G. Shepherd [Norvège] ; E. Tauböll [Norvège] ; S. J. Bakke [Norvège] ; R. Nyberg-Hansen [Norvège]Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage
003199 A. Prochazka [Canada] ; D. J. Bennett [Canada] ; M. J. Stephens [Canada] ; S. K. Patrick [Canada] ; R. Sears-Duru [Canada] ; T. Roberts [Canada] ; J. H. Jhamandas [Canada]Measurement of rigidity in Parkinson's disease
003200 G. K. Wenning [Royaume-Uni] ; S. J. M. Smith [Royaume-Uni]Magnetic brain stimulation in multiple system atrophy
003201 J. H. Friedman [États-Unis]Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone
003202 W. H. Jost [Allemagne] ; K. Schimrigk [Allemagne]Long-term results with cisapride in Parkinson's disease
003203 A. Antonini [Suisse] ; J. Schwarz [Suisse] ; W. H. Oertel [Suisse] ; O. Pogarell [Suisse] ; K. L. Leenders [Suisse, Allemagne]Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease : A study with positron emission tomography and [11C]raclopride
003204 W. Ondo [États-Unis]Lingual dystonia following electrical injury
003206 E. Waubant [France] ; M. Simonetta-Moreau [France] ; M. Clanet [France] ; I. Berry [France] ; A. Bonafe [France]Left arm monoballism as a relapse in multiple sclerosis
003207 P. Kanovsky [République tchèque] ; H. Streitova ; J. Dufek ; I. RektorLateralization of the P22/N30 component of somatosensory evoked potentials of the median nerve in patients with cervical dystonia
003208 H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; I. Daum [Allemagne] ; G. Scharf [Allemagne] ; S. Spieker [Allemagne]Kinematic analysis of articulatory movements in central motor disorders
003209 A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; S. Birdi [Canada] ; R. Macaulay [Canada]Is levodopa toxic to human substantia nigra?
003210 S. P. Swinnen [Belgique] ; L. Van Langendonk [Belgique] ; S. Verschueren [Belgique] ; G. Peeters [Belgique] ; R. Dom [Belgique] ; W. De Weerdt [Belgique]Interlimb coordination deficits in patients with Parkinson's disease during the production of two-joint oscillations in the sagittal plane
003211 A. Strafella [Canada] ; P. Ashby [Canada] ; M. Munz [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada]Inhibition of voluntary activity by thalamic stimulation in humans : Relevance for the control of tremor
003212 P. Krack [Allemagne] ; H. Porschke [Allemagne] ; W. De Decker [Allemagne] ; G. Deuschl [Allemagne]Inability to close eyelids as a feature of palpebral dystonia
003213 J. K. Krauss [États-Unis] ; R. G. Grossman [États-Unis] ; Joseph Jankovic [États-Unis]Improvement of Parkinsonian signs after vascular lesions of the basal ganglia circuitry
003214 M. Stojanovic [Serbie] ; V. Kostic [Serbie] ; P. Stankovic [Serbie] ; N. Sternic [Serbie]Improvement in laryngeal dystonia with background noise
003215 N. Georgiou [Australie] ; J. G. Phillips [Australie] ; J. L. Bradshaw [Australie] ; R. Cunnington [Australie] ; E. Chiu [Australie]Impairments of movement kinematics in patients with Huntington's disease : A comparison with and without a concurrent task
003216 S. Frucht [États-Unis] ; D. Eidelberg [États-Unis]Imipenem-induced myoclonus
003217 P. A. Lewitt [États-Unis] ; R. M. Trosch [États-Unis]Idiosyncratic adverse reactions to intramuscular botulinum toxin type a injection
003218 K. Ikeda [Japon] ; M. Kinoshita [Japon] ; K. Aoki [Japon] ; A. Tomatsuri [Japon]Hydrocephalic parkinsonism due to Paget's disease of bone : Dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy
003219 R. Fitzpatrick [Royaume-Uni] ; V. Peto [Royaume-Uni] ; C. Jenkinson [Royaume-Uni] ; R. Greenhall [Royaume-Uni] ; N. Hyman [Royaume-Uni]Health-related quality of life in Parkinson's disease : A study of outpatient clinic attenders
003220 G. Deuschl [Allemagne] ; F. Heinen [Allemagne] ; B. Guschlbauer [Allemagne] ; S. Schneider [Allemagne] ; F. X. Glocker [Allemagne] ; C. H. Lücking [Allemagne]Hand tremor in patients with spasmodic torticollis
003222 R. Rosin [Allemagne] ; H. Topka [Allemagne] ; J. Dichgans [Allemagne]Gait initiation in Parkinson's disease
003223 P. Chana [Chili] ; A. De Marinis [Chili] ; N. Barrientos [Chili]Gabapentin and motor fluctuations in Parkinson's disease
003224 T. Xie [Hong Kong] ; S. L. Ho [Hong Kong] ; L. S. W. Li [Hong Kong] ; O. C. K. Ma [Hong Kong]G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease
003225 B. Leube [Allemagne] ; K. R. Kessler [Allemagne] ; T. Goecke [Allemagne] ; G. Auburger [Allemagne] ; R. Benecke [Allemagne]Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family
003226 N. Giladi [États-Unis] ; R. Kao [États-Unis] ; S. Fahn [États-Unis]Freezing phenomenon in patients with Parkinsonian syndromes
003227 K. Terada [Japon] ; A. Ikeda [Japon] ; T. Mima [Japon] ; K. Kimura [Japon] ; Y. Nagahama [Japon] ; Y. Kamioka [Japon] ; I. Murone [Japon] ; J. Kimura [Japon] ; H. Shibasaki [Japon]Familial cortical myoclonic tremor as a unique form of cortical reflex myoclonus
003228 S. B. Blunt [Royaume-Uni] ; N. M. Khalil [Royaume-Uni] ; G. D. Perkin [Royaume-Uni]Facial myokymia in multiple system atrophy
003229 J. J. Higgins [États-Unis] ; L. T. Pho [États-Unis] ; S. E. Ide [États-Unis] ; L. E. Nee [États-Unis] ; M. H. Polymeropoulos [États-Unis]Evidence for a new spinocerebellar ataxia locus
003230 L. Almasy [États-Unis] ; S. Bressman [États-Unis] ; D. De Leon [États-Unis] ; N. Risch [États-Unis]Ethnic variation in the clinical expression of idiopathic torsion dystonia
003231 T. Postert [Allemagne] ; G. Amoiridis [Allemagne] ; D. Pöhlau [Allemagne] ; V. Hoffmann [Allemagne] ; H. Przuntek [Allemagne]Episodic undulating hyperkinesias of the tongue associated with brainstem ischemia
003233 K. A. Gwinn [États-Unis] ; J. N. Caviness [États-Unis]Electrophysiological observations in idiopathic opsoclonus-myoclonus syndrome
003234 C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis] ; M. S. Grobman [États-Unis]Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease
003235 J. P. Hubble [États-Unis] ; K. L. Busenbark [États-Unis] ; S. Wilkinson [États-Unis] ; R. Pahwa [États-Unis] ; G. W. Paulson [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Effects of thalamic deep brain stimulation based on tremor type and diagnosis
003236 I. Soykan [États-Unis] ; I. Sarosiek [États-Unis] ; J. Shifflett [États-Unis] ; G. F. Wooten [États-Unis] ; R. W. Mccallum [États-Unis]Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease
003239 J. N. Joyce [États-Unis] ; G. Smutzer [États-Unis] ; C. J. Whitty [États-Unis] ; A. Myers [États-Unis] ; M. J. Bannon [États-Unis]Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease
003240 W. L. Scheider [États-Unis] ; L. A. Hershey [États-Unis] ; J. E. Vena [États-Unis] ; T. Holmlund [États-Unis] ; J. R. Marshall [États-Unis] ; J. L. Freudenheim [États-Unis]Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease
003242 M. W. Becher [États-Unis] ; D. C. Rubinsztein [Royaume-Uni] ; J. Leggo [Royaume-Uni] ; M. V. Wagster [États-Unis] ; O. C. Stine [États-Unis] ; N. G. Ranen [États-Unis] ; M. L. Franz [États-Unis] ; M. H. Abbott [États-Unis] ; M. Sherr [États-Unis] ; J. C. Macmillan [Royaume-Uni] ; L. Barron [Royaume-Uni] ; M. Porteous [Royaume-Uni] ; P. S. Harper [Royaume-Uni] ; C. A. Ross [États-Unis]Dentatorubral and pallidoluysian atrophy (DRPLA) : Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
003243 I. Moroo [Japon] ; K. Hirayama [Japon] ; M. Nakajima [Japon]Delayed onset postural tremor caused by parietal lesion
003244 K. Itoh [Allemagne] ; S. Weis [Allemagne] ; P. Mehraein [Allemagne] ; J. Müller-Höcker [Allemagne]Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease : An immunohistochemical and morphometric study
003245 C. Teo [États-Unis] ; L. Rasco [États-Unis] ; K. Al-Mefty [États-Unis] ; T. D. Skinner [États-Unis] ; F. A. Boop [États-Unis] ; E. Garcia-Rill [États-Unis]Decreased habituation of midlatency auditory evoked responses in Parkinson's disease
003246 C. Sampaio [Portugal] ; J. J. Ferreira [Portugal] ; F. Simoes [Portugal] ; M. J. Rosas [Portugal] ; M. Magalhaes [Portugal] ; A. P. Correia [Portugal] ; A. Bastos-Lima [Portugal] ; R. Martins [Portugal] ; A. Castro-Caldas [Portugal]DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1
003247 J. N. Caviness [États-Unis] ; M. Kurth [États-Unis]Cortical myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential
003248 M. I. Nouzeilles [Argentine] ; M. Merello [Argentine]Correlation between results of motor section of UPDRS and Webster scale
003249 J. Konczak [Allemagne] ; H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; S. Spieker [Allemagne] ; J. Dichgans [Allemagne]Control of repetitive lip and finger movements in Parkinson's disease : Influence of external timing signals and simultaneous execution on motor performance
003250 W. Ashraf [États-Unis] ; R. F. Pfeiffer [États-Unis] ; F. Park [États-Unis] ; J. Lof [États-Unis] ; E. M. M. Quigley [États-Unis]Constipation in Parkinson's disease : Objective assessment and response to psyllium
003251 A. H. Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; A. Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada]Concordance of common movement disorders among familial cases
003252 G. Becker [Allemagne] ; M. Naumann [Allemagne] ; M. Scheubeck [Allemagne] ; E. Hofmann [Allemagne] ; M. Deimling [Allemagne] ; A. Lindner [Allemagne] ; G. Gahn [Allemagne] ; C. Reiners [Allemagne] ; K. V. Toyka [Allemagne] ; K. Reiners [Allemagne]Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis
003253 B. T. Johnston [États-Unis] ; J. A. Castell [États-Unis] ; S. Stumacher [États-Unis] ; T. Colcher [États-Unis] ; R. M. Gideon [États-Unis] ; Q. Li [États-Unis] ; D. O. Castell [États-Unis]Comparison of swallowing function in Parkinson's disease and progressive supranuclear palsy
003254 R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; D. Mcguire [États-Unis] ; P. Silverstein [États-Unis] ; F. Zwiebel [États-Unis] ; M. Robischon [États-Unis] ; W. C. Koller [États-Unis]Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease : Pharmacokinetic and quality-of-life measures
003255 D. Tarsy [États-Unis]Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin
003256 C.-C. Huang [Taïwan] ; N.-S. Chu [Taïwan] ; C.-S. Lu [Taïwan] ; D. B. Calne [Canada]Cock gait in manganese intoxication
003257 V. S. C. Fung [Australie] ; J. G. L. Morris [Australie] ; T. Leicester [Australie] ; Y. S. Soo [Australie] ; L. Davies [Australie]Clonic perseveration following thalamofrontal disconnection : A distinctive movement disorder
003258 J. Montplaisir [Canada] ; S. Boucher [Canada] ; G. Poirier [Canada] ; G. Lavigne [Canada] ; O. Lapierre [Canada] ; P. Lesperance [Canada]Clinical, polysomnographic, and genetic characteristics of restless legs syndrome : A study of 133 patients diagnosed with new standard criteria
003259 S. B. Blunt [Royaume-Uni] ; R. J. M. Lane [Royaume-Uni] ; N. Turjanski [Royaume-Uni] ; G. D. Perkin [Royaume-Uni]Clinical features and management of two cases of Encephalitis lethargica
003260 J. P. Hubble [États-Unis] ; K. L. Busenbark [États-Unis] ; R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis]Clinical expression of essential tremor : Effects of gender and age
003261 G. Gomez Arevalo [Argentine] ; R. Jorge [Argentine] ; S. Garcia [Argentine] ; O. Scipioni [Argentine] ; O. Gershanik [Argentine]Clinical and pharmacological differences in early- versus late-onset Parkinson's disease
003262 J. G. Heckmann [Allemagne] ; C. J. G. Lang [Allemagne] ; A. Druschky [Allemagne] ; D. Claus [Allemagne] ; O. Bartels [Allemagne] ; B. Neundörfer [Allemagne]Chorea resulting from paraneoplastic encephalitis
003263 F. Cardoso [Brésil] ; C. Eduardo [Brésil] ; A. P. Silva [Brésil] ; C. C. C. Mota [Brésil]Chorea in fifty consecutive patients with rheumatic fever
003264 J. K. Krauss [Allemagne, États-Unis] ; W. Seeger [Allemagne] ; Joseph Jankovic [États-Unis]Cervical dystonia associated with tumors of the posterior fossa
003265 E. J. Munoz [Espagne] ; N. Vila [Espagne] ; J. Valls-Sole [Espagne] ; E. Tolosa [Espagne]Cervical and facial myoclonus associated with dolichoectasia of the left vertebral artery
003266 S. Magyar-Lehmann [Suisse] ; A. Antonini [Suisse] ; U. Roelcke [Suisse] ; R. P. Maguire [Suisse] ; J. Missimer [Suisse] ; M. Meyer [Suisse] ; K. L. Leenders [Suisse]Cerebral glucose metabolism in patients with spasmodic torticollis
003267 Y. Nagahama [Japon] ; H. Fukuyama [Japon] ; N. Turjanski [Royaume-Uni] ; A. Kennedy [Royaume-Uni] ; H. Yamauchi [Japon] ; Y. Ouchi [Japon] ; J. Kimura [Japon] ; D. J. Brooks [Royaume-Uni] ; H. Shibasaki [Japon]Cerebral glucose metabolism in corticobasal degeneration : Comparison with progressive supranuclear palsy and normal controls
003268 G. K. Wenning [Royaume-Uni] ; E. Kraft [Royaume-Uni] ; R. Beck [Royaume-Uni] ; C. J. Fowler [Royaume-Uni] ; C. J. Mathias [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; A. E. Harding [Royaume-Uni]Cerebellar presentation of multiple system atrophy
003269 B. Wild [Allemagne, États-Unis] ; D. M. Corcos [États-Unis]Cerebellar hypermetria: Reduction in the early component of the antagonist electromyogram
003270 P. Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Cerebellar axial postural tremor
003272 R. Liguori [Italie] ; C. Cordivari [Italie] ; E. Lugaresi [Italie] ; P. Montagna [Italie]Botulinum toxin a improves muscle spasms and rigidity in Stiff-Person syndrome
003273 D. D. Truong [États-Unis] ; P. A. Cullis [États-Unis] ; C. F. O'Brien [États-Unis] ; M. Koller [États-Unis] ; T. P. Villegas [États-Unis] ; J. D. Wallace [États-Unis]BotB (botulinum toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study)
003275 P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas]Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients
003276 D. G. Le Couteur [Australie] ; P. W. Leighton [Australie] ; S. J. Mccann [Australie] ; S. M. Pond [Australie]Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease
003277 M. Aramideh [Pays-Bas] ; I. H. Kwa [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; J. D. Speelman [Pays-Bas] ; B. W. Ongerboer De Visser [Pays-Bas] ; B. Jr Verbeeten [Pays-Bas]Apraxia of eyelid closure accompanied by denial of eye opening
003279 A. R. Bentivoglio [Italie] ; S. B. Bressman [États-Unis] ; E. Cassetta [Italie] ; D. Carretta [Italie] ; P. Tonali [Italie] ; A. Albanese [Italie]Analysis of blink rate patterns in normal subjects
003280 X. Liu [Royaume-Uni] ; R. C. Miall [Royaume-Uni] ; T. Z. Aziz [Royaume-Uni] ; J. A. Palace [Royaume-Uni] ; P. N. Haggard [Royaume-Uni] ; J. F. Stein [Royaume-Uni]Analysis of action tremor and impaired control of movement velocity in multiple sclerosis during visually guided wrist-tracking tasks
003281 S. Chouinard [États-Unis] ; E. D. Louis [États-Unis] ; S. Fahn [États-Unis]Agreement among movement disorder specialists on the clinical diagnosis of essential tremor
003285 F. Ghika-Schmid [Suisse] ; J. Ghika [Suisse] ; P. Vuadens [Suisse] ; J. Bogousslavsky [Suisse] ; F. Regli [Suisse] ; P. A. Despland [Suisse]Acute reversible myoclonic encephalopathy associated with fluoxetine therapy
003286 A. Gambardella [Italie] ; M. Zappia [Italie] ; P. Valentino [Italie] ; U. Aguglia [Italie] ; F. Fera [Italie] ; K. Pardatscher [Italie] ; A. Quattrone [Italie]Action palatal tremor in a patient with primary intestinal lymphoma
003287 C.-H. Tsai [Taïwan] ; R.-S. Chen [Taïwan] ; H.-C. Chang [Taïwan] ; C.-S. Lu [Taïwan] ; K.-K. Liao [Taïwan]Acanthocytosis and spinocerebellar degeneration : A new association?
003288 J. Maher [Canada] ; S. Choudhri [Canada] ; W. Halliday [Canada] ; C. Power [Canada] ; A. Nath [Canada]AIDS dementia complex with generalized myoclonus
003289 S. Siesling [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; J. P. P. Van Vugt [Pays-Bas] ; K. Kieburtz [États-Unis] ; R. A. C. Roos [Pays-Bas]A shortened version of the motor section of the unified Huntington's disease rating scale
003292 G. Ballan [France] ; F. Tison [France]A historical case of probable corticobasal degeneration?
003293 J. J. Higgins [États-Unis] ; L. T. Pho [États-Unis] ; L. E. Nee [États-Unis]A gene (ETM) for essential tremor maps to chromosome 2p22-p25
003294 N. Andreu [France] ; C. Damase-Michel [France] ; J.-M. Senard [France] ; Olivier Rascol [France] ; J.-L. Montastruc [France]A dose-ranging study of selegiline in patients with Parkinson's disease : Effect on platelet monoamine oxidase activity
003295 P. G. Como [États-Unis] ; A. J. Rubin [États-Unis] ; C. F. O'Brien [États-Unis] ; K. Lawler [États-Unis] ; C. Hickey [États-Unis] ; A. E. Rubin [États-Unis] ; R. Henderson [États-Unis] ; M. P. Mcdermott [États-Unis] ; T. Mcdermott [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis]A controlled trial of fluoxetine in nondepressed patients with Huntington's disease
003296 G. M. Petzinger [États-Unis] ; S. B. Bressman [États-Unis]A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment
003299
003300
003301
003302 Cortical-basal ganglionic degeneration (CBGD) and its relationship to other asymmetrical cortical degeneration syndromes (ACDs)
003303 A. Brashear [États-Unis] ; M. R. Farlow [États-Unis] ; I. J. Butler ; E. J. Kasarskis ; W. B. DobynsVariable phenotype of rapid-onset dystonia-parkinsonism
003304 P. Girlanda [Italie] ; A. Quartarone ; S. Sinicropi ; C. Nicolosi ; C. MassinaUnilateral injection of botulinum toxin in blepharospasm : single fiber electromyography and blink reflex study
003305 J. Kulisevsky [Espagne] ; M. L. Berthier [Espagne] ; A. Avila [Espagne] ; C. Roig [Espagne]Unilateral Parkinsonism and stereotyped movements following of right lenticular infarction
003306 Unified Huntington's Disease Rating Scale : Reliability and consistency
003307 F. Qureshi [États-Unis] ; A. Morales [États-Unis] ; R. J. Elble [États-Unis]Tremor due to infarction in the ventrolateral thalamus
003308 R. Lindeboom [Pays-Bas] ; R. J. De Haan ; M. Aramideh [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; J. D. Speelman [Pays-Bas]Treatment outcomes in cervical dystonia : A clinimetric study
003309 B. L. Scott [États-Unis] ; R. W. Evans [États-Unis] ; Joseph Jankovic [États-Unis]Treatment of palatal myoclonus with sumatriptan
003310 J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Treatment of nonoccupational limb and trunk dystonia with botulinum toxin
003311 F. Stocchi [Italie] ; M. F. De Pandis [Italie] ; F. A. Delfino [Italie] ; T. Anselmo [Italie] ; D. Frongillo [Italie]Transient atrial fibrillation after subcutaneous apomorphine bolus
003312 M. Y. Neufeld [Israël] ; P. Nisipeanu [Israël] ; V. Chistik [Israël] ; A. D. Korczyn [Israël]The electroencephalogram in acetazolamide-responsive periodic ataxia
003313 E. S. Molho [États-Unis] ; S. A. Factor [États-Unis] ; G. D. Podskalny ; D. Brown [États-Unis]The effect of dancing on dystonia
003314 M. Raja [Italie] ; G. Maisto [Italie] ; M. C. Altavista [Italie] ; A. Albanese [Italie]Tardive lingual dystonia treated with clozapine
003315 R. Bordet [France] ; J. Benhadjali [France] ; A. Destee [France] ; J. F. Hurtevent [France] ; J. L. Bourriez [France] ; J. D. Guieu [France]Sympathetic skin response and R-R interval variability in multiple system atrophy and idiopathic Parkinson's disease
003316 C. Armon [États-Unis] ; J. W. Swanson [États-Unis] ; J. M. Mclean [États-Unis] ; P. R. Westbrook [États-Unis] ; H. Okazaki [États-Unis] ; P. J. Kurtin [États-Unis] ; U. P. Kalyan-Raman [États-Unis] ; M. Rodriguez [États-Unis]Subacute encephalomyelitis presenting as Stiff-Person syndrome : Clinical, polygraphic, and pathologic correlations
003317 G. Kiziltan [Turquie] ; M. A. Akalin [Turquie]Stuttering may be a type of action dystonia
003318 F. Cicchetti [Canada] ; A. Parent [Canada]Striatal interneurons in Huntington's disease : Selective increase in the density of calretining-immunoreactive medium-sized neurons
003319 C. Raftopoulos [Belgique] ; S. Dethy ; M. A. Laute ; S. Goldman ; A. B. Naini ; S. Przedborski ; J. HildebrandSlow increase of homovanillic acid in cerebrospinal fluid after levodopa administration
003320 M. S. Lee [Corée du Sud] ; Y. C. Choi [Corée du Sud] ; S. H. Lee [Corée du Sud] ; S. B. Lee [Corée du Sud]Sleep-related periodic leg movements associated with spinal cord lesions
003321 J. K. Krauss [États-Unis] ; Joseph Jankovic [États-Unis]Severe motor tics causing cervical myelopathy in Tourette's syndrome
003322 E. Bollen [Pays-Bas] ; E. Van Exel [Pays-Bas] ; E. A. Van Der Velde [Pays-Bas] ; P. Buytels [Pays-Bas] ; J. Bastiaanse [Pays-Bas] ; J. G. Van Dijk [Pays-Bas]Saccadic eye movements in idiophatic blepharospasm
003323 M. H. Thaut [États-Unis] ; G. C. Mcintosh ; R. R. Rice ; R. A. Miller [États-Unis] ; J. Rathbun [États-Unis] ; J. M. Brault [États-Unis]Rhythmic auditory stimulation in gait training for Parkinson's disease patients
003325 P. E. Greene [États-Unis] ; S. Fahn [États-Unis]Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients
003326 E. D. Louis [États-Unis] ; T. Lynch [États-Unis] ; K. Marder ; S. Fahn [États-Unis]Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale
003327 P. Santens [Belgique] ; L. Crevits [Belgique] ; C. Van Der Linden [Belgique]Raynaud's phenomenon in a case of multiple system atrophy
003328 A. Tan [États-Unis] ; M. Salgado [États-Unis] ; S. Fahn [États-Unis]Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa
003329 J. C. M. Zijlmans [Pays-Bas] ; P. J. E. Poels [Pays-Bas] ; J. Duysens [Pays-Bas] ; J. Van Der Straaten [Pays-Bas] ; T. Thien [Pays-Bas] ; M. A. Van'T Hof [Pays-Bas] ; H. O. M. Thijssen [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas]Quantitative gait analysis in patients with vascular parkinsonism
003330 R. J. Elble [États-Unis] ; M. Brilliant ; K. Leffler ; C. HigginsQuantification of essential tremor in writing and drawing
003331 A. Schulze-Bonhage [Allemagne] ; H. Knott ; A. FerbertPure stimulus-sensitive truncal myoclonus of propriospinal origin
003332 S. D. Taylor-Robinson [Royaume-Uni] ; R. A. Weeks ; D. J. Bryant [Royaume-Uni] ; J. Sargentoni [Royaume-Uni] ; C. D. Marcus [Royaume-Uni] ; A. E. Harding ; D. J. BrooksProton magnetic resonance spectroscopy in Huntington's disease : Evidence in favour of the glutamate excitotoxic theory ?
003333 A. Freese [États-Unis] ; M. Stern [États-Unis] ; M. G. Kaplitt ; W. M. O'Connor [États-Unis] ; M. V. Abbey ; M. J. O'Connor [États-Unis] ; M. J. During [États-Unis]Prospects for gene therapy in Parkinson's disease
003335 F. Picard [France] ; A. De Saint-Martin [France] ; E. Salmon [Belgique] ; E. Hirsch [France] ; C. Marescaux [France]Postencephalitic stereotyped involuntary movements responsive to L-Dopa
003336 R. Pahwa [États-Unis] ; J. Marjama [États-Unis] ; D. Mcguire [États-Unis] ; K. Lyons [États-Unis] ; F. Zwiebel ; P. Silverstein ; R. Ward ; W. C. Koller [États-Unis]Pharmacokinetic comparison of Sinemet and atamet (generic carbidopa/levodopa) : A single-dose study
003337 A. Straube [Allemagne] ; N. Mai [Allemagne] ; E. Walther [Allemagne] ; M. Mayer [Allemagne]Persisting "writer's cramp" as a result of compensation of a temporary palsy due to a hereditary neuropathy with liability to pressure palsies
003338 C. H. Adler [États-Unis] ; R. S. Zimmerman ; M. K. Lyons ; F. Simeone ; M. F. BrinPerioperative use of botulinum toxin for movement disorder-induced cervical spine disease
003340 D. E. Riley [États-Unis]Paroxysmal kinesigenic dystonia associated with a medullary lesion
003342 J. V. H Gglund [Suède] ; S.-M. AquiloniusParkinson's disease after open-heart surgery
003343 M. E. R. Pla [États-Unis] ; T. R. Dillingham ; N. T. Spellman ; E. Colon ; B. JabbariPainful legs and moving toes associated with tarsal tunnel syndrome and accessory soleus muscle
003344 B. Ford [États-Unis] ; E. D. Louis [États-Unis] ; P. Greene [États-Unis] ; S. Fahn [États-Unis]Oral and genital pain syndromes in Parkinson's disease
003345 G. K. Wenning [Royaume-Uni] ; F. Tison [Royaume-Uni] ; L. Elliott ; N. P. Quinn [Royaume-Uni] ; S. E. DanielOlivopontocerebellar pathology in multiple system atrophy
003347 W. A. Rocca [États-Unis] ; D. W. Anderson ; F. Meneghini ; F. Grigoletto ; L. Morgante ; A. Reggio ; G. Savettieri ; R. Di PerriOccupation, education, and Parkinson's disease : A case-control study in an Italian population
003348 E. M. Gatto [Argentine] ; M. C. Carreras ; G. A. Pargament ; N. A. Riobo ; C. Reides ; M. Repetto ; M. M. Fernandez Pardal [Argentine] ; S. Llesuy ; J. J. PoderosoNeutrophil function, nitric oxide, and blood oxidative stress in Parkinson's disese
003349 M. Grasso [Italie] ; L. Mazzini [Italie] ; M. SchieppatiMuscle relaxation in Parkinson's disease : A reaction time study
003350 C. M. Haw [Royaume-Uni] ; T. R. E. Barnes ; K. Clark ; P. Chrichton ; D. KohenMovement disorder in down's syndrome : A possible marker of the severity of mental handicap
003351 T. Gasser [Allemagne] ; B. Bereznai [Allemagne] ; B. Müller ; R. Pruszak-Seel ; R. Damrich ; G. Deuschl ; W. H. Oertel [Allemagne]Linkage studies in alcohol-responsive myoclonic dystonia
003352 E. J. Pappert [États-Unis] ; C. Buhrfiend ; J. W. Lipton ; P. M. Carvey ; G. T. Stebbins ; C. G. GoetzLevedopa stability in solution : time course, environmental effects, and practical recommendations for clinical use
003353 C. H. Adler [États-Unis] ; L. Wrabetz [États-Unis]Lesch-Nyhan variant : Dystonia, ataxia, near-normal intelligence, and no self-mutilation
003354 J. Galazka-Friedman [Pologne] ; E. R. Bauminger ; A. Friedman ; M. Barcikowska ; D. Hechel ; I. NowikIron in parkinsonian and control substantia nigra : a Mössbauer spectroscopy study
003355 S. H. Subramony [États-Unis] ; R. D. Currier [États-Unis]Intrafamilial variability in Machado-Joseph disease
003356 L. M. Shulman [États-Unis] ; C. Singer [États-Unis] ; J. A. Bean ; W. J. Weiner [États-Unis]Internal tremor in patients with Parkinson's disease
003357 B. R. Bloem [Pays-Bas] ; D. J. Beckley [États-Unis] ; J. G. Van Dijk [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; M. P. Remler [États-Unis] ; R. A. C. Roos [Pays-Bas]Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease
003358 C. Geny [France] ; J.-P. Nguyen [France] ; B. Pollin [France] ; A. Feve [France] ; F. Ricolfi [France] ; P. Cesaro [France] ; J.-D. Degos [France]Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation
003359 M. Jauss [Allemagne] ; P. Krack [Allemagne] ; M. Franz [Allemagne] ; R. Klett [Allemagne] ; R. Bauer [Allemagne] ; B. Gallhofer [Allemagne] ; W. Dorndorf [Allemagne]Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome
003360 P. J. Tuite [Canada] ; C. Navarette [Canada] ; V. Bril [Canada] ; A. E. Lang [Canada]Idiopathic generalized myokymia (Isaacs' syndrome) with hand posturing resembling dystonia
003361 J. P. P. Van Vugt [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas]Hypokinesia in Huntington's disease
003362 D. J. Werring [Royaume-Uni] ; K. Ray ChaudhuriHuman immunodeficiency virus-related progressive multifocal leukoencephalopathy presenting with an akinetic rigid syndrome
003363 V. L. Soland [Canada] ; K. P. Bhatia [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Hereditary geniospasm : Two new families
003364 P. Pantano [Italie] ; S. Di Cesare ; M. Ricci [Italie] ; G. F. Gualdi ; U. Sabatini [Italie] ; V. Di PieroHemichorea after a striatal ischemic lesion : Evidence of thalamic disinhibition using single-photon emission computed tomography : A case report
003365 F. Ghika-Schmid [Suisse] ; J. Ghika [Suisse] ; F. Regli [Suisse] ; N. Dworak [Suisse] ; J. Bogousslavsky [Suisse] ; C. St Dler [Suisse] ; L. Portmann [Suisse] ; P. A. Despland [Suisse]Hashimoto's myoclonic encephalopathy : An underdiagnosed treatable condition ?
003366 T. Gasser [États-Unis] ; C. M. Bove [États-Unis] ; L. J. Ozelius [États-Unis] ; M. Hallett ; M. E. Charness ; F. H. Hochberg ; X. O. Breakefield [États-Unis]Haplotype analysis at the DYT1 locus in Ashkenazi Jewish patients with occupational hand dystonia
003367 S. B. Blunt [Royaume-Uni] ; P. G. Richards [Royaume-Uni] ; N. Khalil [Royaume-Uni]Foot dystonia and lumbar canal stenosis
003368 V. L. Soland [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; M. A. Volonte [Italie] ; C. D. Marsden [Royaume-Uni]Focal task-specific tremors
003369 O. C. Cockerell [Royaume-Uni] ; P. Rudge [Royaume-Uni]Focal dystonia secondary to superficial siderosis
003370 D. T. Schloesser [États-Unis] ; T. N. Ward [États-Unis] ; P. D. Williamson [États-Unis]Familial paroxysmal dystonic choreoathetosis revisited
003371 D. S. Sax [États-Unis] ; R. Powsner [États-Unis] ; A. Kim [États-Unis] ; S. Tilak [États-Unis] ; R. Bhatia [États-Unis] ; L. A. Cupples [États-Unis] ; R. H. Myers [États-Unis]Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography
003372 J. Green [États-Unis] ; J. L. Woodard ; B. E. Sirockman ; G. O. Zakers ; C. L. Maier ; R. C. Green ; R. L. WattsEvent-related potential P3 change in mild Parkinson's disease
003373 N. P. Quinn [Royaume-Uni]Essential myoclonus and myoclonic dystonia
003374 G. De Michele [Italie] ; A. Filla [Italie] ; G. Volpe [Italie] ; V. De Marco [Italie] ; A. Gogliettino [Italie] ; G. Ambrosio [Italie] ; R. Marconi ; A. E. Castellano ; G. Campanella [Italie]Environmental and genetic risk factors in Parkinson's disease : a case-control study in southern Italy
003375 P. Gatev [États-Unis] ; S. Thomas [États-Unis] ; J.-S. Lou [États-Unis] ; M. Lim [États-Unis] ; M. Hallett [États-Unis]Effects of diminished and conflicting sensory information on balance in patients with cerebellar deficits
003376 F. Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France]Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
003377 L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis]Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
003378 K. D. Pfann [États-Unis] ; R. D. Penn ; K. M. Shannon ; M. B. Shapiro ; D. M. Corcos [États-Unis]Effect of stimulation in the ventral intermediate nucleus of the thalamus on limb control in Parkinson's disease : A case study
003380 S. H. Subramony [États-Unis] ; J. D. Fratkin ; B. V. Manyam ; R. D. Currier [États-Unis]Dominantly inherited cerebello-olivary atrophy is not due to a mutation at the spinocerebellar ataxia-I, Machado-Joseph disease, or dentato-rubro-pallido-luysian atrophy locus
003381 J. E. Nielsen [Danemark] ; S. A. S Rensen [Danemark] ; L. Hasholt [Danemark] ; A. N Rrem Lle [Danemark]Dentatorubral-pallidoluysian atrophy. Clinical features of a five-generation Danish family
003382 J. H. Friedman [États-Unis] ; W. StoneDelayed-onset dystonia secondary to unilateral schizencephaly
003384 L. J. Born [États-Unis] ; R. H. Harned ; L. F. Fikkers ; R. F. Pfeiffer [États-Unis] ; E. M. M. Quigley [États-Unis]Cricopharyngeal dysfunction in Parkinson's disease : role in dysphagia and response to myotomy
003385 Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD)
003386 T. E. Eichhorn [Allemagne] ; T. Gasser [Allemagne] ; N. Mai [Allemagne] ; C. Marquardt ; G. Arnold [Allemagne] ; J. Schwarz [Allemagne] ; W. H. Oertel [Allemagne]Computational analysis of open loop handwriting movements in Parkinson's disease : A rapid method to detect dopamimetic effects
003387 K. J. Bharucha [États-Unis] ; K. D. Sethi [États-Unis]Complex movement disorders induced by fluoxetine
003388 A. Ikeda [Japon] ; .. Shibasaki [Japon] ; K. Tashiro [Japon] ; Y. Mizuno [Japon] ; J. Kimura [Japon]Clinical trial of piracetam in patients with myoclonus : nationwide multiinstitution study in Japan
003389 C. Trenkwalder [Allemagne] ; V. Collado Seidel [Allemagne] ; T. Gasser ; W. H. OertelClinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome
003390 R. A. C. Roos [Pays-Bas] ; J. C. F. Jongen [Pays-Bas] ; E. A. Van Der VeldeClinical course of patients with idiopathic Parkinson's disease
003391 I. Daum [Allemagne] ; M. M. Schugens [Allemagne] ; C. Breitenstein [Allemagne] ; H. Topka [Allemagne] ; S. Spieker [Allemagne]Classical eyeblink conditioning in Parkinson's disease
003392 P. Maggi [Italie] ; M. De Mari ; R. De Blasi ; S. Armenise ; C. Romanelli [Italie] ; C. Andreula ; G. Zimatore ; G. Angarano [Italie]Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis
003393 G. D. Ppodskalny [États-Unis] ; S. A. Factor [États-Unis]Chorea caused by lithium intoxication : A case report and literature review
003394 M. A. Nance [États-Unis] ; G. Sanders [États-Unis]Characteristics of individuals with Huntington disease long-term care
003395 T. Ashizawa [États-Unis] ; Joseph Jankovic [États-Unis]Cervical dystonia as the initial presentation of Huntington's disease
003396 S. Fahn [États-Unis] ; M. F. Brin ; A. J. Dwork ; W. J. Weiner ; C. G. Goetz ; A. H. RajputCase 1, 1996 : Rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma
003397 G. Geminiani [Italie] ; V. Fetoni [Italie] ; S. Genitrini [Italie] ; P. Giovannini [Italie] ; F. Tamma [Italie] ; T. Caraceni [Italie]Cabergoline in Parkinson's disease complicated by motor fluctuations
003398 P. D. Clouston [Australie] ; C. L. Lim [Australie] ; V. Fung [Australie] ; C. Yiannikas [Australie] ; J. G. L. Morris [Australie]Brainstem myoclonus in a patient with non-dopa-responsive parkinsonism
003399 D. M. Kullmann [Royaume-Uni] ; R. S. Howard [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; N. P. Hirsch [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Brainstem encephalopathy with stimulus-sensitive myoclonus leading to respiratory arrest, but with recovery : A description of two cases and review of the literature
003400 L. Bettendorff [Belgique] ; F. Mastrogiacomo ; J. Lamarche ; S. Dozic ; S. J. KishBrain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1
003401 G. W. Paulson [États-Unis] ; W. Gill [États-Unis]Botulinum toxin is unsatisfactory therapy for fibromyalgia
003403 S. Salloway [États-Unis] ; C. F. Stewart [États-Unis] ; L. Israeli ; X. Morales ; S. Resmussen [États-Unis] ; A. Blitzer [États-Unis] ; M. F. Brin [États-Unis]Botulinum toxin for refractory vocal tics
003404 R. S. Briellmann [Suisse] ; K. M. Rösler [Suisse] ; C. W. Hess [Suisse]Blink reflex excitability is abnormal in patients with periodic leg movements in sleep
003405 F. X. Glocker [Allemagne] ; G. Deuschl [Allemagne] ; B. Volk [Allemagne] ; J. Hasse [Allemagne] ; C. H. Lücking [Allemagne]Bilateral myoclonus of the trapezius muscles after distal lesion of an accessory nerve
003406 S. Jain [Inde] ; S. K. Tamer [Inde] ; S. Hiran [Inde]Beneficial effect of alcohol in hereditary cerebellar ataxia with myoclonus (progressive myoclonic ataxia) : Report of two siblings
003408 F. Q. Ye [Canada] ; P. S. Allen [Canada] ; W. R. W. MartinBasal ganglia iron content in Parkinson's disease measured with magnetic resonance
003409 L. E. Abrey [États-Unis] ; C. H. Waters [États-Unis]Basal ganglia calcification after mumps encephalitis
003410 C. Klein [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Ataxia without telangiectasia masquerading as benign hereditary chorea
003411 A. Feigin [États-Unis] ; K. Kieburtz [États-Unis] ; P. Como [États-Unis] ; C. Hickey [États-Unis] ; K. Claude [États-Unis] ; D. Abwender [États-Unis] ; C. Zimmerman [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis]Assessment of coenzyme Q10 tolerability in Huntington's disease
003412 A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; F. Garcia [Espagne] ; C. Cabezas [Espagne] ; F. Coria [Espagne] ; L. E. Claveria [Espagne]An estimate of the risk of movement disorders associated with the chronic use of clebopride
003414 K. Jendroska [Allemagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche] ; S. E. Daniel [Royaume-Uni]Amyloid β-peptide and the dementia of Parkinson's disease
003416 P. J. Blanchet [États-Unis] ; L. V. Metman [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis]Acute pharmacologic blockade of dyskinesias in Parkinson's disease
003417 F. Valldeoriola [Espagne] ; J. Gonzalez [Espagne] ; N. Vila [Espagne] ; J. Valls-Sole [Espagne] ; M. Sole ; F. Graus [Espagne] ; E. Tolosa [Espagne]Action myoclonus as an early clinical sign of carcinomatous meningitis
003418 A. Ikeda [Japon] ; H. Shibasaki [Japon] ; R. Kaji [Japon] ; K. Terada [Japon] ; T. Nagamine [Japon] ; M. Honda [Japon] ; T. Hamano [Japon] ; J. Kimura [Japon]Abnormal sensorimotor integration in Writer's cramp : Study of contingent negative variation
003419 P. Limousin [France] ; Pierre Pollak [France] ; D. Hoffmann [France] ; ABDELHAMID BENAZZOUZ [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France]Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients
003420 Joseph Jankovic [États-Unis] ; K. Schwartz [États-Unis] ; W. Clemence [États-Unis] ; A. Aswad ; J. MordauntA randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
003421 T. Van Laar [Pays-Bas] ; C. Neef [Pays-Bas] ; M. Danhof [Pays-Bas] ; K. I. Roon [Pays-Bas] ; R. A. C. Roos [Pays-Bas]A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
003422 M. Samuel [Royaume-Uni] ; M. Manford [Royaume-Uni] ; G. Sheean [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]A neuromyotonic process in a transposed latissimus dorsi muscle stemming from radiotherapy and peripheral surgery
003423 K. Kieburtz [États-Unis] ; A. Feigin ; M. Mcdermott ; P. Como ; D. Abwender ; C. Zimmerman ; C. Hickey ; C. Orme ; K. Claude ; J. Sotack ; J. T. Greenamyre ; C. Dunn ; I. ShoulsonA controlled trial of remacemide hydrochloride in Huntington's disease
003424 N. G. Ranen [États-Unis] ; C. E. Peyser [États-Unis] ; J. T. Coyle [États-Unis] ; F. W. Bylsma [États-Unis] ; M. Sherr [États-Unis] ; L. Day [États-Unis] ; M. F. Folstein [États-Unis] ; J. Brandt [États-Unis] ; C. A. Ross [États-Unis] ; S. E. Folstein [États-Unis]A controlled trial of idebenone in Huntington's disease
003425
003427 G. Pezzoli [Italie] ; A. Antonini ; S. Barbieri [Italie] ; M. Canesi [Italie] ; L. Perbellini ; A. Zecchinelli [Italie] ; C. B. Mariani [Italie] ; A. Bonetti [Italie] ; K. L. Leendersn-Hexane-induced Parkinsonism : pathogenetic hypotheses
003428 E. R. P. Brunt [Pays-Bas] ; T. W. Van Weerden ; J. Pruim ; J. W. P. F. Lakke [Pays-Bas]Unique myoclonic pattern in corticobasal degeneration
003429 G. Staude [Allemagne] ; W. Wolf [Allemagne] ; M. Ott ; W. H. Oertel ; R. DenglerTremor as a factor in prolonged reaction times of Parkinsonian patients
003430 A. S. WaltersToward a better definition of the Restless Legs Syndrome
003431 Joseph Jankovic [États-Unis] ; T. AshizawaTourettism associated with Huntington's disease
003432 W. Van Der Kamp [Royaume-Uni] ; J. C. Rothwell ; P. D. Thompson ; B. L. Day ; C. D. MarsdenThe movement-related cortical potential is abnormal in patients with idiopathic torsion dystonia
003433 J. N. Caviness [États-Unis] ; P. A. Forsyth [États-Unis] ; D. D. Layton ; T. J. Mcphee [États-Unis]The movement disorder of adult opsoclonus
003434 E. Tandberg [Norvège] ; J. P. Larsen [Norvège] ; E. G. Nessler [Norvège] ; T. Riise ; J. A. AarliThe epidemiology of Parkinson's disease in the county of Rogaland, Norway
003435 W. Diaz Neira [Espagne] ; V. Sanchez ; M. A. Mena ; J. G. De YebenesThe effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease
003436 R. Lindeboom [Pays-Bas] ; R. De Haan ; M. Aramideh ; J. D. SpeelmanThe blepharospasm disability scale : an instrument for the assessment of functional health in blepharospasm
003437 M. Vidailhet [Royaume-Uni] ; P. R. Atchison ; F. Stocchi ; P. D. Thompson ; J. C. Rothwell ; C. D. MarsdenThe bereitschaftspotential preceding in patients with isolated gait ignition failure
003438 R. Stell [Australie] ; G. W. Thickbroom ; F. L. MastagliaThe audiogenic startle response in Tourette's syndrome
003439 R. K. B. Pearce [Royaume-Uni] ; C. H. Hawkes ; S. E. Daniel [Royaume-Uni]The anterior olfactory nucleus in Parkinson's disease
003440 M. Onofrj [Italie] ; T. Fulgente [Italie] ; G. Malatesta [Italie] ; F. Ferracci [Italie] ; A. Thomas [Italie] ; L. Curatola ; F. Bollettini ; M. RagnoThe abnormality of N30 somatosensory evoked potential in idiopathic Parkinson's disease is unrelated to disease stage or clinical scores and insensitive to dopamine manipulations
003441 C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; T. A. Chmura [États-Unis] ; S. Fahn ; H. L. Klawans [États-Unis] ; C. D. MarsdenTeaching tape for the motor section of the unified Parkinson's disease rating scale
003442 K. J. Bharucha [États-Unis] ; K. D. SethiTardive tourettism after exposure to neuroleptic therapy
003443 F. Valldeoriola [Espagne] ; J. Valls-Sole ; E. S. Tolosa ; M. J. MartiStriated anal sphincter denervation in patients with progressive supranuclear palsy
003444 XIAO-HUI ZHONG [Canada] ; J. W. Haycock ; K. Shannak [Canada] ; Y. Robitaille ; J. Fratkin ; A. H. Koeppen ; O. Hornykiewicz [Canada] ; S. J. Kish [Canada]Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy
003445 F. A. Lenz [États-Unis] ; S. L. Normand ; H. C. Kwan ; D. Andrews ; L. H. Rowland [États-Unis] ; M. W. Jones ; M. Seike [États-Unis] ; Y. C. Lin [États-Unis] ; R. R. Tasker ; J. O. Dostrovsky ; Y. E. Lenz [États-Unis]Statistical prediction of the optimal site for thalamotomy in Parkinsonian tremor
003446 P. Greene [États-Unis] ; UN JUNG KANG ; S. FahnSpread of symptoms in idiopathic torsion dystonia
003447 C. Stewart [États-Unis] ; L. Winfield ; A. Hunt ; S. B. Bressman ; S. Fahn ; A. Blitzer ; M. F. BrinSpeech dysfunction in early Parkinson's disease
003448 J. H. T. M. Koelman [Pays-Bas] ; R. B. Willemse ; L. J. Bour ; A. A. J. Hilgevoord ; J. D. Speelman ; B. W. Ongerboer De VisserSoleux H-reflex tests in dystonia
003449 J. C. Garcia-Monco [Espagne] ; A. Padierna ; M. G. BeldarrainSelegiline, fluoxetine, and depression in Parkinson's disease
003450 J. Duarte [Espagne] ; L. E. Claveria [Espagne] ; J. De Pedro-Cuesta ; A. P. Sempere [Espagne] ; F. Coria [Espagne] ; D. B. CalneScreening Parkinson's disease : a validated questionnaire of high specificity and sensitivity
003451 M. A. J. Tijssen [Pays-Bas] ; E. Bollen ; E. Van Exel ; J. G. Van DijkSaccadic eye movements in hyperekplexia
003452 B. M. S. Dash [Inde]Role of peripheral inputs in cerebellar tremor
003454 A. Verma [États-Unis] ; J. R. Berger [États-Unis] ; B. C. Bowen ; J. Sanchez-Ramos [États-Unis]Reversible Parkinsonian syndrome complicating cysticercus midbrain encephalitis
003456 N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; J. G. Phillips [Australie] ; E. Chiu ; J. A. Bradshaw [Australie]Reliance on advance information and movement sequencing in Huntington's disease
003457 ROU-SHAYN CHEN [Taïwan] ; CHON-HAW TSAI ; CHIN-SONG LUReciprocal inhibition in Writer's cramp
003458 G. J. Rey [États-Unis] ; R. Tomer [États-Unis] ; B. E. Levin [États-Unis] ; J. Sanchez-Ramos [États-Unis] ; B. Bowen ; J. H. BrucePsychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration
003459 K. Nakashima [Japon] ; M. Kusumi [Japon] ; Y. Inoue ; K. Takahashi [Japon]Prevalence of focal dystonias in the Western area of Tottori Prefecture in Japan
003460 S. S. Palmer [États-Unis] ; J. T. HuttonPostural finger tremor exhibited by Parkinson patients and age-matched subjects
003461 B. Bonnefoi-Kyriacou [France] ; E. Trouche [France] ; E. Legallet [France] ; F. Viallet [France]Planning and execution of pointing movements in cerebellar patients
003462 T. Van Laar [Pays-Bas] ; E. N. H. Jansen ; C. Neef ; M. Danhof ; R. A. C. RoosPharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease : a study of five different suppositories
003463 S. Przedborski [Belgique] ; M. Levivier ; C. Raftopoulos ; A. B. Naini ; J. Hildebrand [Belgique]Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans
003464 H. S. Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox ; C. D. Marsden ; D. C. CostaPatterns of regional cerebral blood flow in corticobasal degeneration studies using HMPAO SPECT ; comparison with Parkinson's disease and normal controls
003466 E. D. Louis [États-Unis] ; J. E. Goldman ; J. M. Powers ; S. Fahn [États-Unis]Parkinsonian features of eight pathologically diagnosed cases of diffuse lewy body disease
003467 D. A. Simpson [États-Unis] ; R. Wishnow ; R. B. Gargulinski ; A. M. PawlakOculofacial-skeletal myorhythmia in central nervous System Whipple's disease : additional case and review of the literature
003468 J. E. Ahlskog [États-Unis] ; R. J. Uitti ; P. A. Low [États-Unis] ; G. M. Tyce ; K. K. Nickander [États-Unis] ; R. C. Petersen [États-Unis] ; E. Kokmen [États-Unis]No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease
003470 K. Westermark [Suède] ; J. Tedroff ; K.-A. Thuomas ; P. Hartvig ; B. Langström ; Y. Andersson ; K. Hörnfeldt ; S.-M. AquiloniusNeurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers
003471 H. Nogaki [Japon] ; T. Fukusako ; F. Sasabe ; K. Negoro ; M. MiromatsuMuscle strength in early Parkinson's disease
003472 C. Tranchant [France] ; K. P. Bhatia ; C. D. MarsdenMovement disorders in multiple sclerosis
003473 R. Haaxma [Pays-Bas] ; A. Van Boxtel ; W. H. Brouwer ; L. N. H. Goeken ; J. J. Denier Van Der Gon ; J. G. Colebatch ; A. Martin ; D. J. Brooks ; J. Noth ; C. D. MarsdenMotor function in a patient with bilateral lesions of the globus pallidus
003474 K. Jendroska [Royaume-Uni] ; M. N. Rossor ; C. J. Mathias ; S. E. Daniel [Royaume-Uni]Morphological overlap between corticobasal degeneration and Pick's disease : a clinicopathological report
003475 R. A. Maricle [États-Unis] ; J. G. Nutt ; J. H. CarterMood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion : preliminary findings
003476 J. Valls-Sole [Espagne] ; M. HallettModulation of electromyographic activity of wrist flexor and extensor muscles in patients with Writer's cramp
003477 G. Fabbrini [Italie] ; F. Baronti ; S. Ruggieri ; G. L. LenziMeningioma-induced loss of antiparkinsonian response to levodopa
003479 J. Kulisevsky [Espagne] ; M. L. Berthier ; A. AvilaLongitudinal evolution of prefrontral leucotomy in Tourette's syndrome
003480 R. Inzelberg [Israël] ; P. Nisipeanu ; M. J. Rabey ; A. D. KorczynLong-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease
003481 B. R. Bloem [Pays-Bas] ; D. J. Beckley ; J. P. P. Van Vugt [Pays-Bas] ; J. G. Van Dijk [Pays-Bas] ; M. P. Remler ; J. W. Langston ; R. A. C. Roos [Pays-Bas]Long latency postural reflexes are under supraspinal dopaminergic control
003482 D. Smith [États-Unis] ; T. Ishikawa ; V. Dhawan ; J. S. Winterkorn ; D. Eidelberg [États-Unis]Lid opening apraxia is associated with medial frontal hypometabolism
003483 J. J. Poza [Espagne] ; J. F. Marti Masso [Espagne] ; E. AmatoLate onset familial periodic cerebellar ataxia
003484 J. M. Cooper [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden ; A. H. V. Schapira [Royaume-Uni]L-dihyroxyphenalanine and complex I deficiency in Parkinson's disease brain
003485 J. Opacka-Juffry [Royaume-Uni] ; D. J. BrooksL-dihydroxyphenylalanine and its decarboxylase : new ideas on their neuroregulatory roles
003486 A. Lagueny [France] ; P. Burbaud ; G. Le Masson ; F. X. Bergouignan ; X. Ferrer ; J. JulienInvolvement of respiratory muscles in adult-onset dystonia : a clinical and electrophysiological study
003487 A. Salmaggi [Italie] ; F. Carella ; C. Ciano ; S. Binelli ; P. Giovannini ; E. Palazzini ; F. GirottiIntrathecal immune activation in three patients with progressive myoclonic ataxia
003488 R. D. Penn [États-Unis] ; J. M. Gianino ; M. M. YorkIntrathecal baclofen for motor disorders
003489 W. H. Oertel [Allemagne] ; R. C. DodelInternational guide to drugs for Parkinson's disease
003490 Joseph Jankovic [États-Unis]International classification of diseases, tenth revision : neurological adaptation (ICD-10 NA) : extrapyramidal and movement disorders
003491 J. J. Van Hilten [Pays-Bas] ; E. A. M. Braat [Pays-Bas] ; E. A. Van Der Velde ; H. A. M. Middelkoop [Pays-Bas] ; J. G. Van Dijk [Pays-Bas] ; G. J. Ligthart ; R. A. C. Roos [Pays-Bas]Hypokinesia in Parkinson's disease : influence of age, disease severity, and disease duration
003492 G. Ebersbach [Allemagne] ; C. Kabus ; L. Schelosky [Allemagne] ; L. Terstegge ; Werner Poewe [Allemagne]Hemimasticatory spasm in hemifacial atrophy : diagnostic and therapeutic aspects in two patients
003495 J. M. Wojcieszek [Canada] ; A. E. LangGestes antagonistes in the suppression of tics : "tricks for tics"
003496 A. Feigin [États-Unis] ; K. Kieburtz ; K. Bordwell ; P. Como ; K. Steinberg ; J. Sotack ; C. Zimmerman ; C. Hickey ; C. Orme ; I. ShoulsonFunctional decline in Huntington's disease
003497 K. Bötzel [Allemagne] ; M. Mayer [Allemagne] ; W. H. Oertel [Allemagne] ; W. PaulusFrontal and parietal premovement slow brain potentials in Parkinson's disease and aging
003498 S. Bohlega [Arabie saoudite] ; B. Stigsby [Arabie saoudite] ; M. Z. Al-Kawi [Arabie saoudite] ; D. R. Mclean [Arabie saoudite] ; P. Ozand ; S. Omer [Arabie saoudite] ; P. CoatesFamilial tremulous and myoclonic dystonia with white matter changes in brain magnetic resonance imaging
003499 S. Iannaccone [Italie] ; M. Zucconi ; P. Marchettini ; L. Ferini-Strambi ; R. Nemni ; A. Quattrini ; S. Palazzi ; M. Lacerenza ; F. Formaglio ; S. SmirneEvidence of peripheral axonal neuropathy in primary restless legs syndrome
003500 D. W. Claypool [États-Unis] ; D. D. Duane ; D. M. Ilstrup [États-Unis] ; L. J. Melton [États-Unis]Epidemiology an outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota
003501 T. L. Davis [États-Unis] ; M. Roznoski ; R. S. BurnsEffects of tolcapone in Parkinson's patients taking L-dihydroxyphenalalanine/carbidopa and selegiline
003503 R. Djaldetti [Israël] ; M. Koren ; ILAN ZIV ; A. Achiron ; ELDAD MELAMEDEffect of cisapride on response fluctuations in Parkinson's disease
003504 M. F. Gordon [États-Unis] ; S. Bressman ; M. F. Brin ; D. De Leon ; D. Warburton ; KWAME YEBOA ; S. FahnDystonia in a patient with deletion of 18q
003505 R. Cole [États-Unis] ; M. Hallett ; L. G. CohenDouble-blind trial of botulinum toxin for treatment of focal hand dystonia
003506 C. E. Clarke [Royaume-Uni]Does levodopa therapy delay death in Parkinson's disease ? A review of the evidence
003507 J.-L. Montastruc [France] ; N. Fabre [France] ; O. Blin [France] ; J.-M. Senard [France] ; Olivier Rascol [France] ; A. Rascol [France]Does fluoxetine aggravate Parkinson's disease ? A pilot prospective study
003508 J. Garcia De Yebenes [Espagne]Did Robert Schumann have dystonia ?
003509 J. D. Clark [États-Unis] ; RAJESH PAHWA [États-Unis] ; W. C. Koller [États-Unis] ; D. MoralesDiabetes mellitus presenting as paroxysmal kinesigenic dystonic choreoathetosis
003510 J. G. Colebatch [Australie] ; V. Di Lazzaro ; A. Quartarone ; J. C. Rothwell ; M. GrestyClick-evoked vestibulocollic reflexes in torticollis
003511 M. S. Jog [Canada] ; A. E. LangChronic acquired hepatocerebral degeneration : case reports and new insights
003513 A. Cammarota [Argentine] ; O. S. Gershanik ; S. Garcia ; G. LeraCervical dystonia due to spinal cord ependymoma : involvement of cervical cord segments in the pathogenesis of dystonia
003514 L. M. Shulman [États-Unis] ; A. E. Lang ; Joseph Jankovic [États-Unis] ; N. J. David [États-Unis] ; W. J. Weiner [États-Unis]Case 1, 1995 : psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction
003515 V. Plante-Bordeneuve [Royaume-Uni] ; O. Bandmann ; G. Wenning ; N. P. Quinn ; S. E. Daniel ; A. E. HardingCYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy
003516 D. Claus [Allemagne] ; A. Druschky ; F. ErbguthBotulinum toxin : influence on respiratory heart rate variation
003517 D. Tarsy [États-Unis] ; S. C. SchachterBotulinum toxin treatmenty is not effective for epilepsy partialis continua
003518 M. F. Gordon [États-Unis] ; R. I. Abrams ; D. B. Rubin ; W. B. Barr ; D. D. CorreaBismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus
003519 M. H. Mark [États-Unis] ; J. I. Sage ; A. S. Walters ; R. C. Duvoisin ; D. C. MillerBinswanger's disease presenting as levodopa-responsive parkinsonism : clinicopathologic study of three cases
003520 P. Limousin [France] ; Pierre Pollak [France] ; ABDELHAMID BENAZZOUZ [France] ; D. Hoffmann [France] ; E. Broussolle [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France]Bilateral subthalamic nucleus stimulation for severe Parkinson's disease
003521 O. Suchowersky [Canada] ; S. Furtado ; G. RohsBeneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease
003522 G. Northoff [Allemagne] ; J. Wenke ; W. Krill ; B. PflugBall experiments in 32 acute akinetic catatonic patients : deficits of internal initiation and generation of movements
003523 G. W. Rebok [États-Unis] ; F. W. Bylsma ; P. M. Keyl ; J. Brandt ; S. E. FolsteinAutomobile driving in Huntington's disease
003524 N. J. Scolding [Royaume-Uni] ; S. M. Smith [Royaume-Uni] ; S. Sturman ; G. B. Brookes [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Auctioneer's jaw : a case of occupational oromandibular hemidystonia
003525 R. Sprengelmeyer [Allemagne] ; A. G. M. Canavan ; H. W. Lange ; V. HömbergAssociative learning in degenerative neostriatal disorders : contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases
003526 S. Kuwabara [Japon] ; T. Fukutake ; N. Kasahata ; Y. Shimoe ; I. Yamanaka ; K. HirayamaAssociated movement as a sequel to thoracotomy : aberrant regeneration to the latissimus dorsi muscle
003527 S. T. Gancher [États-Unis] ; J. G. Nutt [États-Unis] ; W. R. WoodwardApomorphine infusional therapy in Parkinson's disease : clinical utility and lack of tolerance
003529 WASEEM ASHRAF [États-Unis] ; Z. K. Wszolek ; R. F. Pfeiffer ; M. Normand ; K. Maurer ; F. Srb [États-Unis] ; L. L. Edwards ; E. M. M. Quigley [États-Unis]Anorectal function in fluctuating (on-off) Parkinson's disease : evaluation by combined anorectal manometry and electromyography
003530 M. T. Dotti [Italie] ; A. FedericoAmiodarone-induced Parkinsonism : a case report and pathogenetic discussion
003531 C. H. Stuppaeck [Autriche] ; C. H. Miller [Autriche] ; H. Ehrmann [Autriche] ; W. W. Fleischhacker [Autriche] ; S. Felber ; Werner Poewe [Autriche]Akathisia induced by necrosis of the basal ganglia after carbon monoxide intoxication
003532 A. Priori [Italie] ; L. Bertolasi ; A. Berardelli ; M. ManfrediActe dystonic reaction to ectasy
003533 A. Hufschmidt [Allemagne] ; C.-H. LückingAbnormalities of tracking behavior in Parkinson's disease
003534 Olivier Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France]Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease
003535 C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. GarnettA probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain
003536 A. Ishikawa [Japon] ; T. MiyatakeA family with hereditary juvenile dystonia-parkinsonism
003537 T. Klockgether [Allemagne] ; M. Borutta ; H. Rapp ; S. Spieker ; J. DichgansA defect of kinesthesia in Parkinson's disease
003538 G. Glosser [États-Unis] ; C. Clark ; B. Freundlich ; L. Kliner-Krenzel ; P. Flaherty ; M. SternA controlled investigation of current and premorbid personality : characteristics of Parkinson's disease patients
003539 G. K. Wenning [Royaume-Uni] ; M. T. O'Connell ; P. N. Patsalos ; N. P. QuinnA clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease
003540 A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine
003542 N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France]"Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study
003543 C. Pacchetti [Italie] ; G. Albani ; E. Martignoni ; L. Godi ; E. Alfonsi ; G. Nappi"Off" painful dystonia in Parkinson's disease treated with botulinum toxin
003544
003545
003546
003547 G. K. Wenning [Royaume-Uni] ; N. Quinn ; M. Magalhaes ; C. Mathias ; S. E. Daniel«Minimal change» multiple system atrophy
003548 A. E. Lang [Canada]Withdrawal akathisia: case reports and a proposed classification of chronic akathisia
003549 J. Wojcieszek [Canada] ; A. E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; P. Greene ; J. DeckWhat is it? Case 1, 1994: rapidly progressive aphasia, apraxia, dementia, myoclonus, and Parkinsonism
003550 B. A. Haug [Allemagne] ; C. Trenkwalder [Allemagne] ; G. B. Arden ; W. H. Oertel ; W. PaulusVisual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease
003551 T. Klockgether [Allemagne] ; J. DichgansVisual control of arm movement in Parkinson's disease
003552 K. P. Bhatia [Royaume-Uni] ; G. Lera [Royaume-Uni] ; P. J. Luthert ; C. D. Marsden [Royaume-Uni]Vascular chorea: case report with pathology
003553 S. Micheli [Argentine] ; M. Fernandez-Pardal ; P. Quesada ; T. Brannan ; J. A. ObesoVariable onset of adult inherited focal dystonia: a problem for genetic studies
003554 C. G. Goetz [États-Unis] ; G. T. Stebbins ; H. M. Shale ; A. E. Lang ; D. A. Chernik ; T. A. Xhmura ; J. E. Ahlskog ; E. E. DorflingerUtility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment
003555 G. Pavesi [Italie] ; D. Medici [Italie] ; G. M. Macaluso ; P. Ventura [Italie] ; I. Allegri [Italie] ; F. Gemignani [Italie]Unusual synkinetic movements between facial muscles and respiration in hemifacial spasm
003556 J. N. Caviness [Royaume-Uni] ; A. Gabellini ; C. S. Kneebone ; P. D. Thompson ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenUnusual focal dyskinesias: the ears, the shoulders, the back, and the abdomen
003557 P. Martinez-Martin [Espagne] ; A. Gil-Nagel [Espagne] ; L. Morlan Gracia [Espagne] ; J. Balseiro Gomez [Espagne] ; J. Martinez-Sarries [Espagne] ; F. BermejoUnified Parkinson's disease rating scale characteristics and structure
003558 V. Plante-Bordeneuve [Royaume-Uni] ; M. B. Davis ; D. M. Maraganore ; C. D. Marsden ; A. E. HardingTyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease
003559 J. M. Trugman [États-Unis] ; R. Leadbetter ; M. E. Zalis ; R. O. Burgdorf ; G. F. Wooten [États-Unis]Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis
003560 D. Dressler [Royaume-Uni] ; P. D. Thompson ; R. F. Gledhill [Royaume-Uni] ; C. D. MarsdenThe syndrome of painful legs and moving toes
003561 E. Beghi [Italie] ; M. L. Monticelli [Italie] ; A. Sessa ; P. SimoneThe prevalence of Parkinsonism in Italy: an epidemiological survey of the disease in general practice
003562 J. O. Rinne [Royaume-Uni] ; S. E. Daniel ; F. Scaravilli ; M. Pires ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The neuropathological features of neuroacanthocytosis
003563 R. J. Elble [États-Unis] ; C. Moody ; K. Leffler ; RAJ SINHAThe initiation of normal walking
003565 F. O. Walker [États-Unis] ; J. R. AbsherThe clinton effect and hemiballism
003566 K. Nakashima [Japon] ; M. Shimoda ; N. Kuno ; K. TakahashiTemporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease
003568 T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. GrimesSymptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride
003569 G. Deuschl [États-Unis] ; C. Toro ; M. HallettSymptomatic and essential palatal tremor. II: Differences of palatal movements
003570 J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. SchuhSuppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction
003571 Y. River [Israël] ; S. Honigman ; J. M. Gomori ; A. RechesSuperficial hemosiderosis of the central nervous system
003572 V. M. S. De Bruin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases
003574 I. Kono [Japon] ; Y. Ueda [Japon] ; K. Araki [Japon] ; K. Nakajima [Japon] ; H. ShibasakiSpinal myoclonus resembling Belly dance
003575 R. Mayeux [États-Unis] ; MING-XIN TANG [États-Unis] ; K. Marder [États-Unis] ; L. J. Cote ; Y. Stern [États-Unis]Smoking and Parkinson's disease
003576 T. R. Jr Zimmerman [États-Unis] ; J. I. Sage ; A. E. Lang ; M. H. MarkSevere evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment
003577 E. C. Lauterbach [États-Unis]Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease
003578 H. Reichmann [Allemagne] ; M. Naumann ; S. Hauck ; B. JanetzkyRespiratory chain and mitochondrial deoxyribonucleic acid in blood cells from patients with focal and generalized dystonia
003579 M. Richards [États-Unis] ; K. Marder [États-Unis] ; L. Cote ; R. Mayeux [États-Unis]Reliability of symptom onset assessment in Parkinson's disease
003580 G. Defazio [Italie] ; V. Lepore [Italie] ; G. Abbruzzese ; E. Barontini ; A. Berardelli ; T. Caraceni ; F. Carella ; P. Girlanda ; M. Manfredi ; C. Messina ; S. Maurri ; E. Ferrari [Italie] ; P. Livrea [Italie]Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia : a multicenter study
003581 J. J. Van Hilten [Pays-Bas] ; A. D. Van Der Zwan [Pays-Bas] ; A. H. Zwinderman ; R. A. C. Roos [Pays-Bas]Rating impairment and disability in Parkinson's Disease: evaluation of the Unified Parkinson's Disease rating Scale
003582 R. K. Mosewich [Canada] ; A. H. Rajput [Canada] ; A. Shuaib [Canada] ; B. Rozdilsky ; L. AngPulmonary embolism: an under-recognized yet frequent cause of death in Parkinsonism
003583 P. Brown [Royaume-Uni] ; J. C. Rothwell ; P. D. Thompson ; C. D. MarsdenPropriospinal myoclonus: evidence for spinal pattern generators in humans
003584 N. Biary [Arabie saoudite] ; B. Singh ; Y. Bahou ; S. M. Al Deeb ; H. SharifPosttraumatic paroxysmal nocturnal hemidystonia
003585 M. P. Caligiuri [États-Unis]Portable device for quantifying parkinsonian wrist rigidity
003586 J. Hermsdörfer [Allemagne] ; K. Wessel ; N. Mai [Allemagne] ; C. Marquardt [Allemagne]Perturbation of precision grip in Friedreich's ataxia and late-onset cerebellar ataxia
003587 M. Scarpa [Italie] ; U. CastielloPerturbation of a prehension movement in Parkinson's disease
003588 G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. MoscarelliPergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study
003589 A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; J. M. Palomares ; F. Coria ; L. E. ClaveriaParkinsonism and tardive dyskinesia after chronic use of clebopride
003590 T. Curran [Canada] ; A. E. LangParkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses
003591 A. T. M. Hageman [Pays-Bas] ; M. W. I. M. HorstinkParkinson due to a subdural hematoma
003593 M. S. Lee [Corée du Sud] ; C. D. MarsdenNeurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings
003594 Olivier Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. RascolNaltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease
003596 M. S. Lee [Royaume-Uni] ; C. D. MarsdenMovement disorders following lesions of the thalamus or subthalamic region
003597 R. J. Labutta [États-Unis] ; R. B. Miles [États-Unis] ; J. N. Sanes ; M. Hallett [États-Unis]Motor program memory storage in Parkinson's disease patients tested with a delayed response task
003598 L. V. Metman [États-Unis] ; V. H. Sethy ; J. R. Roberts ; D. Bravi ; J. I. Hoff ; M. M. Mouradian ; T. N. ChaseMotor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (Preclamol) in Parkinson's disease
003599 J. M. Olive [Espagne] ; L. Masana ; J. GonzalezMeperidine and reversible parkinsonism
003600 M. Merello [Argentine] ; H. Garcia ; M. Nogues ; R. LeiguardaMasticatory muscle spasms in a non-japanese patient with satoyoshi syndrome successfully treated with botulinum toxin
003601 D. Tarsy [États-Unis] ; L. Sudarsky ; M. E. CharnessLimb dystonia following electrical injury
003602 R. Marconi [France] ; D. Lefebvre-Caparros ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] ; Yves Agid [France]Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
003603 S. S. Rich [États-Unis] ; F. OvsiewLeuprolide acetate for exhibitionism in Huntington's disease
003604 J. A. P. Hiel [Pays-Bas] ; C. M. R. Weemaes ; D. F. C. M. Smeets ; C. J. W. Van De Vlasakker ; M. W. I. M. Horstink [Pays-Bas]Late-onset telangiectasia in two brothers presenting with juvenile resting tremor
003605 C. Singer [États-Unis] ; B. A. Green ; J. H. Bruce ; B. C. Woben ; W. J. Weiner [États-Unis]Late presentation of congenital muscular torticollis: use of MR imaging and CT scan in diagnosis
003606 G. K. Wenning [Royaume-Uni] ; R. J Ger [Royaume-Uni] ; B. Kendall ; D. Kingsley [Royaume-Uni] ; S. E. Daniel ; N. P. Quinn [Royaume-Uni]Is cranial computerized tomography useful in the diagnosis of multiple system atrophy?
003607 M. Richards [États-Unis] ; K. Marder ; L. Cote ; R. MayeuxInterrater reliability of the Unified Parkinson's Disease Rating Scale motor examination
003609 D. T. Dexter [Royaume-Uni] ; A. E. Holley ; W. D. Flitter ; T. F. Slater ; F. R. Wells ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. MarsdenIncreated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study
003611 G. S. Hotamisligil [États-Unis] ; A. S. Girmen [États-Unis] ; J. S. Fink [États-Unis] ; E. Tivol [États-Unis] ; C. Shalish [États-Unis] ; J. Trofatter [États-Unis] ; J. Baenziger ; S. Diamond ; C. Markham ; J. Sullivan ; J. Growdon [États-Unis] ; X. O. Breakefield [États-Unis]Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
003612 F. Tison ; C. Coutelle [France] ; P. Henry [France] ; A. CassaigneGlutathion S-transferase (class μ) phenotype in Parkinson's disease
003613 C. Singer [États-Unis] ; J. Sanchez-Ramos ; W. J. WeinerGait abnormality in essential tremor
003614 L. Verhagen Metman [États-Unis] ; J. Hoff ; M. M. Mouradian ; T. N. ChaseFluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa
003615 P. Nisipeanu [Israël] ; A. Kuritzky ; A. D. Korczyn [Israël]Familial levodopa-responsive parkinsonian-pyramidal syndrome
003616 F. Micheli [Argentine] ; M. C. Scorticati ; E. Gatto ; G. Cersosimo ; J. AdiFamilial hemifacial spasm
003617 R. J. Elble [États-Unis] ; C. Higgins ; K. Leffler ; L. HughesFactors influencing the amplitude and frequency of essential tremor
003618 JAU-SHIN LOU [États-Unis] ; J. Valls-Sole ; C. Toro ; M. HallettFacial action myoclonus in patients with olivopontocerebellar atrophy
003619 F. Carella [Italie] ; C. Ciano ; M. Musicco ; V. ScaioliExteroceptive reflexes in dystonia: a study of the recovery cycle of the R2 component of the blink reflex and of exteroceptive suppression of the contracting sternocleidomastoid muscle in blepharospasm and torticollis
003620 S. B. Bressman [États-Unis] ; A. L. Hunt [États-Unis] ; G. A. Heiman [États-Unis] ; M. F. Brin [États-Unis] ; R. E. Burke [États-Unis] ; S. Fahn [États-Unis] ; J. M. Trugman ; D. De Leon [États-Unis] ; P. L. Kramer ; K. C. Wilhelmsen [États-Unis] ; T. G. NygaardExclusion of the DYT1 mocus in a non-jewish family with early-onset dystonia
003621 A. H. V. Schapira [Royaume-Uni]Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal
003622 A. Priori [Italie] ; A. Berardelli ; M. Inghilleri ; L. Polidori ; M. ManfrediElectromyographic silent period after transcranial brain stimulation in Huntington's disease
003623 K. B. Polo [États-Unis] ; BAHMAN JABBARIEffectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin
003624 U. B. Muthane [Inde] ; H. S. Swamy [Inde] ; P. Satishchandra [Inde] ; M. N. Subhash ; S. Rao ; D. SubbakrishnaEarly onset Parkinson's disease: are juvenile- and young-onset different?
003627 M. Kyllerman [Suède] ; O. H. Skjeldal ; M. Lundberg ; I. Holme ; E. Jellum ; U. Von Döbeln ; A. Fossen ; G. CarlssonDystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations
003628 P. Greene [États-Unis] ; S. Fahn [États-Unis] ; B. DiamondDevelopment of resistance to botulinum toxin type A in patients with torticollis
003629 P. D. Thompson [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; P. Brown [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. Pires ; N. P. Quinn [Royaume-Uni] ; P. Luthert ; M. Honovar ; M. D. P'Brien ; C. D. Marsden [Royaume-Uni] ; A. E. Harding [Royaume-Uni]Cortical myoclonus in Huntington's disease
003631 J. H. Friedman [États-Unis]Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases
003632 M. Aramideh [Pays-Bas] ; B. W. Ongerboer De Visser [Pays-Bas] ; J. H. T. M. Koelman [Pays-Bas] ; L. J. Bour [Pays-Bas] ; P. P. Devriese ; J. D. SpeelmanClinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure
003634 J. G. Phillips [Australie] ; J. L. Bradshaw ; E. Chiu ; J. A. BradshawCharacteristics of handwriting of patients with Huntington's disease
003635 C. H. Adler [États-Unis] ; L. Wrabetz ; M. F. Brin ; H. I. Hurtig [États-Unis]Cerebellar ataxia, dystonia, and tremor within a family: variable phenotypes of a single genetic disorder?
003636 M. F. Gordon [États-Unis] ; W. J. Weiner ; W. C. Koller ; T. H. Rao [États-Unis] ; V. Chehebar [États-Unis] ; D. W. DisksonCase 2, 1994 : parkinsonism and cognitive impairment
003637 Joseph Jankovic [États-Unis]Botulinum toxin in the treatment of dystonic tics
003638 R. M. Trosch [États-Unis] ; S. L. PullmanBotulinum toxin A injections for the treatment of hand tremors
003639 J. Kulisevsky [Espagne] ; M. Lima De Freitas ; L. Barraquer-BordasBilateral akinesia in drug-induced parkinsonism after a subthalamic lesion
003640 D. Caparros-Lefebvre [France] ; J. F. Deleume ; N. Bradai ; H. PetitBiballism caused by bilateral infarction in the substantia nigra
003641 T. T. Warner [Royaume-Uni] ; G. G. Lennox ; I. Janota ; A. E. Harding [Royaume-Uni]Autosomal-dominant dentatorubropallidoluysian atrophy in the United Kingdom
003642 R. Pratap Chand [Royaume-Uni] ; D. M. ParkAtypical blepharospasm responsive to sodium valproate
003643 W. Ashraf [États-Unis] ; R. F. Pfeiffer ; E. M. M. Quigley [États-Unis]Anorectal manometry in the assessment of anorectal function in parkinson's disease : a comparison with chronic idiopathic constipation
003644 R. Agostino [Italie] ; A. Berardelli ; A. Formica ; F. Stocchi ; N. Accornero ; M. ManfrediAnalysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease
003645 C. L. Comella [États-Unis] ; C. G. GoetzAkathisia in Parkinson's disease
003646 M. F. Lew [États-Unis] ; M. Shindo ; C. B. Moskowitz ; K. C. Wilhelmsen ; S. Fahn ; C. H. Waters [États-Unis]Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome)
003647 L. Mazzini [Italie] ; M. Zaccala ; C. BalzariniAbnormalities of somatosensory evoked potentials in spasmodic torticollis
003648 C. W. Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J. D. Grimes ; Joseph Jankovic [États-Unis] ; M. Hoehn ; C. H. Markham ; R. Duvoisin ; O. Reinmuth ; H. A. Leonard ; E. Ahlskog ; R. Feldman ; L. Hershey ; M. D. YahrA multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease
003649 C. Hertzman [Canada] ; M. Wiens ; B. Snow ; S. Kelly ; D. CalneA case-control study of Parkinson's disease in a horticultural region of British Columbia
003650 P. Krack [Allemagne] ; M. H. Marion"apraxia of lid opening," a focal eyelid dystonia : clinical study of 32 patients
003651
003652
003653
003654
003655 R. A. Hauser [États-Unis] ; C. W. Olanoworobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease
003656 Joseph Jankovic [États-Unis] ; A. H. Rajput [États-Unis] ; L. I. Golbe [États-Unis] ; J. C. GoodmanWhat is it? Case 1. 1993: Parkinsonism, dysautonomia, and ophthalmoparesis
003657 U. B. Muthane [Inde] ; P. Satishchandra [Inde] ; M. N. SubhashVisual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites
003658 P. E. Greene [États-Unis] ; S. FahnUse of botulinum toxin Type F injections to treat torticollis in patients with immunity to Botulinum toxin Type A
003659 M. De Mari [Italie] ; R. De Blasi ; P. Lamberti ; A. Carella ; E. FerrariUnilateral pallidal lesion after acute disulfiram intoxication: a clinical and magnetic resonance study
003660 J. Kulisevsky [Espagne] ; A. Avila ; C. Roig ; A. EscartinUnilateral blepharospasm stemming from a thalamomesencephalic lesion
003661 A. Ferbert [Allemagne] ; M. GerwigTremor due to stroke
003662 D. Bravi [États-Unis] ; T. L. Davis ; M. M. Mouradian ; T. N. ChaseTreatment of Parkinson's disease with the partial dopamine agonist EMD 49980
003663 C. G. Garner [Allemagne] ; A. Straube ; T. N. Witt ; T. Gasser ; W. H. OertelTime course of distant effects of local injections of botulinum toxin
003664 M. F. Gordon [États-Unis] ; R. Diaz-Olivo ; A. L. Hunt ; S. FahnTherapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders
003665 P. R. Atchison [Royaume-Uni] ; P. D. Thomson [Royaume-Uni] ; R. S. J. Frackowiak ; C. D. Marsden [Royaume-Uni]The syndrome of gait ignition failure: a report of six cases
003666 J. Guridi [Espagne] ; M. R. Luquin ; M. T. Herrero ; J. A. ObesoThe subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease
003667 M. B. H. Youdim [Israël] ; P. RiedererThe relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease
003668 M. B. H. Youdim [Israël] ; D. Ben-Shachar [Israël] ; P. RiedererThe possible role of iron in the etiopathology of Parkinson's disease
003670 G. V. Sawle [Royaume-Uni]The detection of preclinical Parkinson's disease: what is the role of positron emission tomography?
003672 C. Pacchetti [Italie] ; E. Martignoni [Italie] ; P. Bruggi [Italie] ; L. Godi [Italie] ; B. Aufdembrinke ; C. Miltenburger ; B. Voet ; G. Nappi [Italie]Terguride in fluctuating Parkinsonian patients: a double-blind study versus placebo
003673 P. Sachdev [Australie]Tardive and chronically recurrent oculogyric crises
003674 H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France]Symptomatic effect of selegiline in De Novo Parkinsonian patients
003675 SHUU JIUN WANG [Taïwan] ; JONG LING FUH ; D. E. Shan ; KWONG KUM LIAO ; KON PING LIN ; CHING PIAO TSAI ; ZIN AN WUSympathetic skin response and R-R interval variation in Parkinson's disease
003677 A. J. Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. SternSubcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years
003678 K. Kaneko [Japon] ; T. Yuasa [Japon] ; T. Miyatake ; S. Tsuji [Japon]Stereotyped hand clasping: an unusual tardive movement disorder
003679 W. Klostermann [Allemagne] ; P. Vieregge ; D. KömpfSpasmodic torticollis in multiple sclerosis: significance of an upper cervical spinal cord lesion
003680 B. Johnels [Suède] ; P. E. Ingvarsson [Suède] ; B. Holmberg ; M. Matousek [Suède] ; G. Steg [Suède]Single-dose L-dopa response in early parkinson's disease : measurements with optoelectronic recording technique
003682 V. V. Myllyl [Finlande] ; K. A. Sotaniemi ; J. A. Vuorinen ; E. H. HeinonenSelegiline in De Novo Parkinsonian patients: the finnish study
003683 W. G. Tatton [Canada]Selegiline can mediate neuronal rescue rather than neuronal protection
003684 S. Goldman [Belgique] ; D. Amrom ; H. B. Szliwowski ; D. Detemmerman ; S. Goldman ; L. M. Bidaut [Belgique] ; E. Stanus [Belgique] ; A. Luxen [Belgique]Reversible striatal hypermetabolism in a case of Sydenham's chorea
003686 E. Broussolle [France] ; L. Cinotti [France] ; Pierre Pollak [France] ; P. Landais [France] ; D. Le Bars [France] ; G. Galy [France] ; F. Lavenne [France] ; Y. Khalfallah ; G. Chazot [France] ; F. Mauguiere [France]Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease
003687 M. A. Hely [Australie] ; T. Chey [Australie] ; A. Wilson ; P. M. Williamson ; D. J. O'Sullivan ; D. Rail ; J. G. L. Morris [Australie]Reliability of the Columbia scale for assessing signs of Parkinson's disease
003688 F. Ishizaki [Japon] ; T. Harada ; S. Katayama ; H. Abe ; S. NakamuraRelationship between osteopenia and clinical characteristics of Parkinson's disease
003689 R. Larumbe [Espagne] ; J. Vaamonde ; J. Artieda ; J. L. Zubieta ; J. A. ObesoReflex blepharospasm associated with bilateral basal ganglia lesion
003690 A. Mazzucchi [Italie] ; E. Sinforiani ; L. Ludovico [Italie] ; M. Turla ; C. Pacchetti ; R. Brianti [Italie] ; M. Parma [Italie] ; G. NappiReaction time responses in Parkinsonian and Hemiparkinsonian patients
003691 D. Dykstra [États-Unis] ; C. Ellingham ; A. Belfie ; T. Baxter ; M. Lee ; A. VoelkerQuantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin
003692 R. E. A. Van Emmerik [Pays-Bas] ; R. L. Sprague ; K. M. NewellQuantification of postural sway patterns in tardive dyskinesia
003693 M. M. Schugens [Allemagne] ; I. Daum ; S. Richter ; E. Scholz ; A. G. M. CanavanProximal and distal reaction times (RTs) are not differentially affected in Parkinson's disease
003694 A. Achiron [Israël] ; I. Ziv ; M. Goren ; H. Goldberg ; Y. Zoldan ; H. Sroka ; E. MelamedPrimary progressive freezing gait
003695 J. Huttunen [Finlande] ; H. Ter V InenPre- and postcentral cortical somatosensory evoked potentials in hemiparkinsonism
003696 A. Feve [France] ; B. Angelard [France] ; G. Fenelon [France] ; M. Logak [France] ; A. Guillard [France] ; J. Lacau Saint-GuilyPostneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin
003697 M. B. Harrison [États-Unis] ; G. R. Lyons ; E. R. LandowPhenytoin and dyskinesias : a report of two cases and review of the literature
003698 F. Javier Jimenez-Jimenez [Espagne] ; F. Cabrera-Valdivia ; L. Ayuso-Peralta ; J. Tejeiro ; A. Vaquero ; E. Garcia-AlbeaPersistent parkinsonism and tardive dyskinesia induced by clebopride
003699 P. A. Lewitt [États-Unis] ; A. Walters ; W. Hening ; D. MchalePersistent movement disorders induced by buspirone
003700 A. Lagueny [France] ; E. Ellie ; P. Burbaud ; P. Le Collen ; P. DeliacParoxysmal stimulus-sensitive spasmodic torticollis
003701 B. A. Rybicki [États-Unis] ; C. Cole Johnson [États-Unis] ; J. Uman [États-Unis] ; J. M. GorellParkinson's disease mortality and the industrial use of heavy metals in Michigan
003703 J. O. Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. Nagren ; J. Bergman ; U. RuotsalainenPET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease
003704 M. S. Sandy [États-Unis] ; J. W. Langston [États-Unis] ; M. T. Smith ; D. A. Di Monte [États-Unis]PCR analysis of platelet mtDNA : lack of specific changes in parkinson's disease
003705 K. Bhatia [Royaume-Uni] ; S. E. Daniel ; C. D. MarsdenOrofacial dystonia and rest tremor in a patient with normal brain pathology
003706 G. Linazasoro [Espagne] ; J. F. Marti Masso ; J. A. SuarezNocturnal akathisia in Parkinson's disease: treatment with clozapine
003707 J. O. Rinne [Finlande]Nigral degeneration in Parkinson's disease
003709 S. E. Starkstein [Argentine] ; R. LeiguardaNeuropsychological correlates of brain atrophy in parkinson's disease : a CT-scan study
003710 C. H. Waters [États-Unis] ; P. L. Faust ; J. Powers ; H. Vinters ; C. Moskowitz ; T. Nygaard ; A. L. Hunt ; S. FahnNeuropathology of lubag (X-linked dystonia parkinsonism)
003711 A. Ferbert [Allemagne] ; R. Biniek [Allemagne] ; J. Kindler ; N. MaurinMyoclonus and tremor induced acutely by administration of tumor necrosis factor in a patient with Ehlers-Danlos syndrome
003712 A. Nath [Canada] ; D. E. Hobson [Canada] ; A. RussellMovement disorders with cerebral toxoplasmosis and AIDS
003713 G. J. Gomez Arevalo [Argentine] ; O. S. GershanikModulator effect of clozapine on levodopa response in Parkinson's disease: a preliminary study
003714 M. E. Giuffra [États-Unis] ; V. H. Sethy ; T. L. Davis ; M. M. Mouradian ; T. N. ChaseMilacemide therapy for Parkinson's disease
003715 R. Nakamura [Japon] ; K. Kamakura [Japon] ; Y. Tadano [Japon] ; Y. Hosoda [Japon] ; N. Nagata [Japon] ; K. Tsuchiya ; M. Iwata ; H. ShibasakiMR imaging findings of tremors associated with lesions in cerebellar outflow tracts: report of two cases
003716 D. Conway [Royaume-Uni] ; P. G. Bain ; T. T. Warner ; M. B. Davis ; L. J. Findley ; P. D. Thompson ; C. D. Marsden ; A. E. HardingLinkage analysis with chromosome 9 markers in hereditary essential tremor
003717 H. P. H. Kremer [Pays-Bas] ; G. T. A. M. BotsLewy bodies in the lateral hypothalamus: do they imply neuronal loss ?
003718 J. Vaamonde [Suède] ; I. Legarda [Suède] ; J. Jimenez-Jimenez ; J. L. Zubieta [Suède] ; J. A. Obeso [Suède]Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism
003719 JONG SUNG KIM [Corée du Sud] ; MYOUNG CHONG LEELeg tremor mimicking orthostatic tremor as an initial manifestation of Parkinson's disease
003720 R. Inzelberg [Israël] ; N. Zilber ; E. Kahana ; A. D. Korczyn [Israël]Laterality of onset in idiopathic torsion dystonia
003721 M. Merello [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; R. Leiguarda [Royaume-Uni] ; J. Guevara [Royaume-Uni] ; M. Nogues [Royaume-Uni]Inverse masticatory muscle activity due to syringobulbia
003722 J. P. Hubble [États-Unis] ; R. Pahwa [États-Unis] ; D. K. Michalek [États-Unis] ; C. Thomas ; W. C. Koller [États-Unis]Interactive video conferencing: a means of providing interim care to Parkinson's disease patients
003723 W. S. Metzer [États-Unis] ; S. R. Paige ; J. E. O. NewtonInefficacy of propranolol in attenuation of drug-induced parkinsonian tremor
003724 A. Weindl [Allemagne] ; T. Kuwert ; K. L. Leenders ; M. Poremba [Allemagne] ; H. Gr Fin ; H. Von Einsiedel ; A. Antonini ; H. Herzog ; D. Scholz [Allemagne] ; L. E. Feinendegen ; B. ConradIncreased striatal glucose consumption in Sydenham's chorea
003725 V. Leuzzi [Italie] ; V. Ricciotti ; A. PellicciaHemiplegic dystonia associated with regional cortical dysplasia (Pachygyria)
003727 A. Danek [Allemagne]Geniospasm: hereditary chin trembling
003728 L. Edwards [États-Unis] ; E. M. M. Quigley ; R. Hofman [États-Unis] ; R. F. Pfeiffer [États-Unis]Gastrointestinal symptoms in parkinson disease : 18-month follow-up study
003729 V. S. Kostic [Serbie] ; Z. Marinkovic ; S. Filipovic ; D. MomcilovicFunction of dopamine receptors in young-onset Parkinson's disease: prolactin response
003730 P. Martinelli [Italie] ; S. Giuliani [Italie] ; M. Ippoliti [Italie] ; A. Martinelli ; A. Sforza [Italie] ; S. FerrariFamilial idiopathic strio-pallido-dentate calcifications with late onset extrapyramidal syndrome
003731 A. L. Burleigh [États-Unis] ; F. B. Horak [États-Unis] ; K. J. Burchiel ; J. G. NuttEffects of thalamic stimulation on tremor, balance, and step initiation: a single subject study
003732 P. Brown [Royaume-Uni] ; M. J. Steiger [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; M. Salama ; T. Waegemans ; C. D. Marsden [Royaume-Uni]Effectiveness of piracetam in cortical myoclonus
003734 P. Lamberti [Italie] ; M. De Mari ; G. Iliceto ; M. Caldarola ; L. SerlengaEffect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia
003735 S. A. Factor [États-Unis] ; W. J. WeinerEarly combination therapy with bromocriptine and levodopa in Parkinson's disease
003736 P. G. Strange [Royaume-Uni]Dopamine receptors in the basal ganglia: relevance to Parkinson's disease
003737 J. G. Nutt [États-Unis] ; J. H. Carter ; W. Woodward ; J. P. Hammerstad ; S. T. GancherDoes tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions
003738 S. Sveinbjornsdottir [Danemark] ; H. Pakkenberg ; L. WerdelinDevelopmental stuttering followed by intermittent jaw opening dystonia
003739 L. Schelosky [Allemagne] ; J. Hierholzer ; J. Wissel ; M. Cordes ; Werner Poewe [Autriche]Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT
003740 T. Kuwert [Allemagne] ; J. Noth ; D. Scholz [Allemagne] ; M. Schwarz ; H. W. Lange ; R. Töpper ; H. Herzog [Allemagne] ; A. Aulich ; L. E. Feinendegen [Allemagne]Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease
003741 F. E. C. Cardoso [États-Unis] ; Joseph Jankovic [États-Unis]Cocaine-related movement disorders
003742 W. H. Jost [Allemagne] ; K. SchimrigkCisapride treatment of constipation in Parkinson's disease
003743 K. Nakashima [Japon] ; K. Takahashi [Japon] ; M. OtaCessation of writer's cramp after stroke
003744 B. Wild [Allemagne] ; J. DichgansCerebellar ataxia in ataxis hemiparesis ? A kinematic and EMG analysis
003745 S. Przedborski [Belgique] ; S. Goldman ; M. Levivier ; N. Giladi ; L. M. Bidaut ; J. Hildebrand [Belgique] ; E. Stanus ; D. Labar ; A. LuxenBrain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome
003746 G. Pauletti [Italie] ; A. Berardelli ; G. Cruccu ; R. Agostino ; M. ManfrediBlink reflex and the masseter inhibitory reflex in patients with dystonia
003748 E. S. Molho [États-Unis] ; S. A. FactorBasal ganglia infarction as a possible cuase of cervical dystonia
003749 A. P. Feve [France] ; G. Fenelon ; C. Wallays ; P. Remy ; A. GuillardAxial motor disturbances after hypoxic lesions of the globus pallidus
003750 J. H. Friedman [États-Unis] ; A. WeitbergAtaxia without telangiectasia
003751 J. L. Saver [États-Unis] ; P. Greenstein ; M. Ronthal ; M.-M. MesulamAsymmetric catalepsy after right hemisphere stroke
003752 F. W. Bylsma [États-Unis] ; J. Rothlind ; M. R. Hall ; S. E. Folstein ; J. BrandtAssessment of adaptive functioning in Huntington's disease
003753 B. Pardo [États-Unis] ; M. A. Mena [États-Unis] ; S. Fahn ; J. Garcia De YebenesAscorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line
003754 U. Bonuccelli [Italie] ; P. Piccini [Italie] ; P. Del Dotto [Italie] ; G. Rossi ; G. U. Corsini ; A. Muratorio [Italie]Apomorphine test for dopaminergic responsiveness: a dose assessment study
003755 E. R. Siemers [États-Unis] ; A. Shekhar ; K. Quaid ; H. DicksonAnxiety and motor performance in Parkinson's disease
003758 R. J. Uitti [États-Unis] ; D. M. MaraganoreAdult onset familial cervical dystonia: report of a family including monozygotic twins
003760 M. V. Solbrig [États-Unis] ; L. NashefAcute parkinsonism in suspected herpes simplex encephalitis
003761 M. Vidailhet [France] ; C. Bouchard [France] ; P. J. Jedynak [France] ; M. Serdaru [France]Acute and long-term response to apomorphine in cranial dystonia
003762 S. A. Factor [États-Unis]Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease
003763 C. W. Olanow [États-Unis]A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease
003764 M. S. Lee [Corée du Sud] ; S. A. Lee ; J. H. Heo ; I. S. ChoiA patient with a resting tremor and a lacunar infarction at the border between the thalamus and the internal capsule
003765 F. Sellal [France] ; E. Hirsch [France] ; P. Barth [France] ; S. Blond [France] ; C. Marescaux [France]A case of symptomatic hemidystonia improved by ventroposterolateral thalamic electrostimulation
003766 G. Broggi [Italie] ; S. Brock ; A. Franizini ; G. GeminianiA case of posttraumatic tremor treated by chronic stimulation of the thalamus
003767
003768
003769 Andrew Lees (neurologue) [Royaume-Uni]When did Ray Kennedy's Parkinson's disease begin?
003770 P. D. Thompson [Royaume-Uni] ; J. G. Colebatch ; P. Brown ; J. C. Rothwell ; B. L. Day ; J. A. Obeso ; C. D. MarsdenVoluntary stimulus-sensitive jerks and jumps mimiching myoclonus or pathological startle syndromes
003771 N. L. Mcnair [États-Unis] ; K. J. MeadorThe undulating toe flexion sign in brain death
003772 H.-C. Diener [Allemagne] ; J. Dichgans ; B. Guschlbauer ; M. Bacher ; H. Rapp ; T. KlockgetherThe coordination of posture and voluntary movement in patients with cerebellar dysfunction
003773 W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Temporary deterioration in Parkinsonian signs after modest alcohol intake
003774 M. Stacy [États-Unis] ; Joseph Jankovic [États-Unis]Tardive tremor
003775 P. C. G. Nijssen [Pays-Bas] ; C. C. TijssenStimulus-sensitive paroxysmal dyskinesias associated with a thalamic infarct
003776 W. R. G. Gibb [Royaume-Uni] ; L. Kilford ; C. D. MarsdenSevere generalised dystonia associated with a mosaic pattern of striatal gliosis
003778 J. H. Friedman [États-Unis]Rubral' tremor induced by a neuroleptic drug
003781 F. Javier Jimenez-Jimenez [Espagne] ; E. Garcia-Albea ; J. A. Vaquero-Ruiperez ; J. Tejeiro ; F. Cabrera-Valdivia ; L. Ayuso-PeraltaReading as a trick for relieving blepharospasm
003783 F. J. Jimenez-Jimenez [Espagne] ; D. Mateo ; S. Gimenez-RoldanPremorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study
003784 R. S. C. Alves [Brésil] ; E. R. Barbosa ; M. ScaffPostvaccinal parkinsonism
003785 A. Albanese [Italie] ; A. Daniele ; M. Lo Monaco ; V. Di Lazzaro ; D. Restuccia ; M. Milone ; P. TonaliPostural axial tremor in a patient with cerebellar atrophy
003786 B. Jabbari [États-Unis] ; J. Paul ; B. Scherokman ; B. Van DamPosttraumatic segmental axial dystonia
003787 L. G. Miller [États-Unis] ; Joseph Jankovic [États-Unis]Persistent dystonia possibly induced by flecainide
003788 F. Tison [France] ; C. Louvet-Giendaj ; P. Henry ; A. Lagueny [France] ; E. GaujardPermanent Bruxism as a manifestation of the oculo-facial syndrome related to systemic Whipple's disease
003789 H.-C. Diener [Allemagne] ; J. DichgansPathophysiology of cerebellar ataxia
003790 P. Vieregge [Allemagne] ; W. Klostermann ; H. BrückmannParkinsonism in multiple sclerosis
003791 P. Montagna [Italie] ; A. S. Gabellini ; L. Monari ; E. LugaresiParkinsonian syndrome after long-term treatment with clebopride
003792 R. Djaldetti [Israël] ; I. Ziv ; A. Achiron ; E. MelamedParkinson's disease in a patient with mitochondrial myopathy: is there a causative relationship?
003793 A. S. Walters [États-Unis] ; W. A. HeningNoise-induced psychogenic tremor associated with post-traumatic stress disorder
003794 M. A. Mena [Espagne] ; B. Pardo ; M. J. Casarejos ; S. Fahn ; J. G. De YebenesNeurotoxicity of levodopa on catecholamine-rich neurons
003795 D. M. Maraganore [États-Unis] ; W. N. Folger ; J. W. Swanson ; J. E. AhlskogMovement disorders as sequelae of central pontine myelinolysis : report of three cases
003796 J. Schwarz [Allemagne] ; K. Tatsch ; T. Vogl ; C. M. Kirsch ; C. Trenkwalder ; G. Arnold ; T. Gasser ; W. H. OertelMarked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia
003797 R. N. Rosenberg [États-Unis]Machado-Joseph disease : an autosomal dominant motor system degeneration
003798 L. Sudarsky [États-Unis] ; L. Corwin ; D. M. AwsonMachado-Joseph disease in New England : clinical description and distinction from the olivopontocerebellar atrophies
003799 M. R. Luquin [Espagne] ; O. Scipioni ; J. Vaamonde ; O. Gershanik ; J. A. ObesoLevopoda-induced dyskinesias in Parkinson's disease : clinical and pharmacological classification
003800 J.-F. De Saint Victor [France] ; C.-L. GervasonLevopoda-induced diphasic dyskinesias improved by subcutaneous apomorphine
003801 M Contin [Italie] ; R. Riva ; P. Martinelli ; A. BaruzziKinetic-dynamic relationship of oral levopoda : possible biphasic response after sequential doses in Parkinson's disease
003802 J. M. Gobernado [Espagne] ; M. Galarreta ; G. De Blas ; A. Jimenez-Escrig ; A. HernandezIsolated continuous rhythmic lingual myoclonus
003803 H. Meierkord [Royaume-Uni] ; D. R. Fish ; S. J. M. Smith ; C. A. Scott ; S. D. Shorvon ; C. D. MarsdenIs nocturnal paroxysmal dystonia a form of frontal lobe epilepsy ?
003804 F. Stocchi [Italie] ; S. Ruggieri ; A. Carta ; J. Ryatt ; N. Quinn ; P. Jenner ; C. D. Marsden ; A. AgnoliIntravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease
003805 J.-A. C. Lazarus [États-Unis] ; G. E. StelmachInterlimb coordination in Parkinson's disease
003806 I. Rektor [République tchèque] ; M. Svejdova ; C. Silva-Barrat ; C. MeniniInfluence of cholinergic systems on myoclonus in myoclonic epilepsies
003807 S. Przedborski [Belgique] ; A. Liard ; J. HildebrandInduction of mania by apomorphine in a depressed Parkinsonian patient
003808 R. D. Jones [Nouvelle-Zélande] ; I. M. Donaldson ; P. L. TimmingImpairment of high-constrast visual acuity in Parkinson's disease
003809 N. Giladi [États-Unis] ; S. FahnHemiparkinsonism-hemiatrophy syndrome may mimic early-stage cortical-basal ganglionic degeneration
003810 P. Martinelli [Italie] ; S. Giuliani ; M. IppolitiHemifacial spasm due to peripheral injury of facial nerve : a nuclear syndrome?
003811 J. M. Bejar [États-Unis] ; J. Kepes ; W. C. KollerHemiballism and tremor due to ependymal cyst
003812 M. J. Steiger [Royaume-Uni] ; M. Pires ; F. Scaravilli ; N. P. Quinn ; C. D. MarsdenHemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration
003813 P. Sachdev [Australie]Golfers' cramp: clinical characteristics and evidence against it being an anxiety disorder
003814 A. Guala [Italie] ; D. Mittino ; P. Fabbrocini ; T. GhiniFamilial metoclopramide-induced dystonic reactions
003815 F. Javier Jimenez-Jimenez [Espagne] ; D. Mateo ; S. Gimenez-RoldanExposure to well water and pesticides in Parkinson's disease : a case-control study in the Madrid area
003816 E. Pourcher [Canada] ; B. Gomez-Mancilla ; P. J. BedardEthosuximide and tremor in Parkinson's disease : a pilot study
003817 L. Christenson [États-Unis] ; D. F. Emerich ; P. R. SanbergEncapsulated cell implatation for Parkinson's disease
003818 M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. LatasteEffects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease
003820 D. Bravi [États-Unis] ; J. J. Anderson ; F. Dagani ; T. L. Davis ; R. Feerari ; M. Gillespie ; T. N. ChaseEffect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease
003822 J. K. Krauss [Allemagne] ; M. Mohadjer ; D. F. Braus ; A. K. Wakhloo ; F. Nobbe ; F. MundingerDystonia followng head trauma : a report of nine patients and review of the literature
003823 C. E. Clarke [Royaume-Uni] ; J. M. Bamford ; A. HouseDyskinesia in Creutzfeldt-Jakob disease precipitated by antidepressant therapy
003824 V. M. S. De Bruin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; S. E. DanielDiffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report
003825 P. J. Morrison [Royaume-Uni] ; V. H. PattersonCranial dystonia (Meige syndrome) in postencephalitic Parkinsonism
003826 J. Blin [France] ; M.-J. Vidailhet [France] ; B. Pillon [France] ; B. Dubois [France] ; J.-R. Feve [France] ; Yves Agid [France]Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET
003827 J. Artieda [Espagne] ; J. Muruzabal ; R. Larumbe ; C. Garcia De Casasola ; J. A. ObesoCortical mechanisms mediating asterixis
003828 J. William Langston [États-Unis] ; H. Widner ; C. G. Goetz ; D. Brooks ; S. Fahn ; T. Freeman ; R. WattsCore assessment program for intracerebral transplantations (CAPIT)
003829 S. A. Factor [États-Unis] ; D. BrownClozapine prevents recurrence of psychosis in Parkinson's disease
003830 R. A. Wrigth [Nouvelle-Zélande] ; M. Pollock ; I. Mcg. DonaldsonChorea and tuberous sclerosis
003831 E. Fazzini [États-Unis] ; J. Fleming ; S. FahnCerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease
003832 A. Nieoullon [France] ; KERKERIAN-LE GOFFCellular interactions in the striatum involving neuronal systems using classical' neurotransmitters: possible functional implications
003833 B. S. Russman [États-Unis] ; A. E. Lang ; S. Fahn ; P. Greene ; M. L. GrunnetCase 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girl
003834 J. Kulisevsky [Espagne] ; J. Marti-Fabregas ; A. Escartin ; J. PradasBrachial plexus palsy associated with spasmodic torcicolis in a patient with tomaculous neuropathy
003836 J. B. M. Van De Biezenbos [Pays-Bas] ; M. W. I. M. Hortsink ; C. J. W. Van De Vlasakker ; B. G. M. Van Engelen ; O. R. Van Eikema Hommes ; F. BarkhofA case of bilateral alternating hemifacial spasms
003837
003838
003839
003840 J. Rivest ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenWriter's cramp : treatment with botulinum toxin injections
003841 F. Micheli [Argentine] ; M. Fernandez Pardal ; R. Giannaula ; S. FahnWhat it it? case 3, 1991 : moaning in a man with parkinsonian signs
003842 C. J. Vecht [Pays-Bas] ; J. D. Meerwaldt ; Andrew Lees (neurologue) [Royaume-Uni] ; D. Marsden ; S. FahnWhat is it? Case 2, 1991 : unusual tremor, myoclonus, and a limping gait
003843 A. E. Lang [Canada] ; K. D. Sethi ; J. P. Provias ; J. H. DeckWhat is it? Case 1, 1991 : a severe and fatal systemic illness first presenting with a movement disorder
003844 E. Mohr ; P. Browers ; J. J. Claus ; U. M. Mann ; P. Fedio ; T. N. ChaseVisuospatial cognition in Huntington's disease
003845 A. Berardelli ; P. D. Thompson ; M. Zaccagnini ; O. Giardini ; P. D'Eufemia ; R. Massoud ; M. MandrediTwo sisters with generalized dystonia associated with homocystinuria
003846 C. P. Jedynak ; A. M. Bonnet ; Yves Agid [France]Tremor and idiopathic dystonia
003847 I. T. Lorentz [Australie] ; S. Shanthi Subramaniam ; C. YiannikasTreatment of idiopathic spasmodic torticollis with botulinum toxin A : a double-blind study on twenty-three patients
003848 R. C. Peatfield ; B. R. BoothmanTransient myoclonus after exposure to oven cleaner
003849 S. Rittig ; J. Arentsen ; K. Soêrensen ; T. Matthiesen ; E. DupontThe hemodynamic effects of triglycyl-lysine-vasopressin (glypressin) in patients with parkinsonism and orthostatic hypotension
003850 P. Blum ; Joseph Jankovic [États-Unis]Stiff-Person syndrome : an autoimmune disease
003852 M. J. Steiger ; N. P. Quinn ; C. D. MarsdenSickness due to levodopa-induced neck dyskinesias in Parkinson's disease
003854 A. S. Walters ; W. A. Hening ; SUDHANSU CHOKROVERTYReview and videotape recognition of idiopathic restless legs syndrome
003855 E. Sasso ; E. Perucca ; R. Fava ; S. CalzettiQuantitative comparison of barbiturates in essential hand and head tremor
003856 J. S. Duncan ; P. Brown ; C. D. MarsdenProgressive myoclonus and histidinaemia
003857 E. Siemers [États-Unis] ; V. ReddyProfile of patients enrolled in a new movement disorder clinic
003858 E. Siemers [États-Unis] ; V. ReddyProfile of patients enrolled in a new movement disorder clinic
003859 S. A. Factor ; W. J. WeinerPrior history of head trauma in Parkinson's disease
003860 A. J. Hughes ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenParoxysmal dystonic head tremor
003861 P. Brown ; P. D. Thompson ; J. C. Rothwell ; B. L. Day ; C. D. MarsdenParoxysmal axial spasms of spinal origin
003862 V. P. Calabrese ; M. G. HadfieldParkinsonism and extraocular motor abnormalities with unusual neuropathological findings
003863 P. M. Fitzgerald ; Joseph Jankovic [États-Unis]Orthostatic tremor : an association with essential tremor
003865 M. J. Steiger ; N. P. Quinn ; B. Toone ; C. D. MarsdenOff-period screaming accompanying motor fluctuations in Parkinson's disease
003866 W. R. G. Gibb ; T. Scott ; Andrew Lees (neurologue) [Royaume-Uni]Neuronal inclusions of Parkinson's disease
003868 G. Abbruzzese ; M. Tabaton ; M. Morena ; D. Dall'Agata ; E. FavaleMotor and sensory evoked potentials in progressive supranuclear palsy
003869 I. J. Mitchell ; J. M. Brotchie ; G. D. A. Brown ; A. R. CrossmanModeling the functional organization of the basal ganglia : a parallel distributed processing approach
003872 A. Lagueny ; P. Caix ; P. Schuermans ; J. JulienJaw dystonia triggered by biting into hard food
003873 D. E. Robertson-Hoffman ; M. H. Mark ; J. I. SageIsolated lingual/palatal dystonia
003874 J. Grafman ; L. G. Cohen ; M. HallettIs focal hand dystonia associated with psychopathology?
003876 N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. MarsdenIntrafamilial correlation in idiopathic torsion dystonia
003877 G. Geminiani [Italie] ; B. M. Cesana ; F. Tamma ; P. Contri ; C. Pacchetti ; F. Carella ; R. Piolti ; E. Martignoni ; P. Giovannini ; F. Girotti ; T. CaraceniInterobserver reliability between neurologists in training of Parkinson's disease rating scales : A multicenter study
003879 J. Elble [États-Unis]Inhibition of forearm EMG by palatal myoclonus
003880 J. Chan ; M. F. Brin ; S. FahnIdiopathic cervical dystonia : clinical characteristics
003881 A. J. Hughes [Royaume-Uni] ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni]Idiopathic Parkinson's disease combined with multiple system atrophy : A clinicopathological report
003882 J. Vaamonde ; J. Artieda ; J. A. ObesoHereditary paroxysmal ataxia with neuromyotonia
003883 S. Fahn ; O. SjaastadHereditary essential myoclonus in a large Norwegian family
003884 M. B. SternHead trauma as a risk factor for Parkinson's disease
003885 L. L. Edwards ; R. F. Pfeiffer ; E. M. M. Quigley ; R. Hofman ; M. BalluffGastrointestinal symptoms in Parkinson's disease
003886 C. F. Tolge ; S. A. FactorFocal dystonia secondary to cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome
003887 M. Hallett [États-Unis]Extending the concept of ballistic movement orverflow myoclonus
003888 K. R. Nair ; R. Bhaskaran ; C. D. MarsdenEssential tremor associated with paroxysmal kinesigenic dystonia
003889 M. B. SternElectroconvulsive therapy in untreated Parkinson's disease
003890 R. Faber [États-Unis] ; M. R. TrimbleElectroconvulsive therapy in Parkinson's disease and other movement disorders
003891 P. Giovannini ; I. Piccolo ; S. Genitrini ; P. Soliveri ; F. Girotti ; G. Geminiani ; G. Scigliano ; T. CaraceniEarly-onset Parkinson's disease
003893 M. J. Merello ; M. A. Nogues ; R. C. Leiguarda ; C. Lopez SaubidetDystonia and reflex sympathetic dystrophy induced by ergotamine
003894 J. K. Krauss [Allemagne] ; M. Mohadjer ; A. K. Wakhloo ; F. MundingerDystonia and akinesia due to pallidoputaminal lesions after disulfiram intoxication
003895 U. Bonuccelli ; A. Nocchiero ; A. Napolitano ; A. M. Paoletti ; G. B. Melis ; G. U. Corsini ; A. MuratorioDomperidone-induced acute dystonia and polycystic ovary syndrome
003896 F. X. Tison ; X. Ferrer ; J. JulienDelayed onset movement disorders as a complication of central pontine myelinolylis
003897 K. D. Sethi ; D. C. HessCreutzfeldt-Jakob's disease presenting with ataxia and a movement disorder
003898 S. M. Papa ; J. Artieda ; J. A. ObesoCortical activity preceding self-initiated and externally triggered voluntary movement
003900 A. Rapoport ; H. Braun ; A. Aviv ; I. SarovaCombined resting-postural tremor of the head with a changing axis
003901 V. E. Drory ; M. Y. Neufeld ; A. D. KorczynCarpal tunnel syndrome : a complication of idiopathic torsion dystonia
003904 S. T. Gancher ; J. G. Nutt ; W. R. WoodwardAbsorption of apomorphine by various routes in parkinsonism
003905 B.-U. Meyer [Allemagne] ; T. C. Britton ; C. Bischoff ; J. Machetanz ; R. Benecke ; B. ConradAbnormal conduction in corticospinal pathways in Wilson's disease : investigation of nine cases with magnetic brain stimulation
003906 P. Brown ; P. D. Thompson ; J. C. Rothwell ; B. L. Day ; C. D. MarsdenA therapeutic trial of milacemide in myoclonus and the Stiff-Person syndrome
003907 M. Hallett ; J. Ravits ; R. M. Dubinsky ; M. M. Gillespie ; AMIR MOINFARA double-blind trial of isoniazid for essential tremor and other action tremors
003908 D. M. Maraganore ; A. E. Harding ; C. D. MarsdenA clinical and genetic study of familial Parkinson's disease
003909 N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. MarsdenA case-control study of idiopathic torsion dystonia
003910 P. Brown ; P. D. Thompson ; J. C. Rothwell ; B. L. Day ; C. D. MarsdenA case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus
003911 First international congress of movement disorders: abstracts, Washington DC, April 25-27, 1990
003912 A. J. Lewis ; M. J. Gaweldiffuse lewy body disease with dementia and oculomotor dysfunction
003913 J. Rivest ; N. Quinn ; J. Gibbs ; C. D. MarsdenUnilateral abolition of extrapyramidal rigidity after ipsilateral cerebellar infarction
003914 C. J. Hunker ; J. H. AbbsUniform frequency of Parkinsonian resting tremor in the lips, jaw, tongue, and index finger
003915 W. G. Johnson ; S. E. Hodge ; R. DuvoisinTwin studies and the genetics of Parkinson's disease ― a reappraisal
003916 J. Rivest ; C. D. MarsdenTrunk and head tremor as isolated manifestations of dystonia
003917 D. Eidelberg ; J. R. Moeller ; V. Dhawan ; J. J. Sidtis ; J. Z. Ginos ; S. C. Strother ; J. Cedarbaum ; P. Greene ; S. Fahn ; D. A. RottenbergThe metabolic anatomy of Parkinson's disease : complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies
003918 R. Silvestri ; P. De Domenico ; A. E. Di Rosa ; P. Bramanti ; S. Serra ; R. Di PerriThe effect of nocturnal physiological sleep on various movement disorders
003919 A. Achiron ; E. MelamedTardive eating dystonia
003920 J. M. Cedarbaum ; M. Clark ; L. H. Toy ; A. Green-ParsonsSustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease : evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulation
003921 L. G. Miller ; Joseph Jankovic [États-Unis]Sulpiride-induced tardive dystonia
003924 B. S. Koppel ; M. DarasRubral tremor due to midbrain toxoplasma abscess
003926 R. Ranawaya ; D. Riley ; A. LangPsychogenic dyskinesias in patients with organic movement disorders
003927 R. J. Elble ; C. Moody ; C. HigginsPrimary writing tremor: a form of focal dystonia?
003929 U. K. Rinne ; A. Laihinen ; J. O. Rinne ; K. Nagren ; J. Bergman ; U. RuotsalainenPositron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease
003931 A. Camac ; P. Greene ; A. KhandjiParoxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct
003932 M. Shandling ; P. L. Carlen ; A. E. LangParkinsonism in alcohol withdrawal: a follow-up study
003933 B. V. ManyamParalysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise
003934 R. Kurlan ; J. Kersun ; H. T. Jr Ballantine ; E. D. CaineNeurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome
003936 M. E. Rodriguez ; M. R. Luquin ; G. Lera ; G. Delgado ; J. M. Salazar ; J. A. ObesoNeuroleptic malignant syndrome treated with subcutaneous lisuride infusion
003938 D. Truong ; A. E. Harding ; F. Scaravilli ; S. J. M. Smith ; J. A. Morgan-Hughes ; C. D. MarsdenMovement disorders in mitochondrial myopathies: a study of nine cases with two autopsy studies
003939 M. A. Menza ; J. Sage ; E. Marshall ; R. Cody ; R. DuvoisinMood changes and on-off phenomena in Parkinson's disease
003940 A. H. V. Schapira ; I. J. Holt ; M. Sweeney ; A. E. Harding ; P. Jenner ; C. D. MarsdenMitochondrial DNA analysis in Parkinson's disease
003941 J. N. Sanes ; M. HallettLimb positioning and magnitude of essential tremor and other pathological tremors
003942 A. Berardelli ; M. Inghilleri ; A. Priori ; P. D. Thompson ; S. Fabri ; C. Fieschi ; M. ManfrediInvolvement of corticospinal tract in Wilson's disease : a study of three cases with transcranial stimulation
003944 G. Abbruzzese ; D. Dall'Agata ; M. Morena ; L. Spadavecchia ; S. Ratto ; E. FavaleImpaired habituation of long-latency stretch reflexes of the wrist muscles in Huntington's disease
003945 K. Hawker ; A. E. LangHypoxic-ischemic damage of the basal ganglia : case reports and a review of the literature
003946 J. B. Jr Penney ; A. B. Young ; I. Shoulson ; S. Starosta-Rubenstein ; S. R. Snodgrass ; J. Sanchez-Ramos ; M. Ramos-Arroyo ; F. Gomez ; G. Penchaszadeh ; J. Alvir ; J. Esteves ; I. Dequiroz ; N. Marsol ; H. Moreno ; P. M. Conneally ; E. Bonilla ; N. S. WexlerHuntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals
003948 L. W. SvensonGeographic distribution of deaths due to Parkinson's disease in Canada : 1979-1986
003949 J. Artieda ; M. R. Luquin ; J. Vaamonde ; J. Laguna ; J. A. ObesoGeneralized reflex myoclonus in a patient with alcohol-sensitive spontaneous myoclonus and an abnormal gait
003950 K. D. Sethi ; D. C. Hess ; R. C. Harbour ; G. L. HolmesGaze-evoked involuntary movements
003951 L. I. Golbe ; T. M. Farrell ; P. H. DavisFollow-up study of early-life protective and risk factors in Parkinson's disease
003953 M. A. Dietz ; C. G. Goetz ; G. T. StebbinsEvaluation of a modified inverted walking stick as a treatment for Parkinsonian freezing episodes
003954 U. J. Povlsen ; H. PakkenbergEffect of intravenous injection of biperiden and clonazepam in dystonia
003955 J. Vaamonde ; M. R. Luquin ; J. A. ObesoDopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease
003956 P. Montagna ; G. Procaccianti ; A. Lugaresi ; M. Zucconi ; E. LugaresiDiurnal variability in cranial dystonia
003957 G. Iliceto ; P. D. Thompson ; B. L. Day ; J. C. Rothwell ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenDiaphragmatic flutter, the moving umbilicus syndrome and "Belly dancer's" dyskinesia
003958 V. S. Kostic ; N. Covickovic-Sternic ; L. Beslac-Bumbasirevic ; G. Ocic ; D. Pavlovic ; M. NikolicDexamethasone suppression test in patients with Parkinson's disease
003959 R. F. Pfeiffer ; R. D. MccombDentatorubro-pallidoluysian atrophy of the myoclonus epilepsy type with posterior column degeneration
003960 A. Ferbert ; H. B. Rickert ; R. Biniek ; H. BrückmannComplex hyperkinesia during recovery from left temporoparietal cortical infarction
003961 J. H. Friedman ; M. C. LannonClozapine-responsive tremor in Parkinson's disease
003962 R. F. Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. WilsonClozapine for psychosis in Parkinson's disease
003963 V. Hoêmberg ; H. W. LangeCentral motor conduction to hand and leg muscles in Huntington's disease
003964 P. E. Greene ; S. Fahn ; A. E. Lang ; R. L. Watts ; D. Eidelberg ; J. M. PowersCase 1, 1990 : progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb
003965 M. Gatto ; F. Micheli ; M. F. PardalBlepharoclonus and parkinsonism associated with aqueductal stenosis
003966 Werner Poewe [Autriche] ; G. Luef ; B. Kleedorfer ; M. EmreAntiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease
003967 L. HerzbergAn essay on the shaking palsy: reviews and notes on the journals in which they appeared
003968 M. Kyllerman ; L. Forsgren ; G. Sanner ; G. Holmgren ; J. Wahlstroêm ; U. DruggeAlcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation
003969 C. Waters ; H. H. Itabashi ; M. L. J. Apuzzo ; L. P. WeinerAdrenal to caudate transplantation - Postmortem study
003970 K. Marder ; P. Flood ; L. Cote ; R. MayeuxA pilot study of risk factors for dementia in Parkinson's disease
003971 J. B. Winer ; D. R. Fish ; D. Sawyers ; C. D. MarsdenA movement disorder as a presenting feature of recurrent hypoglycaemia
003972 A. R. CrossmanA hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment
003973 M. Sano ; Y. Stern ; K. Marder ; R. MayeuxA controlled trial of piracetam in intellectually impaired patients with Parkinson's disease
003975 M. Bhatt ; E. Wolters ; J. Tsui ; B. J. Snow ; D. B. CalneA case of rabies in North America
003977 W. C. Koller ; N. M. BiaryVolitional control of involuntary movements
003978 F. Andermann ; S. Berkovic ; S. Carpenter ; E. AndermannViewpoints on the Ramsay hunt syndrome. II: The Ramsay Hunt syndrome is no longer a useful diagnostic category
003979 A. E. HardingViewpoints on the Ramsay Hunt syndrome. III: Ramsay Hunt syndrome, Unverricht-Lundborg disease, or what?
003980 C. D. Marsden ; J. A. ObesoViewpoints on the Ramsay Hunt syndrome. I: the Ramsay hunt syndrome is a useful clinical entity
003981 B. Jabbari ; B. Scherokman ; C. H. Gunderson ; M. L. Rosenberg ; J. MillerTreatment of movement disorders with trihexylphenidyl
003983 Fh. McdowellThe use of glutethimide for treatment of essential tremor
003986 R. J. Coleman ; K. W. Lange ; N. P. Quinn ; A. E. Loper ; J. V. Bondi ; M. Hitchens ; S. M. Stahl ; C. D. MarsdenThe antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+ PHNO): preliminary results
003987 R. E. Burke ; UN JUNG KANG ; Joseph Jankovic [États-Unis] ; L. C. Miller ; S. FahnTardive akathisia: an analysis of clinical features and response to open therapeutic trials
003988 M. GrestyStability of the head in pitch (neck flexion-extension): studies in normal subjects and patients with axial rigidity
003989 M. H. Marion ; R. F. Gledhill ; P. D. ThompsonSpasms of amputation stumps: a report of 2 cases
003990 G. T. Plant ; A. G. Kermode ; E. P. G. H. Du Boulay ; W. I. McdonaldSpasmodic torticollis due to a midbrain lesion in a case of multiple sclerosis
003991 U. Andersson ; J.-E. Haggstrom ; E. D. Levin ; U. Bondesson ; M. Valverius ; L. M. GunneReduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia
003992 N. P. Quinn ; P. Luthert ; M. Honavar ; C. D. MarsdenPure akinesia due to Lewy body Parkinson's disease: a case with pathology
003993 W. C. Koller ; G. F. Wong ; A. LangPostraumatic movement disorders: a review
003994 C. H. Adler ; M. B. Stern ; M. L. BrooksParkinsonism secondary to bilateral striatal fungal abscesses
003995 L. I. Golbe ; D. C. Miller ; R. C. DuvoisinParaneoplastic degeneration of the substantia nigra with dystonia and parkinsonism
003997 P. A. Kempster ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Crichton ; J. P. Fkankel ; P. ShorvonOff-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine
003998 F. E. Micheli ; M. M. Fernandez Pardal ; R. Giannaula ; M. Gatto ; I. Casas Parera ; G. Paradiso ; M. Torres ; R. Pikielny ; J. Fernandez PardalMovement disorders and depression due to flunarizine and cinnarizine
003999 P. M. Fitzgerald ; Joseph Jankovic [États-Unis]Lower body Parkinsonism: evidence for vascular etiology
003A01 M. J. M. Dupuis ; P. J. Delwaide ; D. Boucquey ; R. E. GonsetteHomolateral disappearance of essential tremor after cerebellar stroke
003A02 J. R. Sanchez-Ramos ; S. A. Factor ; W. J. Weiner ; J. MarquezHemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosis
003A03 R. M. Dubinsky ; M. Greenberg ; G. Di Chiro ; M. Baker ; M. HallettHemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose
003A04 W. S. Metzer ; J. E. O. Newton ; R. W. Steele ; M. Claybrook ; S. R. Paige ; D. E. Mcmillan ; S. HaysHLA Antigens in drug-induced Parkinsonism
003A05 A. Friedman ; Z. Jamrozik ; J. BojakowskiFamilial hemifacial spasm
003A06 L. I. Golbe ; P. H. Davis ; F. E. LeporeEyelid movement abnormalities in progressive supranuclear palsy
003A07 E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France]Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease
003A08 E. Mohr ; G. Fabbrini ; J. Williams ; J. Schlegel ; C. Cox ; P. Fedio ; T. N. ChaseDopamine and memory function in Parkinson's disease
003A09 Joseph Jankovic [États-Unis] ; K. Schwartz ; C. Vander LindenComparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations
003A10 F. Grandas ; J. Artieda ; J. A. ObesoClinical and CT scan findings in a case of cyanide intoxication
003A11 MOHAMMAD REZA SAMIE ; A. K. AshtonChoresathetosis induced by cyproheptadine
003A13 U. J. Kang ; S. Fahn ; H. Schwarz ; I. Shoulson ; H. Vallejos ; J. GoldmanCase 1, 1989: Juvenile-onset Parkinsonism, dystonia, and pyramidal tract signs
003A14 R. F. Pfeiffer ; L. H. Herrera ; C. S. Glaeske ; R. E. HofmanCQP A01-403 in Parkinson's disease: an open-label pilot study
003A15 M. DeahlBetel nut-induced ectrapyramidal syndrome: an unusual drug interaction
003A16 L. E. Adler ; M. Pecevich ; H. NagamotoBereitschaftspotential in tardive dyskinesia
003A17 R. Stell ; A. M. Bronstein ; G. T. Plant ; A. E. HardingAtaxia telangiectasia: a reappraisal of the ocular motor features and their value in the diagnosis of atypical cases
003A18 J. A. Temlett ; N. P. Quinn ; P. G. Jenner ; C. D. Marsden ; E. Pourcher ; A.-M. Bonnet ; Y. Acid ; R. Markstein ; X. LatasteAntiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease
003A19 M. F. Brin ; A. Blitzer ; S. Fahn ; W. Gould ; R. E. LovelaceAdductor laryngeal dystonia (Spastic dysphonia): treatment with local injections of botulinum toxoin (Botox)
003A20 C. Singer ; J. Sanchez-Ramos ; W. J. WeinerA case of post-traumatic tic disorder
003A22 R. C. Harrington ; A. Wieck ; I. M. Marks ; C. D. MarsdenWriter's cramp: not associated with anxiety
003A23 J. M. WalsheWilson's disease: yesterday, today, and tomorrow
003A25 L. I. Golbe ; J. PaeValidity of a mailed epidemiological questionnaire and physical self-assessment in Parkinson's disease
003A26 S. A. Factor ; J. Sanchez-Ramos ; W. J. WeinerTrauma as an etiology of Parkinsonism: a historical review of the concept
003A27 D. Dung Truong ; S. FahnTherapeutic trial with glycine in myoclonus
003A28 R. Mayeux ; Y. Stern ; M. Sano ; J. B. W. Williams ; L. J. CoteThe relationship of serotonin to depression in Parkinson's disease
003A29 S. Fagioli ; A. Berardelli ; M. Hallett ; N. Accornero ; M. ManfrediThe first agonist and antagonist burst in patients with an upper motor neuron syndrome
003A34 R. L. Albin ; A. B. YoungSomatosensory phenomena in Huntington's disease
003A35 Werner Poewe [Autriche] ; B. Kleedorfer ; J. Willeit ; F. GerstenbrandPrimary CNS lymphoma presenting as a choreic movement disorder followed by segmental dystonia
003A36 W. R. G. Gibb ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. MarsdenPathological report of four patients presenting with cranial dystonias
003A37 S. M. Papa ; O. S. GershanikOrthostatic tremor: an essential tremor variant?
003A38 C. Hausser-Hauw ; E. Roullet ; R. Robert ; R. MarteauOculo-facio-skeletal myorhythmia as a cerebral complication of systemic Whipple's disease
003A41 CHI-CHEN MAO ; S. T. Gancher ; R. M. HerndonMovement disorders in multiple sclerosis
003A42 J. Kulisevsky ; M. J. Marti ; I. Ferrer ; E. TolosaMeige syndrome: neuropathology of a case
003A43 G. Pezzoli ; S. Tesei ; C. Ferrante ; E. Cossutta ; A. Zecchinelli ; G. ScarlatoMadopar HBS in fluctuating Parkinsonian patients: two-year treatment
003A44 F. Viallet ; D. Gambarelli ; B. Alonzo ; R. Sedan ; R. KhalilLong-term follow-up after stereotaxic basal ganglia surgery in Parkinsonism: a neuroanatomical study of a case showing unusual postural disorders
003A45 O. S. Gershanik ; M. R. Luquin ; O. Scipioni ; J. A. ObesoIsoniazid therapy in Parkinson's disease
003A46 D. Riley ; A. E. LangHemiballism in multiple sclerosis
003A48 V. P. Misra ; M. Baraitser ; A. E. HardingGenetic prediction in Huntington's disease: what are the limitations imposed by pedigree structure?
003A49 J. G. Nutt ; M. D. Muenter ; A. AronsonEpidemiology of focal and generalized dystonia in Rochester, Minnesota
003A50 M. Hietanen ; H. TeravainenDementia and treatment with L-dopa in Parkinson's disease
003A51 S. A. Factor ; J. Sanchez-Ramos ; W. J. WeinerDelayed-onset dystonia associated with corticospinal tract dysfunction
003A52 N. A. Fletcher ; R. Stell ; A. E. Harding ; C. D. MarsdenDegenerative cerebellar ataxia and focal dystonia
003A53 J. M. Maloteaux ; E. C. Laterre ; P. M. Laduron ; F. Javoy-Agid ; Yves Agid [France]Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy
003A54 Z. Wszolek ; H. Monsour ; P. Smith ; R. PfeifferCryptococcal meningoencephalitis with Parkinsonian features
003A55 J. P. Ter Bruggen ; C. C. TijssenCrural and axial myoclonic dystonia following meralgia paraesthetica
003A56 R. Agostino ; A. Berardelli ; G. Cruccu ; G. Pauletti ; F. Stocchi ; M. ManfrediCorrelation between facial involuntary movements and abnormalities of blink and corneal reflexes in Huntington's chorea
003A57 E. Lehkuniec ; F. Micheli ; R. De Arbelaiz ; M. Torres ; G. ParadisoConcurrent hypnogenic and reflex paroxysmal dystonia
003A59 R. L. Albin ; M. B. Bromberg ; J. B. Penney ; R. KnappChorea and dystonia: a remote effect of carcinoma
003A60 E. Tolosa ; L. Montserrat ; A. BayesBlink reflex studies in focal dystonias: enhanced excitability of brainstem interneurons in cranial dystonia and spasmodic torticollis
003A61 S. Behrman ; D. F. ScottBlepharoclonus provoked by voluntary eye closure
003A62 P. Greene ; H. Shale ; S. FahnAnalysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs
003A63 R. G. Brown ; C. D. MarsdenAn investigation of the phenomenon of "set" in Parkinson's disease
003A64 R. L. Albin ; A. K. Silverman ; C. N. Ellis ; J. J. Voorhees ; J. W. AlbersA new syndrome of axial muscle rigidity associated with etretinate therapy
003A65 N. Quinn ; P. Critchley ; C. D. MarsdenYoung onset Parkinson's disease
003A66 H. Shale ; S. Fahn ; W. C. Koller ; A. E. LangWhat is it? Case I, 1987: Unusual tremors, bradykinesia, and cerebral lucencies
003A67 I. Landan ; P. A. CullisTorticollis following radiation therapy
003A70 J. T. Little ; Joseph Jankovic [États-Unis]Tardive myoclonus
003A72 M. Guttman ; A. E. Lang ; E. S. Garnett ; C. Nahmias ; G. Firnau ; F. J. Tyndel ; A. S. GordonRegional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea
003A73 F. A. Luque ; J. B. Selhorst ; P. PetruskaParkinsonism induced by high-dose cytosine arabinoside
003A75 M. R. SamieNeuroleptic malignant-like syndrome induced by metoclopramide
003A76 M. F. Brin ; S. Fahn ; C. Moskowitz ; A. Friedman ; H. M. Shale ; P. E. Greene ; A. Blitzer ; T. List ; D. Lange ; R. E. Lovelace ; D. McmahonLocalized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
003A77 M. R. Samie ; M. A. Dannenhoffer ; S. RozekLife-threatening tardive dyskinesia caused by metoclopramide
003A78 J. L. Montastruc ; P. Celsis ; A. Agniel ; J. F. Demonet ; B. Doyon ; M. Puel ; J. P. Marc-Vergnes ; A. RascolLevodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease: lack of correlation with clinical or neuropsychological improvements
003A80 C. Diener ; E. Scholz ; B. Guschlbauer ; J. DichgansIncreased shortening reaction in parkinson's disease reflects a difficulty in modulating long loop reflexes
003A82 R. Kurlan ; J. Behr ; I. ShoulsonHereditary myoclonus and chorea: the spectrum of hereditary nonprogressive hyperkinetic movement disorders
003A83 K. D. Sethi ; F. T. Nichols ; F. YaghmaiGeneralized chorea due to basal ganglia lacunar infarcts
003A84 P. D. Thompson ; C. D. MarsdenGait disorder of subcortical arteriosclerotic encephalopathy: Binswenger's disease
003A85 R. Kurlan ; J. Behr ; L. Medved ; I. ShoulsonFamilial paroxysmal dystonic choreoathetosis: a family study
003A86 N. Biary ; W. C. KollerEssential tongue tremort
003A87 B. Jabbari ; M. Rosenberg ; B. Scherokman ; C. H. Gunderson ; J. W. Mcburney ; W. McclintockEffectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction
003A89 R. Agostino ; A. Berardelli ; G. Cruccu ; F. Stocchi ; M. ManfrediCorneal and blink reflexes in Parkinson's disease with "on-off" fluctuations
003A91 S. M. Schonfeld ; L. I. Golbe ; J. I. Sage ; J. N. Safer ; R. C. DuvoisinComputed tomographic findings in progressive supranuclear palsy: correlation with clinical grade
003A92 A. M. Bonnet ; G. Tell ; P. J. Schechter ; J. Grove ; M. H. Saint-Hilaire ; Y. De Smet ; Yves Agid [France]Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
003A93 G. SternCentral stridor from an ependymoma
003A94 Joseph Jankovic [États-Unis] ; B. M. PattenBlepharospasm and autoimmune diseases
003A95 P. R. Palakurthy ; V. IyerBlepharospasm accompanying hypoxic encephalopathy
003A96 F. Grandas ; N. Quinn ; P. Critchley ; A. Rohan ; C. D. Marsden ; S. M. StahlAntiparkinsonian activity of a single oral dose of PHNO
003A98 M. Nomoto ; P. D. Thompson ; M. P. Sheehy ; N. P. Quinn ; C. D. MarsdenAnticholinergic-induced chorea in the treatment of focal dystonia
003A99 H. Teravainen ; J. HuttunenAdrenergic Beta2-selective blocker in isoprenaline-enhanced essential trmor
003B00 J. H. Friedman ; P. A. HollmannAcetazolamide responsive hereditary paroxysmal ataxia
003B01 L. G. Cohen ; M. Hallett ; L. SudarskyA single family with writer's cramp, essential tremor, and primary writing tremor
003B02 W. J. Weiner ; S. A. Factor ; J. Sanchez-Ramos ; J. BergerA double-blind evaluation of ciladopa in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024